false
0001915328
0001915328
2024-01-02
2024-01-02
0001915328
ISRLU:UnitsEachConsistingOfOneClassOrdinaryShareAndOneRedeemableWarrantMember
2024-01-02
2024-01-02
0001915328
us-gaap:CommonClassAMember
2024-01-02
2024-01-02
0001915328
ISRLU:RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareEachAtExercisePriceOf11.50PerShareMember
2024-01-02
2024-01-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 2, 2024
ISRAEL ACQUISITIONS
CORP
(Exact Name of Registrant as Specified in its Charter)
Cayman Islands |
|
001-41593 |
|
87-3587394 |
(State or other jurisdiction of
incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
12600 Hill Country Blvd, Building R, Suite 275
Bee Cave, Texas |
|
78738 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (800) 508-1531
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
x |
Written communications pursuant to Rule 425 under the Securities Act |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange on
which registered |
Units, each consisting of one Class A ordinary share and one redeemable warrant |
|
ISRLU |
|
The Nasdaq Stock Market LLC |
Class A ordinary shares, par value $0.0001 per share |
|
ISRL |
|
The Nasdaq Stock Market LLC |
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share |
|
ISRLW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry into a Material Definitive Agreement
Business Combination Agreement
On January 2, 2024, Israel Acquisitions Corp, a
Cayman Islands exempted company (the “Company” or “IAC”) and Pomvom Ltd., a company organized under
the laws of the State of Israel (the “Pomvom”) entered into a business combination agreement (the “Agreement”),
pursuant to which, among other things, and subject to the terms and conditions contained therein (i) Pomvom will cause a company organized
under the laws of the State of Israel and wholly owned by a trustee (the “NewPubco”) to be formed, (ii) Pomvom will
cause a Cayman Islands exempted company and wholly owned, direct subsidiary of NewPubco (“Merger Sub”) to be formed,
(iii) Pomvom will cause NewPubco and Merger Sub to become a party to the Agreement by delivering a joinder to the Agreement, (iv) Pomvom
will effect the Share Split, (v) NewPubco, the shareholders of Pomvom and the holders of equity awards of Pomvom will effect the Equity
Exchange, and (vi) Merger Sub will merge with and into IAC, with IAC surviving the merger as a direct wholly owned subsidiary of NewPubCo
(the “Merger”). The collective transactions referenced in (i)-(vi) are hereinafter referred to as the “Transactions”.
The terms of the Agreement, which contain customary representations and warranties, covenants, closing conditions, termination provisions,
and other terms relating to the Merger, are summarized below. Capitalized terms used but not defined herein shall have the meanings ascribed
thereto in the Agreement.
Share Split and Equity Exchange
Prior to the closing of the Transactions (the “Closing”),
Pomvom will effect a share split under which each ordinary share of Pomvom issued and outstanding will be split into a number of ordinary
shares determined by multiplying each such ordinary share of Pomvom by the Split Factor (the “Share Split”).
Under the Agreement, holders of Pomvom equity interests
are expected to receive approximately $125,000,000 (the “Pomvom Equity Value”) in aggregate consideration in the form
of NewPubco Ordinary Shares, equal to the quotient obtained by dividing (a) the Pomvom Equity Value by (b) the fully diluted number of
Pomvom ordinary shares (including ordinary shares issuable upon exercise, vesting and settlement of Pomvom options and Pomvom restricted
stock units).
Immediately after the Share Split, and prior to
the effective time of the Merger, upon the terms and subject to the conditions of the Agreement, NewPubco, the Pomvom’s shareholders
and the holders of Pomvom’s equity awards will effect an equity exchange (the “Equity Exchange”) pursuant to
which, (a) each ordinary share of Pomvom issued and outstanding immediately prior to the Equity Exchange will automatically be exchanged
for a number of NewPubco Ordinary Shares equal to the Company Exchange Ratio, (b) each option of Pomvom that is issued and outstanding
prior to the Equity Exchange Effective Time will automatically be exchanged for an option granted by NewPubco to acquire such number of
NewPubco Ordinary Shares equal to the number of ordinary shares of Pomvom subject to such option, multiplied by the Company Exchange Ratio,
with an exercise price per share equal to the exercise price per share of such option in effect immediately prior to the Equity Exchange
Effective Time, divided by the Company Exchange Ratio, (c) each unit or award pursuant to which the holder is or may become entitled to
acquire one or more ordinary shares of Pomvom (or the cash equivalent thereof) will automatically be exchanged for a restricted stock
unit award granted by NewPubco to receive such number of NewPubco Ordinary Shares equal to the number of ordinary shares of Pomvom subject
thereof immediately prior to the Equity Exchange Effective Time, multiplied by the Company Exchange Ratio, and (d) each dormant share
(menayah redumah) of Pomvom under Israeli Law will not be exchanges and will continue to be a dormant share.
Merger and Merger Consideration
Under the Agreement, at the Merger Effective Time,
(a) each IAC unit will be automatically detached and the holder will be deemed to hold one IAC Class A Share and one IAC Warrant, (b)
each IAC Class B Share will automatically be converted into one IAC Class A Share and each IAC Class B Share will no longer be outstanding
and will be automatically cancelled, (c) each IAC Class A Share issued and outstanding prior the Merger Effective Time will automatically
be cancelled in exchange for the right to receive one NewPubco Ordinary Share for each IAC Class A Share, (d) each IAC Warrant that is
outstanding and unexercised immediately prior to the Merger Effective Time will cease to represent an IAC Warrant in respect of IAC Shares
and will be assumed by NewPubco and automatically converted into a warrant to acquire NewPubco Ordinary Shares, (e) any IAC Share owned
by IAC as treasury shares or by a subsidiary of IAC immediately prior to the Merger Effective Time will be automatically cancelled and
will cease to exist without any conversion or payment therefor, (f) each IAC share subject to redemption rights issued and outstanding
immediately prior to the Merger Effective Time will be automatically cancelled and cease to exist and will thereafter represent only the
right to be paid a pro rata share of the redemption amount in accordance with IAC Articles of Association, (g) each IAC share issued and
outstanding prior to the Merger Effective Time for which any IAC shareholder had validly exercised their dissenters’ rights will
not be exchanged for one NewPubco Ordinary Share and will be automatically cancelled and will thereafter represent only the right to be
paid the fair value of such shares and any other rights granted by the Cayman Companies Law, and (h) each ordinary share of Merger Sub
issued and outstanding immediately prior to the Merger Effective Time will be converted into one ordinary share of the Surviving Company.
Representations and Warranties
The Agreement contains representations and
warranties of the parties thereto that are customary for transactions of this type, including representations and warranties relating
to (a) entity organization, formation and authority, (b) capital structure, (c) authorization to enter into the Agreement, (d) legal compliance
and approvals, (e) financial statements and liabilities, (f) consents and requisite governmental approvals, (g) material contracts, (h)
absence of changes, (i) litigation, (j) compliance with applicable laws, (k) labor matters and employees benefit plans, (l) environmental
matters, (m) intellectual property and privacy, (n) insurance, (o) taxes, (p) real and personal property, and (q) transactions with affiliates,
and with respect to IAC only, (i) public filings, (ii) investment company act and (iii) trust account.
Non-Survival
None of the representations, warranties, covenants,
obligations or other agreements in the Agreement or in any certificate or instrument delivered pursuant to the Agreement, including any
rights arising out of any breach of such representations, warranties, covenants, agreements and other provisions, will survive the Closing
and all such representations, warranties, covenants or other agreements will terminate and expire upon the occurrence of the Closing (and
there will be no liability after the Closing in respect thereof), except for those covenants and agreements contained therein that by
their terms expressly apply in whole or in part after the Closing and then only with respect to any breaches occurring after the Closing.
Conditions to Consummation of the Agreement
Mutual Conditions to Closing
The consummation of the Transactions is conditioned
upon, among other things, (a) receipt of Pomvom’s equityholder approval, (b) the absence of any governmental order, statute, rule
or regulation enjoining or prohibiting the consummation of the Transactions, (c) receipt of IAC’s shareholder approval, (d) receipt
of Israeli Securities Law Approvals, (e) receipt of Section 350 Approval, (f) receipt of the Israeli Tax Ruling and (g) the expiration
or termination of the waiting period under the Hart-Scott-Rodino Act,
IAC’s Conditions to Closing
The obligations of IAC to consummate the Transactions
are conditioned upon, among other things, customary closing conditions, including no Pomvom Material Adverse Effect having occurred.
Pomvom’s Conditions to Closing
The obligations of Pomvom to consummate the
Transactions are also conditioned upon, among other things, customary closing conditions, including, without limitation, (a) Aggregate
Transaction Proceeds being greater than or equal to $20,000,000 (“Minimum Cash Condition”); provided, that this condition
can be waived by Pomvom pursuant to the terms and subject to the conditions set forth in Section 6.3(d) of the Agreement, and (b) no IAC
Material Adverse Effect having occurred.
Termination
The Agreement allows the parties to terminate
the Agreement if specified customary conditions described in the Agreement are not satisfied, subject to certain limited exceptions, and
also if the Transactions have not been consummated by September 30, 2024 (the “Termination Date”); provided, that the
Termination Date will be automatically extended to (a) October 31, 2024 if the Registration Statement is initially filed after February
14, 2024, and (b) December 15, 2024, if the irrevocably committed amount of the Aggregate Transaction Proceeds is more than the Minimum
Cash Condition.
The Agreement also allows the parties to terminate
the Agreement if (a) any Governmental Entity takes action prohibiting the Transactions, (b) if IAC Shareholder Approval is not obtained,
and (c) if Pomvom Equityholder Approval is not obtained.
The Agreement also allows Pomvom to terminate the
Agreement if by June 30, 2024, and based on the status of the PIPE Financing and Equity Financing, the irrevocably committed aggregate
amount of the PIPE Financing plus the Equity Financing is less than $5,000,000; provided, however, that if potential investors have presented
Pomvom with one or more term sheets for aggregate PIPE Financing and Equity Financing on terms that IAC reasonably and in good faith believes
to be “market” equal to or in excess of $5,000,000 prior to June 30, 2024, and Pomvom has, acting reasonably and in good faith,
refused to accept such term sheet(s) (which, for the avoidance of doubt, a reasonable and good faith refusal by Pomvom will specifically
include accepting any such terms sheet(s) that materially and adversely affects the financial position of Pomvom), then Pomvom will not
be entitled to terminate the Agreement under this circumstances.
The Agreement also allows IAC to terminate the
Agreement if IAC has not received (a) by 11:59 p.m. Israel time on the date that is 14 days after the date of the execution of the Agreement,
countersigned copies of Transaction Support Agreements representing at least 30% of the outstanding voting power of Pomvom or (b) by 11:59
p.m. Israel time on the date that is 30 days after the execution of the Agreement, countersigned copies of Transaction Support Agreements
representing at least a majority of the outstanding voting power of Pomvom.
If the Agreement is validly terminated, none
of the parties to the Agreement will have any liability or any further obligation under the Agreement, with the exception of (a) the confidentiality
obligation set forth in Section 5.3(a) and Section 7.2 of the Agreement and (b) the Confidentiality Agreement.
Lastly, IAC and Pomvom, may terminate the
Agreement at any time prior to the Closing in order to enter into a definite agreement with respect to a Superior Proposal in accordance
with the terms of the Agreement. In this event, the terminating party will pay, or cause to be paid, to the other party within 30 days
of such termination a termination fee equal to $10,000,000.
The foregoing description of the Agreement is subject
to and qualified in its entirety by reference to the full text of the Agreement, a copy of which is attached as Exhibit 2.1 hereto, and
the terms of which are incorporated herein by reference.
Certain Related Agreements
Sponsor Support Agreement
Concurrently with the execution of the Agreement,
each of the Sponsor, IAC and Pomvom entered into a Sponsor Support Agreement (the “Sponsor Support Agreement”) whereby
the Sponsor has agreed, among other things, to (a) vote in favor of the Agreement and the Transactions on the terms and subject to the
conditions set forth in the Sponsor Support Agreement and (b) irrevocably forfeit and surrender a number of ordinary shares of NewPubco
equal to (i) the amount of the Transaction Expenses Cap Excess divided by (ii) $10.00, to NewPubco for no consideration. The Sponsor also
agreed that it will not (a) transfer any of the Sponsor Shares or grant any security interest in the Sponsor Shares pursuant to the Agreement
or to another shareholder of IAC, (b) deposit any Sponsor Shares into a voting trust or enter into a voting arrangement that is inconsistent
with the Sponsor Support Agreement or (c) enter into any arrangement with respect to the acquisition or sale of any of the Sponsor Shares.
The Sponsor has also agreed to waive its rights to the treatment of its Sponsor Shares and to not participate in any redemption by tendering
or submitting any IAC equity securities held by the Sponsor for redemption.
The foregoing description of the Sponsor Support
Agreement is subject to and qualified in its entirety by reference to the full text of the Sponsor Support Agreement, a copy of which
is attached as Exhibit 10.1 hereto, and the terms of which are incorporated herein by reference.
Transaction Support Agreement
Concurrently with the execution of the Agreement,
certain Pomvom shareholders entered into Transaction Support Agreements, pursuant to which, among other things, each of such Pomvom shareholders,
separately and independently, has agreed to vote in favor of the approval of the proposals at the applicable Pomvom equityholders’
meetings.
The foregoing description
of the Transaction Support Agreement is subject to and qualified in its entirety by reference to the full text of the Transaction Support
Agreement, a copy of which is attached as Exhibit 10.2 hereto, and the terms of which are incorporated herein by reference.
Registration Rights and Lock-Up Agreement
At the Closing, NewPubco, IAC, specified Pomvom
shareholders and the Sponsor will enter into a Registration Rights and Lock-Up Agreement, (the “Registration Rights Agreement”)
pursuant to which, among other things, the parties thereto will be granted customary demand and piggyback registration rights with respect
to Class A ordinary shares issued by NewPubco at Closing and will have agreed to customary lock-up restrictions for a period of one year
following the Closing with such shares being released from lock-up in twelve monthly increments following such one year period, subject
to earlier release if specified share price hurdles are achieved.
The foregoing description of the Registration Rights
Agreement is subject to and qualified in its entirety by reference to the full text of the form of Registration Rights Agreement, a copy
of which is included as Exhibit 10.3 hereto, and the terms of which are incorporated herein by reference.
Subscription Agreements and PIPE Investment
Prior to the earlier of Closing and the termination
of the Agreement, IAC, NewPubCo and Pomvom will use their commercially reasonable efforts to obtain PIPE Financing by executing PIPE Subscription
Agreements with investors and consummate the purchases contemplated by the PIPE Subscription Agreements.
The closing of the sale of the PIPE Shares
pursuant to the PIPE Subscription Agreements will take place substantially concurrently with the Closing and will be subject to customary
closing conditions. The purpose of the PIPE Investment is to raise additional capital for use by the post-combination company following
the Closing.
The
foregoing description of the PIPE Subscription Agreements is subject to and qualified in its entirety by reference to the full
text of the form of PIPE Subscription Agreement, a copy of which is included as Exhibit 10.4 hereto, and the terms of which are incorporated
herein by reference.
Item 3.02. |
Unregistered Sales of Equity Securities. |
The disclosure set forth in Item 1.01 of this
Current Report on Form 8-K is incorporated by reference herein. The securities of NewPubco that may be issued in connection with the Subscription
Agreements will not be registered under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on
the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.
Item 7.01. |
Regulation FD Disclosure. |
On January 2, 2024, IAC and Pomvom issued
a joint press release announcing the execution of the Agreement, a copy of which is attached as Exhibit 99.1 to this Current Report on
Form 8-K.
The
information in this Item 7.01 of this Current Report on Form 8-K is being “furnished” and shall not be deemed “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), and shall not be incorporated
or deemed to be incorporated by reference into any filing by the Company under the Securities Act of 1933 or the Exchange Act, regardless
of any general incorporation language contained in such filing, unless otherwise expressly stated in such filing.
Forward Looking Statements
This Current Report on
Form 8-K includes forward-looking statements within the meaning of the “safe harbor” provisions Private Securities Litigation
Reform Act of 1995, as amended, including, without limitation, implied and express statements regarding the timing and effects of the
consummation of the Merger and the achievement of certain milestones. All statements, other than statements of historical fact included
in this Current Report on Form 8-K, regarding our strategy, future operations, financial position, estimated revenues, projections, prospects,
plans and objectives of management are forward-looking statements. These forward-looking statements generally are identified by the words
“may,” “might,” “will,” “could,” “would,” “should,” “expect,”
“plan,” “anticipate,” “intend,” “believe,” “estimate,” “seek,”
“predict,” “future,” “project,” “potential,” “ continue,” “shall,”
“will,” and similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking
statements are predictions, projections and other statements about future events that are based on current expectations and assumptions
and, as a result, are subject to risks and uncertainties. Forward-looking statements do not guarantee future performance and involve known
and unknown risks, uncertainties and other factors. Many factors could cause actual future events to differ materially from the forward-looking
statements in this Current Report on Form 8-K, including factors which are beyond the Company’s control.
Such factors include risks
and uncertainties specific to this transaction, including, but not limited to, adverse effects on the market price of the IAC ordinary
shares and on the Company’s results because of any failure to complete the Transactions (including, due to failure to satisfy the
conditions to the closing of the Transactions); uncertainties as to the timing of the consummation of the Transactions; potential litigation
relating to the Transactions; other economic, business, competitive and/or regulatory factors affecting the proposed Transactions; and
other factors discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K filed on April 17, 2023 and
Quarterly Reports on Form 10-Q filed on November 13, 2023 for the quarter ended September 30, 2023, which are on file with the SEC, and
in Company’s subsequent SEC filings. These filings identify and address important risks and uncertainties that could cause actual
events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only
as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no
obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events,
or otherwise. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual
results may vary in material respects from those projected in these forward-looking statements. The Company will not and does not undertake
any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise,
except as may be required under applicable securities laws.
Additional Information and Where to Find It
/ Non-Solicitation
In connection with the proposed transaction, the
Company intends to file a registration statement, which will include a preliminary proxy statement/prospectus with the SEC. The proxy
statement/prospectus will be sent to the stockholders of the Company. The Company and Pomvom also will file other documents regarding
the proposed transaction with the SEC. Before making any voting decision, investors and security holders of the Company are urged
to read the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with the
proposed transaction as they become available because they will contain important information about the proposed transaction. Investors
and security holders will be able to obtain free copies of the proxy statement/prospectus and all other relevant documents filed or that
will be filed with the SEC by the Company and Pomvom through the website maintained by the SEC at www.sec.gov. The documents filed by
the Company with the SEC also may be obtained free of charge at the Company’s website at https://israelacquisitionscorp.com/ or
upon written request to the Company, 12600 Hill Country Blvd, Building R, Suite 275, Bee Cave, Texas, 78738.
Participants in the Solicitation
IAC and its directors and executive officers
may be deemed to be participants in the solicitation of proxies from the shareholders of IAC in connection with the Business Combination.
Pomvom, NewPubco and their respective officers and directors may also be deemed participants in such solicitation. Information about the
directors and executive officers of IAC is set forth in IAC’s Annual Report on Form 10-K, which was filed with the SEC on April
17, 2023. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests,
by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the
SEC when they become available.
No Offer or Solicitation
This Current Report on Form 8-K shall not constitute
a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination. This Current
Report on Form 8-K shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation
of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall
be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or an exemption therefrom.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
* Certain
exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K, Item 601(a)(5). IAC agrees to furnish supplementally
a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon its request.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
ISRAEL ACQUISITIONS CORP |
|
|
|
|
By: |
/s/ Ziv Elul |
|
|
Name: Ziv Elul |
|
|
Title: Chief Executive Officer and Director |
|
Dated: January 2, 2024
Exhibit 2.1
Certain
exhibits and schedules to this Exhibit
marked
with “[***]” have been omitted
in
accordance with Regulation S-K, Item 601(a)(5).
BUSINESS
COMBINATION AGREEMENT
BY
AND BETWEEN
ISRAEL
ACQUISITIONS CORP,
AND
POMVOM
LTD.
DATED
AS OF JANUARY 2, 2024
TABLE
OF CONTENTS
|
Page |
|
|
Article I. CERTAIN DEFINITIONS |
3 |
|
|
|
Section 1.1 |
Definitions |
3 |
|
|
|
Article II. SHARE SPLIT; EQUITY EXCHANGE;
MERGER |
27 |
|
|
|
Section 2.1 |
Share Split. |
27 |
|
|
|
Section 2.2 |
Equity Exchange. |
27 |
|
|
|
Section 2.3 |
The Merger |
29 |
|
|
|
Section 2.4 |
Organizational Documents |
30 |
|
|
|
Section 2.5 |
Directors and Officers of the Surviving Company |
30 |
|
|
|
Section 2.6 |
Effect of the Merger on Securities of SPAC and Merger
Sub |
31 |
|
|
|
Section 2.7 |
Allocation Schedule |
33 |
|
|
|
Section 2.8 |
Closing of the Transactions Contemplated by this Agreement |
34 |
|
|
|
Section 2.9 |
Exchange of Shares and Certificates |
34 |
|
|
|
Section 2.10 |
Withholding |
36 |
|
|
|
Section 2.11 |
Adjustments |
38 |
|
|
|
Article III. REPRESENTATIONS AND WARRANTIES
RELATING TO THE GROUP COMPANIES |
39 |
|
|
|
Section 3.1 |
Organization and Qualification |
39 |
|
|
|
Section 3.2 |
Capitalization of the Group Companies |
40 |
|
|
|
Section 3.3 |
Authority |
41 |
|
|
|
Section 3.4 |
Financial Statements; Undisclosed Liabilities; Company
Reporting Reports |
42 |
|
|
|
Section 3.5 |
Consents and Requisite Governmental Approvals; No Violations |
43 |
|
|
|
Section 3.6 |
Permits |
44 |
|
|
|
Section 3.7 |
Material Contracts; No Defaults |
44 |
Section 3.8 |
Absence of Changes |
47 |
|
|
|
Section 3.9 |
Litigation |
47 |
|
|
|
Section 3.10 |
Compliance with Applicable Law |
47 |
|
|
|
Section 3.11 |
Employee Benefit Plans |
48 |
|
|
|
Section 3.12 |
Environmental Matters |
50 |
|
|
|
Section 3.13 |
Intellectual Property. |
51 |
|
|
|
Section 3.14 |
Privacy |
56 |
|
|
|
Section 3.15 |
Labor Matters; Independent Contractors |
57 |
|
|
|
Section 3.16 |
Insurance |
58 |
|
|
|
Section 3.17 |
Tax Matters |
59 |
|
|
|
Section 3.18 |
Brokers |
61 |
|
|
|
Section 3.19 |
Real and Personal Property |
61 |
|
|
|
Section 3.20 |
Transactions with Affiliates |
62 |
|
|
|
Section 3.21 |
Compliance with International Trade & Anti-Corruption
Laws |
63 |
|
|
|
Section 3.22 |
Customers and Suppliers |
64 |
|
|
|
Section 3.23 |
Information Supplied |
64 |
|
|
|
Section 3.24 |
Governmental Grants |
64 |
|
|
|
Section 3.25 |
HSR Act |
65 |
|
|
|
Section 3.26 |
Investigation; No Other Representations |
65 |
|
|
|
Section 3.27 |
EXCLUSIVITY OF REPRESENTATIONS AND WARRANTIES |
65 |
|
|
|
Article IV. REPRESENTATIONS AND WARRANTIES
RELATING TO SPAC |
66 |
|
|
|
Section 4.1 |
Organization and Qualification |
66 |
|
|
|
Section 4.2 |
Authority |
67 |
|
|
|
Section 4.3 |
Consents and Requisite Governmental Approvals; No Violations |
67 |
|
|
|
Section 4.4 |
Brokers |
68 |
Section 4.5 |
Information Supplied |
68 |
|
|
|
Section 4.6 |
Capitalization of SPAC |
69 |
|
|
|
Section 4.7 |
SEC Filings |
70 |
|
|
|
Section 4.8 |
Trust Account |
70 |
|
|
|
Section 4.9 |
Indebtedness |
71 |
|
|
|
Section 4.10 |
Transactions with Affiliates |
71 |
|
|
|
Section 4.11 |
Litigation |
71 |
|
|
|
Section 4.12 |
Compliance with Applicable Law |
71 |
|
|
|
Section 4.13 |
Business Activities |
71 |
|
|
|
Section 4.14 |
Internal Controls; Listing; Financial Statements |
72 |
|
|
|
Section 4.15 |
No Undisclosed Liabilities |
73 |
|
|
|
Section 4.16 |
Tax Matters |
74 |
|
|
|
Section 4.17 |
Absence of Changes |
75 |
|
|
|
Section 4.18 |
Material Contracts; No Defaults. |
75 |
|
|
|
Section 4.19 |
Investment Company Act |
76 |
|
|
|
Section 4.20 |
Compliance with International Trade & Anti-Corruption
Laws |
76 |
|
|
|
Section 4.21 |
Investigation; No Other Representations |
77 |
|
|
|
Section 4.22 |
EXCLUSIVITY OF REPRESENTATIONS AND WARRANTIES |
77 |
|
|
|
Article V. COVENANTS |
78 |
|
|
|
Section 5.1 |
Conduct of Business of the Company |
78 |
|
|
|
Section 5.2 |
Efforts to Consummate; Transaction Litigation; Incorporation
of NewPubco and Merger Sub |
81 |
|
|
|
Section 5.3 |
Confidentiality and Access to Information |
83 |
|
|
|
Section 5.4 |
Public Announcements |
84 |
|
|
|
Section 5.5 |
Tax Matters; Tax Rulings |
85 |
|
|
|
Section 5.6 |
No Solicitation |
89 |
Section 5.7 |
Preparation of Registration Statement
/ Proxy Statement |
95 |
|
|
|
Section 5.8 |
SPAC Shareholder Approval |
96 |
|
|
|
Section 5.9 |
Conduct of Business of SPAC |
97 |
|
|
|
Section 5.10 |
Nasdaq Listing; SPAC Delisting |
100 |
|
|
|
Section 5.11 |
Trust Account |
100 |
|
|
|
Section 5.12 |
Israeli Securities Law Approvals and TASE Delisting;
Section 350 Proceeding; Company Equityholder Approval |
100 |
|
|
|
Section 5.13 |
Indemnification; Directors’ and Officers’
Insurance |
101 |
|
|
|
Section 5.14 |
Post-Closing Directors and Officers |
102 |
|
|
|
Section 5.15 |
PCAOB Financials |
103 |
|
|
|
Section 5.16 |
Post-Closing NewPubco Incentive Equity Plan |
103 |
|
|
|
Section 5.17 |
Post-Closing Employee Stock Purchase Plan |
104 |
|
|
|
Section 5.18 |
PIPE Investment |
104 |
|
|
|
Section 5.19 |
Company Permitted Interim Financing |
105 |
|
|
|
Section 5.20 |
Post-Closing Officer and Director Remuneration |
105 |
|
|
|
Section 5.21 |
Transaction Support Agreements |
105 |
|
|
|
Section 5.22 |
Further Assurances |
105 |
|
|
|
Article VI. CONDITIONS TO CONSUMMATION
OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT |
106 |
|
|
|
Section 6.1 |
Conditions to the Obligations of the Parties |
106 |
|
|
|
Section 6.2 |
Other Conditions to the Obligations of SPAC |
107 |
|
|
|
Section 6.3 |
Other Conditions to the Obligations of the Company |
107 |
|
|
|
Section 6.4 |
Frustration of Closing Conditions |
108 |
|
|
|
Article VII. TERMINATION |
109 |
|
|
|
Section 7.1 |
Termination |
109 |
|
|
|
Section 7.2 |
Effect of Termination |
111 |
Section 7.3 |
Termination Fee |
111 |
|
|
|
Article VIII. MISCELLANEOUS |
112 |
|
|
|
Section 8.1 |
Non-Survival |
112 |
|
|
|
Section 8.2 |
Entire Agreement; Assignment |
112 |
|
|
|
Section 8.3 |
Amendment |
113 |
|
|
|
Section 8.4 |
Notices |
113 |
|
|
|
Section 8.5 |
Governing Law |
114 |
|
|
|
Section 8.6 |
Fees and Expenses |
114 |
|
|
|
Section 8.7 |
Construction; Interpretation |
115 |
|
|
|
Section 8.8 |
Exhibits and Schedules |
116 |
|
|
|
Section 8.9 |
Parties in Interest |
116 |
|
|
|
Section 8.10 |
Severability |
116 |
|
|
|
Section 8.11 |
Counterparts; Electronic Signatures |
117 |
|
|
|
Section 8.12 |
No Recourse |
117 |
|
|
|
Section 8.13 |
Extension; Waiver |
117 |
|
|
|
Section 8.14 |
Waiver of Jury Trial |
118 |
|
|
|
Section 8.15 |
Submission to Jurisdiction |
118 |
|
|
|
Section 8.16 |
Remedies |
119 |
|
|
|
Section 8.17 |
Arm’s Length Bargaining; No Presumption Against
Drafter |
119 |
|
|
|
Section 8.18 |
Trust Account Waiver |
119 |
|
|
|
EXHIBITS |
|
|
|
|
|
Exhibit A |
Form of Sponsor Support Agreement |
|
|
|
|
Exhibit B |
Form of Transaction Support Agreement |
|
|
|
|
Exhibit C |
Form of Registration Rights and Lock-Up Agreement |
|
BUSINESS
COMBINATION AGREEMENT
This
BUSINESS COMBINATION AGREEMENT (this “Agreement”), dated as of January 2, 2024, is entered into by and between
Israel Acquisitions Corp, a Cayman Islands exempted company (“SPAC”) and Pomvom Ltd., a company organized under the
laws of the State of Israel (the “Company”) whose shares are listed for trading on the TASE. SPAC and the Company
shall each be referred to herein from time to time as a “Party” and collectively as the “Parties.”
Each capitalized term used but not otherwise defined herein has the meaning set forth in Section 1.1.
WHEREAS,
SPAC is a blank check company established for the purpose of effecting a merger, capital share exchange, asset acquisition, stock purchase,
reorganization or other similar Business Combination involving SPAC and one or more businesses or entities;
WHEREAS,
after the date of this Agreement and prior to the Closing Date, the Company shall cause a company organized under the laws of the State
of Israel and wholly owned by a trustee (“NewPubco”) to be formed, and to execute a joinder to this Agreement pursuant
to Section 5.2(e);
WHEREAS,
after the date of this Agreement and prior to the Closing Date, the Company shall cause a Cayman Islands exempted company and wholly
owned, direct Subsidiary of NewPubco (“Merger Sub”) to be formed, and to execute a joinder to this Agreement pursuant
to Section 5.2(e);
WHEREAS,
NewPubco and Merger Sub shall be formed solely for the purposes of consummating the transactions contemplated by this Agreement and the
Ancillary Documents (the “Transactions”);
WHEREAS,
upon the terms and subject to the conditions of this Agreement, promptly following the execution of this Agreement the Company shall
(a) file an application with the ISA for the Israeli Securities Law Approvals, (b) file an application with the TASE for the
delisting of the Company Ordinary Shares effective as of the Closing, and (c) file a motion with the appropriate court in Israel
in accordance with Section 350 of the Israeli Companies Law, requesting that the court (i) convene meetings of the holders
of the Company Ordinary Shares, the Company Options and the Company RSUs to vote on the Company Equityholder Proposals, and (ii) grant
the Section 350 Approvals;
WHEREAS,
prior to the Equity Exchange, the Company shall effect the Share Split in accordance with Section 2.1;
WHEREAS,
upon the terms and subject to the conditions of this Agreement (including receipt of the Israeli Securities Law Approvals, the Section 350
Approval and the SPAC Shareholder Approval), NewPubco and the holders of the Company Ordinary Shares, the Company Options and the Company
RSUs shall effect the Equity Exchange;
WHEREAS,
upon the terms and subject to the conditions of this Agreement, on the Closing Date, in accordance with the Cayman Companies Law, Merger
Sub will merge with and into SPAC (the “Merger”), with SPAC surviving the Merger as a direct wholly owned Subsidiary
of NewPubco;
WHEREAS,
the board of directors of SPAC (the “SPAC Board”) has (a) approved this Agreement, the Ancillary Documents (including
the Plan of Merger) to which SPAC is or will be a party and the Transactions (including the Merger), (b) determined that this Agreement
and the Transactions, including the Merger and Plan of Merger, are advisable and are fair to and in the best interests of SPAC and its
shareholders, and (c) recommended, among other things, approval of this Agreement and the Transactions (including the Merger and
the Plan of Merger) by the holders of SPAC Shares entitled to vote thereon;
WHEREAS,
the board of directors of the Company (the “Company Board”) has (a) (i) approved this Agreement, the Ancillary
Documents to which the Company is or will be a party and the Transactions (including the Share Split and the Equity Exchange), (ii) determined
that this Agreement and the Transactions, including the Equity Exchange, are advisable and are fair to and in the best interests of the
Company and its shareholders, and (iii) recommended that the Company Shareholders and the holders of the Company Options and Company
RSUs approve this Agreement and the Transactions (including the Share Split and the Equity Exchange), and (b) authorized, subject
to the approval of the appropriate court in the Section 350 Proceeding, the calling of the Company Equityholders Meetings (collectively,
the “Company Board Recommendation”);
WHEREAS,
prior to the Closing, NewPubco may enter into subscription agreements, in form to be mutually agreed between SPAC and the Company (as
amended, supplemented or modified from time to time, collectively, the “Subscription Agreements”) with certain investors
(the “Subscribers”), pursuant to which, among other things, (i) each Subscriber shall agree to subscribe for
and purchase on the Closing Date immediately following the Closing, and NewPubco shall agree to issue and sell to each such Subscriber
on the Closing Date immediately following the Closing, the number of NewPubco Ordinary Shares set forth in the applicable Subscription
Agreement in exchange for the purchase price set forth therein (the aggregate purchase price under all Subscription Agreements, collectively,
the “PIPE Financing Amount,” and the equity financing under all Subscription Agreements, collectively, hereinafter
referred to as, the “PIPE Financing”) and (ii) if applicable and unless otherwise consented to by the Company,
each Subscriber shall agree, for the benefit of SPAC, (a) to not exercise its Redemption Rights in respect of the SPAC Shares beneficially
owned by it, or any other shares, capital stock or other equity interests, as applicable, of SPAC, which it holds on the date of the
Subscription Agreements, on the terms and subject to the conditions set forth in the applicable Subscription Agreement;
WHEREAS,
concurrently with the execution of this Agreement, each of the Sponsor, SPAC and the Company are entering into the letter agreement in
substantially the form attached hereto as Exhibit A (the “Sponsor Support Agreement”), pursuant to which,
among other things, the Sponsor has agreed to vote in favor of this Agreement and the Transactions (including the Merger) on the terms
and subject to the conditions set forth in the Sponsor Support Agreement;
WHEREAS,
concurrently with or following the execution of this Agreement, certain Company Shareholders (which shall include all of the directors
concurrently with the execution of this Agreement, collectively, the “Supporting Company Shareholders”), are entering
into transaction support agreements, substantially in the form attached hereto as Exhibit B (collectively, the “Transaction
Support Agreements”), pursuant to which, among other things, each such Supporting Company Shareholder, separately and independently,
has agreed to vote in favor of the approval of the Company Equityholder Proposals at the Company Equityholders Meetings on the terms
and subject to the conditions set forth in the Transaction Support Agreements;
WHEREAS,
pursuant to the Redemption Rights set forth in the SPAC Articles of Association, SPAC is required to provide an opportunity for its Public
Shareholders to have their outstanding SPAC Shares redeemed for the consideration, on the terms and subject to the conditions and limitations
set forth therein and in the Trust Agreement (the “Offer”);
WHEREAS,
at Closing, NewPubco, SPAC, certain Company Shareholders and the Sponsor shall enter into the Registration Rights and Lock-Up Agreement
(the “Registration Rights and Lock-Up Agreement”), substantially in the form set forth on Exhibit C;
WHEREAS,
in connection with the Equity Exchange, subject to receipt of the approval of the holders of the NewPubco Ordinary Shares and the Company
Equityholder Approval, NewPubco intends to adopt the NewPubco A&R Articles of Association to be effective at the Equity Exchange
Effective Time;
WHEREAS,
in connection with the Equity Exchange, the Company intends to adopt the Company A&R Articles of Association to be effective at the
Equity Exchange Effective Time, subject to receipt of approval by the Company’s Shareholders; and
WHEREAS,
for U.S. federal income Tax purposes, it is intended that taken together the Equity Exchange, the Merger, and the PIPE Financing, if
applicable, will qualify as an exchange under Section 351 of the Code (the “Intended U.S. Tax Treatment”).
NOW,
THEREFORE, in consideration of the premises and the mutual promises set forth herein and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:
Article I.
CERTAIN DEFINITIONS
Section 1.1 Definitions.
As used in this Agreement, the following terms have the respective meanings set forth below.
“102
Awards Tax Ruling” has the meaning set forth in Section 5.5(e)(i).
“102
Trustee” means the trustee appointed by the Company from time to time in accordance with the provisions of the Ordinance, and
approved by the ITA, with respect to the Company 102 Options, the Company 102 Restricted Share Units and the Company 102 Shares.
“Additional
Financing” means any commitments or other Contract for the purchase of any debt securities, convertible debt securities or
other Equity Securities of SPAC, NewPubco or the Company, prior to, or upon the Closing, whether funded to SPAC, NewPubco or the Company
or one of their respective Subsidiaries, including, for the avoidance doubt, any Company Permitted Interim Financing.
“Affiliate”
means, with respect to any Person, any other Person who directly or indirectly, through one or more intermediaries, controls, is controlled
by, or is under common control with, such Person. The term “control” means the possession, directly or indirectly, of the
power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities,
by contract or otherwise, and the terms “controlled” and “controlling” have meanings correlative thereto; provided,
that in no event shall any investment fund or portfolio company controlling or under common control with the Sponsor be deemed an Affiliate
of the Company or SPAC.
“Aggregate
Transaction Proceeds” means an amount equal to the sum of (a) the aggregate cash proceeds available prior to the Closing
for release to SPAC (or any designee thereof) from the Trust Account, after giving effect to (i) all of the SPAC Shareholder Redemptions,
(ii) payment of the Company Expenses and SPAC Expenses and (iii) payment of all SPAC Liabilities plus (b) the PIPE
Financing Amount plus (c) the Additional Financing.
“Agreement”
has the meaning set forth in the preamble to this Agreement.
“Ancillary
Documents” means the Sponsor Support Agreement, the Subscription Agreements, the Transaction Support Agreements, the Registration
Rights and Lock-Up Agreement, the Joinder Agreements and each other agreement, document, instrument and/or certificate contemplated by
this Agreement and executed or to be executed in connection with the transactions contemplated hereby.
“Anti-Corruption
Laws” means, collectively, the Foreign Corrupt Practices Act (FCPA), the UK Bribery Act 2010, Sub-chapter 5 of Chapter 9 of
Part B of the Israeli Penal Law, 5737-1977, and any other applicable anti-money laundering, anti-kickback, anti-bribery or anti-corruption
Laws.
“Assumed
Company Options” has the meaning set forth in Section 2.2(a)(ii).
“Assumed
Company RSUs” has the meaning set forth in Section 2.2(a)(iii).
“Benchmark
Analysis” has the meaning set forth in Section 5.20.
“Business
Combination” means a proposed initial merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization
or other similar business combination with one or more businesses or entities.
“Business
Day” means a day, other than a Saturday or Sunday, on which commercial banks in New York, New York are open for the general
transaction of business.
“Cayman
Companies Law” means the Companies Act (as revised) of the Cayman Islands.
“CBA”
means any collective bargaining agreement or other Contract with any labor union, works council, or other labor organization.
“Closing”
has the meaning set forth in Section 2.8.
“Closing
Date” has the meaning set forth in Section 2.8.
“Closing
Filing” has the meaning set forth in Section 5.4(b).
“Closing
Press Release” has the meaning set forth in Section 5.4(b).
“Code”
means the U.S. Internal Revenue Code of 1986, as amended.
“Companies
Registrar” means the Israeli Registrar of Companies.
“Company”
has the meaning set forth in the preamble to this Agreement.
“Company
102 Options” means any Company Options granted under Section 102 of the Ordinance.
“Company
102 Restricted Share Units” means any Company RSUs granted under Section 102 of the Ordinance.
“Company
A&R Articles of Association” means the amended and restated articles of association of the Company to be adopted by the
Company on the Closing Date, in such form as mutually agreed by SPAC and the Company.
“Company
Alternative Acquisition Agreement” has the meaning set forth in Section 5.6(b).
“Company
Allocation Schedule” has the meaning set forth in Section 2.7(c).
“Company
Acquisition Proposal” means any offer, proposal or indication of interest from any Third Party relating to any Company Acquisition
Transaction.
“Company
Acquisition Transaction” means any transaction or series of related transactions (other than the Transactions) involving: (a) any
acquisition by a Third Party, directly or indirectly, of more than 20% of the outstanding Company Ordinary Shares, or any tender offer
(including a self-tender) or exchange offer that, if consummated, would result in any Third Party beneficially owning (as defined under
Section 13(d) of the Exchange Act) more than 20% of the Company Ordinary Shares; or (b) any acquisition by any Third Party,
directly or indirectly, of more than 20% assets (including equity securities of the Company’s Subsidiaries) of the Company (on
a consolidated basis with its Subsidiaries), measured on a fair market value basis, or to which 20% or more of the net revenues or net
income of the Company (on a consolidated basis with its Subsidiaries) are attributable, in the case of each of clause (a) and (b),
whether pursuant to a merger, consolidation, reorganization, recapitalization, liquidation, dissolution, share exchange or other business
combination, sale of shares of capital stock, sale of assets, tender offer, exchange offer or similar transaction involving the Company;
provided that no Company Permitted Interim Financing shall be deemed to constitute a Company Acquisition Proposal.
“Company
Board” has the meaning set forth in the recitals to this Agreement.
“Company
Board Recommendation” has the meaning set forth in the recitals to this Agreement.
“Company
Board Recommendation Change” has the meaning set forth in Section 5.6(f).
“Company
Disclosure Schedules” means the disclosure schedules to this Agreement delivered to SPAC by the Company on the date of this
Agreement.
“Company
Equity Award” means, as of any determination time, each Company Option, Company RSU and each other award to any current or
former director, manager, officer, employee, individual independent contractor or other service provider of any Group Company of rights
of any kind to receive any Equity Security of any Group Company under any Company Equity Plan or otherwise that is outstanding.
“Company
Equity Plan” means the 2022 Share Incentive Plan, as such may have been amended, supplemented or modified from time to time.
“Company
Equity Value” means an amount equal to $125,000,000.
“Company
Equityholder Approval” means the affirmative vote of the Company Shareholders and holders of Company Equity Awards satisfying
the applicable majority, supermajority or other applicable requirements, represented in person or by proxy at the Company Equityholders
Meetings, approving the Company Equityholder Proposals in accordance with the Governing Documents of the Company, the Israeli Companies
Law, the rules and regulations of the TASE, applicable Law and any requirements imposed by the Israeli court in the Section 350
Proceeding.
“Company
Equityholder Proposals” means the proposals for (a) the adoption and approval of this Agreement and Transactions, including
the Equity Exchange and the Merger, (b) contingent upon and simultaneously with the Closing, the delisting of the Company Ordinary
Shares from the TASE and the termination of the Company’s reporting obligations under the Israeli Securities Law, (c) the
adoption and approval of each other proposal reasonably agreed to by the Company and SPAC as necessary or appropriate in connection with
the consummation of the Transactions that would require the approval of the requisite number of Company Ordinary Shares or holders of
Company Options and Company RSUs entitled to vote thereon and (d) the adoption of the Company A&R Articles of Association and
the NewPubco A&R Articles of Association.
“Company
Equityholders Meetings” has the meaning set forth in Section 5.12(b).
“Company
Exchange Consideration” has the meaning set forth in Section 2.2(a)(i).
“Company
Exchange Ratio” means the quotient obtained by dividing (a) the number of NewPubco Ordinary Shares constituting
the Company Exchange Consideration, by (b) the number of shares of Fully-Diluted Company Share Amount.
“Company
Excluded Share” has the meaning set forth in Section 1.1(b).
“Company
Expenses” means, as of any determination time, the aggregate amount of fees, expense, commissions or other amounts incurred
by or on behalf of, or otherwise payable by, whether or not due, any Group Company, NewPubco or Merger Sub in connection with the negotiation,
preparation or execution of this Agreement or any Ancillary Documents, the performance of its covenants or agreements in this Agreement
or any Ancillary Document or the consummation of the Transactions, including (a) the fees and expenses of outside legal counsel,
accountants, advisors, brokers and finders, investment bankers, consultants, or other agents or service providers of any Group Company,
NewPubco or Merger Sub, (b) other fees, expenses, commissions or other amounts that are expressly allocated to Group Company, NewPubco
or Merger Sub pursuant to this Agreement or any Ancillary Document, including (i) fifty percent (50%) of all fees payable to the
SEC for registering the NewPubco Ordinary Shares and NewPubco Warrants on the Registration Statement and (ii) fifty percent (50%)
of all fees payable to the SEC and/or Nasdaq for the application for listing the NewPubco Ordinary Shares and NewPubco Warrants on Nasdaq
(provided, that any fees and expenses of professional advisors incurred by the Company with respect to the registration of the
NewPubco Ordinary Shares and NewPubco Warrants on the Registration Statement and the application for listing the NewPubco Ordinary Shares
and NewPubco Warrants on Nasdaq shall be deemed Company Expenses under clause (a)), (c) fifty percent (50%) of all filing fees to
Governmental Entities in connection with the Transactions, including fifty percent (50%) of all costs, fees and expenses incurred in
connection with filing under the HSR Act and under each foreign antitrust Law and with respect to any other registrations, declarations
and filings required in connection with the execution and delivery of this Agreement, the performance of the obligations hereunder and
the consummation of the Transactions, if applicable, and (d) any other fees, expenses, commissions or other amounts that are expressly
allocated to any Group Company, NewPubco or Merger Sub pursuant to this Agreement or any Ancillary Document; provided, that if
any amounts to be included in the calculation of the Company Expenses which are in a currency other than US dollars, such amounts shall
be deemed converted to US dollars at the prevailing official rate of exchange published by the Federal Reserve Bank of New York for the
conversion of such currency or currency unit into US dollars (except for the conversion of NIS denominated expenses which shall be deemed
converted on the basis of the USD-NIS Representative Rate of Exchange last published) on the fifth (5th) Business Day immediately
preceding the Closing. Notwithstanding the foregoing or anything to the contrary herein, Company Expenses shall not include any SPAC
Expenses.
“Company
Fundamental Representations” means the representations and warranties set forth in Section 3.1(a) and Section 3.1(b) (Organization
and Qualification), Section 3.2(a) (Capitalization of the Group Companies), Section 3.3 (Authority), and
Section 3.18 (Brokers).
“Company
ISA Reports” has the meaning set forth in Section 3.4(d).
“Company
Israeli Tax Rulings” has the meaning set forth in Section 5.5(e)(ii).
“Company
Licensed Intellectual Property” means Intellectual Property Rights owned by any Person (other than a Group Company) that is
licensed to any Group Company.
“Company
Material Adverse Effect” means any change, event, effect or occurrence (an “Effect”) that, individually
or in the aggregate with any other Effect, has had or would reasonably be expected to have a material adverse effect on (a) the
business, results of operations, assets, or financial condition of the Group Companies, taken as a whole or (b) the ability of the
Group Companies to consummate the Transactions on the terms and conditions of this Agreement by the Termination Date; provided,
however, that none of the following shall be deemed to constitute, alone or in combination, or be taken into account in determining
whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur: any adverse Effect arising after the
date of this Agreement from or related to (i) general business or economic conditions in or affecting the United States or Israel,
or changes therein, or the global economy generally, (ii) acts of war, sabotage or terrorism (including cyberterrorism) in the United
States or Israel or any other territories, (iii) changes in conditions of the economic, financial, banking, credit, capital or securities
markets generally, (iv) changes in any applicable Laws or accounting requirements or principles required by IFRS, GAAP or any official
interpretation thereof, (v) any Effect that is generally applicable to the industries or markets in which any Group Company operates,
(vi) the execution or public announcement of this Agreement or the pendency or consummation of the Transactions, including the impact
thereof on the relationships, contractual or otherwise, of any Group Company with employees, customers, investors, contractors, lenders,
suppliers, vendors, partners, licensors, licensees, payors or other third-parties related thereto, (vii) any failure by any Group
Company to meet, or changes to, any internal or published budgets, projections, forecasts, estimates, guidance, milestones, operating
statistics or predictions for any period (it being understood that the underlying facts giving rise or contributing to such failure or
change may be taken into account in determining whether there has been a Company Material Adverse Effect), or (viii) any hurricane,
tornado, flood, earthquake, tsunami, natural disaster, mudslides, wild fires, epidemics, pandemics (including COVID-19 (or any mutation
or variation thereof)) or other outbreaks of diseases or public health events, acts of God or other natural disasters or comparable events,
or any escalation of the foregoing; provided, however, that any Effect resulting from a matter described in any of the
foregoing clauses (i) through (v) or (viii) may be taken into account in determining whether a Company
Material Adverse Effect has occurred or is reasonably likely to occur to the extent such Effect has a disproportionate adverse effect
on the Group Companies, taken as a whole, relative to other participants operating in the industries or markets in which the Group Companies
operate.
“Company
Non-Party Affiliates” means, collectively, each Company Related Party and each former, current or future Affiliates, Representatives,
successors or permitted assigns of any Company Related Party (other than, for the avoidance of doubt, the Company).
“Company
Option” means, as of the Closing, each option to purchase Company Ordinary Shares that is, whether or not exercisable and whether
or not vested, outstanding and unexercised, whether granted under a Company Equity Plan or otherwise.
“Company
Ordinary Shares” means (a) prior to the Share Split ordinary shares of no par value of the Company, and (b) from
and after the Share Split, the ordinary shares of the Company with the par value specified in the Company A&R Articles of Association.
“Company
Owned Intellectual Property” means all Intellectual Property Rights that are owned by any Group Company.
“Company
Parties” means the Company and, from and after their entry into a joinder to this Agreement, NewPubco and Merger Sub.
“Company
Permitted Interim Financing” means any financing arrangement, including any equity and/or debt financing, entered into by the
Company from the date of this Agreement through the Closing Date.
“Company
Products” means all products or services from which any Group Company has, in the past three (3) years preceding the date
hereof, derived or is currently deriving revenue in connection with the sale, license, maintenance or other provision thereof.
“Company
Registered Intellectual Property” means all Registered Intellectual Property owned by any Group Company.
“Company
Related Party” has the meaning set forth in Section 3.20.
“Company
Related Party Transactions” has the meaning set forth in Section 3.20.
“Company
Reporting Documents” means all forms, reports, schedules, statements, exhibits and other documents (including exhibits, financial
statement and schedules thereto and all other information incorporated therein and amendments and supplements thereto) timely filed with
(or furnished to) the ISA or TASE under the ISL or the rules and regulations of the TASE.
“Company
RSU” means, as of the Closing, each unit or award pursuant to which the holder thereof is or may become entitled to acquire
one or more Company Ordinary Share or the cash equivalent thereof (including, without limitation, any performance-based share units),
whether or not vested, that is outstanding immediately prior to the Closing, whether granted under a Company Equity Plan or otherwise.
“Company
Shareholders” means, collectively, the holders of Company Ordinary Shares as of any determination time prior to the Equity
Exchange Effective Time.
“Company
Superior Proposal Notice Period” has the meaning set forth in Section 5.6(f).
“Confidentiality
Agreement” means, that certain Non-Disclosure Agreement, dated as of February 8, 2023, by and between the Company and
SPAC.
“Consent”
means any notice, authorization, qualification, registration, filing, notification, waiver, Order, clearance, consent or approval to
be obtained from, filed with or delivered to, a Governmental Entity or other Person.
“Contract”
or “Contracts” means any agreement, contract, license, franchise, note, bond, mortgage, indenture, guarantee, lease,
obligation, undertaking or other commitment or arrangement (whether oral or written) that is legally binding upon a Person or any of
his, her or its properties or assets, and any amendments thereto.
“Copyrights”
has the meaning set forth in the definition of Intellectual Property Rights.
“COVID-19”
means SARS-CoV-2, coronavirus or COVID-19, and any evolutions thereof or related or associated epidemics, pandemic or disease outbreaks.
“Creator”
has the meaning set forth in Section 3.13(d).
“D&O
Persons” has the meaning set forth in Section 5.13(a).
“Data
Security Requirements” means, collectively, all of the following to the extent relating to Processing or otherwise relating
to data security, or data security breach notification requirements and applicable to the Group Companies, to the conduct of their businesses,
or to any of the IT Assets used for Processing: (a) all applicable Laws, rules and regulations in relation to (i) data
protection, (ii) privacy, and (iii) the confidentiality, collection, use, handling, processing, security, protection or transfer
of Personal Information, namely, California Consumer Privacy Act of 2018, Israeli Protection of Privacy Law, 5741-1981 and all regulations
promulgated thereto, the General Data Protection Regulation (GDPR) (EU) 2016/679) and the Japan Act on the Protection of Personal Information
(APPI), as applicable; and (b) terms of any contracts into which the Group Companies have entered or by which they are otherwise
legally bound relating to the collection, use, storage, disclosure, or cross-border transfer of Personal Information.
“Dissenting
SPAC Share” has the meaning set forth in Section 2.6(f).
“Employee
Benefit Plan” means (a) each “employee benefit plan” (as such term is defined in Section 3(3) of
ERISA, whether or not subject to ERISA), (b) each severance, gratuity, termination indemnity, incentive or bonus, retention, change
in control, deferred compensation, profit sharing, retirement, welfare, post-employment welfare, vacation or paid-time-off, stock purchase,
stock option or equity incentive plan, program, policy, Contract or arrangement and (c) each other equity or equity-based, termination,
severance, transition, employment, individual independent contractor, fringe benefit, or other compensation or benefit plans, agreements,
programs, policies or other arrangements that any Group Company maintains, sponsors, contributes to or is required to contribute to,
or under or with respect to which any Group Company has or could reasonably be expected to have any Liability or obligation to provide
compensation or benefits to or for the benefit of any of its current or former employees, officers, directors or individual independent
contractors, other than any statutory plan, program or arrangement that is required by applicable Law or that is sponsored or maintained
by a Governmental Entity, or as required under applicable Law, CBA and/or any extension order, or, if applicable, under Section 14
Arrangement under the Israeli Severance Pay Law 5723-1963 and the order of the Minister of Labor and Social Affairs as of June 30,
1998.
“Environmental
Condition” means the generation, discharge, emission or release into the environment (including, without limitation, ambient
air, surface water, groundwater or land), of any Hazardous Substances by any person in respect of which remedial action is required under
any Environmental Laws or as to which any liability is currently or in the future imposed upon any person based upon the acts or omissions
of any person with respect to any Hazardous Substances or reporting with respect thereto.
“Environmental
Laws” means all Laws, Orders or binding policy concerning pollution, protection of the environment, natural resources, or human
health or safety (to the extent relating to exposure to Hazardous Substances), including the generation, use, treatment, storage, disposal
or release of any Hazardous Substance.
“Equity
Exchange” has the meaning set forth in Section 2.2(a).
“Equity
Exchange Effective Time” has the meaning set forth in Section 1.1(c).
“Equity
Financing” means any commitments or other Contract (including convertible debt instruments that convert into Equity Securities
prior to or at the Closing) entered into with the Company or the SPAC for the purchase of Equity Securities of SPAC, NewPubco or the
Company, prior to, or upon the Closing, whether funded to SPAC, NewPubco or the Company or one of their respective Subsidiaries.
“Equity
Financing Proceeds” means an amount equal to the sum of (a) the aggregate cash proceeds available prior to the Closing
for release to SPAC (or any designee thereof) from the Trust Account, after giving effect to all of the SPAC Shareholder Redemptions,
plus (b) the PIPE Financing Amount plus (c) the aggregate amount of the Equity Financing; provided, that
any such PIPE Financing and Equity Financing shall exclude any rights offering or issuance to any Company Shareholders not to exceed
an aggregate amount set forth on Schedule 1.1.
“Equity
Securities” means any share, share capital, capital stock, partnership, membership, joint venture or similar interest in any
Person (including any stock appreciation, phantom stock, profit participation or similar rights), and any option, warrant, right or security
(including debt securities) convertible, exchangeable or exercisable for shares, share capital, capital stock, partnership, membership,
joint venture or similar interests prior to or at the Closing.
“ERISA”
means the Employee Retirement Income Security Act of 1974, as amended.
“ERISA
Affiliate” means any entity that together with any member of the Group Companies would be deemed a “single employer”
for purposes of Section 4001(b)(1) of ERISA and/or Sections 414(b), (c) and/or (m) of the Code.
“ESPP”
has the meaning set forth in Section 5.17.
“ETC”
means Equiniti Trust Company, LLC, a New York limited liability trust company.
“Exchange
Act” means the U.S. Securities Exchange Act of 1934, as amended.
“Exchange
Agent” has the meaning set forth in Section 2.9(a).
“Exchange
Fund” has the meaning set forth in Section 2.9(c).
“Federal
Securities Laws” means the Exchange Act, the Securities Act and the other U.S. federal securities laws and the rules and
regulations of the SEC promulgated thereunder or otherwise.
“Financial
Statements” has the meaning set forth in Section 3.4(a).
“Foreign
Benefit Plan” means each Employee Benefit Plan maintained by any of the Group Companies that primarily covers current or former
employees, officers, directors or individual consultants located, or that is subject to the Laws of any jurisdiction, outside of the
United States.
“Fraud”
means common law fraud under New York law.
“Fully-Diluted
Company Share Amount” shall mean, as of immediately prior to the consummation of the Share Split, the total number of (a) issued
and outstanding Company Ordinary Shares plus (b) the total number of Company Ordinary Shares issuable upon exercise, vesting
and/or settlement of all Company Options and Company RSUs (in each case, whether or not vested or currently exercisable). Fully-Diluted
Company Share Amount does not include any Company Ordinary Shares issuable in a PIPE Financing, if any.
“GAAP”
means United States generally accepted accounting principles.
“Governing
Documents” means the legal document(s) by which any Person (other than an individual) establishes its legal existence
or which govern its internal affairs. For example, the “Governing Documents” of a U.S. corporation are its certificate or
articles of incorporation and by-laws, the “Governing Documents” of a U.S. limited partnership are its limited partnership
agreement and certificate of limited partnership, the “Governing Documents” of a U.S. limited liability company are its operating
or limited liability company agreement and certificate of formation, the “Governing Documents” of an Israeli company are
its memorandum of association (if applicable) and articles of association and the “Governing Documents” of an exempted company
incorporated in the Cayman Islands are its certificate of incorporation, memorandum of association and articles of association.
“Governmental
Entity” means any United States, Israeli or other foreign or international (a) federal, state, local, municipal or
other government, (b) governmental or quasi-governmental entity of any nature (including any governmental agency, branch, department,
official, or entity and any court or other tribunal), (c) body exercising or entitled to exercise any administrative, executive,
judicial, legislative, police, regulatory, labor, or taxing authority or power of any nature, including any arbitrator or arbitral tribunal
(public or private) or (d) the Israel Innovation Authority (previously known as the Office of the Chief Scientist at the Israeli
Ministry of Economy), any other body operating under the Israeli Ministry of the Economy or the Israeli Ministry of Finance and/or the
ITA, or the Israeli Ministry of Defense.
“Governmental
Grant” means any grant, incentive, subsidy, award, loan, participation, exemption, status, cost sharing arrangement, reimbursement
arrangement or other benefit, relief or privilege provided or made available by or on behalf of or under the authority of the Israel
Innovation Authority, the Investment Center of the Israeli Ministry of Economy and Industry, the ITA (solely with respect to “
benefitted” or “approved” enterprise status or similar programs), the State of Israel, and any other bi- or multi-national
grant program, framework or foundation (including the BIRD foundation) for research and development, the European Union, the Fund for
Encouragement of Marketing Activities of the Israeli Government or any other Governmental Entity.
“Grants”
has the meaning set forth in Section 3.24.
“Group
Company” and “Group Companies” means, collectively, the Company and its Subsidiaries.
“Hazardous
Substance” means any hazardous, toxic, explosive or radioactive material, substance, waste or other pollutant that is regulated
by, or may give rise to Liability pursuant to, any Environmental Law, or has been defined, designated, regulated or listed by any Governmental
Entity as “hazardous,” “toxic,” a “pollutant,” a “contaminant,” or words of similar import
under any Environmental Law, including any petroleum products or byproducts, asbestos, lead, polychlorinated biphenyls, per- and poly-fluoroakyl
substances, or radon, in each case, to the extent regulated by any Environmental Law, however, notwithstanding the foregoing, shall not
include de minimis or immaterial quantities of the substances enumerated therein.
“HSR
Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated
thereunder.
“IFRS”
means International Financial Reporting Standards.
“IIA”
has the meaning set forth in Section 3.13(o).
“IIA
Funded Technology” has the meaning set forth in Section 3.13(o).
“IIA
Grants” has the meaning set forth in Section 3.13(o).
“Indebtedness”
means, as of any time, without duplication, with respect to any Person, the outstanding principal amount of, accrued and unpaid interest
on, fees, expenses and other payment obligations (including any prepayment penalties, premiums, costs, breakage, termination fees or
other amounts payable upon the discharge thereof) arising under or in respect of (a) indebtedness, whether or not contingent, for
borrowed money or indebtedness issued or incurred in substitution or exchange for indebtedness for borrowed money, (b) other obligations
evidenced by any note, bond, debenture or other debt security, (c) reimbursement and other obligations with respect to letters of
credit, bank guarantees, bankers’ acceptances or other similar instruments, in each case, solely to the extent drawn, and (d) any
of the obligations of any other Person of the type referred to in clauses (a) through (d) above directly or indirectly
guaranteed by such Person or secured by any assets of such Person, whether or not such Indebtedness has been assumed by such Person.
“Intellectual
Property Rights” means all intellectual property and proprietary rights protected, created or arising under the Laws of the
United States or any other jurisdiction or under any international convention, including all (a) patents and patent applications,
industrial designs and design patent rights, including any continuations, divisionals, continuations-in-part and provisional applications
and statutory invention registrations, and any patents issuing on any of the foregoing and any reissues, reexaminations, substitutes,
supplementary protection certificates, extensions of any of the foregoing (collectively, “Patents”); (b) trademarks,
service marks, trade names, service names, brand names, trade dress rights, logos, corporate names and other source or business identifiers,
together with the goodwill associated with any of the foregoing, and all applications, registrations, extensions and renewals of any
of the foregoing (collectively, “Marks”); (c) Internet domain names; (d) copyrights and works of authorship,
and database and design rights, whether or not registered or published, and all registrations, applications, renewals, extensions and
reversions of any of any of the foregoing (collectively, “Copyrights”); (e) trade secrets and other intellectual
property rights in methodologies, know-how and confidential and proprietary information, including invention disclosures, inventions
and formulae, whether patentable or not; and (f) intellectual property rights in or to Software or other technology.
“Intended
U.S. Tax Treatment” has the meaning set forth in the recitals to this Agreement.
“Investment
Company Act” means the Investment Company Act of 1940, as amended.
“IP
Contracts” has the meaning set forth in Section 3.13(c).
“IPO”
has the meaning set forth in Section 8.18.
“IRS”
means the United States Internal Revenue Service.
“ISA”
means the Israel Securities Authority.
“Israeli
Companies Law” or “ICL” means the Israeli Companies Law, 5759-1999, and all the regulations, rules and
orders promulgated thereunder, as amended.
“Israeli
Securities Law” means the Israeli Securities Law, 5728-1968, and all the regulations, rules and orders promulgated thereunder,
as amended.
“Israeli
Securities Law Approvals” means the approval of the ISA and of the appropriate court in Israel, to the extent each is required,
of (a) an exemption under Section 15A of the Israeli Securities Law (to be based on the Registration Statement) from the requirement
to publish an Israeli prospectus with respect to the offering of NewPubco Ordinary Shares in the Equity Exchange, (b) contingent
upon and simultaneously with the Closing, and based on the disclosure obligations of NewPubco under Federal Securities Laws, the termination
of the Company’s reporting obligations under the Israeli Securities Law, and (c) contingent upon and simultaneously with the
Closing, the delisting of the Company Ordinary Shares from the TASE.
“Israeli
Tax Rulings” has the meaning set forth in Section 5.5(e)(iii).
“IT
Assets” means any and all computers, Software, hardware, firmware, middleware, servers, workstations, routers, hubs, switches,
data communications lines, databases, and all other information technology equipment and all associated documentation, in each case,
owned, leased, licensed or under the control of any Group Company and used in connection with, the conduct of the business of any Group
Company as currently conducted.
“ITA”
means the Israel Tax Authority.
“JOBS
Act” means the Jumpstart Our Business Startups Act of 2012.
“Joinder
Agreement” has the meaning set forth in Section 5.2(d).
“knowledge”
or “to the knowledge” or any derivations thereof means the actual knowledge after reasonable investigation, as to
a specified fact or event, of: (a) with respect to the Company, the individuals listed on Section 1.1(a) of the Company
Disclosure Schedules and (b) with respect to SPAC, the individuals listed on Section 1.1(a) of the SPAC Disclosure Schedules.
“Latest
Balance Sheet” has the meaning set forth in Section 3.4(a).
“Law”
means any federal, state, local, foreign (including, for the avoidance of doubt, Israel), national or supranational statute, law
(including common law), act, statute, ordinance, treaty, rule, code, regulation (including, for the avoidance of doubt, of ISA and TASE),
Order, judgment, injunction, ruling, award, decree, writ or other binding directive or guidance issued, promulgated or enforced by a
Governmental Entity having jurisdiction over a given matter.
“Leased
Real Property” has the meaning set forth in Section 3.19(b).
“Letter
of Transmittal” means the letter of transmittal, substantially in the formed agreed to between SPAC and the Company and with
such modifications, amendments or supplements as may be requested by the Exchange Agent and mutually agreed to by each of SPAC and the
Company (in either case, such agreement not to be unreasonably withheld, conditioned or delayed).
“Liability”
or “liability” means any and all debts, liabilities and obligations, whether accrued or fixed, absolute or contingent,
known or unknown, matured or unmatured or determined or determinable, including those arising under any Law, Proceeding or Order and
those arising under any Contract, agreement, arrangement, commitment or undertaking.
“Lien”
means any mortgage, pledge, security interest, encumbrance, lien, license or sub-license, charge, assignment by way of security, hypothecation,
or other similar encumbrance or interest (including, in the case of any Equity Securities, any voting, transfer or similar restrictions).
“Lookback
Date” means January 1, 2021.
“Key
Company Shareholders” shall mean, as of a given date, the officers, directors and holders of 10% of the issued and outstanding
Company Ordinary Shares as of such date.
“Malicious
Code” means any “back door,” “drop dead device,” “time bomb,” “Trojan horse,”
“virus,” “worm,” “spyware” or “adware” (as such terms are commonly understood in the
software industry) or other harmful surreptitious code, including code designed to delete, damage, deactivate, disable, harm or otherwise
impede in any manner (other than as agreed upon with the other party) the operation of any IT Asset.
“Marks”
has the meaning set forth in the definition of Intellectual Property Rights.
“Material
Contracts” has the meaning set forth in Section 3.7(a).
“Material
Customers” has the meaning set forth in Section 3.22(a).
“Material
Permits” has the meaning set forth in Section 3.6.
“Material
Suppliers” has the meaning set forth in Section 3.22(b).
“Merger”
has the meaning set forth in the recitals to this Agreement.
“Merger
Closing Date” has the meaning set forth in Section 2.3(a).
“Merger
Effective Time” has the meaning set forth in Section 2.3(b).
“Merger
Sub” has the meaning set forth in the preamble to this Agreement.
“Minimum
Cash Condition” has the meaning set forth in Section 6.3(e).
“Minimum
Equity Financing Proceeds Termination Date” has the meaning set forth in Section 7.1(j).
“Nasdaq”
means The Nasdaq Global Market.
“NewPubco”
has the meaning set forth in the preamble to this Agreement.
“NewPubco
A&R Articles of Association” means the amended and restated articles of association of NewPubco to be adopted by NewPubco
on the Closing Date, in such form as mutually agreed by SPAC and the Company.
“NewPubco
Board” has the meaning set forth in the recitals to this Agreement.
“NewPubco
Ordinary Shares” means ordinary shares of no par value of NewPubco.
“NewPubco
Warrants” means a warrant of NewPubco entitling the holder to purchase one (1) share of NewPubco Ordinary Shares.
“Non-Party
Affiliate” has the meaning set forth in Section 8.12.
“Off-the-Shelf
Software” means any Software that is made generally and widely available to the public on a commercial basis and is licensed
to any of the Group Companies on a non-exclusive basis.
“Offer”
has the meaning set forth in the recitals to this Agreement.
“Officer”
has the meaning set forth in Section 5.14(c).
“Order”
means any writ, order, judgment, injunction, decision, determination, award, ruling, verdict or decree entered, issued or rendered by
any Governmental Entity.
“Ordinance”
means the Israeli Income Tax Ordinance [New Version], 1961, as amended, and the rules and regulations promulgated thereunder.
“ordinary
course of business” means, when referring to a Group Company, actions taken by a Group Company that are consistent with the
usual day-to-day customs and practices of such Group Company in the ordinary course of operations of the business.
“Party(ies)”
has the meaning set forth in the preamble to this Agreement.
“Patents”
has the meaning set forth in the definition of Intellectual Property Rights.
“Payee”
has the meaning set forth in Section 2.10(b).
“PCAOB”
means the Public Company Accounting Oversight Board.
“Permits”
means any approvals, authorizations, clearances, licenses, registrations, permits or certificates of a Governmental Entity.
“Permitted
Liens” means (a) mechanic’s, materialmen’s, carriers’, repairers’ and other similar statutory
Liens arising or incurred in the ordinary course of business for amounts that are not yet due and payable or are being contested in good
faith by appropriate Proceedings, (b) Liens for Taxes, assessments or other governmental charges not yet due and payable as of the
Closing Date or which are being contested in good faith by appropriate Proceedings and, to the extent applicable with respect to any
Group Company, for which sufficient reserves have been established in accordance with IFRS, (c) all matters of record, as well as
unrecorded encumbrances and restrictions on real property (including easements, covenants, conditions, rights of way and similar restrictions)
that do not prohibit or materially interfere with any of the Group Companies’ use or occupancy of such real property, (d) matters
that would be disclosed by a true and accurate ALTA survey or a physical inspection of the real property, (e) zoning, building codes
and other land use Laws regulating the use or occupancy of real property or the activities conducted thereon that are imposed by any
Governmental Entity having jurisdiction over such real property and which are not materially violated by the use or occupancy of such
real property or the operation of the businesses of the Group Company and do not prohibit or materially interfere with any of the Group
Companies’ use or occupancy of such real property, (f) cash deposits or cash pledges to secure the payment of workers’
compensation, unemployment insurance, social security benefits or obligations arising under similar Laws or to secure the performance
of public or statutory obligations, surety or appeal bonds, and other obligations of a like nature, in each case in the ordinary course
of business and which are not yet due and payable, (g) non-exclusive licenses of Intellectual Property Rights granted in the ordinary
course of business, and (h) the Liens set forth on Section 1.1(b) of the SPAC Disclosure Schedules and Section 1.1(b) of
the Company Disclosure Schedules and/or such other Liens as would not have a material impact on the operation of the businesses of the
Group Company.
“Person”
means an individual, partnership, corporation, limited liability company, joint stock company, unincorporated organization or association,
trust, joint venture or other similar entity, whether or not a legal entity, or Governmental Entity.
“Per
Share Company Value” shall mean the quotient obtained by dividing (a) the Company Equity Value by (b) the Fully-Diluted
Company Share Amount.
“Personal
Information” means any data or information that constitutes personal data or personal information under any applicable Law.
“PIPE
Financing” has the meaning set forth in the recitals to this Agreement.
“PIPE
Financing Amount” has the meaning set forth in the recitals to this Agreement.
“PIPE
Investors” has the meaning set forth in Section 5.18(a).
“PIPE
Subscription Agreements” has the meaning set forth in Section 5.18(a).
“Plan
of Merger” means the Plan of Merger, in such form as mutually agreed by SPAC and the Company prior Closing, to be executed
and delivered by SPAC, NewPubco and Merger Sub under Cayman Companies Law as provided by the terms hereof.
“Proceeding”
means any lawsuit, litigation, action, audit, investigation, inquiry, examination, claim, complaint, charge, grievance, legal proceeding,
administrative enforcement proceeding, suit or arbitration (in each case, whether civil, criminal or administrative and whether public
or private) pending by or before or otherwise involving any Governmental Entity (other than office actions and similar proceedings in
connection with the prosecution of applications for registration or issuance of Intellectual Property Rights).
“Processing”
means any operation or set of operations which is performed on Personal Information or on sets of Personal Information, whether or not
by automated means, such as collection, recording, organization, structuring, storage, adaptation, alteration, retrieval, use, disclosure
by transmission, dissemination or otherwise making available, alignment or combination, restriction, erasure or destruction.
“Proprietary
Software” has the meaning set forth in Section 3.13(l).
“Proxy
Statement” has the meaning set forth in Section 5.7.
“Public
Shareholders” has the meaning set forth in Section 8.18.
“Public
Software” means any Software application that is licensed pursuant to (a) a license that is approved by the Open Source
Initiative and listed at http://www.opensource.org/licenses, including the GNU General Public License (GPL), the GNU Lesser General Public
License (LGPL), the GNU Affero GPL, the MIT license, the Eclipse Public License, the Common Public License, the CDDL, the Mozilla Public
License (MPL), the Artistic License, the Netscape Public License, the Sun Community Source License (SCSL), and the Sun Industry Standards
License (SISL) or any open source, copyleft or similar licensing and distribution models; or (b) any license to Software that is
considered “free” Software or “open source” Software by the Open Source Foundation or the Free Software Foundation
or other similar licensing and distribution models, in each case of (a) or (b), whether or not source code is available
or included in such license, and including under any terms or conditions that impose any requirement that any Software using, linked
with, incorporating, distributed with or derived from such Public Software (i) be made available or distributed or disclosed in
source code form; (ii) be licensed for purposes of making derivative works; or (iii) be redistributable at no, or a nominal,
charge.
“Real
Property Leases” means all leases, sub-leases, licenses or other agreements, in each case, pursuant to which any Group Company
leases, sub-leases or otherwise occupies any real property.
“Redemption
Rights” means the redemption rights provided for in Article 24 of the SPAC Articles of Association.
“Registered
Intellectual Property” means all Intellectual Property Rights that are the subject of an application, certificate, filing,
registration, or other issuance, filed with, or recorded by any Governmental Entity or other legal authority, including issued Patents,
pending Patent applications, registered Marks, pending applications for registration of Marks, registered Copyrights, pending Copyright
applications, and Internet domain name registrations.
“Registration
Rights and Lock-Up Agreement” has the meaning set forth in the recitals to this Agreement.
“Registration
Statement” has the meaning set forth in Section 5.7.
“Registration
Statement / Proxy Statement” has the meaning set forth in Section 5.7.
“Released
Claims” has the meaning set forth in Section 8.18.
“Representatives”
means with respect to any Person, such Person’s Affiliates and its and such Affiliates’ respective directors, managers, officers,
employees, accountants, consultants, advisors, attorneys, agents and other representatives.
“Sanctioned
Country” means any jurisdiction that is, or has been in the past five (5) years, the subject or target of Sanctions, including
Cuba, Iran, North Korea, Syria, the temporarily occupied Crimea region and so-called Donetsk People’s Republic (DNR) and Luhansk
People’s Republic (LNR) regions of Ukraine.
“Sanctioned
Person” means any Person that is the target of Sanctions, including (a) any Person listed in any U.S. or applicable non-U.S.
Sanctions- or export-related list of designated Persons, including the lists maintained by the Office of Foreign Assets Control of the
U.S. Department of Treasury or the U.S. Department of State, the United Nations Security Council, the European Union, any Member State
of the European Union, the United Kingdom, or the State of Israel; (b) any Person in which a Person described in clause (a) otherwise
controls or directly or indirectly owns a 50% or greater interest; (c) any Person operating, organized, resident, or otherwise located
in a Sanctioned Country; (d) the government of a Sanctioned Country or the Government of Venezuela; or (e) any Person with
which U.S. Persons are otherwise prohibited from doing business with under any Sanctions or Trade Control Laws.
“Sanctions”
means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government,
including those administered by the Office of Foreign Assets Control of the U.S. Department of Treasury or the U.S. Department of State,
(b) the United Nations Security Council, the European Union, any European Union member state or His Majesty’s Treasury of
the United Kingdom, or the State of Israel, or (c) United Nations or United Kingdom sanctions as implemented under the laws of the
Cayman Islands or extended to the Cayman Islands by the Orders of His Majesty in Council.
“Sarbanes-Oxley
Act” means the Sarbanes-Oxley Act of 2002.
“SEC”
means the U.S. Securities and Exchange Commission.
“Section 350
Approval” means (a) the approval by the appropriate Israeli court of the Equity Exchange, and the issuance of an order
by such court implementing the Equity Exchange, (b) the issuance of an order by the appropriate Israeli court, to the extent required,
granting the Israeli Securities Law Approvals, and (c) the issuance of an order by the appropriate Israeli court exempting the Company
from the need to convene a meeting of creditors to approve the Transactions.
“Section 350
Proceeding” means the motion to be filed by the Company with the appropriate Israeli court seeking the Section 350 Approval,
and all proceedings relating to such motion.
“Securities Act”
means the Securities Act of 1933, as amended.
“Securities Laws”
means Federal Securities Laws and other applicable foreign and domestic securities or similar Laws.
“Share Split”
has the meaning set forth in Section 2.1(a).
“Signing Filing”
has the meaning set forth in Section 5.4(b).
“Signing Press Release”
has the meaning set forth in Section 5.4(b).
“Software”
shall mean any and all (a) computer programs, including any and all software implementations of algorithms, models and methodologies,
whether in source code or object code; (b) databases, whether machine readable or otherwise; (c) descriptions, flowcharts and
other work product used to design, plan, organize and develop any of the foregoing, screens, user interfaces, report formats, firmware,
development tools, templates, comments, menus, buttons and icons, files, data, scripts, application programming interfaces, architecture,
algorithms related to any of the foregoing; (d) all documentation, including user manuals, design notes, programmers’ notes,
and other training documentation, related to any of the foregoing and all media and other tangible property necessary for the delivery
or transfer of any of the foregoing; and (e) any derivative works, foreign language versions, fixes, upgrades, updates, enhancements,
new versions, previous versions, new releases, and previous releases of any of the foregoing.
“SPAC”
has the meaning set forth in the preamble to this Agreement.
“SPAC Acquisition
Proposal” means (a) any transaction or series of related transactions under which SPAC or any of its controlled Affiliates,
directly or indirectly, (i) acquires or otherwise purchases, or is acquired by or otherwise purchased by, any other Person(s), (ii) solicits,
initiates, knowingly encourages, directly or indirectly, any inquiry, proposal or offer (written or oral) by, or provide any information
to, any Person (other than the Company) concerning any merger, consolidation, purchase of ownership interests or assets of, by or otherwise
involving SPAC, or any recapitalization or a Business Combination or (iii) acquires or otherwise purchases all or a material portion
of the assets or businesses of any other Person(s) (in the case of each of clause (i), (ii) and (iii),
whether by merger, consolidation, recapitalization, purchase or issuance of Equity Securities, tender offer or otherwise) or (iv) otherwise
knowingly cooperate in any way with, or knowingly assist or participate in, or knowingly encourage any effort or attempt by any Person
to do or seek to do any of the foregoing, or (b) any equity, debt or similar investment in SPAC or any of its controlled Affiliates.
SPAC shall, and shall cause its Representatives to, immediately cease and cause to be terminated any and all existing discussions or
negotiations with any Person with respect to any SPAC Acquisition Proposal. Notwithstanding the foregoing or anything to the contrary
herein, none of this Agreement, the Ancillary Documents nor the Transactions shall constitute a SPAC Acquisition Proposal.
“SPAC Allocation
Schedule” has the meaning set forth in Section 2.7(a).
“SPAC Alternative
Acquisition Agreement” has the meaning set forth in Section 5.6(j).
“SPAC Articles of
Association” means the Third Amended and Restated Memorandum and Articles of Association of SPAC, to be adopted on or around,
January 8, 2024.
“SPAC Board”
has the meaning set forth in the recitals to this Agreement.
“SPAC Board Recommendation”
has the meaning set forth in Section 5.8.
“SPAC Class A
Shares” means SPAC’s Class A ordinary shares, par value $0.0001 per share.
“SPAC Class B
Shares” means SPAC’s Class B ordinary shares, par value $0.0001 per share.
“SPAC Disclosure
Schedules” means the disclosure schedules to this Agreement delivered to the Company by SPAC on the date of this Agreement.
“SPAC Expenses”
means, as of any determination time, the aggregate amount of fees, expense, commissions or other amounts incurred by or on behalf of,
or otherwise payable by, whether or not due, SPAC in connection with the negotiation, preparation or execution of a Business Combination,
including this Agreement or any Ancillary Documents, the performance of its covenants or agreements in this Agreement or any Ancillary
Document or the consummation of the Transactions, including (a) the fees and expenses of outside legal counsel, accountants, advisors,
brokers and finders, investment bankers, consultants, or other agents or service providers of SPAC, (b) other fees, expenses, commissions
or other amounts that are expressly allocated to SPAC pursuant to this Agreement or any Ancillary Document, including (i) fifty
percent (50%) of all fees payable to the SEC for registering the NewPubco Ordinary Shares and NewPubco Warrants on the Registration Statement,
(ii) fifty percent (50%) of all fees payable to the SEC and/or Nasdaq for the application for listing the NewPubco Ordinary Shares
and NewPubco Warrants on Nasdaq and (iii) all of the fees of the financial printer, round lot analysis, proxy solicitors and transfer
agent fees (provided, that any fees and expenses of professional advisors incurred by SPAC with respect to the registration of
the NewPubco Ordinary Shares and NewPubco Warrants on the Registration Statement and the application for listing the NewPubco Ordinary
Shares and NewPubco Warrants on Nasdaq shall be deemed SPAC Expenses under clause (a)), (c) fifty percent (50%) of all filing fees
to Governmental Entities in connection with the Transactions, including fifty percent (50%) of all costs, fees and expenses incurred
in connection with filing under the HSR Act and under each foreign antitrust Law and with respect to any other registrations, declarations
and filings required in connection with the execution and delivery of this Agreement, the performance of the obligations hereunder and
the consummation of the Transactions, if applicable, (d) the premiums, commissions and other fees paid or payable in connection
with obtaining directors’ and officers’ liability insurance coverage pursuant to Section 5.13, and (e) any
other fees, expenses, commissions or other amounts that are expressly allocated to SPAC pursuant to this Agreement or any Ancillary Document;
provided, that if any amounts to be included in the calculation of SPAC Expenses which are in a currency other than US dollars,
such amounts shall be deemed converted to US dollars at the prevailing official rate of exchange published by the Federal Reserve Bank
of New York for the conversion of such currency or currency unit into US dollars (except for the conversion of NIS denominated expenses
which shall be deemed converted on the basis of the USD-NIS Representative Rate of Exchange last published) on the fifth (5th)
Business Day immediately preceding the Closing. Notwithstanding the foregoing or anything to the contrary herein, SPAC Expenses shall
not include any Company Expenses.
“SPAC Financial
Statements” means all of the financial statements of SPAC included in the SPAC SEC Reports.
“SPAC Fundamental
Representations” means the representations and warranties set forth in Section 4.1 (Organization and Qualification),
Section 4.2 (Authority), Section 4.4 (Brokers), and Section 4.6(a) (Capitalization of SPAC).
“SPAC
Liabilities” means, as of any determination time, the aggregate amount of Liabilities of SPAC that would be accrued on a balance
sheet in accordance with GAAP, whether or not such Liabilities are due and payable as of such time. Notwithstanding the foregoing
or anything to the contrary herein, SPAC Liabilities shall not include any SPAC Expenses.
“SPAC Israeli Tax
Rulings” has the meaning set forth in Section 5.5(e)(iii).
“SPAC Material Adverse
Effect” means any Effect that, individually or in the aggregate with any other Effect, has had or would reasonably be expected
to have a material adverse effect on (a) the business, results of operations or financial condition of SPAC, or (b) the ability
of SPAC to consummate the Transactions contemplated by this Agreement on the terms and conditions of this Agreement; provided,
however, that, in the case of clause (a), none of the following shall be deemed to constitute, alone or in combination,
or be taken into account in determining whether a SPAC Material Adverse Effect has occurred or is reasonably likely to occur: any adverse
Effect arising after the date of this Agreement from or related to (i) general business or economic conditions in or affecting the
United States or Israel, or changes therein, or the global economy generally, (ii) acts of war, sabotage or terrorism (including
cyberterrorism) in the United States or Israel or any other territories, (iii) changes in conditions of the economic, banking, credit,
capital or securities markets generally, (iv) changes in any applicable Laws or accounting requirements or principles required by
or IFRS or any official interpretation thereof, (v) the execution or public announcement of this Agreement or the pendency or consummation
of the Transactions, including the impact thereof on the relationships, contractual or otherwise, of SPAC with employees, investors,
contractors, lenders, partners or other third-parties related thereto (provided that the exception in this clause (v) shall
not apply to the representations and warranties set forth in Section 4.3(b) to the extent that its purpose is to address
the consequences resulting from the public announcement or pendency or consummation of the Transactions or the condition set forth in
Section 6.2(a) to the extent it relates to such representations and warranties), (vi) any hurricane, tornado, flood,
earthquake, tsunami, natural disaster, mudslides, wild fires, epidemics, pandemics (including COVID-19 (or any mutation or variation
thereof)) or other outbreaks of diseases or public health events, acts of God or other natural disasters or comparable events, (vii) events,
changes or conditions generally affecting participants in the industries and markets in which SPAC operates, (viii) any failure
of SPAC to meet any projections, forecasts, guidance estimates or financial or operating predictions of revenue, earnings, cash flow
or cash position; provided, however, that any Effect resulting from a matter described in any of the foregoing clauses
(i) through (iv) or (vi) may be taken into account in determining whether a SPAC Material Adverse Effect
has occurred or is reasonably likely to occur to the extent such Effect has a disproportionate adverse effect on SPAC, taken as a whole,
relative to other participants operating in the industries or markets in which SPAC operates.
“SPAC Merger Consideration”
has the meaning set forth in Section 2.6(b)(ii).
“SPAC Non-Party
Affiliates” means, collectively, each SPAC Related Party and each of the former, current or future Affiliates, Representatives,
successors or permitted assigns of any SPAC Related Party (other than, for the avoidance of doubt, SPAC).
“SPAC Prospectus”
has the meaning set forth in Section 8.18.
“SPAC Related Party”
has the meaning set forth in Section 4.10.
“SPAC Related Party
Transactions” has the meaning set forth in Section 4.10.
“SPAC SEC Reports”
has the meaning set forth in Section 4.7.
“SPAC Share”
means collectively, the SPAC Class A Shares and SPAC Class B Shares.
“SPAC Shareholder
Approval” means approval of the Transaction Proposals by the affirmative vote of the holders of the requisite number of SPAC
Shares entitled to vote thereon, satisfying the applicable majority, supermajority or other applicable requirements, whether in person
or by proxy at the SPAC Shareholders Meeting (or any adjournment thereof), in accordance with the Governing Documents of SPAC, the rules and
regulations of Nasdaq, and applicable Law.
“SPAC Shareholder
Redemption” means the right of the holders of SPAC Shares to redeem all or a portion of their SPAC Shares (in connection with
the Transactions) as set forth in Governing Documents of SPAC and the Trust Agreement.
“SPAC Shareholders”
means, collectively, holders of SPAC Shares and holders of SPAC Warrants.
“SPAC Shareholders
Meeting” has the meaning set forth in Section 5.8.
“SPAC Superior Proposal
Notice Period” has the meaning set forth in Section 5.6(m).
“SPAC Unit”
means a unit of SPAC, consisting of (a) one (1) SPAC Class A Share and (b) one (1) SPAC Warrant.
“SPAC Warrants”
means a warrant entitling the holder to purchase one (1) SPAC Class A Share per warrant at a price of $11.50 per whole share,
subject to adjustment in accordance with the Warrant Agreement.
“Split Factor”
shall mean the quotient obtained by dividing (a) the Per Share Company Value by (b) $10.00.
“Sponsor”
means Israel Acquisitions Sponsor LLC, a Delaware limited liability company.
“Sponsor Support
Agreement” has the meaning set forth in the recitals to this Agreement.
“Standard
Inbound License” means any Contract for third party Intellectual Property Rights licensed on a non-exclusive basis to a Group
Company that is generally, commercially available Software and (a) has not been modified or customized for and at the request of
a Group Company, and (b) is licensed for a one-time or annual fee under $200,000.
“Subscribers”
has the meaning set forth in the recitals to this Agreement.
“Subscription Agreements”
has the meaning set forth in the recitals to this Agreement.
“Subsidiary”
means, with respect to any Person, any corporation, limited liability company, partnership or other legal entity of which (a) if
a corporation, a majority of the total voting power of Equity Securities entitled (without regard to the occurrence of any contingency)
to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such
Person or one or more of the other Subsidiaries of such Person or a combination thereof, or (b) if a limited liability company,
partnership, association or other business entity (other than a corporation), a majority of the partnership or other similar ownership
interests thereof is at the time owned or controlled, directly or indirectly, by such Person or one or more Subsidiaries of such Person
or a combination thereof and for this purpose, a Person or Persons own a majority ownership interest in such a business entity (other
than a corporation) if such Person or Persons shall be allocated a majority of such business entity’s gains or losses or shall
be a, or control any, managing director or general partner of such business entity (other than a corporation). The term “Subsidiary”
shall include all Subsidiaries of such Subsidiary.
“Superior Proposal”
means any bona fide, written Company Acquisition Proposal (with references to 20% in the definition of Company Acquisition Proposal being
deemed to be replaced with references to 50%) or SPAC Acquisition Proposal made after the date hereof by a Third Party, with respect
to which the Company Board (with respect to a Company Acquisition Proposal) or the SPAC Board (with respect to a SPAC Acquisition Proposal)
shall have determined in good faith, after consultation with such Party’s financial advisors and outside legal counsel, and after
taking into account such factors as the Company Board (with respect to a Company Acquisition Proposal) or the SPAC Board (with respect
to a SPAC Acquisition Proposal) deems to be appropriate, including (to the extent the Company Board or the SPAC Board, as applicable,
deems appropriate) the financial, legal, regulatory and other aspects of such Company Acquisition Proposal or SPAC Acquisition Proposal,
the identity and financial capability of the Third Party making such Company Acquisition Proposal or SPAC Acquisition Proposal, and such
other terms and conditions of such Company Acquisition Proposal or SPAC Acquisition Proposal that the Company Board or the SPAC Board,
as applicable, deems appropriate, that the proposed Company Acquisition Transaction or SPAC Acquisition Proposal is (a) more favorable
to the Company Shareholders (with respect to a Company Acquisition Proposal) or SPAC Shareholders (with respect to a SPAC Acquisition
Proposal) than the Transactions (after taking into account any changes to this Agreement offered by the other Party in writing in response
to such Company Acquisition Proposal or SPAC Acquisition Proposal, as applicable), and (b) reasonably capable of being completed
on the terms proposed; provided, that in no event shall any Company Acquisition Proposal received from another special purpose
acquisition company or other vehicle or company with no commercial operations that is formed to raise capital through a public offering
for the purpose of acquiring an existing company, which for the avoidance of doubt, is deemed to be a “blank check” company
under applicable Securities Laws constitute a Superior Proposal pursuant to which the Company may terminate this Agreement.
“Supporting Company
Shareholders” has the meaning set forth in the recitals to this Agreement.
“Surviving Company”
has the meaning set forth in Section 2.3(a).
“TASE”
means the Tel Aviv Stock Exchange.
“Tax”
means any federal, state, local or non-United States income, gross receipts, franchise, estimated, alternative minimum, sales, use, transfer,
value added, excise, stamp, customs, duties, ad valorem, real property, personal property (tangible and intangible), capital stock, social
security, national insurance (‘bituach leumi’), national health insurance (‘bituach briyut’), unemployment,
payroll, wage, employment, inflation linkage (‘hefreshei hatzmada’), severance, occupation, registration, environmental,
communication, mortgage, profits, license, lease, service, goods and services, withholding, premium, turnover, windfall profits or other
taxes of any kind whatever, whether computed on a separate or combined, unitary or consolidated basis or in any other manner, together
with any interest, deficiencies, penalties, additions to tax, or additional amounts imposed by any Governmental Entity with respect thereto.
“Tax Return”
means returns, information returns, statements, declarations, claims for refund, schedules, attachments and reports relating to Taxes
filed or required to be filed with any Governmental Entity, including any schedule or attachment thereto and including any amendments
thereof.
“Terminating Party”
has the meaning set forth in Section 7.3(a).
“Termination Date”
has the meaning set forth in Section 7.1(d).
“Termination Fee”
means an amount equal to $10,000,000.
“Third Party”
means any Person or “group” (as defined under Section 13(d) of the Exchange Act) of Persons other than SPAC, the
Company, NewPubco, Merger Sub and their respective Affiliates.
“Trade Control Laws”
means any applicable Law related to (a) trade, import and export controls, including the U.S. Export Administration Regulations,
15 C.F.R. Parts 730-774, the Export Controls Act of 2018, 22 U.S.C. 2751 et seq., the International Traffic in Arms Regulations (22 C.F.R.
Parts 120-130), the Foreign Trade Regulations (15 C.F.R. Part 30), the Laws administered by U.S. Customs and Border Protection,
including the Uyghur Forced Labor Prevention Act (Pub. L. No. 117-78), any other applicable Laws relating to the export and import
activities of the Company in the jurisdictions where it operates, the Israeli Control of Products and Services Order (Engagement in Encryption),
5735-1974, the Israeli Control of Products and Services Order (Export of Security Equipment and Defense Know-How), 5752-1991, the Israeli
Defense Export Control Order (Combat Equipment), 5768-2008, the Israeli Defense Export Control Law, 5767-2007, and Israeli Ministry of
Economy List of Source Items and Dual Use Items, and all other import and export control laws, regulations and/or directives administered
by the Israeli Ministry of Defense, including the Israeli Trading With the Enemy Ordinance, 1939 or (b) anti-boycott measures.
“Transaction Expenses
Cap Excess” means the dollar amount by which the SPAC Expenses and SPAC Laibilities(excluding any (i) fees and expenses
in connection with the PIPE Financing and (ii) Company Expenses), exceeds $6,000,000.
“Transaction Litigation”
has the meaning set forth in Section 5.2(c).
“Transaction Proposals”
has the meaning set forth in Section 5.8.
“Transaction Support
Agreements” has the meaning set forth in the recitals to this Agreement.
“Transactions”
has the meaning set forth in the recitals to this Agreement.
“Trust Account”
has the meaning set forth in Section 8.18.
“Trust Agreement”
has the meaning set forth in Section 4.8.
“Trustee”
has the meaning set forth in Section 4.8.
“Unit Separation”
has the meaning set forth in Section 2.6(a).
“Unpaid Company
Expenses” means the Company Expenses that are unpaid as of immediately prior to the Closing.
“Unpaid SPAC Expenses”
means the SPAC Expenses that are unpaid as of immediately prior to the Closing.
“Unpaid
SPAC Liabilities” means the SPAC Liabilities as of immediately prior to the Closing.
“Valid Certificate”
means, in respect of a payor, a valid certificate or ruling issued by the ITA in form and substance reasonably acceptable to the payor
and the Exchange Agent: (a) exempting such payor from the duty to withhold Israeli Taxes with respect to the applicable payment,
(b) determining the applicable rate of Israeli Taxes to be withheld from the applicable payment or (c) providing any other
instructions regarding the payment or withholding with respect to the applicable payment.
“VAT”
has the meaning set forth in Section 3.17(f).
“Warrant Agreement”
means the Warrant Agreement, dated as of January 12, 2023, by and between SPAC and American Stock Transfer & Trust Company.
“Withholding Drop
Date” has the meaning set forth in Section 2.10(b).
Article II.
SHARE SPLIT; EQUITY EXCHANGE; MERGER
Section 2.1 Share
Split.
(a) Prior
to the Equity Exchange Effective Time, the Company shall effect the share split under which each Company Ordinary Share that is issued
and outstanding immediately prior to the Equity Exchange Effective Time shall be split into a number of Company Ordinary Shares determined
by multiplying each such Company Ordinary Share by the Split Factor (the “Share Split”); provided, that no
fraction of a Company Ordinary Share shall be issued by virtue of the Share Split, and each Company Shareholder that would otherwise
be so entitled to a fraction of a Company Ordinary Share (after aggregating all fractional Company Ordinary Shares that otherwise would
be received by such Company Shareholder) shall instead be entitled to receive such number of Company Ordinary Shares to which such Company
Shareholder would otherwise be entitled, rounded to the nearest whole Company Ordinary Share.
(b) Following
the completion of the Share Split, the Company shall promptly update its books and records to account for any Company Ordinary Shares
issued pursuant to the Share Split.
Section 2.2 Equity
Exchange.
(a) Immediately
after the Share Split, and prior to the Merger Effective Time, upon the terms and subject to the conditions of this Agreement, NewPubco,
the Company Shareholders and the holders of Company Equity Awards shall effect an exchange (the “Equity Exchange”),
pursuant to which:
(i) each
Company Ordinary Share issued and outstanding immediately prior to the Equity Exchange (other than any Company Excluded Shares) shall,
in accordance with the Section 350 Approval and without any further action of the Company Shareholders, automatically be exchanged
for a number of validly issued, fully paid and nonassessable NewPubco Ordinary Shares equal to the Company Exchange Ratio (the aggregate
number of NewPubco Ordinary Shares issuable to Company Shareholders pursuant to this subsection, the “Company Exchange Consideration”);
the share transfer books of Company Ordinary Shares shall be closed with respect to all Company Ordinary Shares outstanding and no further
transfer of any such Company Ordinary Shares shall be made on such share transfer books after the Equity Exchange is effected;
(ii) each
Company Option that is outstanding immediately prior to the Equity Exchange Effective Time will, without any action on the part of the
holder thereof, automatically be exchanged for an option granted by NewPubco to acquire such number of NewPubco Ordinary Shares equal
to the number of Company Ordinary Shares subject to such Company Option immediately prior to the Equity Effective Time, multiplied
by the Company Exchange Ratio (rounded to the nearest whole share), with an exercise price per share equal to the exercise price
per share of such Company Option in effect immediately prior to the Equity Effective Time, divided by the Company Exchange Ratio
(rounded to the nearest full cent) (the “Assumed Company Options”). Each holder of Company Options shall receive the
Assumed Company Options to purchase the number of NewPubco Ordinary Shares set forth opposite such holder’s name on the Company
Allocation Schedule. Each Assumed Company Option shall be subject to substantially the same terms and conditions as such Company Option,
including the applicable vesting schedule and payment timing as in effect on the date of this Agreement for the corresponding former
Company Option; provided, that the exercise price and the number of shares of NewPubco Ordinary Shares which can be acquired pursuant
to this Section 2.2(a)(ii) shall be consistent with the requirements of Treasury Regulation Section 1.409A-1(b)(5)(v)(D);
provided, further, that in the case of any Assumed Company Option to which Section 422 of the Code applies, the exercise
price and the number of shares of NewPubco Ordinary Shares which can be acquired pursuant to this Section 2.2(a)(ii) shall
be subject to such adjustments as are necessary in order to satisfy the requirements of Treasury Regulation Section 1.424-1(a).
At or prior to the Equity Exchange Effective Time, the Parties and their boards, as applicable, shall adopt any resolutions and take
any actions that are necessary to effectuate the treatment of the Company Options pursuant to this subsection;
(iii) each
Company RSU that is outstanding immediately prior to the Equity Exchange Effective Time will, without any action on the part of the holder
thereof, automatically be exchanged for a restricted stock unit award granted by NewPubco to receive such number of NewPubco Ordinary
Shares equal to the number of Company Ordinary Shares subject to such Company RSU immediately prior to the Equity Effective Time, multiplied
by the Company Exchange Ratio (rounded to the nearest whole share) (the “Assumed Company RSUs”). Each holder of
Assumed Company RSUs shall receive such number of NewPubco Ordinary Shares set forth opposite such holder’s name on the Company
Allocation Schedule. Each Assumed Company RSU shall be subject to substantially the same terms and conditions as such Company RSU, including
vesting and exercisability terms as in effect on the date of this Agreement for the corresponding former Company RSU and such assumption
and conversion shall occur in a manner intended to comply with the applicable requirements of Section 409A of the Code. At or prior
to the Equity Exchange Effective Time, the Parties and their boards, as applicable, shall adopt any resolutions and take any actions
that are necessary to effectuate the treatment of the Company RSUs pursuant to this subsection; and
(iv) the
ordinary share of NewPubco issued and outstanding immediately prior to the Equity Exchange Effective Time shall, become a dormant share
and shall no represent any voting or economic rights of NewPubco.
(b) Cancellation
of Certain Company Ordinary Shares. Each Company Ordinary Share, if any, that is a dormant share (menayah redumah) under Israeli
Law (each such share, a “Company Excluded Share”) shall not be exchanged in the Equity Exchange and shall continue
to be a dormant share.
(c) Equity
Exchange Effective Time. The Equity Exchange shall become effective at Closing, immediately prior to the Merger Effective Time (such
date and time is hereinafter referred as the “Equity Exchange Effective Time”).
Section 2.3 The
Merger.
(a) Immediately
after the Equity Exchange Effective Time and on the terms and subject to the conditions set forth in this Agreement and in accordance
with the Cayman Companies Law, Merger Sub shall merge with and into SPAC, with SPAC surviving the Merger as a direct wholly owned Subsidiary
of NewPubco. The date on which the foregoing occurs is referred to in this Agreement as the “Merger Closing Date.”
Following the Merger Effective Time, the (i) separate existence of Merger Sub shall cease, it will be struck off the Register of
Companies in the Cayman Islands and SPAC shall continue as the surviving company of the Merger (the “Surviving Company”)
and (ii) SPAC shall (A) become a direct, wholly owned subsidiary of NewPubco, (B) continue to be governed by the Laws
of the Cayman Islands, and (C) succeed to and assume all of the rights, properties and obligations of Merger Sub in accordance with
the Cayman Companies Law, and the SPAC Shareholders shall be entitled to the SPAC Merger Consideration.
(b) Merger
Effective Time. Upon the terms and subject to the conditions set forth herein, on the Merger Closing Date, SPAC, NewPubco and Merger
Sub shall (i) cause the Plan of Merger to be duly executed and filed with the Registrar of Companies of the Cayman Islands as provided
by Section 233 of the Cayman Companies Law, and (ii) make any other filings, recordings or publications required to be made
by SPAC or Merger Sub under the Cayman Companies Law in connection with the Merger. The Merger shall become effective on the date as
specified in the Plan of Merger in accordance with the CICA. The Merger shall become effective at the date and time as specified in the
Plan of Merger that has been registered by the Registrar of Companies of the Cayman Islands (such date and time is hereinafter referred
as the “Merger Effective Time”).
(d) Effect
of the Merger. At and after the Merger Effective Time, the Merger shall have the effects set forth in this Agreement, the Plan of
Merger and the applicable provisions of the Cayman Companies Law. Without limiting the generality of the foregoing, and subject thereto,
at the Merger Effective Time, all the property, rights, privileges, agreements, powers and franchises, Liabilities and duties of SPAC
and Merger Sub shall vest in and become the property, rights, privileges, agreements, powers and franchises, Liabilities and duties of
SPAC as the Surviving Company (including all rights and obligations with respect to the Trust Account), which shall include the assumption
by SPAC of any and all agreements, covenants, duties and obligations of SPAC and Merger Sub set forth in this Agreement and the other
Ancillary Documents to which SPAC or Merger Sub is a party, and SPAC shall thereafter exist as a wholly owned subsidiary of NewPubco
and the separate corporate existence of Merger Sub shall cease to exist.
Section 2.4 Organizational
Documents.
(a) At
the Closing, subject to obtaining the Company Equityholder Approval, (i) the articles of association of NewPubco shall be amended
and restated in their entirety to be in the form of the NewPubco A&R Articles of Association, until thereafter changed or amended
as provided therein or by applicable Law, and the NewPubco A&R Articles of Association shall be filed with the Companies Registrar,
and (ii) the articles of association of the Company shall be amended and restated in their entirety to be in the form of the Company
A&R Articles of Association, until thereafter changed or amended as provided therein or by applicable Law, and the Company A&R
Articles of Association shall be filed with the Companies Registrar.
(b) At
the Merger Effective Time, in accordance with the Plan of Merger, the SPAC Articles of Association, as in effect immediately prior to
the Merger Effective Time, shall be amended and restated in such form in the form annexed to the Plan of Merger at the time of filing
with the Registrar of Companies of the Cayman Islands and as mutually agreed by SPAC and the Company and, as so amended and restated,
shall be the Governing Documents of the Surviving Company on and from the Merger Effective Time until thereafter changed or amended as
provided therein or by applicable Law and such memorandum and articles of association.
(c) In
connection with the Equity Exchange, and subject to obtaining the Company Equityholder Approval, the articles of association of the Company
shall be amended and restated in their entirety to be in the form of the Company A&R Articles of Association, until thereafter changed
or amended as provided therein or by applicable Law, and the Company A&R Articles of Association shall be filed with the Companies
Registrar.
Section 2.5 Directors
and Officers of the Surviving Company.
(a) At
the Merger Effective Time, in accordance with the Plan of Merger, the directors and officers of the SPAC immediately prior to the Merger
Effective Time shall be the initial directors and officers of the Surviving Company, each to hold office in accordance with the SPAC’s
Governing Documents effective at such time until such director’s or officer’s successor is duly elected or appointed and
qualified, or until the earlier of their death, resignation or removal.
(b) The
Parties shall cause the directors and officers of SPAC as of immediately following the Merger Effective Time to be comprised of the individuals
mutually agreed by the Parties, each to hold office in accordance with the SPAC’s Governing Documents effective at such time.
Section 2.6 Effect
of the Merger on Securities of SPAC and Merger Sub. At the Merger Effective Time, by virtue of the Merger and without any further
action on the part of the Parties or any SPAC Shareholder:
(a) SPAC
Units. Each SPAC Unit issued and outstanding immediately prior to the Merger Effective Time shall be automatically detached and the
holder thereof shall be deemed to hold one (1) SPAC Class A Share and one (1) SPAC Warrant in accordance with the terms
of the applicable SPAC Unit (the “Unit Separation”), provided that no fractional SPAC Warrant will be issued
in connection with the Unit Separation such that if a holder of SPAC Units would be entitled to receive a fractional SPAC Warrant upon
the Unit Separation, the number of SPAC Warrants to be issued to such holder upon the Unit Separation shall be rounded down to the nearest
whole number of SPAC Warrants. The underlying SPAC’s securities held or deemed to be held following the Unit Separation shall be
converted in accordance with the applicable terms of this Section 2.6.
(b) SPAC
Shares.
(i) Immediately
prior to the Merger Effective Time, each SPAC Class B Share shall be automatically converted into one (1) SPAC Class A
Share pursuant to and in accordance with the conversion mechanics set forth in Article 17 of the SPAC Articles of Association (without
giving effect to the adjustments set forth in Article 16 thereof) and following such conversion, each SPAC Class B Share shall
no longer be outstanding and shall automatically be cancelled and shall cease to exist, and each former holder of SPAC Class B Shares
shall thereafter cease to have any rights with respect to such securities.
(ii) Each
SPAC Class A Share issued and outstanding immediately prior to the Merger Effective Time (which, for the avoidance of doubt, shall
include the SPAC Class A Shares held as a result of the Unit Separation and any SPAC Class A Shares issued as a result of SPAC
Class B Share conversion set forth in Section 2.6(b)(i), but excluding the SPAC Shares referred to in Section 2.2(d))
shall, in accordance with the Cayman Companies Law, without any further action of the SPAC Shareholders, automatically be cancelled in
exchange for the right to receive one (1) validly issued, fully paid and nonassessable NewPubco Ordinary Share for each SPAC Class A
Share, with each holder of SPAC Class A Share to receive the number of NewPubco Ordinary Shares set forth opposite such holder’s
name on the SPAC Allocation Schedule (the aggregate number of shares of NewPubco Ordinary Shares issuable to SPAC Shareholders pursuant
to this subsection, collectively, the “SPAC Merger Consideration”).
(c) SPAC
Warrants. Each SPAC Warrant that is outstanding and unexercised immediately prior to the Merger Effective Time shall cease to represent
a SPAC Warrant in respect of SPAC Shares and shall be assumed by NewPubco and automatically be converted into a warrant to acquire NewPubco
Ordinary Shares (each, an “Assumed SPAC Warrant”). NewPubco shall assume each such SPAC Warrant in accordance with
its terms, and except as expressly provided above, following the Merger Effective Time, each Assumed SPAC Warrant shall continue to be
governed by the same terms and conditions (including vesting terms) as were applicable to the applicable SPAC Warrant immediately prior
to the Merger Effective Time, except that each SPAC Warrant will be exercisable (or will become exercisable in accordance with its terms)
for that number of whole NewPubco Ordinary Shares equal to the number of SPAC Shares that were issuable upon exercise of such SPAC Warrant
that was outstanding immediately prior to the Merger Effective Time. At or prior to the Merger Effective Time, NewPubco and SPAC shall
adopt any resolutions and take any actions that are necessary to effectuate the treatment of the SPAC Warrants in accordance with this
subsection.
(d) SPAC
Treasury Shares. Notwithstanding any other provision of this Agreement to the contrary, if there are any SPAC Shares that are owned
by SPAC as treasury shares or any SPAC Shares owned by any direct or indirect Subsidiary of SPAC immediately prior to the Merger Effective
Time, such SPAC Shares shall automatically be cancelled and shall cease to exist without any conversion thereof or payment or other consideration
therefor.
(e) Redeeming
SPAC Shares. Each SPAC Share subject to the SPAC Shareholder Redemption issued and outstanding immediately prior to the Merger Effective
Time shall automatically be cancelled and cease to exist and shall thereafter represent only the right to be paid a pro rata share of
the SPAC Shareholder Redemption amount in accordance with the SPAC Articles of Association.
(f) Dissenting
SPAC Shares. Notwithstanding any provision of this Agreement to the contrary and to the extent available under the Cayman Companies
Law, each SPAC Share issued and outstanding immediately prior to the Merger Effective Time for which any SPAC Shareholder has validly
exercised their dissenters’ rights for such SPAC Shares in accordance with Section 238 of the Cayman Companies Law, and has
otherwise complied in all respects with all of the provisions of the Cayman Companies Law relevant to the exercise and perfection of
dissenters’ rights (collectively, the “Dissenting SPAC Shares”) shall (i) not be exchanged for, and such
SPAC Shareholders shall have no right to receive, the SPAC Merger Consideration unless and until such SPAC Shareholder fails to perfect
or withdraws or otherwise loses his, her or its right to dissenters’ rights under the Cayman Companies Law, and (ii) automatically
be cancelled and cease to exist and shall thereafter represent only the right to be paid the fair value of such Dissenting SPAC Share
and such other rights as are granted by the Cayman Companies Law, including but not limited to the rights pursuant to Section 238
of the Cayman Companies Law. For the avoidance of doubt, all SPAC Shares held by dissenting shareholders who shall have not exercised
or perfected or who shall have effectively withdrawn or lost their dissenter rights under Section 238 of the Cayman Companies Law
shall thereupon not be Dissenting SPAC Shares and shall be cancelled and cease to exist as of the Merger Effective Time, in consideration
of the right to receive the SPAC Merger Consideration, without any interest thereon, in the manner provided in this Section 2.6.
SPAC shall give NewPubco (i) prompt notice (and in any event within 48 hours of receipt) of any notices of objection, notices of
approvals, notice of dissent or demands for appraisal or written offers, under Section 238 of the Cayman Companies Law received
by SPAC, attempted withdrawals of such notices, demands or offers, and any other instruments served pursuant to applicable Law of the
Cayman Islands and received by SPAC relating to its shareholders’ rights to dissent from the Merger or dissent rights, and (ii) to
the extent permitted by applicable Law, the opportunity to direct all negotiations and proceedings with respect to any such notice or
demand for appraisal under the Cayman Companies Law. Prior to the Merger Effective Time, SPAC shall not, except with the prior written
consent of NewPubco, voluntarily make any offers or agree to any payment with respect to any exercise by a shareholder of its rights
to dissent from the Merger or any demands for appraisal or offer to settle or settle any such demands or approve any withdrawal of any
such demands. In the event that any written notices of objection to the Merger are served by any shareholders of SPAC pursuant to Section 238(2) of
the Cayman Companies Law, SPAC shall serve written notice of the authorization of the Merger on such shareholders pursuant to Section 238(4) of
the Cayman Companies Law within twenty (20) days of obtaining the SPAC Shareholder Approval.
(g) Merger
Sub shares. Each Merger Sub ordinary share issued and outstanding immediately prior to the Merger Effective Time shall be converted
into and become the right to receive one (1) validly issued, fully paid and nonassessable ordinary share, of the Surviving Company
and such share shall constitute the only outstanding share in the capital of the Surviving Company.
Section 2.7 Allocation
Schedule.
(a) At
least five (5) Business Days prior to the Closing Date, SPAC shall deliver to the Company an allocation schedule (the “SPAC
Allocation Schedule”) setting forth (i) the number of SPAC Class A Shares, SPAC Class B Shares and SPAC Warrants
held by each holder, (ii) such holder’s name and address, and (iii) the allocation of the SPAC Merger Consideration among
the holders of SPAC Class A Shares, SPAC Class B Shares and SPAC Warrants. SPAC will review any comments to the SPAC Allocation
Schedule provided by the Company or any of its Representatives and consider in good faith and incorporate any reasonable comments proposed
by the Company or any of its Representatives.
(b) Notwithstanding
the foregoing or anything to the contrary herein, (i) the aggregate number of NewPubco Ordinary Shares that each SPAC Shareholder
will have a right to receive (or NewPubco Warrants to be issued to each SPAC Shareholder in respect of any other Equity Securities of
SPAC prior to the Closing) under this Agreement will be rounded to the nearest whole share, and (ii) NewPubco and the Company will
be entitled to rely upon the SPAC Allocation Schedule for purposes of allocating NewPubco Ordinary Shares to the SPAC Shareholders and
the conversion of the SPAC Warrants into the Assumed SPAC Warrants pursuant to Section 2.6.
(c) At
least five (5) Business Days prior to the Closing Date, Company shall deliver to SPAC an allocation schedule (the “Company
Allocation Schedule”) setting forth (i) the number of Company Ordinary Shares, Company Options and Company RSUs held by
each holder, (ii) such holder’s name and address, (iii) the allocation of the Company Exchange Consideration among the
holders of Company Ordinary Shares, and (iv) the number of shares of NewPubco Ordinary Shares that will be subject to each Assumed
Company Option and Assumed Company RSU, which shall be determined in accordance with Section 2.2(a)(ii) and Section 2.2(a)(iii).
The Company will review any comments to the Company Allocation Schedule provided by SPAC or any of its Representatives and consider in
good faith and incorporate any reasonable comments proposed by SPAC or any of its Representatives.
(d) Notwithstanding
the foregoing or anything to the contrary herein, (i) the aggregate number of NewPubco Ordinary Shares that each Company Shareholder
will have a right to receive under this Agreement will be rounded to the nearest whole share, and (ii) NewPubco and SPAC will be
entitled to rely upon the Company Allocation Schedule for purposes of allocating NewPubco Ordinary Shares to the Company Shareholders
and the conversion of the Company Options and Company RSUs into the Assumed Company Option and Assumed Company RSUs, pursuant to Section 2.2(a).
Section 2.8 Closing
of the Transactions Contemplated by this Agreement. The closing of the Transactions (the “Closing”) shall take
place electronically by exchange of the closing deliverables by the means provided in Section 8.11 as promptly as reasonably
practicable, but in no event later than the third (3rd) Business Day, following the satisfaction (or, to the extent permitted
by applicable Law, waiver) of the conditions set forth in ARTICLE VI (other than those conditions that by their nature are
to be satisfied at the Closing, but subject to satisfaction or waiver of such conditions) (the “Closing Date”) or
at such other place, date and/or time as SPAC and the Company may agree in writing.
Section 2.9 Exchange
of Shares and Certificates.
(a) As
promptly as reasonably practicable following the date of this Agreement, but in no event later than ten (10) Business Days prior
to the Closing Date, NewPubco shall appoint ETC (or its applicable Affiliate) as an exchange agent, together with such Israeli financial
institution or trust company operating as a subagent and as approved in the Israeli Tax Ruling (the “Exchange Agent”),
and enter into an exchange agent agreement with the Exchange Agent for the purpose of exchanging certificates, if any, representing the
SPAC Shares and each SPAC Share held in book-entry form on the stock transfer books of SPAC immediately prior to the Merger Effective
Time, in either case, for the SPAC Merger Consideration and on the terms and subject to the other conditions set forth in this Agreement.
Notwithstanding the foregoing or anything to the contrary herein, in the event that ETC is unable or unwilling to serve as the Exchange
Agent, then SPAC and the Company shall, as promptly as reasonably practicable thereafter, but in no event later than the Closing Date,
mutually agree upon an exchange agent (in either case, such agreement not to be unreasonably withheld, conditioned or delayed), and NewPubco
shall appoint and enter into an exchange agent agreement with such exchange agent, who shall for all purposes under this Agreement constitute
the Exchange Agent. NewPubco shall, and shall cause its Representatives to, reasonably cooperate with SPAC and the Exchange Agent and
their respective Representatives in connection with the appointment of the Exchange Agent, the entry into an Exchange Agent Agreement
(including, if necessary or advisable, as determined in good faith by SPAC, by also entering into an Exchange Agent Agreement in the
form agreed to by SPAC and the Exchange Agent) and the covenants and agreements in this Section 2.9 (including the provision
of any information, or the entry into any agreements or documentation, necessary or advisable, as determined in good faith by SPAC, or
otherwise required by the Exchange Agent Agreement for the Exchange Agent to fulfill its duties as the Exchange Agent in connection with
the transactions contemplated hereby). The provisions in this Section 2.9 (shall be subject in all respects to any requirements
or restrictions imposed in the Israeli Tax Rulings).
(b) At
least three (3) Business Days prior to the Closing Date, NewPubco shall cause the Exchange Agent to mail or otherwise deliver a
Letter of Transmittal to the Persons that will be the SPAC Shareholders as of immediately prior to the Merger Effective Time.
(c) At
the Merger Effective Time, NewPubco shall deposit, or cause to be deposited, with the Exchange Agent, for the benefit of the SPAC Shareholders,
and for exchange in accordance with this Section 2.9 through the Exchange Agent, evidence of NewPubco Ordinary Shares in
book-entry form representing the SPAC Merger Consideration in exchange for the SPAC Shares outstanding immediately prior to the Merger
Effective Time, in each case after giving effect to any required Tax withholding as provided under this Section 2.9. All
shares in book-entry form representing the SPAC Merger Consideration deposited with the Exchange Agent shall be collectively referred
to in this Agreement as the “Exchange Fund”.
(d) Each
SPAC Shareholder whose SPAC Shares have been converted into the right to receive the SPAC Merger Consideration shall be entitled to receive
the portion of the SPAC Merger Consideration to which he, she or it is entitled upon (i) surrender of a certificate (or affidavit
of loss in lieu thereof in the form required by the Letter of Transmittal), together with the delivery of a properly completed and duly
executed Letter of Transmittal (including, for the avoidance of doubt, any other documents or agreements required by the Letter of Transmittal),
to the Exchange Agent or (ii) delivery of an “agent’s message” in the case of SPAC Shares held in book-entry form,
together with the delivery of a properly completed and duly executed Letter of Transmittal (including, for the avoidance of doubt, any
other documents or agreements required by the Letter of Transmittal), to the exchange Agent. NewPubco shall cause the Exchange Agent
pursuant to irrevocable instructions, to pay the SPAC Merger Consideration out of the Exchange Fund in accordance with this Agreement.
Except as contemplated by Section 2.9(c) hereof, the Exchange Fund shall not be used for any other purpose.
(e) If
a properly completed and duly executed Letter of Transmittal, together with any certificates (or affidavit of loss in lieu thereof in
the form required by the Letter of Transmittal) or an “agent’s message”, as applicable, and any other documents or
agreements required by the Letter of Transmittal, is delivered to the Exchange Agent in accordance with Section 2.9(d) (i) at
least two (2) Business Days prior to the Closing Date, then NewPubco, SPAC and the Company shall use commercially reasonable efforts
to cause the applicable portion of the SPAC Merger Consideration to be issued to the applicable SPAC Shareholder in book-entry form on
the Closing Date, or (ii) less than two (2) Business Days prior to the Closing Date, then NewPubco, SPAC and the Company shall
use commercially reasonable efforts to cause the applicable portion of the SPAC Merger Consideration to be issued to the SPAC Shareholder
in book-entry form within two (2) Business Days after such delivery.
(f) If
any portion of the SPAC Merger Consideration is to be issued to a Person other than the SPAC Shareholder in whose name the surrendered
certificate or the transferred SPAC Share in book-entry form is registered, it shall be a condition to the issuance of the applicable
portion of the SPAC Merger Consideration that, in addition to any other requirements set forth in the Letter of Transmittal or the Exchange
Agent Agreement, (i) either such certificate shall be properly endorsed or shall otherwise be in proper form for transfer or such
SPAC Share in book-entry form shall be properly transferred and (ii) the Person requesting such consideration pay to the Exchange
Agent any transfer or similar Taxes required as a result of such consideration being issued to a Person other than the registered holder
of such certificate or SPAC Share in book-entry form or establish to the satisfaction of the Exchange Agent that such transfer or similar
Taxes have been paid or are not payable. No interest will be paid or accrued on the SPAC Merger Consideration (or any portion thereof).
From and after the Merger Effective Time, until surrendered or transferred, as applicable, in accordance with this Section 2.9,
each SPAC Share shall solely represent the right to receive the SPAC Merger Consideration.
(g) At
the Merger Effective Time, the stock transfer books of the SPAC shall be closed and there shall be no transfers of SPAC Shares that were
outstanding immediately prior to the Merger Effective Time.
(h) Any
portion of the Exchange Fund that remains unclaimed by the SPAC Shareholders twelve (12) months following the Closing Date shall be delivered
to NewPubco or as otherwise instructed by NewPubco, and any SPAC Shareholder who has not exchanged his, her or its SPAC Shares for the
applicable portion of the SPAC Merger Consideration in accordance with this Section 2.9 prior to that time shall thereafter
look only to NewPubco for the issuance of the applicable portion of the SPAC Merger Consideration, without any interest thereon. None
of NewPubco, the Company, the Surviving Company or any of their respective Affiliates shall be liable to any Person in respect of any
consideration delivered to a public official pursuant to any applicable abandoned property, unclaimed property, escheat, or similar Law.
Any portion of the SPAC Merger Consideration remaining unclaimed by the SPAC Shareholders immediately prior to such time when the amounts
would otherwise escheat to or become property of any Governmental Entity shall become, to the extent permitted by applicable Law, the
property of NewPubco free and clear of any claims or interest of any Person previously entitled thereto.
(i) The
SPAC Merger Consideration payable upon conversion of the SPAC Shares in accordance with the terms hereof shall be deemed to have been
paid and issued in full satisfaction of all rights pertaining to such SPAC Shares. The SPAC Merger Consideration shall be adjusted to
reflect appropriately the effect of any share split, reverse share split, share dividend, reorganization, recapitalization, reclassification,
combination, exchange of shares or other like change with respect to NewPubco Ordinary Shares occurring on or after the date hereof and
prior to the Merger Effective Time.
(j) If
any certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming such certificate
to be lost, stolen or destroyed, the Exchange Agent will issue in exchange for such lost, stolen or destroyed certificate, the SPAC Merger
Consideration that such holder is otherwise entitled to receive pursuant to, and in accordance with, the provisions of this Section 2.9.
Section 2.10 Withholding.
(a) Each
of NewPubco, SPAC, the Company, Merger Sub and the Exchange Agent, and each of their respective Affiliates shall be entitled to deduct
and withhold (or cause to be deducted and withheld) from any amount payable pursuant to this Agreement such amounts as are required to
be deducted and withheld under applicable Tax Law. To the extent that amounts are so withheld and remitted to the applicable Governmental
Entity, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which
such deduction and withholding was made. Each of NewPubco, SPAC, the Company, Merger Sub and the Exchange Agent, and each of their respective
Affiliates shall use its commercially reasonable efforts to provide notice of any deduction or withholding that it intends to make (or
cause to be made) from any amount payable to a payee pursuant to this Agreement at least five (5) days prior to the due date of
the relevant payment (provided, however, that the notice requirement shall not apply to any withholding required under
applicable Tax Law for compensatory amounts). Each of NewPubco, SPAC, the Company, Merger Sub and the Exchange Agent, and each of their
respective Affiliates, shall use its commercially reasonable efforts to eliminate or reduce any such deduction or withholding (including
through the request and provision of any statements, forms or other documents to reduce or eliminate any such deduction or withholding).
(b) With
respect to Israeli Taxes, SPAC and the Company will file with the ITA applications for the Israeli Tax Rulings as set forth in Section 5.5(e).
If the Israeli Tax Rulings are obtained by the Closing Date, then the Payor shall comply with the provisions of the Israeli Tax Rulings.
Each Payor shall be entitled to deduct and withhold (or cause to be deducted and withheld) from any amount payable or issued pursuant
to this Agreement to the holders of SPAC Shares, SPAC Warrants, other securities of SPAC, Company Ordinary Shares, Company Options or
Company RSUs (each, a “Payee”). The consideration payable or issued to each Payee shall be retained by the Exchange
Agent for the benefit of each such Payee (except for holders of Company 102 Options, Company 102 Restricted Share Units and Company 102
Shares, who shall be treated in accordance with the terms of the 102 Awards Ruling (or the Interim 102 Awards Ruling)) for a period of
up to 180 days from the Closing Date (which may be extended as the parties agree in good faith) or as otherwise requested by the ITA
(the “Withholding Drop Date”) (during which time (i) no Payor shall make any payments to any Payee or withhold
any amounts for Israeli Taxes from the payments deliverable pursuant to this Agreement, except as provided below and during which time
each Payee may obtain a Valid Certificate and (ii) subject to the terms of the Israeli Tax Ruling (if and to the extent permitted),
a Payee may order the Exchange Agent to sell such Payee’s retained SPAC Shares or Company Ordinary Shares,or a portion thereof).
If a Payee delivers, no later than three (3) Business Days prior to the Withholding Drop Date, a Valid Certificate to the Payor,
then the deduction and withholding of any Israeli Taxes shall be made only in accordance with the provisions of such Valid Certificate,
and the balance of the consideration that is not withheld shall be transferred to such Payee concurrently therewith subject to any non-Israeli
withholding which is applicable to the payment (if any). If any Payee (i) fails to provide the Payor with a Valid Certificate at
least three (3) Business Days prior to the Withholding Drop Date, or (ii) submits a written request to the Exchange Agent to
release its portion of the consideration prior to the Withholding Drop Date and fails to submit a Valid Certificate at or before such
time, then the amount to be withheld from such Payee’s portion of the consideration shall be calculated according to the applicable
withholding rate in accordance with applicable Laws.
(c) To
the extent that the Exchange Agent is obliged to withhold Israeli Taxes, the Payee shall provide the Exchange Agent with the amount due
with regards to such Israeli Taxes prior to the release of the consideration to the Payee. In the event that the Payee fails to provide
the Exchange Agent with the full amount necessary to satisfy such Israeli Taxes no later than three (3) Business Days before the
Withholding Drop Date, the Exchange Agent shall be entitled, subject to the terms of the Israeli Tax Ruling (if and to the extent permitted),
to sell the Payee’s retained Company Ordinary Shares or SPAC Shares to the extent necessary to satisfy the full amount due with
regards to such Israeli Taxes.
(d) Any
withholding made in NIS with respect to payments made hereunder in dollars shall be calculated based on a dollars-to-NIS exchange rate
known on the date of the actual payment.
(e) Each
Payee hereby shall be deemed, by virtue of the Equity Exchange or Merger, as the case may be, to have waived, released and absolutely
and forever discharged the Payor from and against any and all claims for any losses in connection with the forfeiture or sale of any
portion of the Company Ordinary Shares or SPAC Shares otherwise deliverable to such Payee in compliance with the withholding requirements
under this Section 2.10. To the extent that the Exchange Agent is unable, for whatever reason, to sell the applicable portion
of Company Ordinary Shares or SPAC Shares required to finance applicable deduction or withholding requirements, then the Exchange Agent
shall be entitled to hold all of the Company Ordinary Shares or SPAC Shares otherwise deliverable to the applicable Payee until the earlier
of: (i) the receipt of a Valid Certificate fully exempting the Exchange Agent from Tax withholding or receipt of cash amount equal
to the Tax that should be withheld by the Exchange Agent; or (ii) such time when the Exchange Agent is able to sell the portion
of such Company Ordinary Shares or SPAC Shares otherwise deliverable to such Payee that is required to enable the Exchange Agent to comply
with such applicable deduction or withholding requirements. Any costs or expenses incurred by the Exchange Agent in connection with such
sale shall be borne by, and deducted from the payment to, the applicable Payee.
Notwithstanding the above,
any consideration paid or issued to a holder of Company 102 Options, Company 102 Restricted Share Units and Company 102 Shares will be
subject to deduction or withholding of Israeli Tax under the Ordinance on the 15th day of the calendar month following the month during
which the Closing occurs, unless prior to the 15th day of the calendar month following the month during which the Closing occurs, the
102 Awards Ruling (or the Interim 102 Awards Ruling).
Section 2.11 Adjustments.
If, between the date of this Agreement and the Closing, the outstanding Company Ordinary Shares shall have been changed into a different
number of shares or a different class, by reason of any stock dividend, subdivision, reorganization, recapitalization, reclassification,
split, combination, exchange of shares or other like change shall have occurred, or there shall have been any breach of this Agreement
by the Company through any stock dividend, subdivision, reorganization, recapitalization, reclassification, split, combination, exchange
of shares or other like change resulting in a change in outstanding Company Ordinary Shares, then any number, value or amount contained
herein which is based upon the number of Company Ordinary Shares will be appropriately adjusted to provide the Company Shareholders or
the SPAC Shareholders, as applicable, the same economic effect as contemplated by this Agreement prior to such event.
Article III.
REPRESENTATIONS AND WARRANTIES RELATING TO THE GROUP COMPANIES
Except as disclosed in (i) the
Company Reporting Documents filed with the ISA by the Company on or after January 1, 2021 and prior to the date of this Agreement
(but in each case excluding any risk factor disclosure contained in a “risk factors” section (other than any factual information
contained therein) or in any “forward-looking statements” legend or other similar disclosures included therein to the extent
they are similarly predictive or forward-looking in nature), to the extent publicly available on the ISA’s Internet-based “MAGNA”
system and the TASE website or (ii) in the Company Disclosure Schedules, the Company hereby represents and warrants to SPAC as follows:
Section 3.1 Organization
and Qualification.
(a) Each
Group Company is a company, exempted company, corporation, limited liability company or other applicable business entity duly organized,
incorporated or formed, as applicable, validly existing and in good standing (or the equivalent thereof, if applicable, in each case,
with respect to the jurisdictions that recognize the concept of good standing or any equivalent thereof) under the laws of its jurisdiction
of formation or organization (as applicable). Section 3.1(a) of the Company Disclosure Schedules sets forth the jurisdiction
of formation or organization (as applicable) for each Group Company. Each Group Company has the requisite corporate, limited liability
company or other applicable business entity power and authority to own, lease and operate its material properties and to carry on its
businesses as presently conducted in all material respects.
(b) True,
correct and complete copies of the Governing Documents of each Group Company have been made available to SPAC, in each case, as amended
and in effect as of the date of this Agreement. The Governing Documents of each Group Company are in full force and effect and no Group
Company is in breach or violation in any material respect of any provision set forth in its Governing Documents. A correct and complete
list of the directors or managers (as applicable) and officers of each Group Company is set forth on Section 3.1(b) of
the Company Disclosure Schedules.
(c) Each
Group Company is duly qualified or licensed to transact business and is in good standing (or the equivalent thereof, if applicable, in
each case, with respect to the jurisdictions that recognize the concept of good standing or any equivalent thereof) in each jurisdiction
set forth on Section 3.1(c) of the Company Disclosure Schedules in which the property and assets owned, leased or operated
by it, or the nature of the business conducted by it, makes such qualification or licensing necessary, except, in each case, where failure
to be so licensed or qualified would not, individually or in the aggregate, reasonably be expected to have, a Company Material Adverse
Effect.
(d) The
Company has no direct or indirect Subsidiaries other than those listed on Section 3.1(d) of the Company Disclosure Schedules.
Except as set forth on Section 3.1(d) of the Company Disclosure Schedules, the Company owns all of the outstanding Equity
Securities of the Subsidiaries, free and clear of all Liens other than Permitted Liens, either directly or indirectly through one or
more other Subsidiaries. Except with respect to the Subsidiaries, the Company does not own, directly or indirectly, any equity or voting
interest in any Person and, except with respect to the Subsidiaries or as provided by this Agreement, the Company does not have any agreement
or commitment to purchase any such interest, and has not agreed and is not obligated to make nor is bound by any Contract under which
it may become obligated to make any future investment in or capital contribution to any other entity.
(e) NewPubco
shall be formed solely for the purpose of effecting the Transactions and shall not engaged in any business activities or conducted any
operations other than in connection with the Transactions and shall not, prior to the Equity Exchange Effective Time, except as expressly
contemplated by this Agreement, have any assets, liabilities or obligations other than those incident to its formation and shares of
Merger Sub.
(f) Merger
Sub shall be wholly owned Subsidiary of NewPubco, formed solely for the purpose of effecting the Transactions and shall not engage in
any business activities or conducted any operations other than in connection with the Transactions and shall not, and prior to the Merger
Effective Time, except as expressly contemplated by this Agreement, have any assets, liabilities or obligations other than those incident
to its formation.
Section 3.2 Capitalization
of the Group Companies.
(a) Section 3.2(a) of
the Company Disclosure Schedules sets forth a true and complete statement as of the date of this Agreement of the number and class or
series (as applicable) of all of the Equity Securities (other than Company Equity Awards, which are covered by Section 3.11(l) of
the Company Disclosure Schedules) of the Company issued and outstanding and the ownership thereof, including, to the Company’s
knowledge, the name of each record holder who owns equal to or greater than five percent (5%) of the issued and outstanding Equity Security
of the Company, the name of each record holder who is an officer or director of the Company and the number of Equity Securities held
by each such holder. All of the issued and outstanding Equity Securities of the Company have been duly authorized and validly issued.
All of the issued and outstanding Company Ordinary Shares are fully paid and non-assessable. The issuance of Company Ordinary Shares
upon the exercise or conversion, as applicable, of Equity Securities that are derivative securities, will, upon exercise or conversion
in accordance with the terms of such Equity Securities against payment therefor, be duly authorized, validly issued, fully paid and non-assessable.
The Equity Securities of the Company (i) were not issued in violation of the Governing Documents of the Company or any other Contract
to which the Company is party or bound, (ii) are not subject to any preemptive rights, call option, right of first refusal, subscription
rights, transfer restrictions or similar rights of any Person (other than transfer restrictions under applicable Securities Laws or under
the Governing Documents of the Company) and were not issued in violation of any preemptive rights, call option, right of first refusal
or first offer, subscription rights, transfer restrictions or similar rights of any Person and (iii) have been offered, sold and
issued in compliance in all material respects with applicable Law, including Securities Laws. Except for the Company Equity Awards set
forth on Section 3.11(l) of the Company Disclosure Schedules or the Company Equity Awards either permitted by Section 5.1(b) or
issued, granted or entered into in accordance with Section 5.1(b), the Company has no outstanding options, restricted stock,
phantom stock, stock or equity appreciation rights, equity ownership interests or other equity, equity-based or similar rights in the
Company, warrants, purchase rights, subscription rights, conversion rights, exchange rights, calls, puts, preemptive rights, rights of
first refusal or first offer or other Contracts or commitments of any kind of any character, written or oral, that could require the
Company to issue, sell or otherwise cause to become outstanding or to acquire, repurchase or redeem any Equity Securities or securities
convertible into or exchangeable for Equity Securities of the Company.
(b) The
Equity Securities of the Company are free and clear of all Liens (other than transfer restrictions under applicable Securities Law or
Permitted Liens). Except for the Governing Documents of the Company, there are no voting trusts, proxies or other Contracts to which
the Company is a party with respect to the voting or transfer of the Company’s Equity Securities.
(c) Section 3.2(c) of
the Company Disclosure Schedules sets forth a true and complete statement of the number and class or series (as applicable) of all of
the Equity Securities of each Subsidiary of the Company issued and outstanding and the holders of such Equity Securities. Except as set
forth on Section 3.2(c) of the Company Disclosure Schedules, none of the Group Companies owns or controls (of record,
beneficially, legally or otherwise), directly or indirectly, any Equity Securities in any, or has or has had any commitment or obligation
to invest in, purchase any securities or obligations of, fund, guarantee, contribute or maintain the capital of or otherwise financially
support any, Person. None of the Group Companies are a partner or member of any joint venture. Other than as set forth on Section 3.2(c) of
the Company Disclosure Schedules, there are no outstanding (i) stock or equity appreciation, phantom equity, or profit participation
rights or (ii) options, restricted stock, phantom stock, warrants, purchase rights, subscription rights, conversion rights, exchange
rights, calls, puts, preemptive rights, rights of first refusal or first offer or other Contracts or commitments of any kind of any character,
written or oral, that could require any Subsidiary of the Company to issue, sell or otherwise cause to become outstanding or to acquire,
repurchase or redeem any Equity Securities or securities convertible into or exchangeable for Equity Securities of the Subsidiaries of
the Company. Except for their respective Governing Documents, there are no voting trusts, proxies or other Contracts with respect to
the voting or transfer of any Equity Securities of any Subsidiary of the Company.
Section 3.3 Authority.
(a) The
Company has the requisite corporate, limited liability or other similar power and authority to execute and deliver this Agreement and
each Ancillary Document to which it is or will be a party, to perform its obligations hereunder and thereunder, and to consummate the
Transactions. Subject to the receipt of the Company Equityholder Approval, the execution, delivery and performance of this Agreement
and the Ancillary Documents to which the Company is or will be a party and the consummation of the Transactions have been (or, in the
case of any Ancillary Document entered into after the date of this Agreement, will be upon execution thereof) duly authorized by all
necessary corporate, limited liability company (or other similar) action on the part of the Company. Except for the Company Equityholder
Approval and the Section 350 Approval, including the completion of the ISA process, no other corporate or equivalent Proceeding
on the part of the Company is necessary to authorize this Agreement or the Ancillary Documents and the Company’s performance hereunder
or thereunder. This Agreement has been and each Ancillary Document to which the Company is or will be a party has been or will be, upon
execution and delivery thereof, as applicable, duly and validly executed and delivered by the Company, and constitutes or will constitute,
upon execution and delivery thereof, as applicable, a valid, legal and binding obligation of the Company (assuming that this Agreement
and the Ancillary Documents to which the Company is or will be a party are or will be upon execution thereof, as applicable, duly authorized,
executed and delivered by the other Persons party hereto or thereto, as applicable), enforceable against the Company in accordance with
their respective terms (subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other Laws
affecting generally the enforcement of creditors’ rights and subject to general principles of equity).
(b) At
a meeting duly called and held, the Company Board has: (i) determined that this Agreement and the Transactions (including the Share
Split and the Equity Exchange) are advisable to and in the best interests of the Company and the Company Shareholders, (ii) approved
the Transactions (including the Share Split and Equity Exchange), and (iii) resolved to recommend to the Company Shareholders each
of the matters set forth in the Company Equityholder Proposals. The Board has recommended that the Company Shareholders approve and adopt
the Business Combination Agreement, the Ancillary Documents and the Transactions (including the Share Split and the Equity Exchange).
There are additional Company Equityholder Proposals that will be formulated in the course of the Section 350 Proceeding, and therefore
the Board will resolve to recommend to the Company Shareholders each of such additional matters set forth in the Company Equityholder
Proposals at a later stage.
(c) The
affirmative vote (in person or by proxy) of the holders of such majority of the outstanding Company Ordinary Shares and such majority
of the Company Shareholders as is, in each case, specified in Section 350 of the ICL, attending the meeting in person or by proxy
is the only vote of the holders of any Company Ordinary Shares necessary (under applicable Law, the Company’s Articles of Association
or otherwise) to consummate the Transactions, including the Equity Exchange.
Section 3.4 Financial
Statements; Undisclosed Liabilities; Company Reporting Reports.
(a) The
Company has made available to SPAC an accurate, true and complete copy of (i) the audited consolidated balance sheets of the Company
as of December 31, 2021 and December 31, 2022 and the related audited statements of operations, changes in shareholders’
equity and cash flows of the Group Companies for each of the periods then ended and (ii) the unaudited consolidated balance sheet
of the Company as of September 30, 2023 (the “Latest Balance Sheet”) and the related unaudited statement of operations,
changes in shareholders’ equity and cash flows of the Group Companies for the nine (9)-month period then ended (clauses (i) and
(ii), collectively, the “Financial Statements”). Each of the Financial Statements (including the notes thereto)
(A) was prepared in accordance with IFRS applied on a consistent basis (except as may be indicated in the notes thereto) throughout
the periods indicated, (B) is based upon and consistent with information contained in the books and records of the Company (which
books and records are in turn accurate, correct and complete) and (C) fairly presents in all material respects the financial position,
results of operations and cash flows of the Group Companies as at the date thereof and for the period indicated therein, except as otherwise
specifically noted therein (subject, in the case of any unaudited interim financial statements, to normal year-end audit adjustments
(none of which is expected to be material) and the absence of footnotes).
(b) Except
(i) as set forth on the face of the Latest Balance Sheet, (ii) for Liabilities incurred in the ordinary course of business
since the date of the Latest Balance Sheet (none of which is a Liability for breach of Contract, breach of warranty, tort, infringement
or violation of Law), (iii) for Liabilities that would not, individually or in the aggregate, reasonably be expected to be material
to the Group Companies, taken as a whole, and (iv) for Liabilities incurred in connection with the negotiation, preparation or execution
of this Agreement or any Ancillary Documents, the performance of their respective covenants or agreements in this Agreement or any Ancillary
Document or the consummation of the Transactions, none of the Group Companies has any Liabilities of the type required to be set forth
on a balance sheet in accordance with IFRS.
(c) The
Group Companies have performed internal accounting controls that are designed to provide, in all material respects, reasonable assurance
that (i) all transactions are executed in accordance with management’s authorization, and (ii) all material transactions
are recorded as necessary to permit preparation of proper and accurate financial statements in accordance with IFRS and to maintain accountability
for the Group Companies’ assets. The Group Companies maintain and, for all periods covered by the Financial Statements, have maintained
books and records of the Group Companies in the ordinary course of business that are accurate and complete and reflect the revenues,
expenses, assets and liabilities of the Group Companies in all material respects.
(d) The
Company has filed or furnished all statements, forms, reports and documents required to be filed or furnished by it prior to the date
of this Agreement with the ISA and the TASE pursuant to ISL and the TASE Laws since its initial public offering on the TASE (collectively,
and together with any exhibits and schedules thereto and other information incorporated therein, and as they have been supplemented,
modified or amended since the time of filing, the “Company ISA Reports”). To the Company’s knowledge, as of
their respective dates of filing, the Company ISA Reports did not contain a misleading detail (prat mat’eh) within the meaning
of the Israeli Securities Law. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received
from the ISA with respect to the Company ISA Reports.
Section 3.5 Consents
and Requisite Governmental Approvals; No Violations.
(a) Except
as set forth on Section 3.5(a) of the Company Disclosure Schedules, no Consent, Permit, approval or authorization of,
or designation, declaration or filing with or notification to, any Governmental Entity is required on the part of the Company with respect
to the Company’s execution, delivery or performance of its obligations under this Agreement or the Ancillary Documents to which
the Company is or will be party or the consummation of the transactions contemplated by this agreement, except for (i) the filing
with the SEC of (A) the Registration Statement / Proxy Statement and the declaration of the effectiveness thereof by the SEC and
(B) any other documents or information required pursuant to applicable requirements, if any, of the Federal Securities Laws, (ii) compliance
with and filings or notifications required to be filed with state securities regulators pursuant to “blue sky” Laws and state
takeover Laws as may be required in connection with this Agreement, the Ancillary Documents or the Transactions, (iii) receipt of
the Israeli Securities Law Approvals, (iv) applicable requirements of and filings under the Israeli Securities Law or any other
similar Laws, (v) compliance and filings with the TASE, the ISA, the ITA, and the Companies Registrar, (vi) the Company Equityholder
Approval, which shall have been secured on or prior to the Equity Exchange Effective Time, and (vii) any other consents, approvals,
authorizations, designations, declarations, waivers or filings, the absence of which would not, individually or in the aggregate, reasonably
be excepted to have a Company Material Adverse Effect. With respect to Sections 3.5(a)(iv), (v) and (vi), the
nature of such approvals, and potentially additional requirements that will be dictated by the Israeli Governmental Entities or the Israeli
courts in order to obtain the Section 350 Approval, will be identified only in the course of the Section 350 Proceeding.
(b) Subject
to the receipt of the Consents, approvals, authorizations and other requirements set forth in Section 3.5(a), neither the
execution, delivery or performance by the Company of this Agreement nor the Ancillary Documents to which the Company is or will be a
party nor the consummation of Transactions will, directly or indirectly (with or without due notice or lapse of time or both), (i) result
in any breach of any provision of any Governing Documents of the Company, (ii) result in a violation or breach of, or constitute
a default or give rise to any right of termination, consent, cancellation, amendment, modification, suspension, revocation or acceleration
(with or without notice) under, any of the terms, conditions or provisions of (A) any Material Contract to which any Group Company
is a party or (B) any Material Permits, (iii) violate, or constitute a material breach under, any Order or applicable Law (and
for the avoidance of doubt, is made under and in compliance with the Israeli Securities Law – 5728 1968) to which any Group Company
or any of their respective properties or assets are bound, (iv) result in the creation of any Lien upon any of the assets or properties
(other than any Permitted Liens) of any Group Company, except, in the case of any of clauses (ii) through (iv) above,
as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect, or (v) result
in the triggering, acceleration or increase of payment to any Person or accelerated vesting of any Company Option.
Section 3.6 Permits.
To the Company’s knowledge, each of the Group Companies has all material Permits that are required to own, lease or operate its
properties and assets and to conduct its business as currently conducted (the “Material Permits”). Except as is not
and would not reasonably be expected to be material to the Group Companies, taken as a whole, (i) each Material Permit is in full
force and effect in accordance with its terms, (ii) no written notice of violation, modification, suspension, revocation, cancellation
or termination of any Material Permit (or proposed revocation, cancellation or termination) has been received by any of the Group Companies,
and (iii) all applications required for the renewal of each such Material Permit have been duly filed with the appropriate Governmental
Entity.
Section 3.7 Material
Contracts; No Defaults.
(a) Section 3.7(a) of
the Company Disclosure Schedules sets forth a list of the following material Contracts to which a Group Company is, as of the date of
this Agreement, a party (each Contract required to be set forth on Section 3.7(a) of the Company Disclosure Schedules,
together with the IP Contracts required to be set forth on Section 3.13(c) of the Company Disclosure Schedules and each
of the Contracts entered into after the date of this Agreement or prior to the Closing in accordance with this Agreement that would be
required to be set forth on Section 3.7(a) or Section 3.13(c) of the Company Disclosure Schedules if
entered into prior to the execution and delivery of this Agreement, collectively, the “Material Contracts”):
(i) all
Contracts with the top ten (10) Group Company customers based on gross revenues made by any Group Company in the fiscal year ending
December 31, 2022 and to those reasonably expected to be the top ten (10) Group Company customers based on gross revenues made
by any Group Company in the fiscal year ending December 31, 2023;
(ii) any
Contract that (A) limits or purports to limit, in any material respect, the freedom of any Group Company to engage or compete in
any line of business or with any Person or in any area, (B) contains any exclusivity, “most favored nation” or similar
provisions, obligations or restrictions or (C) contains any other provisions restricting or purporting to restrict the ability of
any Group Company to sell, manufacture, develop, commercialize, test or research products, directly or indirectly through third parties,
or to solicit any potential employee or customer in any material respect;
(iii) any
Contract requiring any Group Company to guarantee the Liabilities of any Person (other than the Company or a Subsidiary) or pursuant to
which any Person (other than the Company or a Subsidiary) has guaranteed the Liabilities of a Group Company, in each case in excess of
$2,000,000;
(iv) any
Contract containing any indemnification, warranty, support, maintenance, or service that represents a material obligation of a Group Company
other than in the ordinary course of business;
(v) any
Contract relating to Indebtedness in excess of $2,000,000, whether incurred, assumed, guaranteed, or secured by any asset of a Group Company
or the placing of a Lien (other than a Permitted Lien) on any material assets or properties of any Group Company;
(vi) any
Contract under which any Group Company has, directly or indirectly, made or agreed to make any loan, advance, or assignment of payment
to any Person or made any capital contribution to, or other investment in, any Person;
(vii) any
Contract required to be disclosed on Section 3.20 of the Company Disclosure Schedules;
(viii) any
Contract with any Person (A) pursuant to which any Group Company may be required to pay milestones, royalties or other contingent
payments or (B) under which any Group Company grants to any Person any right of first refusal, right of first negotiation, option
to purchase, option to license or any other similar rights with respect to any Company Product or any Company Owned Intellectual Property;
(ix) any
Contract for the disposition of any portion of the assets or business of any Group Company or for the acquisition by any Group Company
of the assets or business of any other Person (other than acquisitions or dispositions made in the ordinary course of business), or under
which any Group Company has any continuing obligation with respect to an “earn-out”, contingent purchase price or other contingent
or deferred payment obligation;
(x) any
(A) material joint venture, profit sharing, partnership, collaboration, co-promotion, commercialization, research or development
Contract or other similar Contract, or (B) other Contract with respect to material Company Licensed Intellectual Property (other
than Off-the-Shelf Software);
(xi) any
CBA;
(xii) any
settlement, conciliation or similar Contract (A) the performance of which would be reasonably likely to involve any payments after
the date of this Agreement, (B) with a Governmental Entity or (C) that imposes any material, non-monetary obligations on any
Group Company;
(xiii) any
Contract (A) governing the terms of the employment, engagement or services of any current director, manager, officer, employee, individual
independent contractor or other service provider of a Group Company whose annual base salary (or, in the case of an independent contractor,
annual base compensation) is in excess of $250,000 (other than offer letters for “at-will” employment that do not provide
for severance, change of control or retention benefits, or similar payments or Liabilities) or (B) providing for any sale, transaction,
change of control, “stay around”, retention or similar bonuses or payments, severance or termination payments or other similar
amounts that accelerate, accrue or become payable to, or in respect of, any current director, manager, officer, employee, individual independent
contractor or other service provider of a Group Company in connection with the Closing;
(xiv) any
Contract under which any Group Company is lessee of or holds or operates, in each case, any tangible property (other than real property),
owned by any other Person, except for any lease or agreement under which the aggregate rental payments do not exceed $250,000;
(xv) any
Contract under which any Group Company is lessor of or permits any third party to hold or operate, in each case, any tangible property
(other than real property), owned or controlled by such Group Company, except for any lease or agreement under which the aggregate annual
rental payments do not exceed $250,000;
(xvi) any
Contract pursuant to which any Group Company is granted a lease in, a sublease in, or the right to use or occupy any land or building;
and
(xvii) any
other Contract the performance of which requires either (A) annual payments to or from any Group Company in excess of $2,000,000
or (B) aggregate payments to or from any Group Company in excess of $5,000,000 over the life of the agreement and, in each case,
that is not terminable by the applicable Group Company without penalty upon less than thirty (30) day’s prior written notice.
(b) Except
as set forth on Section 3.7(a)(i) of the Company Disclosure Schedules, (i) each Material Contract is valid and binding
on the applicable Group Company and, to the knowledge of the Company, the counterparty thereto, and is in full force and effect, subject
in all respects to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other Laws relating to
or affecting creditors’ rights generally and general equitable principles (whether considered in a Proceeding in equity or at law),
(ii) the applicable Group Company and, to the knowledge of the Company, the counterparties thereto are not in material breach of,
or default under, any Material Contract and, to the knowledge of the Company, no event has occurred which, with or without due notice
or lapse of time or both, would become a material breach or default under any Material Contract, and (iii) the applicable Group Company
has not received written notice from any other party to any such Material Contract that such party intends to terminate or not renew any
such Material Contract.
Section 3.8 Absence
of Changes. From the date of the Latest Balance Sheet through the date of this Agreement, (a) no Company Material Adverse Effect
has occurred, and (b) except for actions expressly contemplated by this Agreement or any Ancillary Document or taken in connection
with the Transactions, (i) the Group Companies have conducted their business in the ordinary course of business in all material respects
and (ii) no Group Company has taken any action that (A) would require the consent of SPAC if taken during the period from the
date of this Agreement until the Closing pursuant to Section 5.1(b)(i), Section 5.1(b)(vi) or Section 5.1(b)(vii) or
(B) is or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Section 3.9 Litigation.
There is (and since the Lookback Date there has been) no Proceeding pending or, to the Company’s knowledge, threatened against or
affecting any Group Company or their assets or properties, including any condemnation or similar Proceedings, or against any of the Company’s
officers, directors or employees (in their capacities as officers, directors or employees of the Company), that, if adversely decided
or resolved, has been or would, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. None
of the Group Companies nor any of their respective properties or assets is subject to any material Order. As of the date of this Agreement,
there are no material Proceedings by a Group Company pending against any other Person. There is no unsatisfied judgment or any open injunction
binding upon any Group Company which would, individually or in the aggregate, reasonably be expected to have a Company Material Adverse
Effect.
Section 3.10 Compliance
with Applicable Law. Each Group Company (a) conducts (and since the Lookback Date, has conducted) its business in accordance
with applicable Laws and Orders and is not in violation of any such Law or Order, and (b) to the knowledge of the Company, has not
received any written communications from a Governmental Entity that alleges that such Group Company is not in compliance with any such
Law or Order, except in each case of clauses (a) and (b), as would not, individually or in the aggregate, reasonably
be expected to have a Company Material Adverse Effect. The Company has adhered, in all material respects, with any reporting or any other
obligation vis-à-vis the Israel Innovation Authority (previously known as the Office of the Chief Scientist at the Israeli Ministry
of Economy) and to its knowledge, it has not breached any obligations it may have vis-à-vis the Israel Innovation Authority, inter-alia,
pursuant to the Israeli Encouragement for Industrial R&D Law 1984.
Section 3.11 Employee
Benefit Plans.
(a) Section 3.11(a) of
the Company Disclosure Schedules sets forth a true and complete list of all material Employee Benefit Plans, other than individual agreements
with current or former employees, directors or contractors of the Group Companies. With respect to each material Employee Benefit Plan
sponsored and maintained by the Company, the Group Companies have provided SPAC with true and complete copies of (as applicable): (i) all
current plan documents pursuant to which the plan is maintained and funded (including any trust agreement, insurance contract or other
funding instrument); (ii) the most recent IRS determination or opinion letter (or, for Foreign Benefit Plans, any similar determination
by an applicable Governmental Entity); (iii) the most recent summary plan description distributed to participants; (iv) copies
of the IRS Form 5500 annual report and accompanying schedules for the three most recent plan years; (v) the nondiscrimination
and compliance testing results for the three most recent plan years; and (vi) all material non-ordinary course communications between
the Company and any Governmental Entity sent or received in the last three (3) years.
(b) Except
as set forth in Section 3.11(b) of the Company Disclosure Schedules, neither the Group Companies nor any of their ERISA
Affiliates currently sponsors, maintains or contributes to, nor has, within the past six (6) years, sponsored, maintained or been
required to contribute to, nor has any liability or obligation (contingent or otherwise) under (i) a multiemployer plan (within the
meaning of Section 3(37) or 4001(a)(3) of ERISA), (ii) a single employer pension plan (within the meaning of Section 4001(a)(15)
of ERISA) subject to Section 412 of the Code and/or Title IV of ERISA, (iii) a multiple employer plan within the meaning of
Section 413 of the Code, or (iv) a multiple employer welfare arrangement as defined in Section 3(40) of ERISA.
(c) No
Group Company has any material Liabilities, under any Employee Benefit Plan, Contract or otherwise, to provide any retiree or post-employment
health or life insurance or other welfare-type benefits to any Person except as may be required by applicable Laws.
(d) Neither
the execution and delivery of this Agreement nor the consummation of the Transactions (whether alone or in combination with any other
event(s)) will (i) result in any material payment or benefit becoming due to or result in the forgiveness of any material Indebtedness
of any employee, officer, director or individual independent contractor or consultant of any of the Group Companies (whether current or
former), (ii) require a material contribution or material payment by any of the Group Companies to any Employee Benefit Plan, (iii) result
in any material obligation by the Group Companies to pay separation, severance or termination pay to any current or former employee, officer,
director or individual independent contractor or consultant or (iv) accelerate the time of payment or vesting, or increase the amount,
of any material benefit or other compensation due to any current or former employee, officer, director or individual independent contractor
or consultant.
(e) No
amount that could be, or has been, received (whether in cash or property or the vesting of property or the cancellation of Indebtedness)
by any employee, officer, director, individual independent contractor or other service provider of any of the Group Companies under any
Employee Benefit Plan, Contract or otherwise as a result of the consummation of the Transactions would reasonably be expected, separately
or in the aggregate, to result in the payment of any “excess parachute payment” (as defined in Section 280G(b)(1) of
the Code).
(f) Each
Foreign Benefit Plan that is required to be registered or intended to be Tax exempt or receive favorable Tax treatment has been registered
(and, where applicable, accepted for registration) and satisfies all applicable qualification requirements and has been maintained in
all material respects in good standing, to the extent applicable, with each Governmental Entity. To the knowledge of the Company, all
material contributions required to have been made by or on behalf of the Group Companies with respect to plans or arrangements maintained
or sponsored a Governmental Entity (including severance, termination indemnities or other similar benefits maintained for employees outside
of the U.S.) have been timely made or accrued in accordance with IFRS.
(g) Except
as set forth on Section 3.11(k) of the Company Disclosure Schedules, or as would not reasonably be expected to be material
to the Group Companies, taken as a whole, (i) all employees and (ii) service providers who have access to material confidential
information of the Group Companies have signed engagement agreements or service agreements that contain confidentiality covenants and
(x) all employees and (y) service providers who have been involved in the development of Company Owned Intellectual Property
have signed engagement agreements or service agreements that contain confidentiality and inventions assignment covenants in substantially
the form delivered or made available to SPAC, to the Company’s knowledge, there has been no material breach of a confidentiality,
non-competition and non-solicitation, invention assignment covenants by any current or former employee of the Group Companies with such
assignment agreements conveying and assigning to the respective Group Company effectively assigning ownership of all material Intellectual
Property Rights developed by such individual or entity in the context of his or her engagement by a Group Company, and, to the extent
permissible under applicable Law, has expressly and irrevocably waived any and all moral rights and any right to receive compensation
in connection therewith (in case of Israeli employees, including without limitation, any right of royalties in connection with “Service
Inventions” under Section 134 of the Israeli Patents Law of 1967, or any other similar provision under any applicable). To
the knowledge of the Company, no current employee or consultant of the Group Companies has excluded any works or inventions necessary
for the conduct of the respective Group Companies’ business from his/her/its assignment of inventions to the respective Group Company,
and to the knowledge of the Group Companies, no current employee or consultant of any Group Company is in material violation, of such
proprietary information and invention assignment agreement. No current employee or consultant engaged by the Company who has contributed
to the conception and development of Intellectual Property Rights of the Company has, since the Lookback Date, asserted in writing any
claim against the Company in connection with such Person’s conception and development of any Intellectual Property Rights of the
Group Companies.
(h) Company
Equity Plan. The Company has duly adopted the Company Equity Plan, which constitutes a Foreign Benefit Plan, and a correct and complete
copy of the Company Equity Plan, as well as a form of all option awards thereunder, have been provided to SPAC. The Company Equity Plan
is the only equity-based incentive plan currently in effect with respect to the Company. Section 3.11(l) of the Company
Disclosure Schedules accurately sets forth the following information with respect to each Company Equity Award, as applicable: (i) the
name of the Company Equity Award recipient; (ii) the number of shares of Company Ordinary Shares subject to such Company Equity Award;
(iii) the exercise price of such Company Equity Award; (iv) the date on which such Company Equity Award was granted; (v) the
vesting schedule applicable to such Company Equity Award; and (vi) the date on which such Company Equity Award expires. The Company
Options, Company RSUs and Company Ordinary Shares that were intended to qualify under the capital gains route of Section 102 of the
Ordinance have received a favorable determination or approval letter from, or have otherwise been approved by, or deemed approved by,
the ITA, and such Company 102 Options, Company 102 Restricted Share Units and Company 102 Shares have been granted and/or issued, as applicable,
in compliance with the applicable requirements of Section 102 of the Ordinance and the written requirements and guidance of the ITA,
including the filing of the necessary documents with the ITA, the appointment of an authorized trustee to hold the Company 102 Options,
Company 102 Restricted Share Units and Company 102 Shares, the receipt of all required consents and Tax rulings and the due and timely
deposit of such Company Options, Company RSUs and Company Ordinary Shares with the 102 Trustee pursuant to the terms of Section 102
of the Ordinance and any regulation, publication or guidance issued by the ITA. The Company does not have any liability to the ITA or
to any relevant fund with respect to any Employee Benefit Plan including, without limitation, the Company Equity Plan. The Company has
provided to SPAC true and complete copies of the Company Equity Plan, all forms of award agreements evidencing such Company Equity Awards,
all material communications to or from the ITA or any other Governmental Entity relating to the Company 102 Options, Company 102 Restricted
Share Units and Company 102 Shares. Each Company Equity Award was duly authorized in all material respects by all necessary corporate
action, including, as applicable, approval by the Company Board and any required shareholder approval by the necessary number of votes
or written consents, and the award agreement governing such grant (if any) was executed and delivered by each party thereto. No Company
Equity Award granted to a recipient that is a United States taxpayer (A) has been granted with an exercise price that is no less
than the fair market value of the underlying Company Ordinary Shares on the date of grant, as determined in accordance with Section 409A
of the Code if applicable and (B) that is intended to qualify as an “incentive stock option” under Section 422 of
the Code so qualifies. Without derogating from the representations and warranties under this Section 3.11(l), all adjustments
or amendments that were made, including to the exercise price, exercise period, vesting schedule or any other material term of any Company
Options or Company RSUs previously awarded, whether through amendment, cancellation, replacement grant, re-pricing, or any other means
in a manner, were made following receipt of any required approvals, inter alia, by the Company Board or Company Shareholders.
Section 3.12 Environmental
Matters.
(a) The
representations and warranties set forth in this Section 3.12 are the sole and exclusive representations and warranties relating
to environmental matters, including Environmental Laws, Environmental Conditions, and Hazardous Substances.
(b) Except
as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect:
(i) To
the knowledge of the Company, none of the Group Companies have received any written notice from any Governmental Entity or any other Person
regarding any actual, alleged, or potential violation of, or a failure to comply with, any Environmental Laws.
(ii) There
is (and since the Lookback Date, or earlier to the extent unresolved, there has been) no Proceeding pending or, to the Company’s
knowledge, threatened in writing against or involving any Group Company pursuant to Environmental Laws.
(iii) To
the knowledge of the Company, there has been no manufacture, release, treatment, storage, disposal, arrangement for disposal, transport
or handling of, or exposure of any Person to, any Hazardous Substances by any Group Company, other than in compliance with Environmental
Laws.
(c) The
Group Companies have made available to SPAC copies of all material environmental, health and safety reports that are in any Group Company’s
possession or control relating to the Environmental Condition of current or former operations, properties or facilities of the Group Companies.
Section 3.13 Intellectual
Property.(a) Section 3.13(a) of
the Company Disclosure Schedules sets forth a true and complete list of (i) all material issued, registered or pending material Company
Registered Intellectual Property and (ii) all material, unregistered Marks included as Company Owned Intellectual Property as of
the date of this Agreement. The Group Companies solely and exclusively own the Company Owned Intellectual Property free and clear of all
Liens (other than Permitted Liens), except as would not reasonably be expected to be material to the Group Companies, taken as a whole.
To the Company’s knowledge, as of the date of this Agreement, no issuance or registration obtained and no application filed by the
Group Companies for any material Company Registered Intellectual Property has been cancelled, abandoned, allowed to lapse or not renewed.
With respect to each item of Company Registered Intellectual Property, all necessary registration, maintenance and renewal fees in connection
with such Company Registered Intellectual Property have been paid and all necessary documents and articles in connection with such Company
Registered Intellectual Property have been filed with the relevant patent, copyright, trademark or other authorities in all relevant jurisdictions
for the purposes of maintaining such Company Registered Intellectual Property. There are no actions that must be taken by the Company
within one hundred and eighty (180) days of the Closing Date, including the payment of any registration, maintenance or renewal fees or
the filing of any documents, applications or articles for the purposes of maintaining, perfecting or preserving or renewing any Company
Registered Intellectual Property. None of the Company has claimed “small business status” or other special status in the application
for or registration of any Company Registered Intellectual Property. All Company Registered Intellectual Property is subsisting and, to
the Company’s knowledge, valid and enforceable, and to the Company’s knowledge, as of the date of this Agreement, there are
no Proceedings pending challenging the ownership, validity or enforceability of any Company Owned Intellectual Property, and, to the Company’s
knowledge, no such Proceedings are threatened by any Person. Except as set forth in Section 3.13(a)of the Company Disclosure
Schedules, Company has not granted any exclusive license of or exclusive right to use, or granted any exclusive rights in or to joint
ownership of, any Company Owned Intellectual Property to any other Person. All Company Owned Intellectual Property is fully transferable,
alienable and licensable by the Company without restriction and without payment of any kind to any Person. The Company maintains its Company
Registered Intellectual Property on an ongoing basis.
(b) Except
as set forth in Section 3.13(b) of the Company Disclosure Schedules, a Group Company exclusively owns (free and clear
of all Liens, except Permitted Liens) all right, title and interest in and to, or has a valid and enforceable right to use, all Intellectual
Property Rights used in or necessary for the operation of the Group Companies’ business as presently conducted, except as would
not reasonably be expected to be material to the Group Companies, taken as a whole. To the Company’s knowledge, neither the execution,
delivery or performance by the Company to this Agreement nor the Ancillary Documents to which the Company is or will be a party nor the
consummation of the Transactions will, directly or indirectly (with or without reasonable due notice or lapse of time or both) result
in the loss, termination or impairment of any material Company Owned Intellectual Property or material Company Licensed Intellectual Property.
(c) Section 3.13(c) of
the Company Disclosure Schedules sets forth a list of all current Contracts (i) pursuant to which any Group Company licenses, or
is otherwise granted a right to use, any material Company Licensed Intellectual Property that is licensed for a one-time or annual fee
greater than $200,000, other than (A) Standard Inbound Licenses, (B) Public Software licenses, and (C) non-disclosure agreements,
(ii) pursuant to which any Group Company is a licensor or otherwise grants to a third party any rights to use any material Intellectual
Property Rights (other than Intellectual Property Rights licensed to customers or suppliers on a non-exclusive basis in the ordinary course
of business), (iii) that contemplate development of material Company Owned Intellectual Property (other than agreements with employees,
individual consultants or contractors of any Group Company that do not materially differ from the Group Companies’ form(s) therefor
that have been made available to SPAC) or (iv) pursuant to which any Group Company has agreed to, or assumed, any obligation or duty
to warrant, indemnify, reimburse, hold harmless, guaranty or otherwise assume or incur any obligation or liability or provide a right
of rescission in connection with the Company Owned Intellectual Property or Company Product (other than customer licenses in the ordinary
course of business) (clauses (i)-(iv) collectively, the “IP Contracts”).
(d) Except
as would not reasonably be expected to be material to the Group Companies, taken as a whole, to the Company’s knowledge, all Persons
including each Group Company’s employees, consultants, and independent contractors who independently or jointly contributed to or
otherwise participated in the authorship, invention, creation, improvement, modification or development of any Company Owned Intellectual
Property (each such person, a “Creator”) have (i) agreed to maintain the confidentiality of the material trade
secrets of the applicable Group Companies and (ii) assigned to such Group Company by way of present assignment exclusive ownership
of all Intellectual Property Rights authored, invented, created, improved, modified, or developed by such Person on behalf of a Group
Company in the course of such Creator’s employment or other engagement with such Group Company.
(e) There
are no current or, to the Company’s knowledge, threatened, claims from any Creator for compensation or remuneration for inventions
invented, copyright works created or any similar claim, including under Israeli Patents Law, 1967.
(f) Each
Group Company has taken reasonable steps to safeguard, protect and maintain the confidentiality and secrecy of any material trade secrets
contained in the Company Owned Intellectual Property. To the Company’s knowledge, (i) there has been no unauthorized access
to or disclosure of any trade secrets owned by a Group Company, (ii) except as would not reasonably be expected to be material to
the Group Companies, taken as a whole, none of the confidential Company Owned Intellectual Property has been disclosed by Group Company
to any third party except pursuant to appropriate non-disclosure or license agreements governing the use thereof, and (iii) no officer,
employee, contractor, consultant or agent of any Group Company has misappropriated any trade secrets or other confidential information
of any other third party in the course of the performance of her, his or its respective duties for a Group Company.
(g) No
facilities of a university, college, other educational institution or research center was used in the development of material Company
Owned Intellectual Property. To the knowledge of the Company, no employee, consultant or independent contractor of the Company who was
involved in, or who contributed to, the creation or development of any Company Owned Intellectual Property, has performed services for
or otherwise was under restrictions resulting from his/her relations with any government, university, college or other educational institution
or research center during a period of time during which any Company Owned Intellectual Property were created or during such time that
such employee, consultant or independent contractor was also performing services for or for the benefit of the Company, nor has any such
Person created or developed any Company Owned Intellectual Property with any Governmental Grant.
(h) To
the Company’s knowledge, (i) the Group Companies are not infringing, diluting, misappropriating, or otherwise violating, and
have not in the past four (4) years infringed, diluted, misappropriated or otherwise violated materially any Intellectual Property
Rights of any other Person, (ii) none of the Company Owned Intellectual Property has been adjudged invalid or unenforceable, in whole
or in part, and (iii) no facts or circumstances exist that would render any Company Owned Intellectual Property invalid or unenforceable.
There is no Proceeding pending or initiated, nor to the Company’s knowledge has any Proceeding been threatened, in the past four
(4) years, alleging that a Group Company has infringed, misappropriated, diluted or otherwise violated any Intellectual Property
Rights of any other Person. To the Company’s knowledge, no Person is infringing, misappropriating, diluting or otherwise violating
any Company Owned Intellectual Property. To the Company’s knowledge, no present or former officer, director, employee, agent, outside
contractor, or consultant of any Group Company holds any right, title or interest, directly or indirectly, in whole or in part, in or
to the Company Owned Intellectual Property, except as would not reasonably be expected to be material to the Group Companies, taken as
a whole. No steps exist that are necessary to protect the Company Owned Intellectual Property which have not been taken, which if not
taken would adversely impact the status or existence of the Company Owned Intellectual Property. In each case in which the Company has
acquired (or purported to acquire) any Intellectual Property from any Person (including any contractor or consultant), the Company has
properly obtained and transferred all rights in such Intellectual Property (including the right to seek past and future damages with respect
thereto) to the Company and, to the maximum extent provided for by, and in accordance with, applicable Laws, the Company has recorded
each such assignment with the relevant patent, copyright, trademark or other authorities in the United States or foreign jurisdictions,
as the case may be.
(i) To
the Company’s knowledge, a Group Company possesses all source code and other documentation and materials necessary to compile and
operate the Company Products. No Group Company has disclosed or delivered to any escrow agent or any other Person, other than employees
or contractors who are subject to written agreement imposing confidentiality obligations, any of the source code that is material Company
Owned Intellectual Property, and, to the Company’s knowledge, no other Person has the right, contingent or otherwise, to obtain
access to or use any such source code. To the Company’s knowledge, no event has occurred, and no circumstance or condition exists,
that (with or without notice or lapse of time or both) would reasonably be expected to, result in the delivery, license or disclosure
of any source code that constitutes material Company Owned Intellectual Property to any Person who is not, as of the date the event occurs
or circumstance or condition comes into existence, a current employee or contractor of a Group Company subject to confidentiality obligations
with respect thereto. No Group Company is under any obligation, whether written or otherwise, to develop any Intellectual Property Rights
(including any element of any Company Product) for any third party.
(j) Except
as would not reasonably be expected to be material to the Group Companies, taken as a whole, no Group Company accesses, uses, modifies,
or links to, nor has accessed, used, modified, linked to, or created derivative works of any Public Software in a manner which would subject
any Company Owned Intellectual Property to any obligations set forth in the license for such Public Software, that (i) require any
Company Owned Intellectual Property to be licensed, sold, disclosed, distributed, hosted or otherwise made available, including in source
code form and/or for the purpose of making derivative works, for any reason, or (ii) grant, or require any Group Company to grant,
the right to decompile, disassemble, reverse engineer or otherwise derive the source code or underlying structure of any Company Owned
Intellectual Property.
(k) Section 3.13(k) of
the Company Disclosure Schedules lists all the IT Assets that are material to the operation of the business of the Group Companies. To
the Company’s knowledge, the Group Companies own, lease, license, or otherwise have the legal right to use all IT Assets. Such IT
Assets are sufficient in all material respects for the current and reasonably anticipated needs of the Group Companies’ business.
The IT Assets operate and perform, in all material respects, as required by the Group Companies. Each Group Company has taken commercially
reasonable actions designed to protect the security of the IT Assets, including by implementing procedures designed to inhibit unauthorized
access and the introduction of any Malicious Code. The Group Companies have implemented and maintain reasonable security, disaster recovery
and business continuity plans and procedures. The Group Companies’ use of each IT Asset does not exceed the scope of the rights
granted to the Group Company with respect thereto, including any applicable limitation upon the usage, type or number of licenses, users,
hardware, time, services or systems.
(l) None
of the proprietary software owned by any Group Company and included in the Company Owned Intellectual Property, including any technical
documentation, specifications, manuals, user guides, promotional material or other written materials related to the Company Owned Intellectual
Property (the “Proprietary Software”) or the IT Assets owned by the Group Companies, to the Company’s knowledge,
as of the date of this Agreement, contain any Malicious Code that would reasonably be expected to, materially disrupt, disable, erase,
or grant unauthorized access to, or harm such Proprietary Software’s or IT Asset’s operation or any other associated Software,
firmware, hardware, computer system or network. To the Company’s knowledge, none of the Proprietary Software contains any bug, defect
or error that (x) adversely affects the functionality or performance of such Proprietary Software or (y) fails to comply with
any written contractual commitment legally binding on the Group Companies relating to the functionality or performance of such Proprietary
Software, in each case (x) and (y), except as would not, individually or in the aggregate, reasonably be expected to have a Company
Material Adverse Effect.
(m) To
the Company’s knowledge, since the Lookback Date, there has been no actual or alleged data security breach, or unauthorized access
to, the IT Assets which resulted in the unauthorized, use, access, deletion, modification, or corruption of any material information or
material data contained therein.
(n) No
Governmental Entity has any government purpose rights in any Intellectual Property Rights of any Company Product, which could reasonably
be expected to diminish the ability of the Group Companies to sell such products to a Governmental Entity or otherwise commercialize such
Company Product in any material respect.
(o) Section 3.13(o) of
the Company Disclosure Schedules sets forth (i) a true and complete list of all items of material Company Owned Intellectual Property
that were developed or derived, in whole or in part, from grants provided by, or are subject to restrictions, constraint, control, supervision,
or limitation imposed by, the Israel Innovation Authority (“IIA”) under the Innovation Law with respect to “know-how”
developed using a grant provided by the IIA (“IIA Funded Technology”).
(p) Except
as set forth on Section 3.13(p) of the Company Disclosure Schedules, the Company does not have any obligations
to the IIA (including any payment or royalties) nor has it applied for any grants from the IIA which has not been repaid in full or terminated.
(q) Except
as set forth on Section 3.13(o) of the Company Disclosure Schedules, there are no restrictions on transferring or pledging
any Company Owned Intellectual Property or manufacturing any Company Owned Intellectual Property outside of Israel, nor is any approval
required from the IIA for any of the Transactions.
(r) Except
as set forth on Section 3.13(r) of the Company Disclosure Schedules, there are no pending, outstanding
and granted grants and incentives from the IIA, granted to the Company (“IIA Grants”) with respect to IIA Funded Technology.
(s) Accurate
copies of all letters of approval, certificates of completion, supplements and amendments thereto and any other documentation granted
or issued to the Company in connection with any IIA Grants were previously made available to the SPAC. The Company is in material compliance
with the terms and conditions of all IIA Grants which have been approved and the laws, rules and guidelines applicable thereto, and
has duly fulfilled in all material respects all the undertakings required thereby and does not have any monetary debts to the IIA. The
IIA Grants are not subject to annulment, revocation, withdrawal, suspension, cancellation, recapture or modification, and there is no
outstanding requirement that the Company return or refund any benefits provided under any IIA Grant.
(t) Section 3.13(t) of
the Company Disclosure Schedules contains a complete and accurate list (by name and version number) of all Company Products and identifies,
for each Company Product, whether the Company provides support or maintenance for such Company Product.
(u) Company
has the right to use all software development tools, software development kits, library functions, compilers, application programming
interfaces, and all other third-party Software that is used in the operation of the business of any Group Company or that is required
to create, modify, compile, operate or support any Software that is incorporated into any Company Product.
(v) Each
of the Group Companies and all of the Company Products comply in all respects with the applicable terms of use, and other applicable terms
and conditions governing the use of, social media websites (e.g., Facebook, X).
Section 3.14 Privacy.
(a) The
Group Companies and the conduct of their businesses are in material compliance with, and, since the Lookback Date, have been in material
compliance with all Data Security Requirements. To the knowledge of the Company, the Transactions will not result in any liabilities in
connection with any Data Security Requirements, except as would not, individually or in the aggregate, reasonably be expected to have
a Company Material Adverse Effect.
(b) The
Company has provided to SPAC true and correct copies of all material currently operative privacy policies adopted by the Group Companies
in connection with their operations. To the Company’s knowledge, each Group Company has, since the Lookback Date, materially implemented
and maintains physical and technical data security measures applicable to the Processing of Personal Information that are reasonably consistent
with (i) reasonable practices in the industry in which such Group Company operates; and (ii) any existing and currently effective
written contractual commitment made by such Group Company that is applicable to the Processing of Personal Information; in each case of
(i) and (ii) that are intended to protect the integrity, security and operations of such Group Company’s IT Assets (and
data therein) against loss, theft, unauthorized access or acquisition, modification, disclosure, corruption, or other unauthorized misuse.
(c) To
the Company’s knowledge, except as would not reasonably be expected to be material to the Group Companies, taken as a whole, none
of the Group Companies has, since the Lookback Date, received any subpoenas, demands or other notices from any Governmental Entity or
other private entity investigating, inquiring into, or otherwise relating to any actual or potential violation of any Data Security Requirements
and to Company’s knowledge, no Group Companies are under investigation by any Governmental Entity or other private entity for any
actual or potential violation of any Data Security Requirements, or alleged violations of Laws with respect to Personal Information possessed
by, for or on behalf of the Group Companies. No written notice, complaint, claim, enforcement action, or litigation has been served on,
or, to the Company’s knowledge, initiated against any of the Group Companies alleging any material violations of any Data Security
Requirements.
Section 3.15 Labor
Matters; Independent Contractors.
(a) None
of the Group Companies (A) has any material Liability for any arrears of wages or other compensation (including salaries, wage premiums,
commissions, fees or bonuses) to their current or former employees and independent contractors under applicable Law, Contract or Group
Company policy or any penalty or other sums for failure to comply with any of the foregoing, or (B) has any material Liability for
any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Entity with respect to unemployment
compensation benefits, social security, social insurances or other benefits or obligations for any employees of any Group Company (other
than routine payments to be made in the normal course of business and consistent with past practice). No officer of a Group Company is
under notice of termination and there are no proposals for such termination or to materially change any terms of employment of any such
officer. The Group Companies have withheld all amounts required by applicable Law or by agreement to be withheld from wages, salaries
and other payments to employees or independent contractors or other service providers of each Group Company, except as has not and would
not reasonably be expected to result in, individually or in the aggregate, material Liability to the Group Companies.
(b) Since
the Lookback Date, there are no, and there have been no unfair labor practice charges, material grievances, arbitrations, strikes, lockouts,
work stoppages, slowdowns, picketing, hand billing or other material labor disputes against or affecting any Group Company in any material
respect.
(c) To
the Company’s knowledge, since the Lookback Date, there are, and there have been, no actual or threatened union, works council,
employee representative or similar labor organizing activities with respect to any employees of any Group Company.
(d) No
Group Company has, since the Lookback Date, incurred any material Liability with respect to any sexual harassment, discrimination, or
retaliation allegations and, to the Company’s knowledge, there have been no such allegations relating to executive officers or directors
of any Group Company, that, if known to the public, would bring the Group Companies into material disrepute.
(e) The
Group Companies have not experienced any material employment-related Liability with respect to or arising out of any Law, Order, directive
or published guidelines by any Governmental Entity in connection with or in response to COVID-19.
(f) Except
as set forth on Section 3.15(f) of the Company Disclosure Schedule, no employee or consultant of the Company has been
granted the right to any special payment triggered at termination or resignation, other than (i) in accordance with the requirements
of Law and (ii) in excess of three (3) months’ salary. No employees of the Company (in their capacity as such) are represented
by any labor union, or subject to any CBA or extension order, except for certain provisions from CBAs incorporated into Israeli Labor
Law by an extension order (צו הרחבה) that generally apply to all employees in Israel
nor, to the Company’s knowledge, are there any union organization activities pending or threatened by the Company’s employees.
(g) Since
the Lookback Date, the Company has complied in all material respects with all labor and social security laws, procedures and agreements,
relating to employment, terms and conditions of employment and all individual or collective labor agreements and internal regulations,
including without limitation, those relating to wages, hours, vacations and working conditions for its employees, equal opportunity, employment
discrimination, disability, civil rights, fair labor standards, occupational safety and health, workers’ compensation, immigration,
and provisions under the Prior Notice to the Employee Law, 2002, the Notice to Employee (Terms of Employment) Law, 2002, the Prevention
of Sexual Harassment Law, 1998, the Hours of Work and Rest Law, 1951, the Annual Leave Law, 1951, the Employment by Human Resource Contractors
Law, 1996, the Advance Notice for Dismissal and Resignation Law, 2001, the Salary Protection Law, 1958, the Law of Increased Enforcement
of Labor Laws, 2011, and wrongful discharge, and to the proper withholding and remission to the proper Tax and other authorities of all
sums required to be withheld from employees under applicable Laws respecting such withholding.
(h) Since
the Lookback Date, each Person who has provided services to the Company and was classified and treated as an independent contractor, consultant,
leased employee, volunteer, or other non-employee service provider was to the Company’s knowledge properly classified and treated
as such for all applicable purposes under applicable Law. Each Contract with such Person contains provisions which state that no employer-employee
relations exist between such consultant or contractor and the Company. Since the Lookback Date, no Company contractor and consultant or
former Company contractor and consultant has issued to the Company a written notice of a claim or any other allegation that such contractor
and/or consultant was not rightly classified as an independent contractor.
Section 3.16 Insurance.
Section 3.16 of the Company Disclosure Schedules sets forth a list of all material policies of fire, liability, workers’
compensation, property, casualty, umbrella, crime, fiduciary, employment practices, directors and officers, cyber, and other forms of
insurance owned or held by any Group Company as of the date of this Agreement. Such policies, with respect to their amounts and types
of coverage, are adequate to insure the Group Companies in all material respects against reasonably foreseeable material risks to which
the Group Companies are exposed in the operation of their respective businesses. Except as set forth on Section 3.16 of the
Company Disclosure Schedules, all such policies are in full force and effect and all premiums due and payable thereon as of the date of
this Agreement have been paid in full as of the date of this Agreement, and true and complete copies of all such policies have been made
available to SPAC. No Group Company has received any written notice of cancellation of any such material insurance policies. As of the
date of this Agreement, and to the knowledge of the Company, no claim by any Group Company is pending under any such material policies
as to which coverage has been denied or disputed, or rights reserved to do so, by the underwriters thereof, except as is not and would
not reasonably be expected to be, individually or in the aggregate, material to the Group Companies, taken as a whole.
Section 3.17 Tax
Matters.
(a) Each
Group Company has timely filed, or caused to be timely filed, all income and other material Tax Returns required to be filed by it (taking
into account all available extensions) and such Tax Returns true, accurate, correct and complete in all material respects. Each Group
Company has timely paid, or caused to be paid, all material Taxes required to be paid, other than such Taxes for which adequate reserves
have been established in accordance with IFRS.
(b) Each
Group Company has complied in all material respects with all applicable Tax Laws relating to withholding and remittance of all material
amounts of Taxes, and all material amounts of Taxes required by applicable Tax Laws to be withheld by any Group Company have been withheld
and timely paid over to the appropriate Governmental Entity.
(c) Except
as set forth on Section 3.17(c) of the Company Disclosure Schedules, there are no material claims, assessments, audits,
examinations, investigations or other Proceedings pending, in progress or threatened in writing against any Group Company in respect of
any material Taxes, and no Group Company has been notified in writing of any material proposed Tax claims or assessments against any Group
Company (other than claims or assessments that have been settled or resolved).
(d) There
are no material Liens with respect to any Taxes upon any Group Company’s assets, other than Permitted Liens. No Group Company has
any outstanding waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding
requests by any Group Company for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to
be due in any Tax Return (other than an automatic extension of time not requiring the consent of the applicable Governmental Entity).
(e) No
Group Company has any Liability for the Taxes of another Person (other than any Group Company) pursuant to Treasury Regulations Section 1.1502-6
(or any similar provision of state, local or non-U.S. Tax law), as a transferee or successor, by contract or otherwise (in each case,
other than any customary commercial agreement, contract or arrangement entered into in the ordinary course of business and the principal
purpose of which does not relate to Taxes). No Group Company is a party to or bound by any Tax indemnity agreement, Tax sharing agreement,
Tax allocation agreement or similar agreement, arrangement or practice with respect to Taxes (including closing agreement or other agreement
relating to Taxes with any Governmental Entity) (other than any (i) such agreement with respect to which any of the Group Companies
are the only parties, or (ii) customary commercial agreement, contract or arrangement entered into in the ordinary course of business
and the principal purpose of which does not relate to Taxes).
(f) Any
Group Company required to be registered for purposes of Israeli value added Tax is duly registered and has complied with all requirements
concerning Israeli value added Tax (“VAT”).
(g) No
Group Company has engaged in or entered into a “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4(b)(2) or
any similar provision of state, local or non-U.S. Tax Law.
(h) No
Group Company has received a written notice from a Governmental Entity in a jurisdiction where a Group Company does not file Tax Returns
that such Group Company is or may be subject to Tax by that jurisdiction.
(i) During
the two (2)-year period ending on the date of this Agreement, no Group Company was a distributing corporation or a controlled corporation
in a transaction purported or intended to be governed by Section 355 of the Code.
(j) Each
Group Company is in compliance in all material respects with all applicable transfer pricing laws and regulations, and the prices for
any property or services provided by or to any Group Company are arm’s length prices for purposes of the applicable Laws, including
Treasury Regulations promulgated under Section 482 of the Code and Section 85A to the Ordinance and the Income Tax Regulations
(Determination of Market Terms) 2006.
(k) Each
Group Company is Tax resident only in its country of incorporation, formation or organization, as applicable.
(l) Except
as set forth on Section 3.17(l) of the Company Disclosure Schedules, no Group Company (i) owns any “Approved
Enterprise”, “Benefitted Enterprise” or “Preferred Enterprise,” as each such term is defined in the Israeli
Law for Encouragement of Capital Investments, 1959, or (ii) is subject to any restrictions or limitations pursuant to Part E2
of the Ordinance or pursuant to any tax ruling made with reference to the provisions of Part E2.
(m) The
Group Companies are in compliance with the terms, conditions and requirements of their Governmental Grants and have duly fulfilled all
the undertakings relating thereto. The Group Companies are in compliance with all conditions and requirements stipulated by the instruments
of approval granted to it.
(n) The
Company has never been at any time a “real property” company (Igud Mekarkein) as such term is defined in the Israeli
Real Property Taxation Law (Capital Gain, Sale and Purchase), 1963.
(o) Neither
the Company nor any of its Subsidiaries participated or engaged in any transaction listed in Section 131(g) of the Ordinance
and the Israeli Income Tax Regulations (Reportable Tax Planning), 2006 promulgated thereunder. The Company does not and has never taken
a tax position that is subject to reporting under Section 131E of the Ordinance. The Company has never obtained a legal or Tax opinion
that is subject to reporting under Section 131D of the Ordinance.
(p) The
Company is not a “surrogate foreign corporation” or “expatriated entity” within the meaning of Section 7874
of the Code or treated as a U.S. corporation for U.S. federal income tax purposes by reason of the application of Section 7874(b) of
the Code.
(q) No
Group Company has taken or agreed to take any action not contemplated by this Agreement and/or any Ancillary Documents that could reasonably
be expected to prevent the Merger or the Equity Exchange from qualifying for the Intended U.S. Tax Treatment. To the knowledge of the
Company, no facts or circumstances exist that could reasonably be expected to prevent the Merger or the Equity Exchange from qualifying
for the Intended U.S. Tax Treatment.
Section 3.18 Brokers.
Except for fees (including the amounts due and payable assuming the Closing occurs) set forth on Section 3.18 of the Company
Disclosure Schedules (which fees shall be the sole responsibility of the Company, except as otherwise provided in Section 8.6),
no broker, finder, investment banker or other Person is entitled to any brokerage fee, finders’ fee or other commission in connection
with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company or any of its Affiliates
for which any of the Group Companies has any obligation.
Section 3.19 Real
and Personal Property.
(a) Owned
Real Property. No Group Company owns a fee interest in any real property.
(b) Leased
Real Property. Section 3.18(b)(i) of the Company Disclosure Schedules sets forth a true and complete list (including
street addresses) of all real property leased, subleased, or similarly used or occupied by any of the Group Companies (the “Leased
Real Property”) and all Real Property Leases pursuant to which any Group Company is a tenant or landlord as of the date of this
Agreement. True and complete copies of all such Real Property Leases (including, for the avoidance of doubt, all amendments, extensions,
renewals, guaranties and other material agreements with respect thereto) have been made available to SPAC. Each Real Property Lease has
been duly authorized and executed by the applicable Group Company party thereto, is in full force and effect, and is a valid, legal and
binding obligation of the applicable Group Company party thereto, enforceable in accordance with its terms against such Group Company
and, to the Company’s knowledge, each other party thereto (subject to applicable bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium or other Laws affecting generally the enforcement of creditors’ rights and subject to general principles
of equity). There is no material breach or default by any Group Company or, to the Company’s knowledge, any counterparty or third-party
under any Real Property Lease, and, to the Company’s knowledge, no event has occurred which (with or without notice or lapse of
time or both) would constitute a material breach or default or would permit termination of, or a material modification or acceleration
thereof by any party to such Real Property Leases. Except as set forth on Section 3.18(b)(ii) of the Company Disclosure
Schedules, with respect to each of the Real Property Leases: (i) the possession and quiet enjoyment of the Leased Real Property by
the applicable Group Company party thereto under such Real Property Lease has not been disturbed, and to the Company’s knowledge,
there are no disputes with respect to such Real Property Lease; (ii) the applicable Group Company party thereto has not subleased,
licensed or otherwise granted any Person the right to use or occupy such Leased Real Property or any portion thereof; and (iii) the
applicable Group Company party thereto has not collaterally assigned or granted any other security interest in such Real Property Lease
or any interest therein. The Leased Real Property comprises all of the real property used or intended to be used in, or otherwise related
to, the business of the Group Companies. No representation or warranty is made herein regarding the status of the fee title (and any matters
pertaining to such fee title) of any real property subject to any Real Property Lease; it being understood and agreed that the provisions
of this Section 3.19(b), as they relate to any Leased Real Property, pertain only to the leasehold interest of the applicable
Group Company.
(c) Personal
Property. Each Group Company has good, marketable and indefeasible title to, or a valid leasehold interest in or license or right
to use, all of the material assets and properties of the Group Companies reflected in the Financial Statements or thereafter acquired
by the Group Companies, except for assets disposed of in the ordinary course of business.
(d) Assets.
Immediately after the Equity Exchange Effective Time, the assets (which, for the avoidance of doubt, shall include any assets held pursuant
to valid leasehold interest, license or other similar interests or right to use any assets) of the Group Companies will constitute all
of the assets necessary to conduct the business of the Group Companies immediately after the Closing in materially the same manner (for
the Group Companies, taken as a whole) as it is conducted on the date of this Agreement.
Section 3.20 Transactions
with Affiliates. Section 3.20 of the Company Disclosure Schedules sets forth all Contracts between any Group Company,
on the one hand, and any officer, director, employee, partner, member, manager, direct or indirect equityholder or Affiliate of any Group
Company or any family member of the foregoing Persons, on the other hand (each Person identified in this clause, a “Company Related
Party”), other than (i) Contracts with respect to a Company Related Party’s employment or other similar engagement
with (including benefit plans and other ordinary course compensation from) any of the Group Companies entered into in the ordinary course
of business, (ii) Contracts with respect to a Company Shareholder’s or a holder of Company Equity Awards’ status as a
holder of Equity Securities of the Company and (iii) Contracts entered into after the date of this Agreement that are either permitted
pursuant to Section 5.1(b) or entered into in accordance with Section 5.1(b). All Contracts, arrangements,
understandings, interests and other matters that are required to be disclosed pursuant to this Section 3.20 are referred to
herein as “Company Related Party Transactions.” All of the Company Related Party Transactions that required approvals
pursuant to Sections 268 to 284 of the Israeli Companies Law, or pursuant to the Governing Documents of the Company have been duly approved.
To the Company’s knowledge, no officer or director of any Group Company: (i) has any direct or indirect financial interest
in, or is an officer, director, manager, employee or consultant of, (A) any competitor, supplier, licensor, distributor, lessor,
independent contractor or customer of any Group Company or (B) any other entity in any business arrangement or relationship with
any Group Company; provided, however, for purposes of the foregoing clauses (A) and (B), that the ownership
of securities listed on any national securities exchange representing less than five (5%) of the outstanding voting power of any Person
shall not be deemed to be a “financial interest” in any such Person; (ii) has any interest in any property, asset or
right used by the Group Company for the business; (iii) has outstanding any Indebtedness owed to any Group Company; or (iv) has
received any funds from the Group Company since the date of the Latest Balance Sheet, except for employment-related compensation received
in the ordinary course of business.
Section 3.21 Compliance
with International Trade & Anti-Corruption Laws.
(a) Since
January 1, 2019, and except where the failure to be, or to have been, in compliance with such Laws has not been or would not, individually
or in the aggregate, reasonably be expected to be material to the Company taken as a whole, neither the Group Companies nor, to the Company’s
knowledge, any of their Representatives, or any other Persons acting for or on behalf of any of the foregoing, (i) is or has been
a Sanctioned Person, nor (ii) has engaged or is engaging in any dealings or transactions with, or for the benefit of, any Sanctioned
Person or in any Sanctioned Country.
(b) Since
January 1, 2019, and except where the failure to be, or to have been, in compliance with such Laws has not been or would not, individually
or in the aggregate, reasonably be expected to be material to the Company taken as a whole, to the Company's knowledge, the Group Companies
have been in compliance with applicable Sanctions and Trade Control Laws, including (i) having engaged or is engaging in any business
dealings within the scope of any required licenses or authorizations under Sanctions and Trade Control Laws, (ii) having sourced
and imported inventory, materials, and other goods in compliance with Sanctions and Trade Control Laws, and (iii) having paid in
full any material customs duties, fees, assessments, charges and other Taxes or other payments of any kind owed with respect to the Group
Companies’ export, import, or manufacturing activities.
(c) Neither
the Group Companies, their directors or officers, nor, to the Company’s knowledge, any of their employees, agents, or any other
Persons acting for or on behalf of any of the Group Companies has, directly or knowingly indirectly (i) made, offered, promised,
authorized, paid or received any unlawful bribes, kickbacks, gifts, contributions, payment, or other similar benefits to or from any Person,
(ii) made, offered, promised, authorized or paid any unlawful contributions to a domestic or foreign political party, office, or
candidate (iii) otherwise made, offered, promised, authorized, paid or received any improper payment in violation of any Anti-Corruption
Laws, (iv) established or maintained any unrecorded fund or asset or made any false entries in any books or records for any purpose,
(v) has established or maintained, or is maintaining, any unlawful fund of corporate monies or other properties; or (vi) has
violated or is violating any Anti-Corruption Laws.
(d) To
the knowledge of the Company, there is no current investigation, allegation, request for information, or other inquiry by any Governmental
Entity regarding the actual or possible violation of the Anti-Corruption Laws, Sanctions, or Trade Control Laws by any Group Company and
since the Lookback Date, no Group Company has received any written or unwritten notice that there is any investigation, allegation, request
for information, or other inquiry by any Governmental Entity regarding an actual or possible violation of the Anti-Corruption Laws, Sanctions,
or Trade Control Laws.
(e) Except
as set forth on Section 3.21(e) of the Company Disclosure Schedule, (i) no Group Company is, or is required to be,
registered with the Israeli Ministry of Defense as a security exporter, (ii) the business of the Group Companies does not involve
the use or development of, or engagement in, encryption technology, or other technology whose development, commercialization, marketing
or export is restricted under Israeli Law, and (iii) the business of the Group Companies does not require any Group Company to obtain
a license from the Israeli Ministry of Economy and/or the Israeli Ministry of Defense or an authorized body thereof pursuant to Section 2(a) of
the Israeli Control of Products and Services Declaration (Engagement in Encryption), 1974, or any other legislation regulating the development,
commercialization, marketing or export of technology, and such licenses as are required have been or in the process of being obtained
and are listed in Section 3.21(e) of the Company Disclosure Schedule.
Section 3.22 Customers
and Suppliers.
(a) Section 3.22(a) of
the Company Disclosure Schedules sets forth a list of the top ten (10) customers (by revenue) of the Group Companies, as a whole,
for each of the years ended December 31, 2021 and December 31, 2022 (collectively, the “Material Customers”)
and the aggregate amount of consideration paid to the Group Companies by each Material Customer during such periods. No Material Customer
has expressed to any Group Company in writing, and no Group Company has any knowledge of, any Material Customer’s intention to cancel
or otherwise terminate, or materially reduce or adversely modify, its relationship with any Group Company or of a material breach of the
terms of any Contract with such Material Customer. No Material Customer has asserted or threatened to assert a force majeure event or
anticipated inability to perform, in whole or in part, arising out of COVID-19.
(b) Section 3.22(b)(i) of
the Company Disclosure Schedules sets forth a list of the top ten (10) vendors to or suppliers of (by spend) of the Group Companies
for each of the years ended December 31, 2021 and December 31, 2022 (collectively, the “Material Suppliers”)
and the amount of consideration paid to each Material Supplier by the Group Companies during such periods. Except as set forth in Section 3.22(b)(ii) of
the Company Disclosure Schedules, no Material Supplier is the sole source of the goods or services as to which it is a Material Supplier.
Section 3.23 Information
Supplied. None of the information relating to the Group Companies that has been requested by the SPAC and supplied or to be supplied
by or on behalf of the Group Companies expressly for inclusion or incorporation by reference prior to the Closing in the Registration
Statement / Proxy Statement will, when the Registration Statement / Proxy Statement is declared effective or first mailed to the SPAC
Shareholders or at the time of the SPAC Shareholders Meeting, and in the case of any amendment thereto, at the time of such amendment,
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order
to make the statements therein, in light of the circumstances under which they are made, not misleading.
Section 3.24 Governmental
Grants. Except as set forth in Section 3.24 of the Company Disclosure Schedule, no government funding, facilities, faculty
or students of a university, college, other educational institution or research center or funding from third parties was used in the development
of the Intellectual Property Rights of the Company (“Grants”). Section 3.24 of the Company Disclosure Schedules
sets forth: (a) the aggregate amount of each Grant; (b) the aggregate outstanding obligations of Company under each Grant with
respect to royalties or other payments; (c) the outstanding amounts to be paid to Company under the Grants by the Governmental Entity,
if any; and (d) the composition of such obligations or amount by the patent, other Intellectual Property Rights, product or product
family to which it relates. Company is in material compliance with the terms and conditions of each Grant. There is no event or other
set of circumstances which would reasonably be expected to lead to the revocation or material modification of any Grant.
Section 3.25 HSR
Act. The Company (a) is its own “ultimate parent entity”; (b) is not “engaged in manufacturing”;
and (c) does not have “total assets” of $22.3 million or “annual net sales” of $222.7 million or more, as
the quoted terms are defined in 16 C.F.R. §§ 801.1, 801.11.
Section 3.26 Investigation;
No Other Representations.
(a) The
Company, on its own behalf and on behalf of its Representatives, acknowledges, represents, warrants and agrees that (i) it has conducted
its own independent review and analysis of, and, based thereon, has formed an independent judgment concerning, the business, assets, condition,
operations and prospects of, SPAC and (ii) it has been furnished with or given access to such documents and information about SPAC
and its businesses and operations as it and its Representatives have deemed necessary to enable it to make an informed decision with respect
to the execution, delivery and performance of this Agreement and the Ancillary Documents and the consummation of the Transactions.
(b) In
entering into this Agreement and the Ancillary Documents to which it is or will be a party, the Company has relied solely on its own investigation
and analysis and the representations and warranties expressly set forth in ARTICLE IV, in the Ancillary Documents to which
it is or will be a party, and any certificates delivered by SPAC or an officer thereof, and no other representations or warranties of
SPAC, any SPAC Non-Party Affiliate or any other Person, either express or implied, and the Company, on its own behalf and on behalf of
its Representatives, acknowledges, represents, warrants and agrees that, except for the representations and warranties expressly set forth
in ARTICLE IV and in the Ancillary Documents to which it is or will be a party, none of SPAC, any SPAC Non-Party Affiliate
or any other Person makes or has made any representation or warranty, either express or implied, in connection with or related to this
Agreement, the Ancillary Documents or the Transactions.
Section 3.27 EXCLUSIVITY
OF REPRESENTATIONS AND WARRANTIES. NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO SPAC OR ANY OF ITS REPRESENTATIVES OF ANY DOCUMENTATION
OR OTHER INFORMATION (INCLUDING ANY FINANCIAL PROJECTIONS OR OTHER SUPPLEMENTAL DATA), EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN THIS
ARTICLE III, THE ANCILLARY DOCUMENTS OR CERTIFICATES DELIVERED BY THE COMPANY OR ANY OFFICER THEREOF, NONE OF THE COMPANY,
ANY COMPANY NON-PARTY AFFILIATE OR ANY OTHER PERSON MAKES, AND THE COMPANY EXPRESSLY DISCLAIMS, ANY REPRESENTATIONS OR WARRANTIES OF ANY
KIND OR NATURE, EXPRESS OR IMPLIED, IN CONNECTION WITH THIS AGREEMENT, THE ANCILLARY DOCUMENTS, THE CERTIFICATES DELIVERED BY THE
COMPANY OR ANY OFFICER THEREOF, OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, INCLUDING AS TO THE MATERIALS RELATING
TO THE BUSINESS AND AFFAIRS OR HOLDINGS OF THE GROUP COMPANIES THAT HAVE BEEN MADE AVAILABLE TO SPAC OR ANY OF ITS REPRESENTATIVES OR
IN ANY PRESENTATION OF THE BUSINESS AND AFFAIRS OF THE GROUP COMPANIES BY OR ON BEHALF OF THE MANAGEMENT OF THE COMPANY OR OTHERS IN CONNECTION
WITH THE TRANSACTIONS, AND NO STATEMENT CONTAINED IN ANY OF SUCH MATERIALS OR MADE IN ANY SUCH PRESENTATION SHALL BE DEEMED A REPRESENTATION
OR WARRANTY HEREUNDER OR OTHERWISE OR DEEMED TO BE RELIED UPON BY SPAC OR ANY SPAC NON-PARTY AFFILIATE IN EXECUTING, DELIVERING AND PERFORMING
THIS AGREEMENT, THE ANCILLARY DOCUMENTS, THE CERTIFICATES DELIVERED BY THE COMPANY OR ANY OFFICER THEREOF OR THE TRANSACTIONS CONTEMPLATED
HEREBY OR THEREBY. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES EXPRESSLY SET FORTH IN THIS ARTICLE III. THE ANCILLARY DOCUMENTS,
OR THE CERTIFICATES DELIVERED BY THE COMPANY OR ANY OFFICER THEREOF, IT IS UNDERSTOOD THAT ANY COST ESTIMATES, PROJECTIONS OR OTHER
PREDICTIONS, ANY DATA, ANY FINANCIAL INFORMATION OR ANY MEMORANDA OR OFFERING MATERIALS OR PRESENTATIONS, INCLUDING, BUT NOT LIMITED
TO, ANY OFFERING MEMORANDUM OR SIMILAR MATERIALS MADE AVAILABLE BY OR ON BEHALF OF ANY GROUP COMPANY ARE NOT AND SHALL NOT BE DEEMED TO
BE OR TO INCLUDE REPRESENTATIONS OR WARRANTIES OF THE COMPANY, ANY COMPANY NON-PARTY AFFILIATE OR ANY OTHER PERSON, AND ARE NOT AND SHALL
NOT BE DEEMED TO BE RELIED UPON BY SPAC OR ANY SPAC NON-PARTY AFFILIATE IN EXECUTING, DELIVERING OR PERFORMING THIS AGREEMENT, THE ANCILLARY
DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. NOTWITHSTANDING THE FOREGOING, THE PROVISIONS OF THIS Section 3.
SHALL NOT EXCUSE ANY FRAUD OR WILLFUL MISCONDUCT OF THE COMPANY.
Article IV.
REPRESENTATIONS AND WARRANTIES RELATING TO SPAC
Subject to Section 8.8,
except as set forth in the SPAC Disclosure Schedules, or except as set forth in any SPAC SEC Reports, excluding (a) any disclosures
in any “risk factors” section that do not constitute statements of fact, disclosures in any forward-looking statements disclaimers
and other disclosures that are generally cautionary, predictive or forward-looking in nature, or (b) any information incorporated
by reference into the SPAC SEC Reports (other than from other SPAC SEC Reports), SPAC hereby represents and warrants to the Company as
follows:
Section 4.1 Organization
and Qualification.
(a) SPAC
is an exempted company incorporated, validly existing and, to the extent such concept exists under the Laws applicable to it, in good
standing under the Laws of the Cayman Islands. SPAC has the requisite corporate power and authority to own, lease and operate its properties
and to carry on its businesses as presently conducted in all material respects. True, correct and complete copies of the Governing Documents
of SPAC have been made available to the Company, in each case, as amended and in effect as of the date of this Agreement. The Governing
Documents of SPAC are in full force and effect, and SPAC is not, and at all times has not been, in breach or violation in any material
respect of any provision set forth in its Governing Documents.
(b) At
a meeting dully called and held, the SPAC Board has (a) approved this Agreement, the Ancillary Documents to which SPAC is or will
be a party and the Transactions (including the Merger), (b) determined that this Agreement and the Transactions, including the Merger,
are advisable and are fair to and in the best interests of SPAC and its shareholders, and (c) recommended, among other things, approval
of this Agreement and the Transactions (including the Merger) by the holders of SPAC Shares entitled to vote thereon
Section 4.2 Authority(a) .
SPAC has the requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is
or will be a party, to perform its obligations hereunder and thereunder, and to consummate the Transactions. Subject to the receipt of
the SPAC Shareholder Approval, the execution, delivery and performance of this Agreement and the Ancillary Documents to which SPAC is
or will be a party and the consummation of the Transactions have been (or, in the case of any Ancillary Document entered into after the
date of this Agreement, will be upon execution thereof) duly authorized by all necessary corporate action on the part of SPAC. Except
for the SPAC Shareholder Approval, no other corporate or equivalent proceeding on the part of SPAC is necessary to authorize this Agreement
or the Ancillary Documents and or SPAC’s performance hereunder or thereunder. This Agreement has been and each Ancillary Document
to which SPAC is or will be a party has been or will be, upon execution and delivery thereof, duly and validly executed and delivered
by SPAC and constitutes or will constitute, upon execution and delivery thereof, as applicable, a valid, legal and binding obligation
of SPAC (assuming this Agreement has been and the Ancillary Documents to which SPAC is or will be a party are or will be, upon execution
thereof, as applicable, duly authorized, executed and delivered by the other Persons party hereto or thereto, as applicable), enforceable
against SPAC in accordance with their respective terms (subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium or other Laws affecting generally the enforcement of creditors’ rights and subject to general principles of equity).
Section 4.3 Consents
and Requisite Governmental Approvals; No Violations.
(a) No
Consent, Permit, approval or authorization of, or designation, declaration, filing with or notification to, any Governmental Entity is
required on the part of SPAC with respect SPAC’s execution, delivery or performance of its obligations under this Agreement or the
Ancillary Documents to which it is or will be party or the consummation of the transactions contemplated by this Agreement, except for
(i) compliance with and filings and Consents under the HSR Act, if any, (ii) the filing with the SEC of (A) the Registration
Statement / Proxy Statement and the declaration of the effectiveness thereof by the SEC, (B) any other documents or information required
pursuant to applicable requirements, if any, of the Federal Securities Laws, and (C) such reports under Section 13(a) or
15(d) of the Exchange Act as may be required in connection with this Agreement, the Ancillary Documents or the Transactions, (iii) compliance
with and filings or notifications required to be filed with state securities regulators pursuant to “blue sky” Laws and state
takeover Laws as may be required in connection with this Agreement, the Ancillary Documents or the Transactions, (iv) receipt of
the ISA Exemptions, (v) filing of the Plan of Merger with the Registrar of Companies of the Cayman Islands and all such other notices
or filings required under the Cayman Companies Law with respect to the consummation of the Merger and the issuance of the certificate
of merger by the Companies Registrar, (vi) applicable requirements of and filings under the ISL or any other similar Laws, (vii) compliance
and filings with the TASE, the ISA, the ITA, and the Companies Registrar, (viii) compliance with, applicable requirements of and
filings under the Cayman Companies Law or any other similar Laws, (ix) the SPAC Shareholder Approval, which shall have been secured
on or prior to the Merger Effective Time, or (x) any other consents, approvals, authorizations, designations, declarations, waivers
or filings, the absence of which would not, individually or in the aggregate, reasonably be expected to have a SPAC Material Adverse Effect.
(b) Subject
to the receipt of the Consents, approvals, authorizations and other requirements set forth in Section 4.3(a), neither the
execution, delivery or performance by SPAC of this Agreement nor the Ancillary Documents to which SPAC is or will be a party nor the consummation
of the Transactions, directly or indirectly (with or without due notice or lapse of time or both), (i) result in any breach of any
provision of the Governing Documents of SPAC, (ii) result in a violation or breach of, or constitute a default or give rise to any
right of termination, consent, cancellation, amendment, modification, suspension, revocation or acceleration (with or without notice)
under, any of the terms, conditions or provisions of any Contract to which SPAC is a party, (iii) violate, or constitute a breach
under, any Order or applicable Law to which SPAC or any of its properties or assets are bound or (iv) result in the creation of any
Lien upon any of the assets or properties (other than any Permitted Liens) of SPAC, except, in the case of any of clauses (ii) through
(iv) above, as would not, individually or in the aggregate, reasonably be expected to have a SPAC Material Adverse Effect
or prevent, materially delay or materially impair the ability of SPAC to consummate the Transactions.
(c) None
of SPAC or any entity controlled, directly or indirectly through any Person, by SPAC beneficially owns any Company Ordinary Shares.
Section 4.4 Brokers.
Except for fees (including the amounts due and payable assuming the Closing occurs) set forth on Section 4.4 of the SPAC Disclosure
Schedules (which fees shall be the sole responsibility of SPAC, except as otherwise provided in Section 8.6), no broker, finder,
investment banker or other Person is entitled to any brokerage fee, finders’ fee or other commission in connection with the transactions
contemplated by this Agreement based upon arrangements made by or on behalf of SPAC for which SPAC or any of its Affiliates, including
the Sponsor, has any obligation.
Section 4.5 Information
Supplied. None of the information supplied or to be supplied by or on behalf of SPAC expressly for inclusion or incorporation by reference
prior to the Closing in the Registration Statement / Proxy Statement will, when the Registration Statement / Proxy Statement is declared
effective or when the Registration Statement / Proxy Statement is mailed to the SPAC Shareholders or at the time of the SPAC Shareholders
Meeting, and in the case of any amendment thereto, at the time of such amendment, contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they are made, not misleading.
Section 4.6 Capitalization
of SPAC.
(a) Section 4.6(a) of
the SPAC Disclosure Schedules sets forth a true and complete statement as of the date of this Agreement of the number and class or series
(as applicable) of the issued and outstanding SPAC Shares and SPAC Warrants. All outstanding Equity Securities of SPAC have been duly
authorized and validly issued and are fully paid and non-assessable. The issuance of SPAC Shares upon the exercise or conversion, as applicable,
of Equity Securities that are derivative securities, will, upon exercise or conversion in accordance with the terms of such Equity Securities
against payment therefore, if any, be duly authorized, validly issued, fully paid, and non-assessable. Except as set forth on Section 4.6(a) of
the SPAC Disclosure Schedules, such Equity Securities (i) were not issued in violation of the Governing Documents of SPAC, (ii) are
not subject to any preemptive rights, call option, right of first refusal, subscription rights, transfer restrictions or similar rights
of any Person (other than transfer restrictions under applicable Securities Laws or under the Governing Documents of SPAC) and were not
issued in violation of any preemptive rights, call option, right of first refusal, subscription rights, transfer restrictions or similar
rights of any Person and (iii) have been offered, sold and issued in compliance in all material respects with applicable Law. Except
for the SPAC Shares and SPAC Warrants set forth on Section 4.6(a) of the SPAC Disclosure Schedules (subject to any SPAC
Shareholder Redemptions), immediately prior to Closing, there shall be no other outstanding Equity Securities of SPAC.
(b) Except
as disclosed in the SPAC SEC Reports, as set forth on Section 4.6(a) of the SPAC Disclosure Schedules, as expressly contemplated
by this Agreement, the Ancillary Documents or the Transactions or as otherwise mutually agreed to in writing by the Company and SPAC,
there are no outstanding (i) equity appreciation, phantom equity or profit participation rights or (ii) options, restricted
stock, phantom stock, warrants, purchase rights, subscription rights, conversion rights, exchange rights, calls, puts, rights of first
refusal or first offer or other Contracts or commitments of any kind of any character, written or oral, that could require SPAC, and,
except as expressly contemplated by this Agreement, the Ancillary Documents or the Transactions or as otherwise mutually agreed to in
writing by the Company and SPAC, there is no obligation of SPAC, to issue, sell or otherwise cause to become outstanding or to acquire,
repurchase or redeem any Equity Securities or securities convertible into or exchangeable for Equity Securities of SPAC. Except as disclosed
in the SPAC SEC Reports or SPAC’s Governing Documents, there are no outstanding contractual obligations of SPAC to repurchase, redeem
or otherwise acquire any securities or Equity Securities of SPAC. Except as disclosed in the SPAC SEC Reports or in Section 4.6(a) of
the SPAC Disclosure Schedules, there are no outstanding bonds, debentures, notes or other Indebtedness of SPAC having the right to vote
(or convertible into, or exchangeable for, securities having the right to vote) on any matter for which SPAC Shareholders may vote. Except
for the Sponsor Support Agreement, Registration Rights and Lock-Up Agreement or as otherwise as disclosed in the SPAC SEC Reports or in
Section 4.6(a) of the SPAC Disclosure Schedules, SPAC is not a party to any shareholders agreement, voting agreement
or registration rights agreement relating to SPAC Shares or any other Equity Securities of SPAC. SPAC does not own any Equity Securities
in any Person or has any right, option, warrant, conversion right, stock appreciation right, redemption right, repurchase right, agreement,
arrangement or commitment of any character under which a Person is or may become obligated to issue or sell, or give any right to subscribe
for or acquire, or in any way dispose of, any Equity Securities, or any securities or obligations exercisable or exchangeable for or convertible
into any Equity Securities, of such Person.
Section 4.7 SEC
Filings. SPAC has timely filed or furnished all statements, forms, reports and documents required to be filed or furnished by it
prior to the date of this Agreement with the SEC pursuant to Federal Securities Laws since its IPO (collectively, and together with any
exhibits and schedules thereto and other information incorporated therein, and as they have been supplemented, modified or amended since
the time of filing, the “SPAC SEC Reports”). Each of the SPAC SEC Reports, as of their respective dates of filing,
and as of the date of any amendment or filing that superseded the initial filing, complied in all material respects with the applicable
requirements of the Federal Securities Laws (including, as applicable, the Sarbanes-Oxley Act and any rules and regulations promulgated
thereunder) applicable to the SPAC SEC Reports. As of their respective dates of filing, the SPAC SEC Reports did not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no outstanding
or unresolved comments in comment letters received from the SEC with respect to the SPAC SEC Reports.
Section 4.8 Trust
Account. As of the date of this Agreement, SPAC has an amount in cash in the Trust Account of at least $151,672,581. The funds held
in the Trust Account are (i) invested in United States “government securities” within the meaning of Section 2(a)(16)
of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations and (ii) held in trust
pursuant to that certain Investment Management Trust Agreement, dated as of January 12, 2023 (the “Trust Agreement”),
by and between SPAC and ETC, as trustee (the “Trustee”). There are no separate agreements, side letters or other agreements
or understandings (whether written or unwritten, express or implied) that would cause the description of the Trust Agreement in the SPAC
SEC Reports to be inaccurate in any material respect or, to the SPAC’s knowledge, that would entitle any Person to any portion
of the funds in the Trust Account (other than (x) in respect of deferred underwriting commissions or Taxes, (y) the SPAC Shareholders
who shall have elected to redeem their SPAC Shares pursuant to the Governing Documents of SPAC or (z) if SPAC fails to complete
a Business Combination within the allotted time period set forth in the Governing Documents of SPAC and liquidates the Trust Account,
subject to the terms of the Trust Agreement, SPAC (in limited amounts to permit SPAC to pay the expenses of the Trust Account’s
liquidation, dissolution and winding up of SPAC) and then the SPAC Shareholders). Prior to the Closing, none of the funds held in the
Trust Account are permitted to be released, except in the circumstances described in the Governing Documents of SPAC and the Trust Agreement.
SPAC has performed all material obligations required to be performed by it to date under, and is not in material default, breach or delinquent
in performance or any other respect (claimed or actual) in connection with the Trust Agreement, and, to SPAC’s knowledge, no event
has occurred which, with due notice or lapse of time or both, would constitute a material default under the Trust Agreement. As of the
date of this Agreement, there are no Proceedings pending with respect to the Trust Account. Since January 17, 2023, SPAC has not
released any money from the Trust Account (other than interest income earned on the funds held in the Trust Account as permitted by the
Trust Agreement). Upon the consummation of the Transactions contemplated by this Agreement, including the distribution of assets from
the Trust Account (A) in respect of deferred underwriting commissions or Taxes or (B) to the SPAC Shareholders who have elected
to redeem their SPAC Shares pursuant to the Governing Documents of SPAC, each in accordance with the terms of and as set forth in the
Trust Agreement, SPAC shall have no further obligation under either the Trust Agreement or the Governing Documents of SPAC to liquidate
or distribute any assets held in the Trust Account, and the Trust Agreement shall terminate in accordance with its terms.
Section 4.9 Indebtedness.
As of the date hereof, SPAC does not have, or have any Contract requiring it to enter into or incur, any obligations with respect to
or under any Indebtedness.
Section 4.10 Transactions
with Affiliates. Section 4.10 of the SPAC Disclosure Schedules sets forth all Contracts between (a) SPAC, on the
one hand, and (b) any officer, director, employee, partner, member, manager, direct or indirect equityholder (including the Sponsor),
or Affiliate of either SPAC or the Sponsor, on the other hand (each Person identified in this clause (b), a “SPAC Related
Party”), other than Contracts with respect to a SPAC Related Party’s employment with, or the provision of services to,
SPAC entered into in the ordinary course of business. Except as set forth in Section 4.10 of the SPAC Disclosure Schedules,
no SPAC Related Party (A) owns any interest in any material asset used in the business of SPAC, (B) possesses, directly or
indirectly, any material financial interest in, or is a director or executive officer of, any Person which is a material client, supplier,
customer, lessor or lessee of SPAC or (C) owes any material amount to, or is owed material any amount by, SPAC. All Contracts, arrangements,
understandings, interests and other matters that are required to be disclosed pursuant to this Section 4.10 are referred
to herein as “SPAC Related Party Transactions”.
Section 4.11 Litigation.
There is (and since its organization, incorporation or formation, as applicable, there has been) no Proceeding pending or, to SPAC’s
knowledge, threatened against or involving SPAC or its assets or properties, including any condemnation or similar Proceedings, or against
any of SPAC’s officers, directors or employees (in their capacities as officers, directors or employees of SPAC), that, if adversely
decided or resolved, would, individually or in the aggregate, reasonably be expected to have a SPAC Material Adverse Effect. Neither
SPAC nor any of its properties or assets is subject to any material Order. As of the date of this Agreement, there are no material Proceedings
by SPAC pending against any other Person. There is no unsatisfied judgment or any open injunction binding upon SPAC which would, individually
or in the aggregate, reasonably be expected to have a SPAC Material Adverse Effect.
Section 4.12 Compliance
with Applicable Law. SPAC is (and since its organization, incorporation or formation, as applicable, has been) in compliance with
all applicable Laws, except as would not have a SPAC Material Adverse Effect. SPAC has not received any written notice from any Governmental
Entity of a violation of any applicable Law by SPAC at any time since its formation, which violation would reasonably be expected to
have a material effect on the ability of SPAC to enter into, perform its obligations under this Agreement and consummate the Transactions.
Section 4.13 Business
Activities.
(a) Since
its IPO, SPAC has held all IPO proceeds in the Trust Account (other than any amounts permitted to be disbursed under the terms of the
Trust Agreement and as described in the SPAC Prospectus) for the purpose of being used in the conduct of business following its Business
Combination. Except as set forth in SPAC’s Governing Documents, there is no Contract binding upon SPAC or to which SPAC is a party
which has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of it, any
acquisition of property by it or the conduct of business by it (including, in each case, following the Closing).
(b) SPAC
does not own or have a right to acquire, directly or indirectly, any interest or investment (whether equity or debt) in any corporation,
partnership, joint venture, business, trust or other entity. Except for this Agreement and the Transactions, SPAC has no interests, rights,
obligations or liabilities with respect to, or is party to, bound by or has its assets or property subject to, in each case whether directly
or indirectly, any Contract or transaction which is, or could reasonably be interpreted as constituting, a Business Combination.
(c) Except
for this Agreement and the agreements expressly contemplated hereby or as set forth in Section 4.13(c) of the SPAC Disclosure
Schedules, SPAC is and at no time has been, party to any Contract with any other Person that would require payments by SPAC in excess
of $25,000 in the aggregate with respect to any individual Contract or more than $50,000 in the aggregate when taken together with all
other Contracts (other than this Agreement and the agreements expressly contemplated hereby and Contracts set forth in Section 4.13(c) of
the SPAC Disclosure Schedules).
(d) There
is no liability, debt or obligation against SPAC, except for liabilities and obligations (i) reflected or reserved for on SPAC’s
consolidated balance sheet as of September 30, 2023 or disclosed in the notes thereto, (ii) that have arisen since the date
of SPAC’s consolidated balance sheet as of September 30, 2023 in the ordinary course of the operation of business of SPAC,
(iii) incurred in connection with or contemplated by this Agreement and/or the Transactions or (iv) that would not reasonably
be expected to be, individually or in the aggregate, material to SPAC.
Section 4.14 Internal
Controls; Listing; Financial Statements.
(a) Except
as is not required in reliance on exemptions from various reporting requirements by virtue of SPAC’s status as an “emerging
growth company” within the meaning of the Securities Act, as modified by the JOBS Act, or “smaller reporting company”
within the meaning of the Exchange Act, since its IPO, (i) SPAC has established and maintained a system of internal controls over
financial reporting (as defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act) sufficient to provide reasonable assurance
regarding the reliability of SPAC’s financial reporting and the preparation of the SPAC Financial Statements for external purposes
in accordance with GAAP and (ii) SPAC has established and maintained disclosure controls and procedures (as defined in Rule 13a-15
and Rule 15d-15 under the Exchange Act) designed to ensure that material information relating to SPAC is made known to SPAC’s
principal executive officer and principal financial officer by others within SPAC. Such disclosure controls and procedures are effective
in timely alerting SPAC’s principal executive officer and principal financial officer to material information required to be included
in the SPAC Financial Statements included in SPAC’s periodic reports required under the Exchange Act.
(b) SPAC
has not taken any action prohibited by Section 402 of the Sarbanes-Oxley Act. There are no outstanding loans or other extensions
of credit made by SPAC to any executive officer (as defined in Rule 3b-7 under the Exchange Act) or director of SPAC.
(c) Since
its IPO, SPAC has complied in all material respects with all applicable listing and corporate governance rules and regulations of
Nasdaq. The issued and outstanding SPAC Units are registered pursuant to Section 12(b) of the Exchange Act and are listed for
trading on Nasdaq under the symbol “ISRLU”. The issued and outstanding SPAC Shares are registered pursuant to Section 12(b) of
the Exchange Act and are listed for trading on Nasdaq under the symbol “ISRL”. The issued and outstanding SPAC Warrants are
registered pursuant to Section 12(b) of the Exchange Act and are listed for trading on Nasdaq under the symbol “ISRLW”.
As of the date of this Agreement, there is no material Proceeding pending or, to the knowledge of SPAC, threatened against SPAC by Nasdaq
or the SEC with respect to any intention by such entity to deregister the SPAC Units, SPAC Shares or SPAC Warrants or prohibit or terminate
the listing of the SPAC Units, SPAC Shares or SPAC Warrants on Nasdaq. Neither SPAC nor any of its Affiliates has taken any action that
is designed to terminate the registration of the SPAC Units, SPAC Shares or SPAC Warrants under the Exchange Act except as contemplated
by this Agreement. SPAC has not received any notice from Nasdaq or the SEC regarding the revocation of such listing or otherwise regarding
the delisting of the SPAC Units, SPAC Shares or SPAC Warrants from Nasdaq or the SEC.
(d) SPAC
has established and maintains systems of internal accounting controls that are designed to provide, in all material respects, reasonable
assurance that (i) all transactions are executed in accordance with management’s authorization and (ii) all transactions
are recorded as necessary to permit preparation of proper and accurate financial statements in accordance with GAAP and to maintain accountability
for SPAC’s assets. SPAC maintains and, for all periods covered by the SPAC Financial Statements, has maintained books and records
of SPAC in the ordinary course of business that are accurate and complete and reflect the revenues, expenses, assets and liabilities
of SPAC in all material respects.
(e) Since
its incorporation, SPAC has not received any written complaint, allegation, assertion or claim that there is (i) a “significant
deficiency” in the internal controls over financial reporting of SPAC, (ii) a “material weakness” in the internal
controls over financial reporting of SPAC or (iii) Fraud, whether or not material, that involves management or other employees of
SPAC who have a significant role in the internal controls over financial reporting of SPAC.
Section 4.15 No
Undisclosed Liabilities. Except for the Liabilities (a) set forth in Section 4.15 of the SPAC Disclosure Schedules,
(b) incurred in connection with the negotiation, preparation or execution of this Agreement or any Ancillary Documents, the performance
of its covenants or agreements in this Agreement or any Ancillary Document or the consummation of the Transactions (it being understood
and agreed that the expected third-parties that are, as of the date hereof, entitled to fees, expenses or other payments in connection
with the matters described in this clause (a) shall be set forth on Section 4.15 of the SPAC Disclosure Schedules),
(c) that are incurred in connection with or incident or related to SPAC’s incorporation or continuing corporate existence,
which are immaterial in nature, (d) that are incurred in connection with activities that are administrative or ministerial, in each
case, which are immaterial in nature, (e) that are either permitted pursuant to Section 5.9(e) or incurred in accordance
with Section 5.9(e) (for the avoidance of doubt, in each case, with the written consent of the Company), (f) set
forth or disclosed in the SPAC Financial Statements included in the SPAC SEC Reports, (g) that have arising since the date of the
most recent balance sheet included in the SPAC SEC Reports in the ordinary course of business, or (h) that are not, and would not
reasonably be expected to be, individually or in the aggregate, material to SPAC, taken as a whole, SPAC has no Liabilities of the type
required to be set forth on a balance sheet in accordance with GAAP.
Section 4.16 Tax
Matters.
(a) SPAC
has timely filed, or caused to be timely filed, all income and other material Tax Returns required to be filed by it (taking into account
all available extensions) and such Tax Returns are true, accurate, correct and complete in all material respects. SPAC has timely paid,
or caused to be paid, all material Taxes required to be paid, other than such Taxes for which adequate reserves have been established.
(b) SPAC
has complied in all material respects with all applicable Tax Laws relating to withholding and remittance of all material amounts of
Taxes, and all material amounts of Taxes required by applicable Tax Laws to be withheld by SPAC have been withheld and timely paid over
to the appropriate Governmental Entity.
(c) There
are no material claims, assessments, audits, examinations, investigations or other Proceedings pending, in progress or threatened in
writing against SPAC in respect of any material Taxes, and SPAC has not been notified in writing of any material proposed Tax claims
or assessments against it (other than claims or assessments that have been settled or resolved).
(d) There
are no material Liens with respect to any Taxes upon any of SPAC’s assets, other than Permitted Liens. SPAC does not have any outstanding
waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding requests
by SPAC for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to be due in any Tax Return
(other than an automatic extension of time not requiring the consent of the applicable Governmental Entity).
(e) SPAC
does not have any Liability for the Taxes of another Person pursuant to Treasury Regulations Section 1.1502-6 (or any similar provision
of state, local or non-U.S. Tax Law), as a transferee or successor, by contract or otherwise (in each case, other than any customary
commercial agreement, contract or arrangement entered into in the ordinary course of business and the principal purpose of which does
not relate to Taxes). SPAC is not a party to or bound by any Tax indemnity agreement, Tax sharing agreement, Tax allocation agreement
or similar agreement, arrangement or practice with respect to Taxes (including closing agreement or other agreement relating to Taxes
with any Governmental Entity) (other than any customary commercial agreement, contract or arrangement entered into in the ordinary course
of business and the principal purpose of which does not relate to Taxes).
(f) SPAC
has not engaged in or entered into a “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4(b)(2) or
any similar provision of state, local or non-U.S. Tax Law.
(g) SPAC
has not received a written notice from a Governmental Entity in a jurisdiction where it does not file Tax Returns that SPAC is or may
be subject to Tax by that jurisdiction.
(h) During
the two (2)-year period ending on the date of this Agreement, SPAC was not a distributing corporation or a controlled corporation in
a transaction purported or intended to be governed by Section 355 of the Code.
(i) SPAC
is a Tax resident only in its country of incorporation.
(j) SPAC
is not a “surrogate foreign corporation” or “expatriated entity” within the meaning of Section 7874 of the
Code or treated as a U.S. corporation for U.S. federal income tax purposes by reason of the application of Section 7874(b) of
the Code.
(k) SPAC
has not taken or agreed to take any action not contemplated by this Agreement and/or any Ancillary Documents that could reasonably be
expected to prevent the Merger or the Equity Exchange from qualifying for the Intended U.S. Tax Treatment. To the knowledge of SPAC,
no facts or circumstances exist that could reasonably be expected to prevent the Merger or the Equity Exchange from qualifying for the
Intended U.S. Tax Treatment.
Section 4.17 Absence
of Changes. During the period beginning on the date of SPAC’s incorporation and ending on the date of this Agreement, (a) no
SPAC Material Adverse Effect has occurred and (b) except for actions expressly contemplated by this Agreement or any Ancillary Document
or taken in connection with the Transactions, SPAC has conducted its businesses in the ordinary course in all material respects.
Section 4.18 Material
Contracts; No Defaults.
(a) SPAC
has filed as an exhibit to the SPAC SEC Reports all Contracts, including every “material contract” (as such term is defined
in Item 601(b)(10) of Regulation S-K of the SEC) (other than confidentiality and non-disclosure agreements and this Agreement) to
which, as of the date of this Agreement, SPAC is a party or by which any of its respective assets are bound.
(b) The SPAC
SEC Reports contain true, correct and complete copies of the applicable SPAC Financial Statements. The SPAC Financial Statements (i) fairly
present in all material respects the financial position of SPAC as at the respective dates thereof, and the results of its operations,
shareholders’ equity and cash flows for the respective periods then ended (subject, in the case of any unaudited interim financial
statements, to normal year-end audit adjustments (none of which is expected to be material) and the absence of footnotes), (ii) were
prepared in conformity with GAAP applied on a consistent basis (except, in the case of any audited financial statements, as may be indicated
in the notes thereto and subject, in the case of any unaudited financial statements, to normal year-end audit adjustments (none of which
is expected to be material) and the absence of footnotes), (iii) in the case of the audited SPAC Financial Statements, were audited
in accordance with the standards of the PCAOB and (iv) comply in all material respects with the applicable accounting requirements
and with the rules and regulations of the SEC, the Exchange Act and the Securities Act in effect as of the respective dates thereof
(including Regulation S-X or Regulation S-K, as applicable).
(c) Each
Contract of a type required to be filed as an exhibit to the SPAC SEC Reports, whether or not filed, was entered into at arm’s
length. Except for any Contract that has terminated or will terminate upon the expiration of the stated term thereof prior to the Closing
Date, with respect to any Contract of the type required to be filed as an exhibit to the SPAC SEC Reports, whether or not filed, (i) such
Contracts are in full force and effect and represent the legal, valid and binding obligations of SPAC, and, to the knowledge of SPAC,
the other parties thereto, and are enforceable by SPAC to the extent a party thereto in accordance with their terms, subject in all respects
to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other Laws relating to or affecting creditors’
rights generally and general equitable principles (whether considered in a Proceeding in equity or at law), (ii) SPAC and, to the
knowledge of SPAC, the counterparties thereto, are not in material breach of or material default (or would be in material breach, violation
or default but for the existence of a cure period) under any such Contract, (iii) SPAC has not received any written or oral claim
or notice of material breach of or material default under any such Contract, (iv) no event has occurred which, individually or together
with other events, would reasonably be expected to result in a material breach of or a material default under any such Contract by SPAC
or any other party thereto (in each case, with or without notice or lapse of time or both) and (v) SPAC has not received written
notice from any other party to any such Contract that such party intends to terminate or not renew any such Contract.
Section 4.19 Investment
Company Act. SPAC is not an “investment company” within the meaning of the Investment Company Act.
Section 4.20 Compliance
with International Trade & Anti-Corruption Laws.
(a) Since
SPAC’s incorporation, neither SPAC nor, to SPAC’s knowledge, any of its Representatives, or any other Persons acting for
or on behalf of any of the foregoing, is or has been, a Sanctioned Person.
(b) Since
SPAC’s incorporation, to SPAC’s knowledge, SPAC has been in compliance with applicable Sanctions and Trade Control Laws.
(c) Since
SPAC’s incorporation, none of SPAC, any of its respective directors or officers, nor, to SPAC’s knowledge, any of its Representatives,
or any other Persons acting for or on behalf of SPAC has, directly or indirectly, (i) made, offered, promised, authorized, paid
or received any unlawful bribes, kickbacks or other similar payments to or from any Person, (ii) made, offered, promised, authorized
or paid any unlawful contributions to a domestic or foreign political party or candidate or (iii) otherwise made, offered, promised,
authorized, paid or received any improper payment in violation of any Anti-Corruption Laws. SPAC has implemented and maintained policies
and procedures reasonably designed to ensure compliance with Anti-Corruption Laws, Sanctions and Export Control Laws.
(d) To
the knowledge of SPAC, there is no current investigation, allegation, request for information, or other inquiry by any Governmental Entity
regarding the actual or possible violation of the Anti-Corruption Laws or Trade Control Laws by SPAC, its directors or officers, nor,
to SPAC’s knowledge, any of its employees, agents or any other Persons acting for or on behalf of any of SPAC and since its date
of incorporation, SPAC has not received any written notice that there is any investigation, allegation, request for information, or other
inquiry by any Governmental Entity regarding an actual or possible violation of the Anti-Corruption Laws or Trade Control Laws.
Section 4.21 Investigation;
No Other Representations.
(a) SPAC,
on its own behalf and on behalf of its Representatives, acknowledges, represents, warrants and agrees that (i) it has conducted
its own independent review and analysis of, and, based thereon, has formed an independent judgment concerning, the business, assets,
condition, operations and prospects, of the Group Companies and (ii) it has been furnished with or given access to such documents
and information about the Group Companies and their respective businesses and operations as it and its Representatives have deemed necessary
to enable it to make an informed decision with respect to the execution, delivery and performance of this Agreement and the Ancillary
Documents and the consummation of the Transactions.
(b) In
entering into this Agreement and the Ancillary Documents to which it is or will be a party, SPAC has relied solely on its own investigation
and analysis and the representations and warranties expressly set forth in Article III
and in the Ancillary Documents to which it is or will be a party and no other representations or warranties of the Company,
any Company Non-Party Affiliate or any other Person, either express or implied, and SPAC, on its own behalf and on behalf of its Representatives,
acknowledges, represents, warrants and agrees that, except for the representations and warranties expressly set forth in Article III,
in the Ancillary Documents to which it is or will be a party, and any certificates delivered by the Company or any officer thereof, none
of the Company, any Company Non-Party Affiliate or any other Person makes or has made any representation or warranty, either express
or implied, in connection with or related to this Agreement, the Ancillary Documents or the Transactions.
Section 4.22 EXCLUSIVITY
OF REPRESENTATIONS AND WARRANTIES. NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO THE COMPANY OR ANY OF ITS RESPECTIVE REPRESENTATIVES
OF ANY DOCUMENTATION OR OTHER INFORMATION (INCLUDING ANY FINANCIAL PROJECTIONS OR OTHER SUPPLEMENTAL DATA), EXCEPT AS OTHERWISE EXPRESSLY
SET FORTH IN THIS Article IV, THE ANCILLARY DOCUMENTS, AND ANY CERTIFICATES
DELIVERED BY SPAC OR ANY OFFICER THEREOF, NEITHER SPAC NOR ANY SPAC NON-PARTY AFFILIATE OR ANY OTHER PERSON MAKES, AND SPAC EXPRESSLY
DISCLAIMS, ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE, EXPRESS OR IMPLIED, IN CONNECTION WITH THIS AGREEMENT, THE ANCILLARY
DOCUMENTS, THE CERTIFICATES DELIVERED BY SPAC OR ANY OFFICER THEREOF. OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, INCLUDING
AS TO THE MATERIALS RELATING TO THE BUSINESS AND AFFAIRS OR HOLDINGS OF SPAC THAT HAVE BEEN MADE AVAILABLE TO THE COMPANY OR ANY OF ITS
RESPECTIVE REPRESENTATIVES OR IN ANY PRESENTATION OF THE BUSINESS AND AFFAIRS OF SPAC BY OR ON BEHALF OF THE MANAGEMENT OF SPAC OR OTHERS
IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED HEREBY, BY THE ANCILLARY DOCUMENTS, OR THE CERTIFICATES DELIVERED BY SPAC OR ANY OFFICER
THEREOF, AND NO STATEMENT CONTAINED IN ANY OF SUCH MATERIALS OR MADE IN ANY SUCH PRESENTATION SHALL BE DEEMED A REPRESENTATION OR WARRANTY
HEREUNDER OR OTHERWISE OR DEEMED TO BE RELIED UPON BY THE COMPANY, MERGER SUB, OR ANY COMPANY NON-PARTY AFFILIATE IN EXECUTING, DELIVERING
AND PERFORMING THIS AGREEMENT, THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EXCEPT FOR THE REPRESENTATIONS
AND WARRANTIES EXPRESSLY SET FORTH IN THIS Article IV. THE ANCILLARY DOCUMENTS,
OR ANY CERTIFICATE DELIVERED BY SPAC OR ANY OFFICER THEREOF, IT IS UNDERSTOOD THAT ANY COST ESTIMATES, PROJECTIONS OR OTHER PREDICTIONS,
ANY DATA, ANY FINANCIAL INFORMATION, ANY SPAC SEC REPORTS, OR ANY MEMORANDA OR OFFERING MATERIALS OR PRESENTATIONS, INCLUDING, BUT
NOT LIMITED TO, ANY OFFERING MEMORANDUM OR SIMILAR MATERIALS MADE AVAILABLE BY OR ON BEHALF OF SPAC ARE NOT AND SHALL NOT BE DEEMED TO
BE OR TO INCLUDE REPRESENTATIONS OR WARRANTIES OF SPAC, ANY SPAC NON-PARTY AFFILIATE OR ANY OTHER PERSON, AND ARE NOT AND SHALL NOT BE
DEEMED TO BE RELIED UPON BY THE COMPANY OR ANY COMPANY NON-PARTY AFFILIATE IN EXECUTING, DELIVERING OR PERFORMING THIS AGREEMENT, THE
ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. NOTWITHSTANDING THE FOREGOING, THE PROVISIONS OF THIS Section 4.22
SHALL NOT EXCUSE ANY FRAUD OR WILLFUL MISCONDUCT OF SPAC.
Article V.
COVENANTS
Section 5.1 Conduct
of Business of the Company.
(a) From
and after the date of this Agreement until the earlier of the Closing or the termination of this Agreement in accordance with its terms,
the Company shall, and the Company shall cause its Subsidiaries to, except as expressly contemplated by this Agreement or any Ancillary
Document, as required by applicable Law or Governmental Entity, as set forth on Section 5.1(a) of the Company Disclosure
Schedules, or as consented to in writing by SPAC (such consent not to be unreasonably withheld, conditioned or delayed), use its commercially
reasonable efforts to (i) conduct and operate the business of the Group Companies in the ordinary course of business in all material
respects, consistent with past practice and in material compliance with all applicable Laws, and (ii) maintain and preserve in all
material respects the business organization, assets, properties and material business relations of the Group Companies, taken as a whole.
(b) Without
limiting the generality of the foregoing, from and after the date of this Agreement until the earlier of the Closing or the termination
of this Agreement in accordance with its terms, the Company shall, and the Company shall cause its Subsidiaries to, except (r) as
expressly contemplated by this Agreement or any Ancillary Document, (s) as required by applicable Law, (t) as set forth on
Section 5.1(b) of the Company Disclosure Schedules, (u) as consented to in writing by SPAC (such consent not to
be unreasonably withheld, conditioned or delayed) or (v) as contemplated, permitted or pursuant to any Company Permitted Interim
Financing, not do any of the following:
(i) except
for transactions solely among the Company and any of the Company’s Subsidiaries and the Share Split, split, reserve split, reclassify,
recapitalize, repurchase, redeem or otherwise acquire, offer to repurchase, redeem or otherwise acquire, any outstanding Equity Securities
of any Group Company, other than (x) the issuance of securities upon exercise of Company Options, or Company RSUs or pursuant to
any Company Permitted Interim Financing and (y) the issuance of Company Options and Company RSUs under the Company Equity Plan;
(ii) (A) merge,
consolidate, combine or amalgamate any Group Company with any Person or (B) purchase or otherwise acquire (whether by merging or
consolidating with, purchasing any Equity Security in or a substantial portion of the assets of, or by any other manner) any corporation,
partnership, association or other business entity or organization or division thereof;
(iii) adopt
any amendments, supplements, restatements or modifications to any Group Company’s Governing Documents;
(iv) except
for the Equity Exchange, transfer, issue, sell, grant, pledge, or otherwise directly or indirectly dispose of, or subject to a Lien,
other than in the ordinary course, (A) any Equity Securities of any Group Company or (B) any options, restricted stock, warrants,
rights of conversion or other rights, agreements, arrangements or commitments obligating any Group Company to issue, deliver or sell
any Equity Securities of any Group Company, other than (x) the issuance of shares of capital stock of the Company upon the exercise
of any Company Equity Award outstanding on the date of this Agreement in accordance with the terms of the applicable Company Equity Plan
and the underlying grant, award or similar agreement, (y) the issuance of Company Equity Awards in the ordinary course of business
or (z) the issuance of Equity Securities pursuant to any Company Permitted Interim Financing; provided, however, that
to the extent the Company enters into an agreement to issue common equity in financing transactions that are to be consummated substantially
simultaneously with Closing, the implied equity valuation of the Company in such financing transactions must be equal to or in excess
of the Company Equity Value;
(v) incur,
create or assume any Indebtedness other than (A) ordinary course trade payables, (B) between the Company and any of its wholly
owned Subsidiaries or between any of such wholly owned Subsidiaries or (C) in connection with borrowings, extensions of credit and
other financial accommodations under the Company’s and Subsidiaries’ existing credit facilities, notes and other existing
Indebtedness and, in each case, any refinancing thereof; provided, however, that the Company may incur Indebtedness from
(i) a commercial bank, (ii) a third-party institutional lender or (iii) any other third-party lender or debt provider
where such Indebtedness is not convertible into Equity Securities of the Company, in each case, on arms’-length or better terms
for the Company and on terms that do not materially and adversely affect the interests of SPAC, Sponsor, NewPubco (after the Closing
Date) or the likelihood of the Closing, including the ability to meet the Minimum Cash Condition;
(vi) make
any loans, advances or capital contributions to, or guarantees for the benefit of, or any investments in, any Person, other than (A) intercompany
loans or capital contributions between the Company and any of its wholly owned Subsidiaries, (B) the reimbursement of expenses of
employees in the ordinary course of business, (C) prepayments, loans and deposits paid to customers or suppliers of any Group Company
in the ordinary course of business, (D) trade credit extended to customers of the Group Companies in the ordinary course of business
and (E) advances to wholly owned Subsidiaries of the Company;
(vii) authorize,
recommend, propose or announce an intention to adopt, or otherwise effect, a plan of complete or partial liquidation, dissolution, restructuring,
recapitalization, reorganization or similar transaction involving any Group Company;
(viii) enter
into any settlement, conciliation or similar Contract outside of the ordinary course of business the performance of which would involve
the payment by the Group Companies in excess of $2,000,000, in the aggregate, or that imposes, or by its terms will impose at any point
in the future, any material, non-monetary obligations on any Group Company (or SPAC or any of its Affiliates after the Closing);
(ix) change
any Group Company’s accounting principles or methods of accounting in any material respect, other than changes that are made in
accordance with PCAOB standards or IFRS;
(x) except
as set forth on Section 3.18 of the Company Disclosure Schedules, enter into any Contract with any broker, finder, investment
banker or other Person under which such Person is or will be entitled to any brokerage fee, finders’ fee or other commission in
connection with the transactions contemplated by this Agreement;
(xi) (A) change
any material method of Tax accounting, (B) make (inconsistent with past practice), change or rescind any material election relating
to Taxes, (C) settle or compromise any audit, assessment, claim or other Proceeding in respect of material Taxes other than such
settlement or compromise with the ITA, (D) enter into any closing agreement in respect of material Taxes or enter into any Tax sharing
or similar Tax agreement (which this (D) does not include any customary commercial agreement entered into in the ordinary course
of business and the principal purpose of which does not relate to Taxes), (E) surrender or allow to expire any right to claim a
refund of material Taxes or (F) consent to any extension or waiver of the statute of limitations period applicable to any claim
or assessment in respect of material Taxes; or
(xii) enter
into any Contract to take, or cause to be taken, any of the foregoing actions set forth in clauses (i) through (vii).
(c) Notwithstanding
anything in this Section 5.1 or this Agreement to the contrary, nothing set forth in this Agreement shall give SPAC, directly
or indirectly, the right to control or direct the operations of any Group Company, NewPubco or Merger Sub prior to the Closing.
Section 5.2 Efforts
to Consummate; Transaction Litigation; Incorporation of NewPubco and Merger Sub.
(a) Subject
to the terms and conditions herein provided, each of the Parties shall (and shall cause their Affiliates to) use reasonable best efforts
to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary or advisable to consummate
and make effective as promptly as reasonably practicable the Transactions contemplated by this Agreement (including (i) the satisfaction,
but not waiver, of the closing conditions set forth in ARTICLE VI and, in the case of any Ancillary Document to which such
Party will be a party after the date of this Agreement, to execute and deliver such Ancillary Document when required pursuant to this
Agreement, and (ii) using reasonable best efforts to assist in the delisting from the TASE of the Company Ordinary Shares, including
approaching any relevant judicial or regulatory body in connection therewith). Without limiting the generality of the foregoing, each
of the Parties shall (and shall cause their Affiliates to) use reasonable best efforts to obtain, file with or deliver to, as applicable,
as promptly as reasonably practicable any Consents of any Governmental Entities or other Persons necessary, proper or advisable to consummate
the Transactions. Each Party shall (i) make all required filings, notifications and applications, if any, pursuant to the HSR Act
and any other applicable antitrust, competition, merger control and foreign investment Laws with respect to the Transactions as promptly
as reasonably practicable (and, with respect to the HSR Act, no later than ten (10) Business Days) following the date of this Agreement
and (ii) respond as promptly as reasonably practicable to any requests by any Governmental Entity for additional information and
documentary material that may be requested pursuant to the HSR Act or any other Law. SPAC shall promptly inform the Company of any communication
between SPAC or any of its Affiliates, on the one hand, and any Governmental Entity, on the other hand, and the Company shall promptly
inform SPAC of any communication between the Company, on the one hand, and any Governmental Entity, on the other hand, in either case,
regarding any of the Transactions. Without limiting the foregoing, each Party and its respective Affiliates shall not extend any waiting
period, review period or comparable period under the HSR Act or any other applicable antitrust, competition, merger control or foreign
investment Law, or enter into any agreement with any Governmental Entity to delay or not to consummate the Transactions, except with
the prior written consent of SPAC and the Company, as applicable. Nothing in this Section 5.2 obligates any Party or any
of its Affiliates to agree to (A) sell, license or otherwise dispose of, or hold separate and agree to sell, license or otherwise
dispose of, any entities, assets or facilities of any Group Company or any entity, facility or asset of such Party or any of its Affiliates,
(B) terminate, amend or assign existing relationships and contractual rights or obligations, (C) amend, assign or terminate
existing licenses or other agreements, or (D) enter into new licenses or other agreements. No Party shall agree to any of the foregoing
measures with respect to any other Party or any of its Affiliates, except with SPAC’s and the Company’s prior written consent.
(b) From
and after the date of this Agreement until the earlier of the Closing or termination of this Agreement in accordance with its terms,
SPAC, on the one hand, and the Company and its Affiliates, on the other hand, shall give counsel for the Company (in the case of SPAC)
or counsel for SPAC (in the case of the Company), a reasonable opportunity to review in advance, and consider in good faith the views
of the other in connection with, any proposed written communication to any Governmental Entity relating to the Transactions. Each of
the Parties and its Affiliates agrees not to participate in any substantive meeting or discussion, either in person or by telephone with
any Governmental Entity in connection with the transactions contemplated by this Agreement unless it consults with, in the case of the
Company, SPAC, or, in the case of SPAC, the Company in advance and, to the extent not prohibited by such Governmental Entity, gives,
in the case of the Company, SPAC, or, in the case of SPAC, the Company, the opportunity to attend and participate in such meeting or
discussion. If any Party receives a request for additional information or documentary material from any Governmental Entity with respect
to the Transactions, then such Party will use its reasonable best efforts to make, or cause to be made, as expeditiously as possible
and after consultation with the other Parties, an appropriate response to such request.
(c) From
and after the date of this Agreement until the earlier of the Closing or termination of this Agreement in accordance with its terms,
SPAC, on the one hand, and the Company, on the other hand, shall each notify the other in writing promptly after learning of any shareholder
demands or other shareholder Proceedings (including derivative claims) relating to this Agreement, any Ancillary Document or any matters
relating thereto (collectively, the “Transaction Litigation”) commenced against, in the case of SPAC, SPAC or any
of its Representatives (in their capacity as a Representative of SPAC) or, in the case of the Company, NewPubco, Merger Sub, any Group
Company, or any of their respective Representatives (in their capacity as a Representative of any Group Company, NewPubco or Merger Sub).
SPAC and the Company shall each (i) keep the other reasonably informed regarding any Transaction Litigation, (ii) give the
other the opportunity to, at its own cost and expense, participate in the defense, settlement and compromise of any such Transaction
Litigation and reasonably cooperate with the other in connection with the defense, settlement and compromise of any such Transaction
Litigation, (iii) consider in good faith the other’s advice with respect to any such Transaction Litigation and (iv) reasonably
cooperate with each other. Notwithstanding the foregoing, the Company shall, subject to and without limiting the covenants and agreements,
and the rights of SPAC, set forth in the immediately preceding sentence, control the negotiation, defense and settlement of any such
Transaction Litigation.
(d) Promptly
following the date hereof, the Company shall cause (i) NewPubco to be formed under the laws of the State of Israel, and (ii) for
NewPubco to form Merger Sub, as a Cayman Islands exempted company and a wholly owned, direct Subsidiary of NewPubco.
(e) Promptly
after the Company receives the certificate of incorporation (or equivalent document) following the incorporation of NewPubco and Merger
Sub, the Company shall cause each of NewPubco and Merger Sub to execute and deliver to SPAC a joinder agreement in form and substance
to be mutually agreed by SPAC and the Company, pursuant to which, among other things, each NewPubco and Merger Sub shall (i) become
a party to this Agreement as of the date thereof and (ii) agree to be bound by the terms, covenants and other provisions of this
Agreement applicable to it as a Company Party and shall assume all rights and obligations of a Company Party hereunder, with the same
force and effect as if originally named herein (a “Joinder Agreement”), and (iii) NewPubco in its capacity as
sole shareholder of Merger Sub, shall deliver its adoption and approval of this Agreement and the Merger in accordance with the Cayman
Companies Law in the form of written shareholder resolution.
Section 5.3 Confidentiality
and Access to Information.
(a) The
Parties hereby acknowledge and agree that the information being provided in connection with this Agreement and the consummation of the
Transactions is subject to the terms of the Confidentiality Agreement, the terms of which are incorporated herein by reference. Notwithstanding
the foregoing or anything to the contrary in this Agreement, in the event that this Section 5.3(a) or the Confidentiality
Agreement conflicts with any other covenant or agreement contained herein or any Ancillary Document that contemplates the disclosure,
use or provision of information or otherwise, then such other covenant or agreement contained herein or therein shall govern and control
to the extent of such conflict.
(b) From
and after the date of this Agreement until the earlier of the Closing Date or the termination of this Agreement in accordance with its
terms, upon reasonable advance written notice, the Company shall provide, or cause to be provided, to SPAC and its Representatives during
normal business hours reasonable access to the directors, officers, employee, consultants, advisors, books and records of the Group Companies,
including financial information of the Group Companies used in the preparation of the Financial Statements and in the unaudited projected
financial information to be included in the Registration Statement (in a manner so as to not materially interfere with the normal business
operations of the Group Companies). Notwithstanding the foregoing, none of the Group Companies shall be required to provide to SPAC or
any of its Representatives any information (i) if and to the extent doing so would (A) violate any Law to which any Group Company
is subject, (B) result in the disclosure of any trade secrets of third-parties in breach of any Contract with such third-party,
(C) violate any legally binding obligation of any Group Company with respect to confidentiality, non-disclosure or privacy or (D) jeopardize
protections afforded to any Group Company under the attorney-client privilege or the attorney work product doctrine (provided
that, in case of each of clauses (A) through (D), the Company shall, and shall cause the other Group Companies to,
use commercially reasonable efforts to (x) provide such access as can be provided (or otherwise convey such information regarding
the applicable matter as can be conveyed) without violating such privilege, doctrine, Contract, obligation or Law and (y) provide
such information in a manner without violating such privilege, doctrine, Contract, obligation or Law), or (ii) if any Group Company,
NewPubco or Merger Sub, on the one hand, and SPAC, any SPAC Non-Party Affiliate or any of their respective Representatives, on the other
hand, are adverse parties in a litigation or other Proceeding and such information is reasonably pertinent thereto; provided that
the Company shall, in the case of clause (i) or (ii), provide prompt written notice of the withholding of access or
information on any such basis.
(c) From
and after the date of this Agreement until the earlier of the Closing Date or the termination of this Agreement in accordance with its
terms, upon reasonable advance written notice, SPAC shall provide, or cause to be provided, to the Company and its Representatives during
normal business hours reasonable access to the directors, officers, books and records of SPAC (in a manner so as to not interfere with
the normal business operations of SPAC). Notwithstanding the foregoing, SPAC shall not be required to provide, or cause to be provided
to, the Company or any of its Representatives any information (i) if and to the extent doing so would (A) violate any Law to
which SPAC is subject, (B) result in the disclosure of any trade secrets of third-parties in breach of any Contract with such third-party,
(C) violate any legally binding obligation of SPAC with respect to confidentiality, non-disclosure or privacy or (D) jeopardize
protections afforded to SPAC under the attorney-client privilege or the attorney work product doctrine (provided that, in case
of each of clauses (A) through (D), SPAC shall use commercially reasonable efforts to (x) provide such access
as can be provided (or otherwise convey such information regarding the applicable matter as can be conveyed) without violating such privilege,
doctrine, Contract, obligation or Law and (y) provide such information in a manner without violating such privilege, doctrine, Contract,
obligation or Law), or (ii) if SPAC, on the one hand, and any Group Company, any Company Non-Party Affiliate, NewPubco, Merger Sub
or any of their respective Representatives, on the other hand, are adverse parties in a litigation or other Proceedings and such information
is reasonably pertinent thereto; provided that SPAC shall, in the case of clause (i) or (ii), provide prompt
written notice of the withholding of access or information on any such basis.
Section 5.4 Public
Announcements.
(a) None
of the Parties or any of their respective Representatives shall issue any press releases or make any public announcements with respect
to this Agreement or the transactions contemplated by this Agreement without the prior written consent of, prior to the Closing, the
Company and SPAC or, after the Closing, the Company; provided, however, that each Party may make any such announcement
or other communication (i) if, subject to subsection (iv) below, such announcement or other communication is required by applicable
Law (including the requirements of Nasdaq), in which case (A) prior to the Closing, the disclosing Party and its Representatives
shall use commercially reasonable efforts to consult with the Company, if the disclosing party is SPAC, or SPAC, if the disclosing party
is the Company, to review such announcement or communication and the opportunity to comment thereon and the disclosing party shall consider
such comments in good faith and in recognition of the obligations of the Parties to coordinate their disclosure while remaining in compliance
with their respective disclosure requirements, or (B) after the Closing, the disclosing Party and its Representatives shall use
commercially reasonable efforts to consult with the Company and the disclosing Party shall consider such comments in good faith, (ii) to
the extent such announcements or other communications contain only information previously disclosed in a public statement, press release
or other communication previously approved in accordance with this Section 5.4, (iii) subject to the terms of Section 5.2,
to Governmental Entities in connection with any Consents required to be made under this Agreement, the Ancillary Documents or in connection
with the Transactions and (iv) if, with respect to the Company, such announcement or other communication is required by applicable
Israeli Law (including the requirements of TASE), the Company shall have no obligation to consult with SPAC with respect to such announcement
or communication and SPAC shall have no right to review and comment on such announcement or communication.
(b) The
initial press release concerning this Agreement and the transactions contemplated by this Agreement shall be a joint press release in
the form agreed by the Company and SPAC prior to the execution of this Agreement and such initial press release (the “Signing
Press Release”) shall be released as promptly as reasonably practicable after the execution of this Agreement on the day thereof.
Promptly after the execution of this Agreement (and in any event within four (4) Business Days hereof), SPAC shall file a current
report on Form 8-K (the “Signing Filing”) with the Signing Press Release and a description of this Agreement
as required by, and in compliance with, the Securities Laws, which the Company shall have the opportunity to review and comment upon
prior to filing and SPAC shall consider such comments in good faith. The Company shall file an immediate report to the TASE and the ISA
following the Signing Filing, which the SPAC shall have the opportunity to review and comment upon prior to filing and the Company shall
consider such comments in good faith, subject to the SPAC completing such review and providing such comments, if any, within the timeline
that will allow the Company to comply with any applicable Law. The Company, on the one hand, and SPAC, on the other hand, shall mutually
agree upon (such agreement not to be unreasonably withheld, conditioned or delayed by either the Company or SPAC, as applicable) a press
release announcing the consummation of the transactions contemplated by this Agreement (the “Closing Press Release”)
prior to the Closing, and, on the Closing Date, the Parties shall cause the Closing Press Release to be released. Promptly after the
Closing (but in any event within four (4) Business Days after the Closing), the Company shall file a current report on Form 8-K
(the “Closing Filing”), and the Company shall file an immediate report to the TASE and the ISA, in each case with
the Closing Press Release and a description of the Closing as required by Securities Laws, which Closing Filing shall be mutually agreed
upon by the Company and SPAC prior to the Closing (such agreement not to be unreasonably withheld, conditioned or delayed by either the
Company or SPAC, as applicable). In connection with the preparation of each of the Signing Press Release, the Signing Filing, the Closing
Press Release and the Closing Filing, each Party shall, upon written request by any other Party, furnish such other Party with all information
concerning itself, its directors, officers and equity holders, and such other matters as may be reasonably necessary for such press release
or filing.
Section 5.5 Tax
Matters; Tax Rulings.
(a) Notwithstanding
anything to the contrary herein, each Party shall pay its own transfer, documentary, sales, use, real property transfer, stamp, registration
and other similar Taxes, fees and costs incurred in connection with the Transactions.
(b) Each
Party shall, and shall cause its Affiliates to, use commercially reasonable efforts to cause the transactions contemplated herein to
qualify for, and agree not to, and not to permit or cause any Affiliate, or any Subsidiary to, take any actions or cause any action to
be taken that could reasonably be expected to prevent, impair or impede the Intended U.S. Tax Treatment. From and after the Closing,
neither NewPubco nor its Affiliates will take any action, make any Tax election or engage in any transaction that would result in the
liquidation of SPAC or the Company for U.S. federal income tax purposes within two (2) calendar years following the Closing Date.
The Parties shall, and shall cause their respective Affiliates to, file all Tax Returns consistent with, and not take any position for
Tax purposes (whether in Tax Proceeding or otherwise) inconsistent with, the Intended U.S. Tax Treatment. The Parties further acknowledge
that each of the Equity Exchange and the Merger may also independently qualify as a “reorganization” within the meaning of
Section 368(a) of the Code, and for the avoidance of doubt, the preceding sentence shall not be interpreted to prevent a person
from reporting either the Equity Exchange or the Merger as a “reorganization” within the meaning of Section 368(a) of
the Code (other than Section 368(a)(1)(F) of the Code). To the extent applicable, the Parties hereby adopt this Agreement as
a “plan of reorganization” within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3(a).
(c) If,
in connection with the preparation and filing of the Registration Statement / Proxy Statement, the SEC requires any opinion to be provided
in respect of the Tax consequences of the Transactions: (i) to the extent such opinion is with respect to the Intended U.S. Tax
Treatment or other Tax consequences of the Transactions to equityholders of the Company, the Company shall use commercially reasonable
efforts to cause such opinion (as so required by the SEC) to be provided, subject to customary assumptions and limitations, by its Tax
advisors or counsel, and (ii) to the extent such opinion is with respect to the Intended U.S. Tax Treatment or other Tax consequences
of the Transactions to equityholders of SPAC and not otherwise not covered in (i), SPAC shall use commercially reasonable efforts to
cause such opinion (as so required by the SEC) to be provided, subject to customary assumptions and limitations, by its Tax advisors
or counsel. Each of the Parties shall use commercially reasonable efforts to, and to cause its Affiliates to, cooperate with one another
and their respective Tax advisors or counsel in connection with the issuance of an opinion described under this Section 5.5(c),
including, upon the reasonable request of any Tax advisors or counsel, using commercially reasonable efforts to deliver to such Tax advisors
or counsel certificates (dated as of the necessary date and signed by an officer of each such Party or its Affiliates) containing such
customary representations as are reasonably necessary or appropriate for such Tax advisors or counsel to render such opinion. Notwithstanding
anything to the contrary in this Agreement, none of the Company, SPAC or their respective Tax advisors are obligated to provide any opinion
that the Transactions contemplated by this Agreement qualify Intended U.S. Tax Treatment, other than a customary opinion regarding the
material accuracy of any disclosure regarding U.S. federal income tax considerations of the Transactions included in the Registration
Statement / Proxy Statement as may be required to satisfy applicable rules and regulations promulgated by the SEC, nor will the
provision of any Tax opinion be a condition precedent to the Transactions.
(d) Each
of the Parties shall, and shall cause their respective Affiliates to, cooperate fully, as and to the extent reasonably requested by another
Party, in connection with the filing of relevant Tax Returns and any Tax audit or Proceeding or to determine the Tax treatment of any
aspect of the Transactions. Such cooperation shall include the retention and (upon the other Party’s request) the provision (with
the right to make copies) of records and information reasonably relevant to any Tax Proceeding or audit, making employees reasonably
available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder (to the
extent such information or explanation is not publicly or otherwise reasonably available) NewPubco shall use commercially reasonable
efforts to make available to the former SPAC Shareholders information reasonably necessary to compute any income of any such former SPAC
Shareholder (or its direct or indirect owners) arising, if applicable, as a result of SPAC’s status as a “passive foreign
investment company” within the meaning of Section 1297(a) of the Code or a “controlled foreign corporation”
within the meaning of Section 957(a) of the Code for any Tax period that includes the Closing Date, including following a written
request by any such former SPAC Shareholder timely providing (i) a PFIC annual information statement meeting the requirements of
Treasury Regulations Section 1.1295-1(g)(1) to enable such former SPAC Shareholder (or its direct or indirect owners) to make
a “qualifying electing fund” election under Section 1295 of the Code for any such Tax period, and (ii) information
to enable any applicable former SPAC Shareholder (or its direct or indirect owners) to report its allocable share of “subpart F”
income under Section 951 of the Code for any such Tax period.
(e) Tax
Rulings:
(i) 102
Awards Tax Ruling. As soon as reasonably practicable after the execution of this Agreement, the Company shall instruct its legal
counsel, advisors and accountants, in coordination with SPAC, to prepare and file with the ITA an application in form and substance reasonably
acceptable to SPAC for a ruling, which may be included as part of the Company Israeli Tax Ruling, that will provide, among other things,
that: (i) SPAC, NewPubco, the Company and anyone acting on their behalf shall be exempt from withholding Tax in relation to the
exchange of Company 102 Options for NewPubco Stock Options, the exchange of Company 102 RSUs for NewPubco RSUs and the exchange of Company
102 Shares for NewPubco Ordinary Shares, and (ii) the exchange of Company 102 Options for NewPubco Stock Options, the exchange of
Company 102 RSUs for NewPubco RSUs and the exchange of Company 102 Shares for NewPubco Ordinary Shares shall not constitute a Taxable
event and Tax continuity shall apply to the stock options, RSUs, or Ordinary Shares of NewPubco issued in exchange for such Company 102
Options, Company 102 RSUs or Comp any 102 Shares (which ruling may be subject to customary conditions regularly associated with such
a ruling) (the “102 Awards Tax Ruling”). Each of the Company and SPAC shall cause their respective legal counsel,
advisors and accountants to coordinate all activities, and to cooperate with each other, with respect to the preparation and filing of
such application and in the preparation of any written or oral submissions that may be necessary, proper or advisable to obtain the 102
Awards Tax Ruling. Subject to the terms and conditions hereof, the Company shall use commercially reasonable efforts to promptly take,
or cause to be taken, all action and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws to obtain
the 102 Awards Tax Ruling as promptly as practicable. The final text of the 102 Awards Tax Ruling, including all appendices thereof,
shall in all circumstances be subject to the prior written confirmation of SPAC or its counsel, which consent shall not unreasonably
be withheld, conditioned or delayed.
(ii) Company
Israeli Tax Ruling. As soon as reasonably practicable after the execution of this Agreement, the Company shall instruct its legal
counsel, advisors and accountants, in coordination with SPAC, to prepare and file with the ITA an application for a ruling or rulings
(or interim ruling or rulings, if applicable) providing for the deferral of any applicable Israeli Tax, if applied, with respect to such
NewPubco equity consideration that each Company Shareholder, and holder of Company Equity Awards is entitled to receive pursuant to this
Agreement until the date of the sale, transfer or other conveyance for cash of such NewPubco share consideration (such ruling, rulings,
interim ruling or interim rulings, collectively, the “Company Israeli Tax Ruling”). The Company shall cooperate with
SPAC, and their Israeli counsel and Tax advisors with respect to the preparation and filing of such application and in the preparation
of any written or oral submissions that may be necessary, proper or advisable to obtain the Company Israeli Tax Ruling; provided that
any costs associated with the application for the Company Israeli Tax Ruling shall be paid by the Company prior to the Closing; provided, further,
that the Company Israeli Interim Tax Ruling or the Company Israeli Tax Ruling shall not impose any restrictions or obligations on SPAC,
the Company or any of their Affiliates without the prior written consent of SPAC or the Company, respectively. For the avoidance of doubt,
the Company shall not make any application to the ITA with respect to any matter relating to the Company Israeli Tax Ruling without first
consulting with SPAC and its legal counsel and Tax advisors granting SPAC and its legal counsel and tax advisors the opportunity to review,
comment and approve the draft application for such ruling, and the Company and any of its Representatives shall enable SPAC and its legal
counsel and tax advisors to participate in all discussions and meetings with the ITA relating thereto. The final text of the Company
Israeli Interim Tax Ruling (if applicable) or the Company Israeli Tax Ruling shall be subject to the prior written confirmation of both
SPAC and the Company and their respective legal counsel and Tax advisors.
(iii) SPAC
Israeli Tax Ruling. As soon as reasonably practicable after the execution of this Agreement, SPAC shall instruct its legal counsel,
advisors and accountants, in coordination with the Company, to prepare and file with the ITA an application for a ruling or rulings (or
interim ruling or rulings, if applicable) providing for the deferral of any applicable Israeli Tax, if applied, with respect to such
NewPubco equity consideration that each SPAC Shareholder and holder of SPAC Warrants is entitled to receive pursuant to this Agreement
until the date of the sale, transfer or other conveyance for cash of such NewPubco share consideration (such ruling, rulings, interim
ruling or interim rulings, collectively, the “SPAC Israeli Tax Ruling” and together with the Company Israeli Tax Ruling,
the “Israeli Tax Rulings”). SPAC shall cooperate with the Company, and their Israeli counsel and Tax advisors with
respect to the preparation and filing of such application and in the preparation of any written or oral submissions that may be necessary,
proper or advisable to obtain the SPAC Israeli Tax Ruling; provided that any costs associated with the application for the SPAC Israeli
Tax Ruling shall be paid by SPAC prior to the Closing; provided, further, that the SPAC Israeli Interim Tax Ruling or the SPAC
Israeli Tax Ruling shall not impose any restrictions or obligations on SPAC, the Company or any of their Affiliates without the prior
written consent of SPAC or the Company, respectively. For the avoidance of doubt, SPAC shall not make any application to the ITA with
respect to any matter relating to the SPAC Israeli Tax Ruling without first consulting with the Company and its legal counsel and Tax
advisors granting the Company and its legal counsel and tax advisors the opportunity to review, comment and approve the draft application
for such ruling, and SPAC and any of its Representatives shall enable the Company and its legal counsel and tax advisors to participate
in all discussions and meetings with the ITA relating thereto. The final text of the SPAC Israeli Interim Tax Ruling (if applicable)
or the SPAC Israeli Tax Ruling shall be subject to the prior written confirmation of both SPAC and the Company and their respective legal
counsel and Tax advisors.
Section 5.6 No
Solicitation; Company Board Recommendation; SPAC Board Recommendation.
(a) From
the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to ARTICLE VII and the
Merger Effective Time, except as expressly permitted by this Section 5.6, the Company shall, and shall cause its Subsidiaries
and its and their respective officers and directors to, and shall instruct and use its commercially reasonable efforts to cause its and
their respective other Representatives to, immediately cease and cause to be terminated, and shall not authorize or knowingly permit
any of its Representatives to continue, any and all existing discussions or negotiations with any Third Party conducted prior to the
date hereof by the Company, any of its Subsidiaries or any of their respective Representatives that constitute or could reasonably be
expected to lead to any Company Acquisition Proposal, and shall promptly terminate access by each such Third Party and such Third Party’s
Representatives to any data room (whether online or otherwise) containing information in respect of the Company or its Subsidiaries.
The Company shall, within two (2) Business Days following the date of this Agreement, request in writing that each Third Party that
has previously executed a confidentiality agreement in connection with its consideration of making a Company Acquisition Proposal in
the one (1) year period prior to the date of this Agreement promptly return or destroy all confidential information previously furnished
to such Third Party by or on behalf of the Company, any of its Subsidiaries or any of their respective Representatives in accordance
with the terms of the applicable confidentiality agreement.
(b) At
all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of
the termination of this Agreement pursuant to ARTICLE VII and the Merger Effective Time, except as expressly permitted by
this Section 5.6, the Company shall not, nor shall its Subsidiaries or any of their respective officers and directors, and
the Company shall instruct and shall use commercially reasonable efforts to cause its and its Subsidiaries’ other Representatives
not to, directly or indirectly, (i) whether publicly or otherwise, solicit, initiate, knowingly encourage or knowingly facilitate
or induce the making, submission or announcement of a Company Acquisition Proposal or any inquiry, offer, proposal or indication of interest
that constitutes or could reasonably be expected to lead to any Company Acquisition Proposal; (ii) in connection with or in response
to any Company Acquisition Proposal or any inquiry, offer, proposal or indication of interest that could reasonably be expected to lead
to a Company Acquisition Proposal, furnish to any Third Party any non-public information relating to the Company or any of its Subsidiaries,
or afford access to the business, properties, assets, books or records or other information of the Company or any of its Subsidiaries
to any Third Party; (iii) enter into, conduct, participate or engage in negotiations or discussions with any Third Party (other
than solely to inform such Third Party that the terms of this Agreement prohibits such discussions) relating to or for the purpose of
encouraging or facilitating a Company Acquisition Proposal; (iv) execute or enter into any letter of intent, memorandum of understanding,
agreement in principle, term sheet, merger agreement or Contract contemplating or otherwise relating to a Company Acquisition Transaction
(a “Company Alternative Acquisition Agreement”) or requiring the Company to abandon, terminate or fail to consummate
the Transactions contemplated by this Agreement; (v) terminate, amend, modify, waive or release any rights under any “standstill”
or other similar agreement (unless the Company Board determines in good faith (after consultation with its outside legal counsel) that
the failure to grant any waiver or release under any standstill or similar agreement would reasonably be expected to be inconsistent
with its fiduciary duties under applicable Law); or (vi) resolve, propose or agree to do any of the foregoing. Notwithstanding the
foregoing, prior to obtaining the Company Equityholder Approval, if at any time the Company receives an unsolicited bona fide written
Company Acquisition Proposal after the date of this Agreement that did not result from a material breach of this Section 5.6
the Company Board determines in good faith (after consultation with the Company’s financial advisors and outside legal counsel)
that such Company Acquisition Proposal constitutes or could reasonably be expected to lead to a Superior Proposal and that the failure
to take such actions could reasonably be expected to be inconsistent with the fiduciary duties of the Company Board under applicable
Law, then the Company in response to such Company Acquisition Proposal may (A) contact the Third Party or any of its Representatives
who has made such Company Acquisition Proposal solely for the purpose of seeking clarification of the terms or conditions of such Company
Acquisition Proposal, (B) engage or participate in discussions or negotiations with such Third Party or any of its Representatives
regarding such Company Acquisition Proposal and (C) afford access and furnish to such Third Party or to any of its Representatives
any information relating to the Company, to any of its Subsidiaries or to their respective businesses, properties or assets or provide
access to data room (virtual or physical) pursuant to a confidentiality agreement (which the Company and its Representatives will be
permitted to negotiate and enter into) the terms of which, taken as a whole, are no less favorable to the Company than those contained
in the Confidentiality Agreement and do not include any provision granting such counterparty the exclusive right to negotiate with the
Company or having the effect of prohibiting the Company from satisfying its obligations hereunder (it being understood that such an agreement
need not include any “standstill” or similar provisions); provided, that any material non-public information relating
to the Company, to any of its Subsidiaries or to their respective businesses, properties or assets furnished to such Third Party (to
the extent that such information has not been previously provided or made available to SPAC) is furnished or made available to SPAC promptly
(and in any event within 48 hours) following the provision or making available of such information to such Third Party.
(c) Without
limiting the generality of the foregoing, SPAC and the Company acknowledge and agree that any violation of the restrictions set forth
in this Section 5.6 by any Subsidiary of the Company or any directors or officers of the Company or its Subsidiaries, shall
be deemed to be a breach of this Section 5.6 by the Company. The Company shall use its commercially reasonable efforts to
cause its and its Subsidiaries’ other Representatives to comply with the restrictions set forth in this Section 5.6.
(d) In
addition to the obligations of the Company set forth in Section 5.6(b), the Company shall promptly, and in all cases within
48 hours of its receipt, advise SPAC orally and in writing of any (i) Company Acquisition Proposal or (ii) request for information
or request to engage in negotiations or discussions or any other inquiry with respect to, or that could reasonably be expected to lead
to, a Company Acquisition Proposal, and provide SPAC with (A) copies of all written materials provided by such Person in connection
with such Company Acquisition Proposal, request or inquiry (redacted so as not to identify the Person who has made such Company Acquisition
Proposal, request or inquiry) and (B) a written summary of any material terms and conditions of such Company Acquisition Proposal
(other than the identity of the Third Party who has made the Company Acquisition Proposal, request or inquiry) not included in such written
materials.
(e) The
Company shall keep SPAC reasonably informed of the status of discussions relating to, and the material terms and conditions (including
all amendments or proposed amendments to such material terms and conditions) of any such Company Acquisition Proposal, request or inquiry,
and promptly (and in no event later than 48 hours thereafter) shall provide SPAC with copies of any revised written proposals or draft
agreements relating to any Company Acquisition Proposal, request or inquiry (redacted so as not to identify the Person who has made such
Company Acquisition Proposal, request or inquiry).
(f) Other
than in accordance with the terms of this Section 5.6(f), from the date of this Agreement until the earlier of the Merger
Effective Time or the termination of this Agreement pursuant to ARTICLE VII, the Company Board shall not (i) withhold,
amend, withdraw or modify in a manner adverse to SPAC the Company Board Recommendation, (ii) adopt, approve or recommend (or publicly
propose to adopt, approve or recommend) any Company Acquisition Proposal, (iii) if a Company Acquisition Proposal has been publicly
announced, following the failure of the Company Board to publicly reaffirm the Company Board Recommendation within ten (10) Business
Days after receipt of SPAC’s written request to do so (provided that the Company Board shall not be required to make any such public
reaffirmation on more than one occasion in respect of any Company Acquisition Proposal), publicly recommend such Company Acquisition
Proposal, or (iv) fail to include the Company Board Recommendation in the Proxy Statement (collectively, a “Company Board
Recommendation Change”). Notwithstanding anything to the contrary set forth in this Agreement, at any time prior to obtaining
the Company Equityholder Approval, the Company Board may, in response to an unsolicited bona fide written Superior Proposal that has
not been withdrawn, (A) effect a Company Board Recommendation Change with respect to such Superior Proposal and (B) terminate
this Agreement pursuant to Section 7.1(h) in order to enter into a definitive Company Alternative Acquisition Agreement
providing for such Superior Proposal if, in each case (1) the Company Board determines in good faith, after consultation with the
Company’s financial advisors and outside legal counsel, that in light of such Superior Proposal, failure to effect a Company Board
Recommendation Change and failure to terminate this Agreement in order to enter into a definitive Company Alternative Acquisition Agreement
would be inconsistent with the fiduciary duties of the Company Board under applicable Law; (2) SPAC receives written notice from
the Company confirming that the Company Board has determined to change its recommendation at least four (4) Business Days in advance
of the Company Board Recommendation Change (the “Company Superior Proposal Notice Period”); (3) the Company has,
and has caused its financial and legal advisors to, during the Company Superior Proposal Notice Period, negotiate with SPAC in good faith
any proposed modifications to the terms and conditions of this Agreement in response to such Superior Proposal; and (4) after taking
into account any counter-offer or proposal offered by SPAC within the Company Superior Proposal Notice Period in writing, if any, the
Company Board confirms the determination that the Company Acquisition Proposal still constitutes a Superior Proposal (it being understood
that the Company shall promptly notify SPAC of any material amendment or modification to the terms of a Superior Proposal, including
any revision in price (in any event within one (1) Business Day from such amendment or modification); provided, that the
period during which the Company and its Representatives are required to negotiate with SPAC in good faith regarding any modified terms
proposed by SPAC in response to such amendment or modification of a Superior Proposal shall expire on the earlier to occur of (x) two
(2) Business Days after the Company provides written notice of such amendment or modification and (y) the end of the original
Company Superior Proposal Notice Period).
(g) Nothing
in this Agreement shall prohibit the Company or Company Board from (i) taking and/or disclosing to Company Shareholders a position
contemplated by Rule 14e-2(a) under the Exchange Act or complying with the provisions of Rule 14d-9 under the Exchange
Act and, to the extent referenced therein, Item 1012(a) of Regulation M-A under the Exchange Act; (ii) taking and disclosing
to the Company Shareholders a position contemplated by Section 329 of the ICL (or making any similar communication to the Company
Shareholders required under Israeli law); (iii) making a “stop, look and listen” communication to Company Shareholders
pursuant to Rule 14d-9(f) under the Exchange Act; or (iv) making any other disclosure or communication to Company Shareholders
if the Company Board has determined in good faith after consultation with the Company’s outside legal counsel that such disclosure
or communication is required under applicable Law or that the failure to make such disclosure or communication would reasonably be expected
to be inconsistent with the fiduciary duties of the Company Board under applicable Law; provided, however, that the taking
of any such position or making of any such disclosure or communication contemplated by this Section 5.6(g) shall not
affect the definition of “Company Board Recommendation Change” and the Company Board may not effect a Company Board Recommendation
Change except in compliance with this Section 5.6(g) (it being understood, for the avoidance of doubt, that the making
of any disclosure or communication permitted under this Section 5.6(g) shall not constitute a Company Board Recommendation
Change).
(h) Except
as otherwise permitted by this Section 5.6, prior to the earlier to occur of the Merger Effective Time and the termination
of this Agreement pursuant to ARTICLE VII, the Company shall not take any action to approve any transaction under, or exempt
any Person (other than SPAC and its Affiliates) from the provisions of, any takeover Law or any anti-takeover provision in the Governing
Documents of the Company or otherwise cause such restrictions not to apply.
(i) From
the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to ARTICLE VII and the
Merger Effective Time, except as expressly permitted by this Section 5.6, SPAC shall, and shall cause its Affiliates and
its and their respective officers and directors to, and shall instruct and use its commercially reasonable efforts to cause its and their
respective other Representatives to, immediately cease and cause to be terminated, and shall not authorize or knowingly permit any of
its Representatives to continue, any and all existing discussions or negotiations with any Third Party conducted prior to the date hereof
by SPAC, any of its Affiliates or any of their respective Representatives that constitute or could reasonably be expected to lead to
any SPAC Acquisition Proposal.
(j) At
all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of
the termination of this Agreement pursuant to ARTICLE VII and the Merger Effective Time, except as expressly permitted by
this Section 5.6, SPAC shall not, nor shall its Affiliates or any of their respective officers and directors, and SPAC shall
instruct and shall use commercially reasonable efforts to cause its and its Affiliates’ other Representatives not to, directly
or indirectly, (i) whether publicly or otherwise, solicit, initiate, knowingly encourage or knowingly facilitate or induce the making,
submission or announcement of a SPAC Acquisition Proposal or any inquiry, offer, proposal or indication of interest that constitutes
or could reasonably be expected to lead to any SPAC Acquisition Proposal; (ii) in connection with or in response to any SPAC Acquisition
Proposal or any inquiry, offer, proposal or indication of interest that could reasonably be expected to lead to a SPAC Acquisition Proposal,
furnish to any Third Party any information relating to the SPAC or any of its Affiliates, or afford access to the business, assets, books
or records or other information of SPAC or any of its Affiliates to any Third Party; (iii) enter into, conduct, participate or engage
in negotiations or discussions with any Third Party (other than solely to inform such Third Party that the terms of this Agreement prohibits
such discussions) relating to or for the purpose of encouraging or facilitating a SPAC Acquisition Proposal; (iv) execute or enter
into any letter of intent, memorandum of understanding, agreement in principle, term sheet, merger agreement or Contract contemplating
or otherwise relating to a SPAC Acquisition Transaction (an “SPAC Alternative Acquisition Agreement”) or requiring
SPAC to abandon, terminate or fail to consummate the Transactions contemplated by this Agreement; (v) terminate, amend, modify,
waive or release any rights under any “standstill” or other similar agreement (unless the SPAC Board determines in good faith
(after consultation with its outside legal counsel) that the failure to grant any waiver or release under any standstill or similar agreement
would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law); or (vi) resolve, propose or agree
to do any of the foregoing. Notwithstanding the foregoing, prior to obtaining the SPAC Shareholder Approval, if at any time SPAC receives
an unsolicited bona fide written SPAC Acquisition Proposal after the date of this Agreement that did not result from a material breach
of this Section 5.6 the SPAC Board determines in good faith (after consultation with SPAC’s financial advisors and
outside legal counsel) that such SPAC Acquisition Proposal constitutes or could reasonably be expected to lead to a Superior Proposal
and that the failure to take such actions could reasonably be expected to be inconsistent with the fiduciary duties of the SPAC Board
under applicable Law, then SPAC in response to such SPAC Acquisition Proposal may (A) contact the Third Party or any of its Representatives
who has made such SPAC Acquisition Proposal solely for the purpose of seeking clarification of the terms or conditions of such SPAC Acquisition
Proposal, (B) engage or participate in discussions or negotiations with such Third Party or any of its Representatives regarding
such SPAC Acquisition Proposal and (C) afford access and furnish to such Third Party or to any of its Representatives any information
relating to SPAC pursuant to a confidentiality agreement (which SPAC and its Representatives will be permitted to negotiate and enter
into) the terms of which, taken as a whole, are no less favorable to SPAC than those contained in the Confidentiality Agreement and do
not include any provision granting such counterparty the exclusive right to negotiate with SPAC or having the effect of prohibiting SPAC
from satisfying its obligations hereunder (it being understood that such an agreement need not include any “standstill” or
similar provisions); provided, that any material non-public information relating to SPAC, to any of its Affiliates or to their
respective businesses, properties or assets furnished to such Third Party (to the extent that such information has not been previously
provided or made available to the Company) is furnished or made available to the Company promptly (and in any event within 48 hours)
following the provision or making available of such information to such Third Party.
(k) Without
limiting the generality of the foregoing, SPAC and the Company acknowledge and agree that any violation of the restrictions set forth
in this Section 5.6 by any Affiliate of SPAC or any directors or officers of SPAC, shall be deemed to be a breach of this
Section 5.6 by SPAC. SPAC shall use its commercially reasonable efforts to cause its and its Affiliates Representatives to
comply with the restrictions set forth in this Section 5.6.
(l) In
addition to the obligations of SPAC set forth in Section 5.6(j), SPAC shall promptly, and in all cases within 48 hours of
its receipt, advise the Company orally and in writing of any (i) SPAC Acquisition Proposal or (ii) request for information
or request to engage in negotiations or discussions or any other inquiry with respect to, or that could reasonably be expected to lead
to, a SPAC Acquisition Proposal, and provide the Company with (A) copies of all written materials provided by such Person in connection
with such SPAC Acquisition Proposal, request or inquiry (redacted so as not to identify the Person who has made such SPAC Acquisition
Proposal, request or inquiry) and (B) a written summary of any material terms and conditions of such SPAC Acquisition Proposal (other
than the identity of the Third Party who has made the SPAC Acquisition Proposal, request or inquiry) not included in such written materials.
(m) SPAC
shall keep the Company reasonably informed of the status of discussions relating to, and the material terms and conditions (including
all amendments or proposed amendments to such material terms and conditions) of any such SPAC Acquisition Proposal, request or inquiry,
and promptly (and in no event later than 48 hours thereafter) shall provide the Company with copies of any revised written proposals
or draft agreements relating to any SPAC Acquisition Proposal, request or inquiry (redacted so as not to identify the Person who has
made such SPAC Acquisition Proposal, request or inquiry).Other than in accordance with the terms of this Section 5.6(m) from
the date of this Agreement until the earlier of the Merger Effective Time or the termination of this Agreement pursuant to ARTICLE VII,
the SPAC Board shall not (i) withhold, amend, withdraw or modify in a manner adverse to the Company the SPAC Board Recommendation,
(ii) adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any SPAC Acquisition Proposal, (iii) if
a SPAC Acquisition Proposal has been publicly announced, following the failure of the SPAC Board to publicly reaffirm the SPAC Board
Recommendation within ten (10) Business Days after receipt of the Company’s written request to do so (provided that the SPAC
Board shall not be required to make any such public reaffirmation on more than one occasion in respect of any SPAC Acquisition Proposal),
publicly recommend such SPAC Acquisition Proposal, or (iv) fail to include the SPAC Board Recommendation in the Proxy Statement
(collectively, a “SPAC Board Recommendation Change”). Notwithstanding anything to the contrary set forth in this Agreement,
at any time prior to obtaining the SPAC Shareholder Approval, the SPAC Board may, in response to an unsolicited bona fide written Superior
Proposal that has not been withdrawn, (A) effect a SPAC Board Recommendation Change with respect to such Superior Proposal and (B) terminate
this Agreement pursuant to Section 7.1(i) in order to enter into a definitive SPAC Alternative Acquisition Agreement
providing for such Superior Proposal if, in each case (1) the SPAC Board determines in good faith, after consultation with SPAC’s
financial advisors and outside legal counsel, that in light of such Superior Proposal, failure to effect a SPAC Board Recommendation
Change and failure to terminate this Agreement in order to enter into a definitive SPAC Alternative Acquisition Agreement would be inconsistent
with the fiduciary duties of the SPAC Board under applicable Law; (2) the Company receives written notice from SPAC confirming that
the SPAC Board has determined to change its recommendation at least four (4) Business Days in advance of the SPAC Board Recommendation
Change (the “SPAC Superior Proposal Notice Period”); (3) SPAC has, and has caused its financial and legal advisors
to, during the SPAC Superior Proposal Notice Period, negotiate with the Company in good faith any proposed modifications to the terms
and conditions of this Agreement in response to such Superior Proposal; and (4) after taking into account any counter-offer or proposal
offered by the Company within the SPAC Superior Proposal Notice Period in writing, if any, the SPAC Board confirms the determination
that the SPAC Acquisition Proposal still constitutes a Superior Proposal (it being understood that SPAC shall promptly notify the Company
of any material amendment or modification to the terms of a Superior Proposal (in any event within one (1) Business Day from such
amendment or modification); provided, that the period during which SPAC and its Representatives are required to negotiate with
the Company in good faith regarding any modified terms proposed by the Company in response to such amendment or modification of a Superior
Proposal shall expire on the earlier to occur of (x) two (2) Business Days after SPAC provides written notice of such amendment
or modification and (y) the end of the original SPAC Superior Proposal Notice Period).
Section 5.7 Preparation
of Registration Statement / Proxy Statement. As promptly as reasonably practicable following the date of this Agreement, (a) NewPubco,
SPAC and the Company, shall prepare a proxy statement (which, depending on the Section 350 Proceeding, may be a joint proxy statement)
(the “Proxy Statement”) to be filed with the SEC by SPAC relating to (i) the Transaction Proposals to be submitted
to the holders of SPAC Shares at the SPAC Shareholders Meeting and providing the Public Shareholders an opportunity to have their SPAC
Shares redeemed, all in accordance with and as required by SPAC’s Governing Documents, applicable Law, and any applicable rules and
regulations of the SEC and Nasdaq, and (ii) the Transaction Proposals to be submitted to the holders of Company Ordinary Shares
at the Company Equityholders Meetings, all in accordance with and as required by Company’s Governing Documents, applicable Law,
and any applicable rules and regulations of the SEC, ISA and TASE, and (b) NewPubco, SPAC and the Company shall prepare,
and NewPubco shall file with the SEC a registration statement on Form F-4 or such other applicable form as the Company and SPAC
may agree (as amended or supplemented from time to time, the “Registration Statement”) pursuant to which the NewPubco
Ordinary Shares and NewPubco Warrants issuable in the Merger will be registered with the SEC and that will include the Proxy Statement
(such document, the “Registration Statement / Proxy Statement”), all in accordance with and as required by NewPubco
and SPAC’s Governing Documents, applicable Law, and any applicable rules and regulations of the SEC and Nasdaq, and the Company’s
Governing Documents, applicable Law, and any applicable rules and regulations of the SEC, ISA and TASE. Each of NewPubco, SPAC
and the Company shall use its commercially reasonable efforts to (a) cause the Registration Statement / Proxy Statement to comply
in all material respects with the applicable rules and regulations promulgated by the SEC (including, with respect to the Group
Companies, the provision of financial statements of, and any other information with respect to, the Group Companies for all periods,
and in the form, required to be included in the Registration Statement / Proxy Statement under Securities Laws (after giving effect to
any waivers received) or in response to any comments or requests from the SEC); (b) promptly notify the other party of, reasonably
cooperate with each other with respect to and respond promptly to any comments or requests of the SEC or its staff; (c) promptly
prepare and mutually agree upon (such agreement not to be unreasonably withheld, conditioned or delayed by any of NewPubco, SPAC or the
Company, as applicable) any amendments or supplements to the Registration Statement / Proxy Statement in order to address comments or
requests from the SEC or its staff (which amendments or supplements shall be promptly filed by the Parties); (d) have the Registration
Statement / Proxy Statement declared effective under the Securities Act as promptly as reasonably practicable after it is filed with
the SEC; and (e) keep the Registration Statement / Proxy Statement effective through the Closing in order to permit the consummation
of the transactions contemplated by this Agreement. Each of SPAC, NewPubco and the Company, on the other hand, shall promptly furnish,
or cause to be furnished, to the other all information concerning such Party, its Non-Party Affiliates and their respective Representatives
that may be required or reasonably requested in connection with any action contemplated by this Section 5.7 or for inclusion
in any other statement, filing, notice or application made by or on behalf of the NewPubco, Company or SPAC to the SEC or Nasdaq in connection
with the Transactions. If any Party becomes aware of any information that should be disclosed in an amendment or supplement to the Registration
Statement / Proxy Statement, then (i) such Party shall promptly inform each other Party thereof; (ii) such Party shall prepare
and mutually agree upon with the other Parties (in either case, such agreement not to be unreasonably withheld, conditioned or delayed),
an amendment or supplement to the Registration Statement / Proxy Statement; (iii) NewPubco shall as promptly as and as reasonably
practicable file such mutually agreed upon amendment or supplement with the SEC; and (iv) the Parties shall reasonably cooperate,
if appropriate, in mailing such amendment or supplement to the SPAC Shareholders and the Company Shareholders. NewPubco shall as promptly
as reasonably practicable advise SPAC and the Company of the time of effectiveness of the Registration Statement / Proxy Statement or
the issuance of any stop order relating thereto, SPAC shall as promptly as reasonably practical advise NewPubco and the Company of the
suspension of the qualification of the SPAC Shares for offering or sale in any jurisdiction, and NewPubco, the Company and SPAC shall
each use its commercially reasonable efforts to have any such stop order or suspension lifted, reversed or otherwise terminated. Each
of the Parties shall use commercially reasonable efforts to ensure that none of the information related to it or any of its Non-Party
Affiliates or its or their respective Representatives, supplied by or on its behalf for inclusion or incorporation by reference in the
Registration Statement / Proxy Statement will, at the time the Registration Statement / Proxy Statement is initially filed with the SEC,
at each time at which it is amended, or at the time it becomes effective under the Securities Act contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they are made, not misleading. SPAC shall bear all fees and expenses in connection with the registration of NewPubco Ordinary
Shares and NewPubco Warrants and the filing of the Registration Statement / Proxy Statement.
Section 5.8 SPAC
Shareholder Approval. SPAC shall use its commercially reasonable efforts to, as promptly as practicable, (i) establish the record
date for, duly call, give notice of, convene and hold the meeting of the SPAC Shareholders (the “SPAC Shareholders Meeting”)
in accordance with the Governing Documents of SPAC and the Cayman Companies Law, (ii) after the Registration Statement / Proxy Statement
is declared effective under the Securities Act, (x) file the Proxy Statement contained therein with the SEC in definitive form and
(y) cause the Proxy Statement contained therein to be disseminated to the SPAC Shareholders and (iii) after the Registration
Statement / Proxy Statement is declared effective under the Securities Act, solicit proxies from the SPAC Shareholders to vote in accordance
with the SPAC Board Recommendation, and, if applicable, any approvals related thereto, and providing the SPAC Shareholders with the Offer.
SPAC shall, through approval of the SPAC Board, recommend to its shareholders (the “SPAC Board Recommendation”), (i) the
adoption and approval of this Agreement and the Transactions (including each of the Merger, the Plan of Merger and the amended and restated
SPAC Articles); (ii) the adoption and approval of each other proposal that either the SEC or Nasdaq (or the respective staff members
thereof) indicates is necessary in its comments to the Registration Statement / Proxy Statement or in correspondence related thereto;
(iii) the adoption and approval of each other proposal reasonably agreed to by SPAC, NewPubco, and the Company as necessary or appropriate
in connection with the consummation of the Transactions; and (iv) the adoption and approval of a proposal for the adjournment of
the SPAC Shareholders Meeting, if necessary, to permit further solicitation of proxies because there are not sufficient votes to approve
and adopt any of the foregoing (such proposals in (i) through (iv) together, the “Transaction Proposals”);
provided, that SPAC may adjourn the SPAC Shareholders Meeting (A) to solicit additional proxies for the purpose of obtaining
the SPAC Shareholder Approval, (B) for the absence of a quorum, (C) to allow reasonable additional time for the filing or mailing
of any supplemental or amended disclosures that SPAC has determined, based on the advice of outside legal counsel, is reasonably likely
to be required under applicable Law and for such supplemental or amended disclosure to be disseminated and reviewed by the SPAC Shareholders
prior to the SPAC Shareholders Meeting, or (D) if holders of SPAC Shares have elected to redeem a number of SPAC Shares as of such
time that would reasonably be expected to result in the Minimum Cash Condition not being satisfied; provided that, without the
consent of the Company, in no event shall SPAC adjourn the SPAC Shareholders Meeting for more than fifteen (15) Business Days later than
the most recently adjourned meeting or to a date that is beyond the Termination Date. The SPAC Board Recommendation shall be included
in the Registration Statement / Proxy Statement. Except as otherwise required by applicable Law, SPAC covenants that none of the SPAC
Board or SPAC nor any committee of the SPAC Board shall change, withdraw, withhold or modify, or propose publicly or by formal action
of the SPAC Board, any committee of the SPAC Board or SPAC to change, withdraw, withhold or modify the SPAC Board Recommendation or any
other recommendation by the SPAC Board or SPAC of the proposals set forth in the Registration Statement / Proxy Statement.
Section 5.9 Conduct
of Business of SPAC. From and after the date of this Agreement until the earlier of the Closing or the termination of this Agreement
in accordance with its terms, SPAC shall, except as expressly contemplated by this Agreement or any Ancillary Document, as required by
applicable Law or as consented in writing by the Company (such consent not to be unreasonably withheld, conditioned or delayed), use
its commercially reasonable efforts to comply with and continue performing under SPAC’s Governing Documents, the Trust Agreement
and all other agreements or Contracts to which SPAC may be a party. Without limiting the generality of the foregoing, from and after
the date of this Agreement until the earlier of the Closing or the termination of this Agreement in accordance with its terms, SPAC shall
not, except as expressly contemplated by this Agreement or any Ancillary Document, as required by applicable Law, as set forth on Section 5.9
of the SPAC Disclosure Schedules or as consented to in writing by the Company (such consent not to be unreasonably withheld, conditioned
or delayed), do any of the following:
(a) adopt
any amendments, supplements, restatements or modifications to the Trust Agreement, Warrant Agreement or the Governing Documents of SPAC;
(b) declare,
set aside, make or pay a dividend on, or make any other distribution or payment (whether in cash, stock or property) in respect of, any
Equity Securities of SPAC, or repurchase, redeem (other than in connection with the Offer) or otherwise acquire, or offer to repurchase,
redeem or otherwise acquire, any outstanding Equity Securities of SPAC;
(c) (i) merge,
consolidate, combine or amalgamate SPAC with any Person or (ii) purchase or otherwise acquire (whether by merging or consolidating
with, purchasing any Equity Security in or a substantial portion of the assets of, or by any other manner) any corporation, partnership,
association or other business entity or organization or division thereof;
(d) split,
combine or reclassify any of its capital stock or other Equity Securities or issue any other security in respect of, in lieu of or in
substitution for shares of its capital stock;
(e) incur,
create, assume, refinance, guarantee or otherwise become liable for (whether directly, contingently, or otherwise) any Indebtedness or
other Liability other than working capital or extension loans from the Sponsor in an amount not to exceed $1,500,000;
(f) make
any loans or advances to, or capital contributions to, or guarantees for the benefit of, or any investment in, any other Person, other
than to, of, or in, SPAC;
(g) issue,
grant, sell, deliver or dispose of any Equity Securities of SPAC or securities exercisable for or convertible into Equity Securities
of SPAC (including options, warrants or stock appreciation rights with respect to Equity Securities of SPAC);
(h) (i) enter
into, renew, modify or revise any SPAC Related Party Transaction, other than (A) the entry into any Contract with a SPAC Related
Party with respect to the incurrence of Indebtedness permitted by Section 5.9(e) or (B) for the avoidance of doubt,
any expiration or automatic extension or renewal of any Contract pursuant to its terms, or (ii) enter into any Contract that if
entered into prior to the execution and delivery of this Agreement would be a SPAC Related Party Transaction;
(i) pay,
distribute or advance any assets or property to any of its officers, directors, stockholders or other Affiliates (other than its Subsidiaries)
or enter into or amend any agreement with respect to the foregoing, other than regarding (A) payments or distributions relating
to obligations in respect of arm’s-length commercial transactions or (B) reimbursement for reasonable expenses incurred in
connection with SPAC or its Subsidiaries;
(j) engage
in any activities or business, other than activities or business (i) in connection with or incident or related to SPAC’s incorporation
or continuing corporate (or similar) existence, (ii) contemplated by, or incident or related to, this Agreement, any Ancillary Document,
the performance of covenants or agreements hereunder or thereunder or the consummation of the Transactions or (iii) those that are
administrative or ministerial, in each case, which are immaterial in nature;
(k) (i) change
any material method of Tax accounting, (ii) make (inconsistent with past practice), change or rescind any material election relating
to Taxes, (iii) settle or compromise any material Tax audit, assessment, claim or other Proceeding, (iv) enter into any closing
agreement in respect of material Taxes or enter into any Tax sharing or similar Tax agreement (which this (iv) does not include
any customary commercial agreement entered into in the ordinary course of business and the principal purpose of which does not relate
to Taxes), (v) surrender or allow to expire any right to claim a refund of material Taxes or (vi) consent to any extension
or waiver of the statute of limitations period applicable to any claim or assessment in respect of material Taxes, in each case, that
could reasonably be expected to have an adverse and material impact on SPAC;
(l) authorize,
recommend, propose or announce an intention to adopt, or otherwise effect, a plan of complete or partial liquidation, dissolution, restructuring,
recapitalization, reorganization or similar transaction involving SPAC;
(m) change
SPAC’s methods of accounting in any material respect, other than changes that are made in accordance with PCAOB standards or as
required by any Governmental Entity;
(n) enter
into any Contract with any broker, finder, investment banker or other Person under which such Person is or will be entitled to any brokerage
fee, finders’ fee or other commission in connection with the transactions contemplated by this Agreement;
(o) except
for entries, modifications, amendments, waivers, terminations or non-renewals in the ordinary course of business, enter into, materially
modify, materially amend, waive any material right under, terminate (excluding any expiration in accordance with its terms) or fail to
renew, any Material Contract of the type described in Section 4.18 (excluding, for the avoidance of doubt, any expiration
or automatic extension or renewal of any such Material Contract pursuant to its terms);
(p) form
any Subsidiary; or
(q) enter
into any Contract to take, or cause to be taken, any of the foregoing actions set forth in clauses (a) through (o) other
than the entry into additional Subscription Agreements or PIPE Subscription Agreements pursuant to which SPAC agrees to issue and sell
on the Closing Date SPAC Shares as additional PIPE Financing.
Notwithstanding anything
in this Section 5.9 or this Agreement to the contrary, nothing set forth in this Agreement shall give the Company, directly
or indirectly, the right to control or direct the operations of SPAC.
Section 5.10 Nasdaq
Listing; SPAC Delisting. NewPubco, SPAC and the Company shall use their respective reasonable best efforts to cause: (a) NewPubco’s
initial listing application with Nasdaq in connection with the transactions contemplated by this Agreement to have been approved; (b) NewPubco
to satisfy all applicable initial listing requirements of Nasdaq; and (c) the NewPubco Ordinary Shares and NewPubco Warrants issuable
in accordance with this Agreement, including pursuant to the Equity Exchange and the Merger, and the NewPubco Ordinary Shares that will
become issuable upon the exercise of the NewPubco Warrants, to be approved for listing on Nasdaq (and the Company shall reasonably cooperate
in connection therewith), subject to official notice of issuance, in each case, as promptly as reasonably practicable after the date
of this Agreement, and in any event prior to the Merger Effective Time. SPAC shall pay, on behalf of NewPubco, all fees of Nasdaq in
connection with the application to list and the listing of NewPubco Ordinary Shares and NewPubco Warrants on Nasdaq. The Company, NewPubco
and SPAC shall use their respective reasonable best efforts to cause the SPAC Units, SPAC Shares and SPAC Warrants to be delisted from
Nasdaq (or be succeeded by the respective NewPubco securities) and to terminate its registration with the SEC pursuant to Sections 12(b),
12(g) and 15(d) of the Exchange Act (or be succeeded by NewPubco) as of the Closing Date or as soon as practicable thereafter.
Section 5.11 Trust
Account. Upon satisfaction or, to the extent permitted by applicable Law, waiver of the conditions set forth in ARTICLE VI
and provision of notice thereof to the Trustee, (a) at the Closing, SPAC shall (i) cause the documents, certificates and
notices required to be delivered to the Trustee pursuant to the Trust Agreement to be so delivered, and (ii) make all appropriate
arrangements to cause the Trustee to (A) pay as and when due all amounts, if any, payable to the Public Shareholders of SPAC pursuant
to the SPAC Shareholder Redemption, (B) immediately upon Closing (as permitted by the Trustee) pay all Unpaid Company Expenses,
Unpaid SPAC Expenses and Unpaid SPAC Liabilities and (C) immediately thereafter, pay all remaining amounts then available in the
Trust Account to an account designated by the Company in accordance with the Trust Agreement, and (b) thereafter, the Trust Account
shall terminate, except as otherwise provided therein.
Section 5.12 Israeli
Securities Law Approvals and TASE Delisting; Section 350 Proceeding; Company Equityholder Approval.
(a)
Following the date hereof, the Company
shall cause its Israeli counsel, in coordination with SPAC’s Israeli counsel, to prepare and file:
(i) with
the ISA, an application for the Israeli Securities Law Approvals, to the extent required,
(ii) with
the TASE, an application for delisting of the Company Ordinary Shares effective as of the Closing, and
(iii) with
the appropriate Israeli Court, the motion to initiate the Section 350 Proceeding.
(b) In
the context of the Section 350 Proceeding, the Company shall use its commercially reasonable efforts to establish the record date
for, duly call and give notice of, convene and hold a meeting of the Company Shareholders and the holders of Company Equity Awards, it
being understood that the Company may be required to hold separate meetings of the Company Shareholders, the holders of Company Options
and the holders of Company RSUs (collectively, together with any adjournment or postponement thereof, the “Company Equityholders
Meetings”), at such time as shall be agreed with SPAC, in each case in accordance with the Governing Documents of the Company
and the Laws of the State of Israel, at which the Company Shareholders and the holders of Company Equity Awards shall vote on the Company
Equityholder Proposals applicable to them. The Company may adjourn the Company Equityholders Meetings, if necessary, to permit further
solicitation of approvals because there are not sufficient votes to approve and adopt the Company Equityholder Proposals or because of
the absence of a quorum. Furthermore, there are additional Company Equityholder Proposals that will be formulated in the course of the
Section 350 Proceeding pursuant to which the Company Board will resolve to recommend to the Company Shareholders each of such additional
matters set forth in the Company Equityholder Proposals after the date of this Agreement.
Section 5.13 Indemnification;
Directors’ and Officers’ Insurance.
(a) To
the maximum extent permitted under applicable Law and Section 5.13(b), all rights to indemnification or exculpation now existing
in favor of the directors and officers of the SPAC and the Company, as provided in the Governing Documents of SPAC and the Company, as
applicable, or otherwise in effect as of immediately prior to the Merger Effective Time solely with respect to any matters occurring
on or prior to the Merger Effective Time shall survive the Transactions and shall continue in full force and effect from and after the
Merger Effective Time for a period of six (6) years and NewPubco shall perform and discharge, or cause to be performed and discharged,
all obligations to provide such indemnity and exculpation during such six (6)-year period. The indemnification and liability limitation
or exculpation provisions of the Governing Documents of the Company and SPAC as are in effect as of the Closing shall not, during such
six (6)-year period, be amended, repealed or otherwise modified after the Merger Effective Time in any manner that would materially and
adversely affect the rights thereunder of individuals who, as of immediately prior to the Merger Effective Time, or at any time prior
to such time, were directors or officers of the Company and SPAC (the “D&O Persons”) entitled to be so indemnified,
their liability limited or be exculpated with respect to any matters occurring on or prior to the Merger Effective Time and relating
to the fact that such D&O Person was a director or officer of the Company or SPAC immediately prior to the Merger Effective Time,
unless such amendment, repeal or other modification is required by applicable Law.
(b) NewPubco
shall not have any obligation under this Section 5.13 to any D&O Person when and if a court of competent jurisdiction
shall ultimately determine (and such determination shall have become final and non-appealable) that the indemnification of such D&O
Person in the manner contemplated hereby is prohibited by applicable Law.
(c) For
a period of six (6) years after the Merger Effective Time, (i) the Company (after the Equity Exchange) and (ii) the Surviving
Company, shall maintain, without any lapses in coverage, directors’ and officers’ liability insurance coverage for the benefit
of those Persons who are currently covered (whether directly, via endorsement or otherwise) by any comparable insurance policies of the
Company or SPAC, as applicable, in effect as of the date of this Agreement with respect to matters occurring on or prior to the Merger
Effective Time (i.e., “tail coverage”). Such insurance policies shall provide coverage on terms (with respect to coverage
and amount) that are substantially the same as (and no less favorable in the aggregate to the insured than) the coverage provided under
SPAC’s or the Company’s, as applicable, directors’ and officers’ liability insurance policies in effect as of
the date of this Agreement (provided that any limitations or exclusions in, or provided under, the existing policies relating to a Business
Combination shall be removed therefrom and such policies shall, for the avoidance of doubt, be effective from an after the consummation
of the Transactions) and shall be obtained from an insurance carrier with the same or better credit rating as the current insurance carrier
of SPAC and the Company with respect to directors’ and officers’ liability insurance; provided that the Company and
the Surviving Company shall not be obligated to pay annual premiums in excess of two hundred percent (200%) of the most recent annual
premium paid by the Company or SPAC, as applicable, prior to the date of this Agreement and, in such event, the Company and the Surviving
Company shall purchase the maximum coverage available for two hundred percent (200%) of the most recent annual premium paid by the Company
or SPAC, as applicable, prior to the date of this Agreement.
(d) If
NewPubco, the Surviving Company or the Company, or any of its successors or assigns (i) shall merge or consolidate with or merge
into any other corporation or entity and shall not be the surviving or continuing corporation or entity of such consolidation or merger
or (ii) shall transfer all or substantially all of their respective properties and assets as an entity in one or a series of related
transactions to any Person, then in each such case, proper provisions shall be made so that the successors or assigns of NewPubco, the
Surviving Company or the Company, as the case may be, shall assume all of the obligations set forth in this Section 5.13.
(e) The
D&O Persons entitled to the indemnification, expense reimbursement, liability limitation, exculpation and/or insurance coverage set
forth in this Section 5.13 are intended to be third-party beneficiaries of this Section 5.13. This Section 5.13
shall survive the consummation of the Transactions and shall be binding on all successors and assigns of the Surviving Company.
Section 5.14 Post-Closing
Directors and Officers. NewPubco shall take all actions reasonably necessary or appropriate such that effective immediately after
the Merger Effective Time:
(a) the
NewPubco Board shall initially consist of up to seven (7) directors, which shall initially include:
(i) two
(2) directors designated solely by SPAC;
(ii) up
to five (5) directors designated by the Company; provided, that if the Company designates more than three (3) directors,
then any additional directors designated by the Company shall be approved by SPAC; provided further, that all directors to the
NewPubco Board shall be agreed upon by April 30, 2024;
(b) at
least a majority of the directors of the NewPubco Board shall qualify as “independent directors” and otherwise meet the requirements
as specified in the rules and regulations of the SEC and Nasdaq; and
(c) the
officers of NewPubco (the “Officers”) shall be the individuals set forth on Section 5.14 of the Company
Disclosure Schedules.
Section 5.15 PCAOB
Financials.
(a) As
promptly as reasonably practicable, the Company shall deliver to SPAC the financial statements required to be included in the Registration
Statement / Proxy Statement and any other filings to be made by the Company, NewPubco and/or SPAC with the SEC in connection with the
Transactions (including the financial statements for the fiscal years ended December 31, 2021 and December 31, 2022). All such
financial statements, together with any unaudited consolidated balance sheet and the related statements of operations, changes in shareholders’
equity and cash flows of the Group Companies as of and for a year-to-date period ended as of the end of a different fiscal quarter that
is required to be included in the Registration Statement / Proxy Statement and any other filings to be made by the Company, NewPubco
and/or SPAC with the SEC in connection with the Transactions, (A) will be prepared in accordance with IFRS applied on a consistent
basis (except as may be indicated in the notes thereto) throughout the periods indicated, (B) will fairly present, in all material
respects, the financial position, results of operations and cash flows of the Group Companies as of the date thereof and for the period
indicated therein, except as otherwise specifically noted therein, and (C) will, in the case of the audited financial statements
of the Company, have been audited in accordance with the standards of the PCAOB. The auditor engaged to audit the audited financial statements
of the Company and to review the unaudited financial statements is an independent registered public accounting firm with respect to the
Company within the meaning of the Exchange Act and the applicable rules and regulations thereunder adopted by the SEC and the PCAOB.
(b) The
Company shall use its commercially reasonable efforts (i) to assist, upon reasonable advance written notice, during normal business
hours and in a manner such as to not unreasonably interfere with the normal operation of any member of such Group Company, SPAC in causing
to be prepared in a timely manner any other financial information or statements (including customary pro forma financial statements)
that are required to be included in the Registration Statement / Proxy Statement and any other filings to be made by the Company with
the SEC in connection with the Transactions and (ii) to obtain the consents of its auditors with respect thereto as may be required
by applicable Law or requested by the SEC.
Section 5.16 Post-Closing
NewPubco Incentive Equity Plan. Prior to the effectiveness of the Registration Statement / Proxy Statement, the NewPubco Board shall
approve and adopt an equity incentive plan in a form to be mutually agreed between NewPubco, SPAC and the Company (such agreement not
to be unreasonably withheld, conditioned or delayed) in the manner prescribed under applicable Laws, effective as of the Closing Date,
which shall provide for (a) an aggregate share reserve thereunder equal to ten percent (10%) of the number of NewPubco Ordinary
Shares on a fully diluted basis at the Closing, subject to any adjustments as set forth thereof and (b) an increase commencing on
January 1, 2025 and continuing annually on the anniversary thereof through (and including) January 1, 2034, equal to one percent
(1%) of the number of NewPubco Ordinary Shares on a fully diluted basis on the last day of the immediately preceding calendar year.
Section 5.17 Post-Closing
Employee Stock Purchase Plan. Prior to the effectiveness of the Registration Statement / Proxy Statement, the NewPubco Board shall
approve and adopt an employee stock purchase plan (“ESPP”) in a form to be mutually agreed between SPAC, NewPubco
and the Company (such agreement not to be unreasonably withheld, conditioned or delayed), in the manner prescribed under applicable Laws,
effective as of the Closing Date, which shall provide for (a) an initial aggregate share reserve thereunder equal to ten percent
(10%) of the number of NewPubco Ordinary Shares on a fully diluted basis at the Closing, subject to any adjustments as set forth in such
ESPP, and (b) an increase commencing on January 1, 2025 and continuing annually on the anniversary thereof through (and including)
January 1, 2034, equal to one percent (1%) of the number of NewPubco Ordinary Shares on a fully diluted basis on the last day of
the immediately preceding calendar year.
Section 5.18 PIPE
Investment. Prior to the earlier of the Closing and the termination of this Agreement in accordance with its terms:
(a) The
Company, NewPubco and SPAC shall use their commercially reasonable efforts to (i) obtain additional PIPE Financing, enforce the
obligations of the new subscribers (“PIPE Investors”) under new Subscription Agreements (“PIPE Subscription
Agreements”), and consummate the purchases contemplated by the PIPE Subscription Agreements on the terms and subject to the
conditions set forth in the PIPE Subscription Agreements, (ii) satisfy all conditions to the PIPE Financing set forth in the PIPE
Subscription Agreements that are within their control and (iii) satisfy and comply with their respective obligations under the PIPE
Subscription Agreements. SPAC and the Company shall each use its commercially reasonable efforts to, and shall use its commercially reasonable
efforts to cause its respective Representatives to, cooperate with the other Parties and their Representatives in connection with the
matters specified in this Section 5.18. If reasonably requested by the Company, or SPAC, as applicable, the other Party shall,
to the extent it has such rights under any PIPE Subscription Agreement, waive any breach of any representation, warranty, covenant or
agreement of such PIPE Subscription Agreement by the applicable PIPE Investor to the extent necessary to cause the satisfaction of the
conditions to closing of the PIPE Financing set forth in the PIPE Subscription Agreements and solely for the purpose of consummating
the Closing.
(b) Unless
otherwise consented in writing by each of the Company and SPAC, NewPubco or SPAC shall not amend, modify or waive any provisions of any
PIPE Subscription Agreements without the prior written consent of the Company; provided that any amendment, modification
or waiver that is solely ministerial in nature or otherwise immaterial, and, in each case, that does not affect any economic or any other
material term, shall not require the prior written consent of the Company, so long as SPAC or NewPubco has provided to the Company no
less than five (5) Business Days’ prior written notice of such amendment, modification or waiver (including the form thereof),
it being understood, but without limiting the foregoing, that it shall be deemed material if any amendment, modification or waiver (i) reduces
or is reasonably expected to reduce the amount of the PIPE Financing available under any PIPE Subscription Agreement, (ii) imposes
new or additional conditions or otherwise expands, amends or modifies any of the conditions to the receipt of the PIPE Financing or (iii) prevents,
impedes or delays or is expected to prevent, impede or delay the consummation of the Transactions. Without limiting the generality of
the foregoing, the Company, SPAC or NewPubco, as applicable, shall each give the other Parties prompt written notice: (A) of any
breach or default (or any event or circumstance that, with or without notice, lapse of time or both, could give rise to any breach or
default) by any party to any PIPE Subscription Agreements known to the Company, SPAC or NewPubco, as applicable; (B) of the receipt
of any notice or other communication from any PIPE Investors by the Company, SPAC or NewPubco, as applicable, with respect to any actual,
potential, threatened or claimed expiration, lapse, withdrawal, material breach, material default, termination or repudiation by any
party to any PIPE Subscription Agreement or any provisions of any PIPE Subscription Agreement; and (C) if the Company, SPAC or NewPubco,
as applicable, do not expect NewPubco to receive, all or any portion of the PIPE Financing proceeds on the terms, in the manner or from
one or more PIPE Investors.
Section 5.19 Company
Permitted Interim Financing. The Company shall keep SPAC reasonably informed with respect any Company Permitted Interim Financing.
Section 5.20 Post-Closing
Officer and Director Remuneration. As soon as practicable after the execution of this Agreement, the Company shall retain an independent
compensation consultant to conduct a benchmark analysis of the compensation packages for officers and directors of public market companies
that are comparable to the Company (the “Benchmark Analysis”) in order to provide compensation packages to the officers
and directors of the Company after the Closing Date that are in line with public market practices. The Benchmark Analysis, as well as
the recommendations contained therein, shall be presented to the Company’s Compensation Committee and Company Board in connection
with their review and approval of such compensation packages by April 30, 2024, which shall, subject to the receipt of any required
approval of the Company Shareholders, be effective as of the Closing Date.
Section 5.21 Transaction
Support Agreements. The Company shall use its reasonable best efforts to cause the Key Company Shareholders to enter into transaction
support agreements, each in substantially the same form as the Transaction Support Agreement set forth on Exhibit B hereto,
such that the aggregate voting power in the Company of such Company Shareholders, when combined with the aggregate voting power in the
Company of the Supporting Company Shareholders who have already entered into Transaction Support Agreements, will be sufficient as of
the time of the Company Equityholders Meetings to obtain the Company Equityholder Approval.
Section 5.22 Further
Assurances. If, prior to the Merger Effective Time, the applicable parties hereto are unable to obtain the Israeli Securities Law Approval,
the Section 350 Approval, the Israeli Tax Rulings, or any other Consent from a Governmental Entity necessary to effectuate the Transaction,
each of SPAC, the Company, NewPubco and Merger Sub shall use (and the Company shall cause each of its Subsidiaries to use) its commercially
reasonable efforts to (a) take all such actions that are necessary, proper or appropriate to consummate the Transactions, including
negotiating in good faith to modify the structure of the Transactions (provided that such modifications do not materially adversely affect
the other parties hereto) and the execution and delivery of any documents, certificates, instruments or other papers that are reasonably
required for the consummation of the Transactions; and (b) cause the fulfillment at the earliest practicable date of all of the
conditions to their respective obligations to consummate and make effective the Transactions.
Article VI.
CONDITIONS TO CONSUMMATION OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT
Section 6.1 Conditions
to the Obligations of the Parties. The obligations of the Parties to consummate the transactions contemplated by this Agreement are
subject to the satisfaction or waiver, if permitted by applicable Law, in writing by the Party for whose benefit such condition exists
of the following conditions:
(a) all
applicable waiting periods (and any extensions thereof), if any, under the HSR Act with respect to the Transactions, and any commitment
to, or agreement (including any timing agreement) with, any Governmental Entity not to close the Transactions, shall have expired or
been terminated;
(b) there
shall not have been entered, issued, enacted or promulgated any Law or Order enjoining, prohibiting, restricting or making unlawful the
consummation of the Transactions;
(c) the
Registration Statement / Proxy Statement shall have become effective in accordance with the provisions of the Securities Act, no stop
order suspending the effectiveness of the Registration Statement / Proxy Statement shall have been issued by the SEC and shall remain
in effect with respect to the Registration Statement / Proxy Statement, and no Proceeding seeking such a stop order shall have been threatened
or initiated by the SEC and remain pending;
(d) the
Company Equityholder Approval shall have been obtained;
(e) the
SPAC Shareholder Approval shall have been obtained;
(f) the
Israeli Securities Law Approvals shall have been obtained;
(g) the
Section 350 Approval shall have been obtained;
(h) the
Israeli Tax Rulings shall have been obtained;
(i) the
approval of the IIA to the Transactions; and
(j) the
NewPubco Ordinary Shares and NewPubco Warrants (including, for the avoidance of doubt, the NewPubco Ordinary Shares and NewPubco Warrants
to be issued pursuant to the Merger) shall have been approved for listing on Nasdaq, subject only to official notice of issuance thereof
and the requirement to have a sufficient number of round lot holders.
Section 6.2 Other
Conditions to the Obligations of SPAC. The obligations of SPAC to consummate the Transactions are subject to the satisfaction or
waiver, if permitted by applicable Law, in writing by SPAC of the following further conditions:
(a) (i) the
Company Fundamental Representations (other than the representations and warranties set forth in Section 3.2(a)) shall be
true and correct (without giving effect to any limitation as to “materiality” or “Company Material Adverse Effect”
or any similar limitation set forth therein) in all material respects as of the Closing Date, as though made on and as of the Closing
Date (except to the extent that any such representation and warranty is made as of an earlier date, in which case such representation
and warranty shall be true and correct in all material respects as of such earlier date), (ii) the representations and warranties
set forth in Section 3.2(a) shall be true and correct in all respects (except for de minimis inaccuracies) as
of the Closing Date, as though made on and as of the Closing Date (except to the extent that any such representation and warranty is
made as of an earlier date, in which case such representation and warranty shall be true and correct in all respects (except for de
minimis inaccuracies) as of such earlier date), and (iii) the representations and warranties of the Company set forth in ARTICLE III
(other than the Company Fundamental Representations) shall be true and correct (without giving effect to any limitation as to “materiality”
or “Company Material Adverse Effect” or any similar limitation set forth herein) in all respects as of the Closing Date,
as though made on and as of the Closing Date (except to the extent that any such representation and warranty is made as of an earlier
date, in which case such representation and warranty shall be true and correct in all respects as of such earlier date), except where
the failure of such representations and warranties to be true and correct, taken as a whole, does not cause a Company Material Adverse
Effect;
(b) the
Company shall have performed and complied in all material respects with the covenants and agreements required to be performed or complied
with by the Company under this Agreement at or prior to the Closing;
(c) since
the date of this Agreement, no Company Material Adverse Effect has occurred that is continuing; and
(d) at
or prior to the Closing, the Company shall have delivered, or caused to be delivered, to SPAC a certificate duly executed by an authorized
officer of the Company, dated as of the Closing Date, to the effect that the conditions specified in Section 6.2(a), Section 6.2(b) and
Section 6.2(c) are satisfied, in a form and substance reasonably satisfactory to SPAC.
(e) At
or prior to the Closing, the Key Company Shareholders shall have delivered to the SPAC countersigned copies of the Registration Rights
and Lock-Up Agreement.
Section 6.3 Other
Conditions to the Obligations of the Company. The obligations of the Company to consummate the Transactions are subject to the satisfaction
or waiver, if permitted by applicable Law, in writing by the Company of the following further conditions:
(a) (i) the
SPAC Fundamental Representations (other than the representations and warranties set forth in Section 4.6(a)) shall be true
and correct (without giving effect to any limitation as to “materiality” or “SPAC Material Adverse Effect” or
any similar limitation set forth therein) in all material respects as of the Closing Date, as though made on and as of the Closing Date
(except to the extent that any such representation and warranty is made as of an earlier date, in which case such representation and
warranty shall be true and correct in all material respects as of such earlier date), (ii) the representations and warranties set
forth in Section 4.6(a) shall be true and correct in all respects (except for de minimis inaccuracies) as of
the Closing Date, as though made on and as of the Closing Date (except to the extent that any such representation and warranty is made
as of an earlier date, in which case such representation and warranty shall be true and correct in all respects (except for de minimis
inaccuracies) as of such earlier date), and (iii) the representations and warranties of SPAC set forth in ARTICLE IV
(other than the SPAC Fundamental Representations) shall be true and correct (without giving effect to any limitation as to “materiality”
or “SPAC Material Adverse Effect” or any similar limitation set forth herein) in all respects as of the Closing Date, as
though made on and as of the Closing Date (except to the extent that any such representation and warranty is made as of an earlier date,
in which case such representation and warranty shall be true and correct in all respects as of such earlier date), except where the failure
of such representations and warranties to be true and correct, taken as a whole, does not cause a SPAC Material Adverse Effect;
(b) SPAC
shall have performed and complied in all material respects with the covenants and agreements required to be performed or complied with
by SPAC under this Agreement at or prior to the Closing;
(c) since
the date of this Agreement, no SPAC Material Adverse Effect has occurred that is continuing;
(d) the
Aggregate Transaction Proceeds shall be greater than or equal to $20,000,000 (the “Minimum Cash Condition”), provided,
that if the Company has been presented with a term sheet(s) for PIPE Financing or Additional Financing (x) with respect to
debt financings, where the term sheet(s) provide for an interest rate at or below the rate set forth on Schedule 6.3(d) and
(y) with respect to Equity Financings or debt convertible into equity, where the conversion is an the Company Equity Value, and
the Company has refused to accept such term sheet(s), then this condition shall be deemed to have been waived by the Company; provided,
however, that if the Company refuses to accept such terms sheet(s) because it, reasonably and in good faith, believes that the terms
(other than interest or conversion price in such terms sheet(s)) and/or such debt financing, Equity Financing or debt convertible into
equity, taken as a whole, will materially and adversely affect the financial or operational position of the Company, then this condition
shall not be deemed to have been waived by the Company;
(e) at
the Closing, SPAC shall have delivered to the Company an executed resignation from each director and officer of SPAC other than those
listed on Exhibit F;
(f) at
or prior to the Closing, SPAC shall have delivered, or caused to be delivered, to the Company a certificate duly executed by an authorized
officer of SPAC, dated as of the Closing Date, to the effect that the conditions specified in Section 6.3(a), Section 6.3(b) and
Section 6.3(c) are satisfied, in a form and substance reasonably satisfactory to the Company; and
(g) at
or prior to the Closing, Sponsor shall have delivered to the Company a countersigned copy of the Registration Rights and Lock-Up Agreement.
Section 6.4 Frustration
of Closing Conditions. The Company may not rely on the failure of any condition set forth in this ARTICLE VI to be satisfied
if such failure was proximately caused by the Company’s failure to comply with or perform any of its covenants or obligations set
forth in this Agreement or use reasonable best efforts to cause the Closing to occur, as required by Section 5.2. SPAC may
not rely on the failure of any condition set forth in this ARTICLE IV to be satisfied if such failure was proximately caused
by either of SPAC’s failure to comply with or perform any of its covenants or obligations set forth in this Agreement or use commercially
reasonable efforts to cause the Closing to occur, as required by Section 5.2.
Article VII.
TERMINATION
Section 7.1 Termination.
This Agreement may be terminated and the Transactions may be abandoned at any time prior to the Closing:
(a) by
mutual written consent of SPAC and the Company;
(b) by
SPAC, if any of the representations or warranties set forth in ARTICLE III shall not be true and correct or if the Company
has failed to perform any covenant or agreement on the part of the Company set forth in this Agreement (including an obligation to consummate
the Closing) such that the condition to Closing set forth in either Section 6.2(a) or Section 6.2(b) could
not be satisfied and the breach or breaches causing such representations or warranties not to be true and correct, or the failures to
perform any covenant or agreement, as applicable, is (or are) not cured or cannot be cured within thirty (30) days after written notice
thereof is delivered to the Company by SPAC; provided, however, that SPAC is not then in breach of this Agreement so as
to prevent the condition to Closing set forth in either Section 6.3(a) or Section 6.3(b) from being
satisfied;
(c) by
the Company, if any of the representations or warranties set forth in ARTICLE IV shall not be true and correct or if SPAC
has failed to perform any covenant or agreement on the part of SPAC set forth in this Agreement (including an obligation to consummate
the Closing) such that the condition to Closing set forth in either Section 6.3(a) or Section 6.3(b) could
not be satisfied and the breach or breaches causing such representations or warranties not to be true and correct, or the failures to
perform any covenant or agreement, as applicable, is (or are) not cured or cannot be cured within thirty (30) days after written notice
thereof is delivered to SPAC by the Company; provided, however, the Company is not then in breach of this Agreement so
as to prevent the condition to Closing set forth in Section 6.2(a) or Section 6.2(b) from being satisfied;
(d) by
either SPAC or the Company, if the Transactions have not been consummated on or prior to September 30, 2024 (the “Termination
Date”); provided, that (i) the right to terminate this Agreement pursuant to this Section 7.1(d) shall
not be available to SPAC if SPAC’s breach of any of its covenants or obligations under this Agreement shall have proximately caused
the failure to consummate the transactions contemplated by this Agreement on or before the Termination Date, (ii) the right to terminate
this Agreement pursuant to this Section 7.1(d) shall not be available to the Company if the Company’s breach of
its covenants or obligations under this Agreement shall have proximately caused the failure to consummate the transactions contemplated
by this Agreement on or before the Termination Date, and (iii) that the Termination Date shall be automatically extended to (x) October 31,
2024 if the Registration Statement is initially filed after February 14, 2024, and (y) December 15, 2024, if the irrevocably
committed amount of the Aggregate Transaction Proceeds is more than the Minimum Cash Condition;
(e) by
either SPAC or the Company, if any Governmental Entity shall have issued an Order, promulgated a Law or taken any other action permanently
enjoining, restraining or otherwise prohibiting the transactions contemplated by this Agreement and such Order or other action shall
have become final and nonappealable; provided, that (i) the right to terminate this Agreement under this Section 7.1(e) shall
not be available to SPAC if (A) SPAC’s failure to fulfill any covenant or obligation under this Agreement has been the primary
cause of, or primarily resulted in, such Order, Law or other action or (B) SPAC is in material breach of its covenants or obligations
under this Agreement on such date and (ii) the right to terminate this Agreement under this Section 7.1(e) shall
not be available to the Company if (A) the Company’s failure to fulfill any covenant or obligation under this Agreement has
been the primary cause of, or primarily resulted in, such Order, Law or other action or (B) the Company is in material breach of
its obligations under this Agreement on such date;
(f) by
either SPAC or the Company if the SPAC Shareholders Meeting has been held (including any adjournment thereof), has concluded, SPAC Shareholders
have duly voted and the SPAC Shareholder Approval was not obtained;
(g) by
either SPAC or the Company if the Company Equityholders Meetings has been held (including any adjournment thereof), has concluded, Company
Shareholders have duly voted and the Company Equityholder Approval was not obtained;
(h) by
the Company in order to enter into a definitive agreement with respect to a Superior Proposal in accordance with Section 5.6;
(i) by
SPAC in order to enter into a definitive agreement with respect to a Superior Proposal in accordance with Section 5.6; or
(j) by
the Company if by June 30, 2024 (the “Minimum Equity Financing Proceeds Termination Date”) and based on the status
of the PIPE Financing and Equity Financing, as of the Minimum Equity Financing Proceeds Termination Date, the irrevocably committed aggregate
amount of the PIPE Financing plus the Equity Financing is less than $5,000,000; provided, however, that that if potential
investors have presented the Company with one or more term sheets for aggregate PIPE Financing and Equity Financing on terms that the
SPAC reasonably and in good faith believes to be “market”, equal to or in excess of $5,000,000 prior to the Minimum Equity
Financing Proceeds Termination Date and the Company has, acting reasonably and in good faith, refused to accept such term sheet(s), then
the Company shall not be entitled to terminate this Agreement pursuant to this Section 7.1(j); provided, however,
that if such term sheet(s) provide terms that value the Company equity value less than the Company Equity Value (without taking
into account any parallel transactions) and the Company refuses to accept such terms sheet(s) because it, reasonably and in good
faith, believes that the terms in such terms sheet(s) (i) are not “market” or (ii) will materially and adversely
affect the financial or operational position of the Company, then the Company shall be entitled to terminate this Agreement pursuant
to this Section 7.1(j).
(k) By
the SPAC if the SPAC has not received, by 11:59 p.m. Israel time on the date that is 14 days after the execution of this Agreement,
countersigned copies of the Transaction Support Agreement from (i) Key Company Shareholders representing at least 30% of the outstanding
voting power of the Company and (ii) the officers of the Company.
(l) By
the SPAC if the SPAC has not received, by 11:59 p.m. Israel time on the date that is 30 days after the execution of this Agreement,
countersigned copies of the Transaction Support Agreement from Key Company Shareholders representing at least a majority of the outstanding
voting power of the Company.
Section 7.2 Effect
of Termination. In the event of the termination of this Agreement pursuant to Section 7.1, this entire Agreement shall
forthwith become void (and there shall be no Liability or obligation on the part of the Parties and their respective Non-Party Affiliates)
with the exception of (a) the confidentiality obligation set forth in Section 5.3(a), this Section 7.2,
ARTICLE I and ARTICLE VIII (to the extent related to the foregoing), each of which shall survive such termination
and remain valid and binding obligations of the Parties and (b) the Confidentiality Agreement, which shall survive such termination
and remain valid and binding obligations of the parties thereto in accordance with their respective terms. Notwithstanding the foregoing
or anything to the contrary herein, the termination of this Agreement pursuant to Section 7.1 shall not affect (i) any
Liability on the part of any Party for Fraud or (ii) any Person’s Liability under any Subscription Agreement, PIPE Subscription
Agreement, the Confidentiality Agreement, any Transaction Support Agreement or the Sponsor Support Agreement to which he, she or it is
a party to the extent arising from a claim against such Person by another Person party to such agreement on the terms and subject to
the conditions thereunder.
Section 7.3 Termination
Fee.
(a) In
the event that this Agreement is terminated by the Company pursuant to Section 7.1(h) or by SPAC pursuant to Section 7.1(i) (as
applicable, the “Terminating Party”), then the Terminating Party, shall pay, or cause to be paid, to the other Party,
within thirty (30) days of such termination, an amount equal to the Termination Fee by wire transfer of immediately available funds to
an account or accounts designated in writing by such Party.
(b) The
Parties acknowledge and agree that the provisions for payment of the Termination Fee are an integral part of the Transactions and are
included herein in order to induce the Parties to enter into this Agreement. The Parties acknowledge and agree that (i) in no event
shall the Terminating Party be required to pay the Termination Fee on more than one occasion, whether or not the Termination Fee may
be payable upon the occurrence of different events, and (ii) notwithstanding that SPAC or the Company, as applicable, may have the
right to simultaneously seek specific performance of the Terminating Party’s obligation to consummate the Closing, on the one hand,
and the Termination Fee, on the other hand, it may only obtain either specific performance of the Terminating Party’s obligation
to consummate the Closing, on the one hand, or the Termination Fee, on the other hand. Notwithstanding anything to the contrary in this
Agreement (subject to such Party’s right to seek specific performance pursuant to this Agreement, as and to the extent permitted
thereunder), if SPAC or the Company, as applicable, is entitled to receive the Termination Fee pursuant to this Section 7.3,
such Party’s right to receive payment of the Termination Fee shall be the sole and exclusive remedy of such Party and its Affiliates
against the Terminating Party or any of the Terminating Party’s non-party Affiliates for any breach of this Agreement (including
any failure to consummate the Closing in accordance herewith) or otherwise under this Agreement or arising out of or related to the Transactions,
and upon payment of the Termination Fee, the Terminating Party and its Affiliates shall have no any liability or obligation of any kind
or nature relating to or arising out of this Agreement or the transactions contemplated hereby, in each case, whether based on contract,
tort or strict liability, by the enforcement of any assessment, by any legal or equitable proceeding, by virtue of any statute, regulation
or applicable Law or otherwise. SPAC and the Company further agree that, in the event of termination of this Agreement, the maximum aggregate
liability of the Terminating Party under this Agreement shall be limited to an amount equal to the Termination Fee and in no event shall
seek to recover, or be entitled to recover, from the Terminating Party or its Affiliates any monetary damages of any kind, character
or description in excess of such amount.
Article VIII.
MISCELLANEOUS
Section 8.1 Non-Survival.
The representations and warranties of SPAC and the Company contained in this Agreement or any certificate or instrument delivered pursuant
to this Agreement shall terminate at the Merger Effective Time, and only the covenants that by their terms survive the Merger Effective
Time and this Article VIII shall survive the Merger Effective Time, such that no claim for breach of any such representation,
warranty, agreement or covenant, detrimental reliance or other right or remedy (whether in contract, in tort, at law, in equity or otherwise)
may be brought with respect thereto after the Merger Effective Time against any Party, any Company Non-Party Affiliate or any SPAC Non-Party
Affiliate. Each covenant and agreement contained herein that, by its terms, expressly contemplates performance after the Merger Effective
Time shall so survive the Merger Effective Time in accordance with its terms, and each covenant and agreement contained in any Ancillary
Document that, by its terms, expressly contemplates performance after the Merger Effective Time shall so survive the Merger Effective
Time in accordance with its terms and any other provision in any Ancillary Document that expressly survives the Merger Effective Time
shall so survive the Merger Effective Time in accordance with the terms of such Ancillary Document.
Section 8.2 Entire
Agreement; Assignment. This Agreement (together with the Ancillary Documents), the Confidentiality Agreement, and any other documents,
instruments and certificates explicitly referred to herein, constitute the entire agreement among the Parties with respect to the subject
matter hereof and supersedes all other prior agreements and understandings, both written and oral, among the Parties or any of their
respective Subsidiaries with respect to the subject matter hereof. No representations, warranties, covenants, understandings, agreements,
oral or otherwise, with respect to the subject matter contemplated by this Agreement exist between the Parties, except as expressly set
forth or referenced in this Agreement and the Confidentiality Agreement. No Party shall assign, delegate or otherwise transfer this Agreement
or any part hereof without the prior written consent of the other Parties (including the Sponsor after the Closing). Subject to the foregoing,
this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective permitted successors and assigns.
Any attempted assignment in violation of the terms of this Section 8.2 shall be null and void, ab initio.
Section 8.3 Amendment.
This Agreement may be amended or modified in whole or in part, only by a duly authorized agreement in writing executed by each of the
Parties in the same manner as this Agreement and which makes reference to this Agreement. This Agreement may not be modified or amended
except as provided in the immediately preceding sentence and any purported amendment by any Party or Parties effected in a manner which
does not comply with this Section 8.3 shall be null and void, ab initio.
Section 8.4 Notices.
All notices, requests, claims, demands and other communications among the Parties shall be in writing and shall be deemed to have been
duly given (i) when delivered in person, (ii) when delivered after posting in the United States mail having been sent registered
or certified mail return receipt requested, postage prepaid, (iii) when delivered by FedEx or other nationally recognized overnight
delivery service or (iv) when e-mailed (having obtained electronic delivery confirmation thereof (i.e., an electronic record
of the sender that the e-mail was sent to the intended recipient thereof without an “error” or similar message that such
e-mail was not received by such intended recipient)) during normal business hours (and otherwise as of the immediately following Business
Day), addressed as follows:
Israel
Acquisitions Corp
12600 Hill Country Blvd, Building R, Suite 275
Bee Cave, Texas 78738
Attention: Ziv Elul; Sharon Barzik Cohen
Email: ziv@israelspac.com; sharon@israelspac.com
with a copy (which shall not constitute notice) to:
Reed Smith LLP
2850 N. Harwood Street, Suite 1500
Dallas, Texas 75201
Attention: Lynwood Reinhardt
E-mail: lreinhardt@reedsmith.com
and
Naschitz, Brandes, Amir & Co.
5 Tuval Street
Tel Aviv 6789717, Israel
Attention: Tuvia Geffen and Asi Moravchick
Email: tgeffen@nblaw.com; amoravchick@nblaw.com
| (b) | If
to the Company, to: |
Pomvom Ltd.,
35 Hamasger St., Tel Aviv, Israel
Attention: Yehuda Minkovicz, CEO
Email: yehuda.minkovicz@pomvom.com
with a copy (which shall not constitute notice) to:
Greenberg Traurig LLP
One Vanderbilt Avenue
New York, NY 10017
Attention: Eyal Peled
E-mail: Eyal.Peled@gtlaw.com
and
Goldfarb Gross Seligman & Co.
1 Azrieli Center, Round Tower
Tel Aviv 6701101, Israel
Attention: Aaron M. Lampert
Email: aaron.lampert@goldfarb.com
or to such other address as the Party to whom
notice is given may have previously furnished to the others in writing in the manner set forth above.
Section 8.5 Governing
Law. This Agreement, and all claims or causes of action (whether in contract, tort or statute) that may be based upon, arise out
of or relate to this Agreement, or the negotiation, execution or performance of this Agreement or the Transactions, or in any way connected
with or related or incidental to the dealings of the Parties in respect of this Agreement or any of the Transactions (including any claim
or cause of action based upon, arising out of or related to any representation or warranty made in or connection with this Agreement
or as an inducement to enter into this Agreement), shall be governed by, and construed in accordance with, the Laws of the State of New
York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other
jurisdiction) that would cause the application of the Law of any jurisdiction other than the State of New York; provided that
provisions related to the matters set forth in Article II that relate to the effectuation of the Equity Exchange, and all
other provisions of this Agreement that are expressly or otherwise required to be governed by the Laws of the State of Israel shall be
exclusively governed by the Laws of the State of Israel; and provided, further, that provisions related to the matters
set forth in Article II that relate to the effectuation of the Merger shall be exclusively governed by the Laws of the Cayman
Islands.
Section 8.6 Fees
and Expenses.
(a) Except
as otherwise set forth in this Agreement, all fees and expenses incurred in connection with this Agreement, the Ancillary Documents and
the Transactions, including the fees and disbursements of counsel, financial advisors and accountants, shall be paid by the Party incurring
such fees or expenses; provided that, for the avoidance of doubt, (a) if this Agreement is terminated in accordance with
its terms, the Company shall pay, or cause to be paid, all Unpaid Company Expenses and SPAC shall pay, or cause to be paid, all Unpaid
SPAC Expenses and (b) if the Closing occurs, then immediately upon the Closing (as permitted by the Trustee) the Surviving Company
shall pay, or cause to be paid, all Unpaid Company Expenses and all Unpaid SPAC Expenses. If, immediately prior to or at the Closing,
there is a Transaction Expenses Cap Excess, SPAC shall be required to obtain the prior written consent of the Company to incur such Transaction
Expenses Cap Excess; provided that, in the event of incurrence of Transaction Expenses Cap Excess by SPAC without the prior written
consent of the Company, SPAC shall cause Sponsor to irrevocably forfeit and surrender a number of NewPubco Ordinary Shares equal to (i) the
amount of the Transaction Expenses Cap Excess divided by (ii) $10.00, to NewPubco for no consideration and SPAC shall, and
shall cause Sponsor to, take any other action reasonably requested by the Company to evidence such forfeiture and surrender.
(b) At
least five (5) Business Days prior to the Closing Date, SPAC shall cause the Chief Financial Officer of SPAC (solely in his capacity
as such) to deliver to the Company a certificate certified by such Chief Financial Officer (solely in his capacity as such) setting forth
SPAC’s good faith estimate of the SPAC Expenses, including reasonable supporting materials and invoices for the amount of each
item included in the SPAC Expenses.
(c) At
least five (5) Business Days prior to the Closing Date, the Company shall cause the Chief Financial Officer of the Company (solely
in his capacity as such) to deliver to SPAC a certificate certified by such Chief Financial Officer (solely in his capacity as such)
setting forth the Company’s good faith estimate of the Company Expenses, including reasonable supporting materials and invoices
for the amount of each item included in the Company Expenses.
Section 8.7 Construction;
Interpretation. The term “this Agreement” means this Business Combination Agreement together with the Schedules and Exhibits
hereto, as the same may from time to time be amended, modified, supplemented or restated in accordance with the terms hereof. The headings
set forth in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement.
No Party, nor their respective counsels, shall be deemed the drafter of this Agreement for purposes of construing the provisions hereof,
and all provisions of this Agreement shall be construed according to their fair meaning and not strictly for or against any Party. Unless
otherwise indicated to the contrary herein by the context or use thereof: (a) the words, “herein,” “hereto,”
“hereof” and words of similar import refer to this Agreement as a whole, including the Schedules and Exhibits, and not to
any particular section, subsection, paragraph, subparagraph or clause set forth in this Agreement; (b) masculine gender shall also
include the feminine and neutral genders, and vice versa; (c) words importing the singular shall also include the plural, and vice
versa; (d) the words “include,” “includes” or “including” shall be deemed to be followed by
the words “without limitation”; (e) references to “$” or “dollar” or “US$” shall
be references to United States dollars; (f) the word “or” is disjunctive but not necessarily exclusive; (g) the
words “writing”, “written” and comparable terms refer to printing, typing and other means of reproducing words
(including electronic media) in a visible form; (h) the word “day” means calendar day unless Business Day is expressly
specified; (i) reference from or through any date mean from and including or through and including such date, respectively, (j) the
word “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and such
phrase shall not mean simply “if”; (k) all references to Articles, Sections, Exhibits or Schedules are to Articles,
Sections, Exhibits and Schedules of this Agreement; (l) the words “provided”, “delivered” or “made
available” or words of similar import (regardless of whether capitalized or not) shall mean, when used with reference to documents
or other materials required to be provided or made available to SPAC, any documents or other materials posted to the electronic data
room located at datasite.com under the project name “ISRL POMVOM” as of 5:00 p.m., Eastern Time, at least one (1) Business
Day prior to the date of this Agreement; (m) all references to any Law will be to such Law as amended, supplemented or otherwise
modified or re-enacted from time to time; and (n) all references to any Contract are to that Contract as amended or modified from
time to time in accordance with the terms thereof (subject to any restrictions on amendments or modifications set forth in this Agreement).
If any action under this Agreement is required to be done or taken on a day that is not a Business Day, then such action shall be required
to be done or taken not on such day but on the first succeeding Business Day thereafter.
Section 8.8 Exhibits
and Schedules. All Exhibits and Schedules, or documents expressly incorporated into this Agreement, are hereby incorporated into
this Agreement and are hereby made a part hereof as if set out in full in this Agreement. The Schedules shall be arranged in sections
and subsections corresponding to the numbered and lettered Sections and subsections set forth in this Agreement. Any item disclosed in
the Company Disclosure Schedules or in the SPAC Disclosure Schedules corresponding to any Section or subsection of ARTICLE III
(in the case of the Company Disclosure Schedules) or ARTICLE IV (in the case of the SPAC Disclosure Schedules) shall
be deemed to have been disclosed with respect to every other section and subsection of ARTICLE III (in the case of the Company
Disclosure Schedules) or ARTICLE IV (in the case of the SPAC Disclosure Schedules), as applicable, where the relevance of
such disclosure to such other Section or subsection is reasonably apparent on the face of the disclosure. Certain information set
forth in the Company Disclosure Schedules and the SPAC Disclosure Schedules is included solely for informational purposes and may not
be required to be disclosed pursuant to this Agreement. The disclosure of any information shall not be deemed to constitute an acknowledgment
that such information is required to be disclosed under this Agreement, nor shall such information be deemed to establish a standard
of materiality.
Section 8.9 Parties
in Interest. This Agreement shall be binding upon and inure solely to the benefit of each Party and its respective successors and
permitted assigns and, except as provided in Section 5.11 and the two subsequent sentences of this Section 8.9,
nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person any rights, benefits or remedies
of any nature whatsoever under or by reason of this Agreement. The Sponsor shall be an express third-party beneficiary of Section 8.2,
Section 8.13 and this Section 8.9 (to the extent related to the foregoing). Each of the Non-Party Affiliates
shall be an express third-party beneficiary of Section 8.12 and this Section 8.9 (to the extent related to the
foregoing).
Section 8.10 Severability.
Whenever possible, each provision of this Agreement will be interpreted in such a manner as to be effective and valid under applicable
Law, but if any term or other provision of this Agreement is held to be invalid, illegal or unenforceable under applicable Law, all other
provisions of this Agreement shall remain in full force and effect so long as the economic or legal substance of the transactions contemplated
hereby is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision of this
Agreement is invalid, illegal or unenforceable under applicable Law, the Parties shall negotiate in good faith to modify this Agreement
so as to effect the original intent of the Parties as closely as possible in an acceptable manner in order that the transactions contemplated
hereby are consummated as originally contemplated to the greatest extent possible.
Section 8.11 Counterparts;
Electronic Signatures. This Agreement and each Ancillary Document (including any of the closing deliverables contemplated hereby)
may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and
the same agreement. Delivery of an executed counterpart of a signature page to this Agreement or any Ancillary Document (including
any of the closing deliverables contemplated hereby) by electronic means, including DocuSign, Adobe Sign or other similar e-signature
services, e-mail or scanned pages shall be effective as delivery of a manually executed counterpart to this Agreement or any such
Ancillary Document.
Section 8.12 No
Recourse. Except for claims pursuant to any Ancillary Document by any party(ies) thereto against any Company Non-Party Affiliate
or any SPAC Non-Party Affiliate (each, a “Non-Party Affiliate”), and then solely with respect to claims against the
Non-Party Affiliates that are party to the applicable Ancillary Document, each Party agrees on behalf of itself and on behalf of the
Company Non-Party Affiliates, in the case of the Company, and the SPAC Non-Party Affiliates, in the case of SPAC, that (a) this
Agreement may only be enforced against, and any action for breach of this Agreement may only be made against, the Parties, and no claims
of any nature whatsoever arising under or relating to this Agreement, the negotiation hereof or its subject matter, or the transactions
contemplated hereby shall be asserted against any Non-Party Affiliate, and (b) none of the Non-Party Affiliates shall have any Liability
arising out of or relating to this Agreement, the negotiation hereof or its subject matter, or the transactions contemplated hereby,
including with respect to any claim (whether in tort, contract or otherwise) for breach of this Agreement or in respect of any written
or oral representations made or alleged to be made in connection herewith, as expressly provided herein, or for any actual or alleged
inaccuracies, misstatements or omissions with respect to any information or materials of any kind furnished by the Company, SPAC or any
Non-Party Affiliate concerning any Group Company, SPAC, this Agreement or the transactions contemplated hereby.
Section 8.13 Extension;
Waiver. The Company, prior to the Closing, and the Company and the Sponsor, after the Closing, may (a) extend the time for the
performance of any of the obligations or other acts of SPAC set forth herein, (b) waive any inaccuracies in the representations
and warranties of SPAC set forth herein or (c) waive compliance by SPAC with any of the agreements or conditions set forth herein.
SPAC may (i) extend the time for the performance of any of the obligations or other acts of the Company, set forth herein, (ii) waive
any inaccuracies in the representations and warranties of the Company set forth herein or (iii) waive compliance by the Company
with any of the agreements or conditions set forth herein. Any agreement on the part of any such Party to any such extension or waiver
shall be valid only if set forth in a written instrument signed on behalf of such Party. Any waiver of any term or condition shall not
be construed as a waiver of any subsequent breach or a subsequent waiver of the same term or condition, or a waiver of any other term
or condition of this Agreement. The failure of any Party to assert any of its rights hereunder shall not constitute a waiver of such
rights.
Section 8.14 Waiver
of Jury Trial. THE PARTIES EACH HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY PROCEEDING,
CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (I) ARISING UNDER THIS AGREEMENT OR UNDER ANY ANCILLARY DOCUMENT OR (II) IN ANY WAY
CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES IN RESPECT OF THIS AGREEMENT OR ANY ANCILLARY DOCUMENT OR ANY
OF THE TRANSACTIONS OR ANY FINANCING IN CONNECTION WITH THE TRANSACTIONS, IN EACH CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING,
AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. THE PARTIES EACH HEREBY AGREES AND CONSENTS THAT ANY SUCH PROCEEDING, CLAIM, DEMAND,
ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES MAY FILE AN ORIGINAL COUNTERPART OF
A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL
BY JURY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) EACH
SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY AND
(D) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION 8.14.
Section 8.15 Submission
to Jurisdiction. Each of the Parties irrevocably and unconditionally submits to the exclusive jurisdiction of the United States District
Court for the Southern District of New York for the purposes of any Proceeding, claim, demand, action or cause of action (a) arising
under this Agreement or under any Ancillary Document or (b) in any way connected with or related or incidental to the dealings of
the Parties in respect of this Agreement or any Ancillary Document or any of the Transactions, and irrevocably and unconditionally waives
any objection to the laying of venue of any such Proceeding in any such court, and further irrevocably and unconditionally waives and
agrees not to plead or claim in any such court that any such Proceeding has been brought in an inconvenient forum. Each Party hereby
irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any
Proceeding claim, demand, action or cause of action against such Party (i) arising under this Agreement or under any Ancillary Document
or (ii) in any way connected with or related or incidental to the dealings of the Parties in respect of this Agreement or any Ancillary
Document or any of the Transactions, (A) any claim that such Party is not personally subject to the jurisdiction of the courts as
described in this Section 8.15 for any reason, (B) that such Party or such Party’s property is exempt or immune
from the jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment
prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (C) that (x) the Proceeding,
claim, demand, action or cause of action in any such court is brought against such Party in an inconvenient forum, (y) the venue
of such Proceeding, claim, demand, action or cause of action against such Party is improper or (z) this Agreement, or the subject
matter hereof, may not be enforced against such Party in or by such courts. Each Party agrees that service of any process, summons, notice
or document by registered mail to such party’s respective address set forth in Section 8.4 shall be effective service
of process for any such Proceeding, claim, demand, action or cause of action.
Section 8.16 Remedies.
Except as otherwise expressly provided herein, any and all remedies provided herein will be deemed cumulative with and not exclusive
of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude
the exercise of any other remedy. The Parties agree that irreparable damage for which monetary damages, even if available, would not
be an adequate remedy, would occur in the event that the Parties do not perform their obligations under the provisions of this Agreement
(including failing to take such actions as are required of them hereunder to consummate this Agreement) in accordance with its specified
terms or otherwise breach such provisions. The Parties acknowledge and agree that (i) the Parties may be entitled to an injunction,
specific performance, or other equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions
hereof and thereof, without proof of damages and without posting a bond, prior to the valid termination of this Agreement in accordance
with Section 7.1, this being in addition to any other remedy to which they are entitled under this Agreement, and (ii) the
right of specific enforcement is an integral part of the transactions contemplated by this Agreement and without that right, none of
the Parties would have entered into this Agreement. Each Party agrees that it will not oppose the granting of specific performance and
other equitable relief on the basis that the other Parties have an adequate remedy at law or that an award of specific performance is
not an appropriate remedy for any reason at law or equity. The Parties acknowledge and agree that any Party seeking an injunction to
prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this Section 8.16
shall not be required to provide any bond or other security in connection with any such injunction.
Section 8.17 Arm’s
Length Bargaining; No Presumption Against Drafter. This Agreement has been negotiated at arm’s-length by parties of equal bargaining
strength, each represented by counsel and having participated in the drafting of this Agreement. This Agreement creates no fiduciary
or other special relationship between the parties, and no such relationship otherwise exists. No presumption in favor of or against any
party in the construction or interpretation of this Agreement or any provision hereof shall be made based upon which Person might have
drafted this Agreement or such provision.
Section 8.18 Trust
Account Waiver. Reference is made to the final prospectus of SPAC, filed with the SEC (File No. 333-263658) on January 17,
2023 (the “SPAC Prospectus”). The Company acknowledges, agrees and understands that SPAC has established a trust account
(the “Trust Account”) containing the proceeds of its initial public offering (the “IPO”) and from
certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit
of SPAC’s public shareholders (including overallotment shares acquired by SPAC’s underwriters, the “Public Shareholders”),
and that, except as otherwise described in the SPAC Prospectus, SPAC may disburse monies from the Trust Account only in the express circumstances
described in the SPAC Prospectus. For and in consideration of SPAC entering into this Agreement, and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the Company hereby agrees on behalf of itself, its shareholders, and its
Affiliates that, none of the Company, its shareholders nor any of its Affiliates does now or shall at any time hereafter have any right,
title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the
Trust Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or
relating in any way to, this Agreement or any proposed or actual business relationship between SPAC or any of its Representatives, on
the one hand, and the Company or any of its Representatives or Affiliates, on the other hand, or any other matter, and regardless of
whether such claim arises based on contract, tort, equity or any other theory of legal liability (any and all such claims are collectively
referred to hereafter as the “Released Claims”). The Company on behalf of itself, its shareholders and its Affiliates
hereby irrevocably waives any Released Claims that it or any of its Representatives or Affiliates may have against the Trust Account
(including any distributions therefrom) now or in the future as a result of, or arising out of, any negotiations, Contracts with SPAC
or its Representatives and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever
(including for an alleged breach of any agreement with SPAC or its Affiliates). Notwithstanding the foregoing, nothing contained in this
Section 8.18 shall serve to limit or prohibit (x) the Company’s right to pursue a claim against SPAC for breach
for legal relief against assets held outside the Trust Account (other than distributions therefrom to Public Shareholders), for specific
performance or other non-monetary relief, or (y) any claims that the Company may have in the future against SPAC’s assets
or funds that are not held in the Trust Account (including any funds that have been released from the Trust Account (excluding distributions
therefrom directly to Public Shareholders) and any assets that have been purchased or acquired with any such funds).
* * * * * *
IN WITNESS WHEREOF, each
of the Parties has caused this Business Combination Agreement to be duly executed on its behalf as of the day and year first above written.
|
ISRAEL ACQUISITIONS CORP |
|
|
|
By: |
/s/
Ziv Elul |
|
Name: Ziv Elul |
|
Title: Chief Executive Officer |
|
POMVOM LTD |
|
|
|
By: |
/s/
Yehuda Minkovicz |
|
Name: Yehuda Minkovicz |
|
Title: Chief Executive Officer |
|
|
|
By: |
/s/ Alon Shtruzman |
|
Name: Alon Shtruzman |
|
Title: Chairman of the Board |
[Signature Page to Business Combination
Agreement]
Schedule 1.1
[***]
Schedule 6.3(d)
[***]
Exhibit 10.1
SPONSOR SUPPORT AGREEMENT
This SPONSOR SUPPORT AGREEMENT
(this “Agreement”), dated as of January [__], 2024, by and among Israel Acquisitions Sponsor LLC, a Delaware limited
liability company (the “Sponsor”), Pomvom Ltd., a company organized under the laws of the State of Israel (the “Company”),
and Israel Acquisitions Corp, a Cayman Islands exempted company (“SPAC”). The Sponsor, the Company and SPAC are referred
to from time to time in this Agreement individually as a “Party” and collectively as the “Parties”.
WHEREAS, concurrently with
the execution of this Agreement, SPAC and the Company are entering into a Business Combination Agreement, dated as of the date hereof
(as amended, supplemented, restated or otherwise modified from time to time, the “BCA”; capitalized terms used but
not defined in this Agreement shall have the meanings ascribed to such terms in the BCA), pursuant to which, among other things, (i) NewPubco,
the Company Shareholders and the holders of Company Equity Awards will effect the Equity Exchange and (ii) Merger Sub will merge
with and into SPAC, with SPAC surviving the Merger as a direct wholly-owned Subsidiary of NewPubco;
WHEREAS, as of the date hereof,
the Sponsor is the holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act)
of 4,696,167 SPAC Class B Shares (the “Sponsor Shares”);
WHEREAS, the Sponsor is the
holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act) of 637,500 warrants
(each a “SPAC Warrant”) to purchase one (1) SPAC Class A Share per warrant at a price of $11.50 per whole
share; and
WHEREAS, as an inducement
to the Company to enter into the BCA and to consummate the Transactions, each of the Sponsor, SPAC and the Company desire to enter into
this Agreement.
NOW, THEREFORE, in consideration
of the foregoing and of the mutual covenants and agreements contained herein, the receipt and sufficiency of which is hereby acknowledged,
and intending to be legally bound, each of the Sponsor, the Company and SPAC hereby agree as follows:
1. Agreement
to Vote. The Sponsor, by this Agreement, with respect to the Sponsor Shares (together with any other equity securities of SPAC that
Sponsor holds of record or beneficially as of the date of this Agreement or acquires record or beneficial ownership of after the date
hereof, collectively, the “Subject SPAC Equity Securities”), hereby agrees during the term of this Agreement: (a) to
vote (or cause to be voted), in person or by proxy, or execute and deliver a written consent (or cause a written consent to be executed
and delivered), at any meeting of the shareholders of SPAC, including the SPAC Shareholders Meeting, however called, or any adjournment
thereof, and in any action by written consent of the SPAC Shareholders, or in any other circumstance in which the vote, consent or other
approval of the shareholders of SPAC is sought (and appear at any such meeting, in person or by proxy, or otherwise cause all of such
holder’s Subject SPAC Equity Securities to be counted as present thereat for purposes of establishing a quorum), all of the Subject
SPAC Equity Securities held by the Sponsor at such time (i) in favor of the approval and adoption of the BCA and the approval of
the Transactions, including the Merger, and the other Transaction Proposals and in favor of any other matter reasonably necessary to the
consummation of the Transactions, (ii) against any arrangement, merger, amalgamation, consolidation, combination, sale of substantial
assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by the SPAC (other than the Transactions), (iii) against
any change in the business, management or SPAC Board other than as required or permitted under the BCA and Ancillary Documents and (iv) against
any action, agreement or transaction or proposal that would reasonably be expected to result in a breach of any covenant, representation
or warranty or any other obligation or agreement of SPAC under the BCA or that would reasonably be expected to result in the failure of
the Transactions from being consummated or that would impede, frustrate, prevent or nullify any provision of this Agreement, the BCA or
any Ancillary Document; (b) not to redeem, elect to redeem or tender or submit any of its Subject SPAC Equity Securities for redemption
in connection with the BCA or the Transactions; (c) not to commit or agree to take any action inconsistent with the foregoing; and
(d) not to modify or amend any agreement, contract or arrangement between or among Sponsor and any Affiliate of such Sponsor (other
than SPAC or any of its subsidiaries), on the one hand, and SPAC or any of SPAC’s subsidiaries, on the other hand, related to the
Transactions.
2. Transfer
of Sponsor Shares. Subject to the earlier termination of this Agreement in accordance with Section 10, Sponsor agrees
that it shall not, except as otherwise contemplated by this Agreement or with the consent of the Company, directly or indirectly, (a) sell,
assign, transfer (including by operation of Law), gift, convey, Lien, pledge, dispose of or otherwise encumber any of the Sponsor Shares
or grant any security interest in, or otherwise agree to do any of the foregoing (any of the foregoing, a “Transfer”), except
for a sale, assignment or transfer of the Sponsor Shares pursuant to the BCA or to another shareholder of SPAC and bound by the terms
and obligations hereof, (b) deposit any Sponsor Shares into a voting trust or enter into a voting agreement or arrangement or grant
any proxy or power of attorney with respect thereto that is inconsistent with this Agreement, or (c) enter into any contract, option
or other arrangement or undertaking with respect to the direct or indirect acquisition or sale, assignment, transfer (including by operation
of Law), or other disposition of any of the Sponsor Shares. Notwithstanding the foregoing, this Section 2 shall not prohibit
a Transfer of Sponsor Shares by Sponsor to a permitted transferee pursuant to Section 5(c) of the Insider Letter Agreement;
provided, that such Transfer shall be permitted only if, prior to or in connection with such Transfer, such permitted transferee
agrees in writing, reasonably satisfactory in form and substance to the Company, to assume all of the obligations of Sponsor hereunder
and to be bound by the terms of this Agreement.
3. Registration
Rights Agreement. At the Closing, the Sponsor shall deliver to SPAC a duly executed copy of that certain Registration Rights and Lock-Up
Agreement, by and among NewPubco and the additional signatories thereto, in substantially the form attached as Exhibit C to the BCA.
4. Waiver
of Redemption Rights. The Sponsor agrees during the term of this Agreement not to (a) demand that SPAC redeem the Subject SPAC
Equity Securities held by the Sponsor and (b) otherwise participate in any such redemption by tendering or submitting any of the
Subject SPAC Equity Securities held by the Sponsor for redemption.
5. Waiver
of Anti-Dilution Provision. The Sponsor, solely in connection with and only for the purpose of the Transactions, hereby irrevocably
and unconditionally waives, to the fullest extent permitted by Law, its rights to the treatment of its Sponsor Shares as set forth in
Section 24 of the SPAC Articles of Association, in connection with the Transactions, and agrees not to assert or perfect any rights
to adjustment or other anti-dilution protections with respect thereto.
6. Expenses.
If, immediately prior to or at the Closing, SPAC incurs a Transaction Expenses Cap Excess without obtaining the prior written consent
of the Company to incur such Transaction Expenses Cap Excess, then Sponsor shall forfeit and surrender a number of NewPubco Ordinary Shares
equal to (a) the amount of the Transaction Expenses Cap Excess divided by (b) $10.00, to NewPubco for no consideration
and Sponsor shall take any other action reasonably requested by the Company to evidence such forfeiture and surrender.
7. PIPE
Financing. Sponsor shall use its reasonable best efforts to raise the PIPE Financing, including, in each case, utilizing the Sponsor
Shares and the Sponsor’s SPAC Warrants in connection with such effort, which for the avoidance of doubt, may include transferring
or forfeiting such Sponsor Shares or SPAC Warrants.
8. Insider
Letter Agreement. Each of Sponsor and SPAC shall comply with, and fully perform all of its obligations, covenants, and agreements
set forth in the Insider Letter Agreement, dated as of January 12, 2023, among Sponsor, SPAC and the other parties thereto (the “Insider
Letter Agreement”). Without the prior written consent of the Company, each of Sponsor and SPAC hereby agree that from the date
hereof until the termination of this Agreement, it shall not amend, modify or vary the Insider Letter Agreement in any manner whatsoever.
9. Representations
and Warranties. The Sponsor hereby represents and warrants to the Company as follows:
(a) Organization;
Due Authorization. The Sponsor is duly organized, validly existing and in good standing under the laws of the jurisdiction in which
it is incorporated, formed, organized or constituted, and the execution, delivery and performance of this Agreement by the Sponsor and
the consummation by the Sponsor of the transactions contemplated hereby are within the Sponsor’s limited liability company powers
and have been duly authorized by all necessary limited liability company actions on the part of the Sponsor. This Agreement has been duly
authorized, executed and delivered by the Sponsor and, assuming due authorization, execution and delivery by the other Parties to this
Agreement, this Agreement constitutes a legally valid and binding obligation of the Sponsor, enforceable against the Sponsor in accordance
with the terms hereof (except as enforceability may be limited by bankruptcy laws, other similar laws affecting creditors’ rights
and general principles of equity affecting the availability of specific performance and other equitable remedies).
(b) Ownership.
The Sponsor is the record and beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of, and has good title to,
all of the Sponsor Shares and there exist no Liens or any other limitation or restriction (including any restriction on the right to vote,
sell or otherwise dispose of such Sponsor Shares (other than transfer restrictions under the Securities Act)) affecting any such Sponsor
Shares, other than any Permitted Liens or pursuant to (i) this Agreement, (ii) the SPAC Articles of Association (iii) the
BCA or (iv) any applicable securities Laws. Except for the SPAC Warrants, the Sponsor does not hold or own any rights to acquire
(directly or indirectly) any equity securities of SPAC or any equity securities convertible into, or which can be exchanged for, equity
securities of SPAC.
(c) No
Conflicts. The execution and delivery of this Agreement by the Sponsor does not, and the performance by the Sponsor of its obligations
hereunder will not, (i) conflict with or result in a violation of the organizational documents of the Sponsor or (ii) require
any consent or approval with respect to the Sponsor that has not been given or other action that has not been taken by any person (including
under any contract binding upon the Sponsor or the Sponsor Shares), in each case to the extent such consent, approval or other action
would prevent, enjoin or materially delay the performance by the Sponsor of its obligations under this Agreement.
(d) Litigation.
There are no Proceedings pending against the Sponsor or, to the knowledge of the Sponsor, threatened against the Sponsor before (or, in
the case of threatened legal proceedings, that would be before) any Governmental Entity, which in any manner challenges or seeks to prevent,
enjoin or materially delay the performance by the Sponsor of its obligations under this Agreement.
(e) Acknowledgment.
The Sponsor understands and acknowledges that each of the SPAC and Company is entering into the BCA in reliance upon the Sponsor’s
execution and delivery of this Agreement. The Sponsor has had the opportunity to read the BCA and this Agreement and has had the opportunity
to consult with its tax and legal advisors.
10. Termination.
This Agreement and the obligations of the Sponsor under this Agreement shall automatically terminate upon the earlier of: (a) the
Closing and (b) the termination of the BCA in accordance with its terms. Upon termination of this Agreement, no Party shall have
any further obligations or liabilities under this Agreement; provided that (i) nothing in this Section 10 shall
relieve any Party from liability for fraud or willful breach of this Agreement occurring prior to its termination and (ii) the provisions
of this Section 10 and Section 12 (other than Section 12(i)) shall survive any termination of this
Agreement.
11. No
Solicitation. Section 5.06(i) and (j) of the BCA shall apply mutatis mutandis to Sponsor.
12. Miscellaneous.
(a) All
notices, requests, claims, demands and other communications among the Parties shall be in writing and shall be deemed to have been duly
given (i) when delivered in person, (ii) when delivered after posting in the United States mail having been sent registered
or certified mail return receipt requested, postage prepaid, (iii) when delivered by FedEx or other nationally recognized overnight
delivery service or (iv) when e-mailed (having obtained electronic delivery confirmation thereof (i.e., an electronic record
of the sender that the e-mail was sent to the intended recipient thereof without an “error” or similar message that such e-mail
was not received by such intended recipient)) during normal business hours (and otherwise as of the immediately following Business Day),
addressed as follows:
If to the Sponsor, to:
Israel Acquisitions Sponsor LLC
12600 Hill Country Blvd, Building R, Suite 275
Bee Cave, Texas 78738
Attention: Alex Greystoke
Email: alex@israelspac.com
with a copy (which shall not constitute
notice) to:
Reed Smith LLP
2850 N. Harwood Street, Suite 1500
Dallas, Texas 75201
Attention: Lynwood Reinhardt
E-mail: lreinhardt@reedsmith.com
and
Naschitz, Brandes, Amir & Co.
5 Tuval Street
Tel Aviv 6789717, Israel
Attention: Tuvia Geffen and Asi Moravchick
Email: tgeffen@nblaw.com;
amoravchick@nblaw.com
If to SPAC, to:
Israel Acquisitions Corp
12600 Hill Country Blvd, Building R, Suite 275
Bee Cave, Texas 78738
Attention: Ziv Elul and Sharon Barzik Cohen
Email: Ziv@israelspac.com; Sharon@israelspac.com
with a copy (which shall not constitute
notice) to:
Reed Smith LLP
2850 N. Harwood Street, Suite 1500
Dallas, Texas 75201
Attention: Lynwood Reinhardt
E-mail: lreinhardt@reedsmith.com
and
Naschitz, Brandes, Amir & Co.
5 Tuval Street
Tel Aviv 6789717, Israel
Attention: Tuvia Geffen and Asi Moravchick
Email: tgeffen@nblaw.com;
amoravchick@nblaw.com
If to the Company,
to:
Pomvom Ltd.
35 Hamasger St., Tel Aviv, Israel
Attention: Yehuda Minkovicz, CEO
Email: yehuda.minkovicz@pomvom.com
with a copy (which shall not constitute
notice) to:
Greenberg Traurig LLP
One Vanderbilt Avenue
New York, NY 10017
Attention: Eyal Peled
E-mail: Eyal.Peled@gtlaw.com
and
Goldfarb Gross Seligman & Co.
1 Azrieli Center, Round Tower
Tel Aviv 6701101, Israel
Attention: Aaron M. Lampert
Email: aaron.lampert@goldfarb.com
(b) Whenever
possible, each provision of this Agreement will be interpreted in such a manner as to be effective and valid under applicable Law, but
if any term or other provision of this Agreement is held to be invalid, illegal or unenforceable under applicable Law, all other provisions
of this Agreement shall remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby
is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision of this Agreement
is invalid, illegal or unenforceable under applicable Law, the Parties shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the Parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby
are consummated as originally contemplated to the greatest extent possible.
(c) This
Agreement (together with the BCA and the other agreements referenced herein and therein) constitutes the entire agreement among the Parties
with respect to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the Parties,
or any of them, with respect to the subject matter hereof.
(d) This
Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns; provided,
however, that no Party may assign, delegate or otherwise transfer any of its rights or obligations pursuant to this Agreement without
the prior written consent of the other Parties. Any attempted assignment of this Agreement not in accordance with the terms of this Section 12(d) shall
be void ab initio.
(e) The
Parties agree that irreparable damage, for which monetary damages (even if available) would not be an adequate remedy, shall occur in
the event that the Parties do not perform the provisions of this Agreement (including failing to take such actions as are required of
them hereunder to consummate the Transactions) in accordance with its specified terms or otherwise breach such provisions. Accordingly,
the Parties acknowledge and agree that (i) the Parties shall be entitled to an injunction, specific performance or other equitable
relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof (which, for the avoidance of
doubt, includes the Parties’ obligation to consummate the Merger), in addition to any other remedy to which they are entitled at
Law or in equity and (ii) the right to specific enforcement is an integral part of the Transactions and without that right, none
of the Parties would have entered into this Agreement. Each of the Parties agrees that it shall not oppose the granting of an injunction,
specific performance and/or other equitable relief on any basis, including the basis that any other Party has an adequate remedy at Law
or that any award of an injunction, specific performance and/or other equitable relief is not an appropriate remedy for any reason at
Law or in equity. Any Party seeking: (A) an injunction or injunctions to prevent breaches of this Agreement; (B) to enforce
specifically the terms and provisions of this Agreement; and/or (C) other equitable relief, shall not be required to show proof of
actual damages or to provide any bond or other security in connection with any such remedy.
(f) This
Agreement, and all claims or causes of action (whether in contract, tort or statute) that may be based upon, arise out of or relate to
this Agreement, or the negotiation, execution or performance of this Agreement or the transactions contemplated hereby, or in any way
connected with or related or incidental to the dealings of the Parties in respect of this Agreement or any of the transactions contemplated
hereby (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or connection
with this Agreement or as an inducement to enter into this Agreement), shall be governed by, and construed in accordance with, the Laws
of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
New York or any other jurisdiction) that would cause the application of the Law of any jurisdiction other than the State of New York.
(g) Each
of the Parties irrevocably and unconditionally submits to the exclusive jurisdiction of the United States District Court for the Southern
District of New York for the purposes of any Proceeding, claim, demand, action or cause of action (i) arising under this Agreement
or (ii) in any way connected with or related or incidental to the dealings of the Parties in respect of this Agreement or the transactions
contemplated hereby, and irrevocably and unconditionally waives any objection to the laying of venue of any such Proceeding in any such
court, and further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such Proceeding
has been brought in an inconvenient forum. Each Party hereby irrevocably and unconditionally waives, and agrees not to assert, by way
of motion or as a defense, counterclaim or otherwise, in any Proceeding claim, demand, action or cause of action against such Party (A) arising
under this Agreement or (B) in any way connected with or related or incidental to the dealings of the Parties in respect of this
Agreement or the transactions contemplated hereby, (x) any claim that such Party is not personally subject to the jurisdiction of
the courts as described in this Section 12(g) for any reason, (y) that such Party or such Party’s property
is exempt or immune from the jurisdiction of any such court or from any legal process commenced in such courts (whether through service
of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (z) that
(1) the Proceeding, claim, demand, action or cause of action in any such court is brought against such Party in an inconvenient forum,
(2) the venue of such Proceeding, claim, demand, action or cause of action against such Party is improper or (3) this Agreement,
or the subject matter hereof, may not be enforced against such Party in or by such courts. Each Party agrees that service of any process,
summons, notice or document by registered mail to such party’s respective address set forth in Section 12(a) shall
be effective service of process for any such Proceeding, claim, demand, action or cause of action.
(h) This
Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute
one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement (including any of the closing
deliverables contemplated hereby) by electronic means, including DocuSign, Adobe Sign or other similar e-signature services, e-mail or
scanned pages shall be effective as delivery of a manually executed counterpart to this Agreement.
(i) Each
Party shall use its reasonable best efforts to (i) execute and deliver or cause to be executed and delivered such additional documents
and instruments and (ii) take all such further action as may be reasonably necessary or desirable to consummate the transactions
contemplated by this Agreement.
(j) This
Agreement shall not be effective or binding upon any Party until after such time as the BCA is executed and delivered by SPAC and the
Company.
(k) This
Agreement may be amended in writing by the Parties hereto at any time prior to the Merger Effective Time. This Agreement may not be amended
except by an instrument in writing signed by each of the Parties hereto.
(l) The
Sponsor shall permit and hereby consents to and authorizes SPAC and the Company to publish and disclose (i) all documents and schedules
filed with the SEC, (ii) any press release or other disclosure document that SPAC or the Company reasonably determines to be necessary
in connection with the Merger or any of the other Transactions, (iii) a copy of this Agreement, (iv) the Sponsor’s identity,
(v) the number of the Sponsor Shares and (vi) the nature of such the Sponsor’s commitments and obligations under this
Agreement.
[Signature page follows]
IN
WITNESS WHEREOF, the Sponsor, the Company and SPAC have caused this Agreement to be executed as of the date first written above
by their respective officers thereunto duly authorized.
|
ISRAEL
AcquisitionS Sponsor LLC |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
|
|
ISRAEL ACQUISITIONS CORP |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
|
|
POMVOM
LTD. |
|
|
|
By: |
|
|
Name: |
|
Title: |
[Signature
Page to Sponsor Support Agreement]
Exhibit 10.2
TRANSACTION SUPPORT AGREEMENT
This TRANSACTION SUPPORT AGREEMENT
(this “Agreement”), dated as of January [__], 2024, is entered into by and among Pomvom Ltd., a company organized
under the laws of the State of Israel (the “Company”), Israel Acquisitions Corp, a Cayman Islands exempted company
(“SPAC”), and the Company Shareholder whose name appears on the signature page of this Agreement (the “Supporting
Company Shareholder”). The Company, SPAC and the Supporting Company Shareholder are referred to from time to time in this Agreement
individually as a “Party” and collectively as the “Parties”.
WHEREAS, concurrently with
the execution of this Agreement, SPAC and the Company are entering into a Business Combination Agreement, dated as of the date hereof
(as amended, supplemented, restated or otherwise modified from time to time, the “BCA”; capitalized terms used but
not defined in this Agreement shall have the meanings ascribed to such terms in the BCA), pursuant to which, among other things, (i) NewPubco,
the Company Shareholders and the holders of Company Equity Awards will effect the Equity Exchange and (ii) Merger Sub will merge
with and into SPAC, with SPAC surviving the Merger as a direct wholly-owned Subsidiary of NewPubco;
WHEREAS, as of the date hereof,
the Supporting Company Shareholder is the holder of record and the “beneficial owner” of the number of Company Ordinary Shares
as set forth opposite the Supporting Company Shareholder’s name on Exhibit A hereto; and
WHEREAS, as an inducement
to SPAC to enter into the BCA and to consummate the Transactions, each of the Company, SPAC and the Supporting Company Shareholder desires
to enter into this Agreement.
NOW, THEREFORE, in consideration
of the foregoing and of the mutual covenants and agreements contained herein, the receipt and sufficiency of which are hereby acknowledged,
and intending to be legally bound, each of the Company, SPAC and the Supporting Company Shareholder hereby agrees as follows:
1. Voting
Obligations. The Supporting Company Shareholder, with respect to its Company Ordinary Shares (together with any other equity securities
of the Company that the Supporting Company Shareholder acquires record or beneficial ownership of after the date hereof, collectively,
the “Subject Company Equity Securities”), hereby agrees during the term of this Agreement, as follows: (a) to
vote (or cause to be voted), at any meeting of the equityholders of the Company, however called, or any adjournment thereof, and in any
action by written consent of the equityholders of the Company, or in any other circumstance in which the vote, consent or other approval
of the equityholders of the Company is sought (and appear at any such meeting, in person or by proxy, or otherwise cause all of the Supporting
Company Shareholder’s Subject Company Equity Securities to be counted as present thereat for purposes of establishing a quorum),
all of the Subject Company Equity Securities held by the Supporting Company Shareholder at such time (i) in favor of the Company
Equityholder Proposals and (ii) against any action, agreement or transaction or proposal that would reasonably be expected to result
in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company under the BCA or that would
reasonably be expected to result in the failure of the Transactions from being consummated and (b) not to commit or agree to take
any action inconsistent with the foregoing.
2. Registration
Rights Agreement. The Company shall use commercially reasonable efforts to cause the Supporting Company Shareholder to deliver, at
the Closing, to SPAC a duly executed copy of that certain Registration Rights and Lock-Up Agreement, by and among NewPubco and the additional
signatories thereto, in substantially the form attached as Exhibit C to the BCA.
3. Transfer
of Shares. The Supporting Company Shareholder agrees during the term of this Agreement that it shall not, directly or indirectly,
(a) sell, assign, transfer (including by operation of Law), lien, pledge, dispose of or otherwise encumber any of the Subject Company
Equity Securities held by the Supporting Company Shareholder or otherwise agree to do any of the foregoing (collectively, a “Transfer”),
(b) deposit any Subject Company Equity Securities held by the Supporting Company Shareholder into a voting trust or enter into a
voting agreement or arrangement or grant any proxy or power of attorney with respect to any Subject Company Equity Securities held by
the Supporting Company Shareholder that is inconsistent with the provisions of this Agreement or (c) enter into any contract, option
or other arrangement or undertaking with respect to the direct or indirect acquisition or sale, assignment, Transfer (including by operation
of law) or other disposition of any Subject Company Equity Securities held by the Supporting Company Shareholder; provided, that
the foregoing shall not prohibit the Transfer of the Subject Company Equity Securities (i) pursuant to the terms of the BCA and Ancillary
Documents, or (ii) under a Permitted Transfer (as defined below), but only if such Permitted Transferee (as defined below) shall
execute a joinder to this Agreement, in a form reasonably acceptable to SPAC, agreeing to become a party to this Agreement. Any transfer
or assignment made other than as provided in this Section 3 shall be null and void.
4. Permitted
Transfers. Section 3 shall not prohibit a Transfer of Subject Company Equity Securities by the Supporting Company Shareholder
(a) to any family member or trust for the benefit of any family member, (b) to any shareholder, member or partner of the Supporting
Company Shareholder, if an entity; (c) to any Affiliate of the Supporting Company Shareholder or a Permitted Transferee pursuant
to the existing Articles of Association of the Company); (d) to any person or entity if and to the extent required by any non-consensual
Order, by divorce decree or by will, intestacy, laws of descent and distribution upon death or other similar applicable Law; (e) by
private sales or transfers made in connection with the Transactions; or (f) by virtue of the Supporting Company Shareholder’s
Governing Documents upon liquidation or dissolution thereof, as applicable, in each case, the transferee being referred to as a “Permitted
Transferee”, and each Transfer, a “Permitted Transfer”; provided, that, in each case of a Permitted
Transfer, such Permitted Transferee shall execute a joinder to this Agreement agreeing to become a party to this Agreement and be bound
by the terms and conditions set forth herein.
5. Representations
and Warranties. The Supporting Company Shareholder hereby represents and warrants to SPAC and the Company as follows:
(a) Organization;
Due Authorization. The Supporting Company Shareholder (x) if not a natural person, is duly organized, validly existing and in
good standing under the laws of the jurisdiction in which it is incorporated, formed, organized or constituted, and the execution, delivery
and performance of this Agreement by the Supporting Company Shareholder and the consummation by the Supporting Company Shareholder of
the transactions contemplated hereby are within the Supporting Company Shareholder’s charter, partnership agreement, operating agreement
or similar organizational documents and have been duly authorized by all necessary action on the part of the Supporting Company Shareholder
or (y) if a natural person, has full legal capacity to execute and deliver this Agreement and to perform its obligations hereunder.
This Agreement has been duly authorized, executed and delivered by the Supporting Company Shareholder and, assuming due authorization,
execution and delivery by the other Parties to this Agreement, this Agreement constitutes a legally valid and binding obligation of the
Supporting Company Shareholder, enforceable against the Supporting Company Shareholder in accordance with the terms hereof (except as
enforceability may be limited by bankruptcy laws, other similar laws affecting creditors’ rights and general principles of equity
affecting the availability of specific performance and other equitable remedies).
(b) Ownership.
The Supporting Company Shareholder is the record and beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of,
and has good and valid title to, all of its Subject Company Equity Securities free and clear of any security interest, lien, claim, pledge,
proxy, option, right of first refusal, agreement, voting restriction, limitation on disposition, charge, adverse claim of ownership or
use or other encumbrance of any kind, other than pursuant to (i) this Agreement, (ii) applicable securities Laws, and (iii) the
Governing Documents of the Company, the Supporting Company Shareholder has the sole power to vote and right, power and authority to sell,
transfer and deliver such Company Ordinary Shares, and the Supporting Company Shareholder does not hold or own any additional rights to
acquire (directly or indirectly) any equity securities of the Company or any equity securities convertible into, or which can be exchanged
for, equity securities the Company.
(c) No
Conflicts. The execution and delivery of this Agreement by the Supporting Company Shareholder does not, and the performance by the
Supporting Company Shareholder of its obligations hereunder will not, (i) conflict with or result in a violation of the Governing
Documents of the Supporting Company Shareholder, as applicable, or (ii) require any consent or approval with respect to the Supporting
Company Shareholder that has not been given or other action that has not been taken by any person (including under any contract binding
upon the Supporting Company Shareholder or the Subject Company Equity Securities held by the Supporting Company Shareholder), in each
case to the extent such consent, approval or other action would prevent, enjoin or materially delay the performance by the Supporting
Company Shareholder of its obligations under this Agreement.
(d) Litigation.
There are no Proceedings pending against the Supporting Company Shareholder or, to the knowledge of the Supporting Company Shareholder,
threatened against the Supporting Company Shareholder before (or, in the case of threatened legal proceedings, that would be before) any
Governmental Entity, which in any manner challenges or seeks to prevent, enjoin or materially delay the performance by the Supporting
Company Shareholder of its obligations under this Agreement.
(e) Acknowledgment.
The Supporting Company Shareholder understands and acknowledges that each of SPAC and the Company is entering into the BCA in reliance
upon the Supporting Company Shareholder’s execution and delivery of this Agreement. The Supporting Company Shareholder has had the
opportunity to read the BCA and this Agreement and has had the opportunity to consult with its tax and legal advisors.
6. Termination.
This Agreement and the obligations of the Supporting Company Shareholder under this Agreement shall automatically terminate upon the earlier
of: (a) the Closing and (b) the termination of the BCA in accordance with its terms. Upon termination of this Agreement, no
Party shall have any further obligations or liabilities under this Agreement; provided that (i) nothing in this Section 6
shall relieve any Party of liability for fraud or willful breach of this Agreement occurring prior to its termination and (ii) the
provisions of this Section 6 and Section 7 (other than Section 7(i)) shall survive any termination
of this Agreement.
7. Miscellaneous.
(a) All
notices, requests, claims, demands and other communications among the Parties shall be in writing and shall be deemed to have been duly
given (i) when delivered in person, (ii) when delivered after posting in the United States mail having been sent registered
or certified mail return receipt requested, postage prepaid, (iii) when delivered by FedEx or other nationally recognized overnight
delivery service or (iv) when e-mailed (having obtained electronic delivery confirmation thereof (i.e., an electronic record
of the sender that the e-mail was sent to the intended recipient thereof without an “error” or similar message that such e-mail
was not received by such intended recipient)) during normal business hours (and otherwise as of the immediately following Business Day),
addressed as follows:
If to SPAC, to:
Israel Acquisitions Corp
12600 Hill Country Blvd, Building R, Suite 275
Bee Cave, Texas 78738
Attention: Ziv Elul and Sharon Barzik Cohen
Email: Ziv@israelspac.com; Sharon@israelspac.com
with a copy (which shall not constitute
notice) to:
Reed Smith LLP
2850 N. Harwood Street, Suite 1500
Dallas, Texas 75201
Attention: Lynwood Reinhardt
E-mail: lreinhardt@reedsmith.com
and
Naschitz, Brandes, Amir & Co.
5 Tuval Street
Tel Aviv 6789717, Israel
Attention: Tuvia Geffen and Asi Moravchick
Email: tgeffen@nblaw.com;
amoravchick@nblaw.com
If to the Company, to:
Pomvom Ltd.
35 Hamasger St., Tel Aviv, Israel
Attention: Yehuda Minkovicz, CEO
Email: yehuda.minkovicz@pomvom.com
with a copy (which shall not constitute notice) to:
Greenberg Traurig LLP
One Vanderbilt Avenue
New York, NY 10017
Attention: Eyal Peled
E-mail: Eyal.Peled@gtlaw.com
and
Goldfarb Gross Seligman & Co.
1 Azrieli Center, Round Tower
Tel Aviv 6701101, Israel
Attention: Aaron M. Lampert
If to the Supporting Company
Shareholder, to the address or email address as set forth on the signature page hereof.
(b) Whenever
possible, each provision of this Agreement will be interpreted in such a manner as to be effective and valid under applicable Law, but
if any term or other provision of this Agreement is held to be invalid, illegal or unenforceable under applicable Law, all other provisions
of this Agreement shall remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby
is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision of this Agreement
is invalid, illegal or unenforceable under applicable Law, the Parties shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the Parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby
are consummated as originally contemplated to the greatest extent possible.
(c) This
Agreement (together with the BCA and the other agreements referenced herein and therein) constitutes the entire agreement among the Parties
with respect to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the Parties,
or any of them, with respect to the subject matter hereof.
(d) This
Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns; provided,
however, that no Party may assign, delegate or otherwise transfer any of its rights or obligations pursuant to this Agreement without
the prior written consent of the other Parties. Any attempted assignment of this Agreement not in accordance with the terms of this Section 7(d) shall
be void ab initio.
(e) The
Parties agree that irreparable damage, for which monetary damages (even if available) would not be an adequate remedy, shall occur in
the event that the Parties do not perform the provisions of this Agreement (including failing to take such actions as are required of
them hereunder to consummate the Transactions) in accordance with its specified terms or otherwise breach such provisions. Accordingly,
the Parties acknowledge and agree that (i) the Parties shall be entitled to an injunction, specific performance or other equitable
relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy
to which they are entitled at Law or in equity and (ii) the right to specific enforcement is an integral part of the Transactions
and without that right, none of the Parties would have entered into this Agreement. Each of the Parties agrees that it shall not oppose
the granting of an injunction, specific performance and/or other equitable relief on any basis, including the basis that any other Party
has an adequate remedy at Law or that any award of an injunction, specific performance and/or other equitable relief is not an appropriate
remedy for any reason at Law or in equity. Any Party seeking: (A) an injunction or injunctions to prevent breaches of this Agreement;
(B) to enforce specifically the terms and provisions of this Agreement; and/or (C) other equitable relief, shall not be required
to show proof of actual damages or to provide any bond or other security in connection with any such remedy.
(f) This
Agreement, and all claims or causes of action (whether in contract, tort or statute) that may be based upon, arise out of or relate to
this Agreement, or the negotiation, execution or performance of this Agreement or the transactions contemplated hereby, or in any way
connected with or related or incidental to the dealings of the Parties in respect of this Agreement or any of the transactions contemplated
hereby (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or connection
with this Agreement or as an inducement to enter into this Agreement), shall be governed by, and construed in accordance with, the Laws
of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
New York or any other jurisdiction) that would cause the application of the Law of any jurisdiction other than the State of New York.
(g) Each
of the Parties irrevocably and unconditionally submits to the exclusive jurisdiction of the United States District Court for the Southern
District of New York for the purposes of any Proceeding, claim, demand, action or cause of action (i) arising under this Agreement
or (ii) in any way connected with or related or incidental to the dealings of the Parties in respect of this Agreement or the transactions
contemplated hereby, and irrevocably and unconditionally waives any objection to the laying of venue of any such Proceeding in any such
court, and further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such Proceeding
has been brought in an inconvenient forum. Each Party hereby irrevocably and unconditionally waives, and agrees not to assert, by way
of motion or as a defense, counterclaim or otherwise, in any Proceeding claim, demand, action or cause of action against such Party (A) arising
under this Agreement or (B) in any way connected with or related or incidental to the dealings of the Parties in respect of this
Agreement or the transactions contemplated hereby, (x) any claim that such Party is not personally subject to the jurisdiction of
the courts as described in this Section 7(g) for any reason, (y) that such Party or such Party’s property
is exempt or immune from the jurisdiction of any such court or from any legal process commenced in such courts (whether through service
of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (z) that
(1) the Proceeding, claim, demand, action or cause of action in any such court is brought against such Party in an inconvenient forum,
(2) the venue of such Proceeding, claim, demand, action or cause of action against such Party is improper or (3) this Agreement,
or the subject matter hereof, may not be enforced against such Party in or by such courts. Each Party agrees that service of any process,
summons, notice or document by registered mail to such party’s respective address set forth in Section 7(a) shall
be effective service of process for any such Proceeding, claim, demand, action or cause of action.
(h) This
Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute
one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement (including any of the closing
deliverables contemplated hereby) by electronic means, including DocuSign, Adobe Sign or other similar e-signature services, e-mail or
scanned pages shall be effective as delivery of a manually executed counterpart to this Agreement.
(i) Each
Party shall use its reasonable best efforts to (i) execute and deliver or cause to be executed and delivered such additional documents
and instruments and (ii) take all such further action as may be reasonably necessary or desirable to consummate the transactions
contemplated by this Agreement.
(j) This
Agreement shall not be effective or binding upon any Party until after such time as the BCA is executed and delivered by SPAC and the
Company
(k) This
Agreement may be amended in writing by the Parties hereto at any time prior to the Merger Effective Time. This Agreement may not be amended
except by an instrument in writing signed by each of the Parties hereto.
(l) The
Supporting Company Shareholder shall permit and hereby consents to and authorizes SPAC and the Company to publish and disclose a copy
of this Agreement.
(m) The
Supporting Company Shareholder signs this Agreement solely in its capacity as a shareholder of the Company. The Supporting Company Shareholder
makes no agreement or understanding in this Agreement in its capacity (or in the capacity of any Affiliate, partner or employee of the
Supporting Company Shareholder) as a director or officer of the Company (if the Supporting Company Shareholder holds such office). Nothing
in this Agreement will limit or affect any actions or omissions taken by the Supporting Company Shareholder (or any Affiliate, partner
or employee of the Supporting Company Shareholder) in his, her or its capacity as a director or officer of the Company, and no actions
or omissions taken in the Supporting Company Shareholder’s capacity (or in the capacity of any Affiliate, partner or employee of
the Supporting Company Shareholder) as a director or officer of the Company shall be deemed a breach of this Agreement. Nothing in this
Agreement will be construed to prohibit, limit or restrict the Supporting Company Shareholder (or any Affiliate, partner or employee of
the Supporting Company Shareholder) from exercising his or her fiduciary duties as an officer or director of the Company.
[Signature page follows]
IN
WITNESS WHEREOF, the Company, SPAC and the Supporting Company Shareholder have caused this Agreement to be executed as of the
date first written above by their respective officers thereunto duly authorized.
|
POMVOM
LTD. |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
|
|
ISRAEL
ACQUISITIONS CORP |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
|
|
[Supporting
Company Shareholder] |
|
|
|
By: |
|
|
Name: |
|
Title: |
|
|
|
For purposes of Section 7(a): |
|
Address: |
|
Email: |
[Signature
Page to Transaction Support Agreement]
EXHIBIT A
Supporting Company Shareholder
Company Shareholder |
Number of Owned Company Ordinary Shares |
|
|
Exhibit 10.3
REGISTRATION RIGHTS
AND LOCK-UP AGREEMENT
THIS
REGISTRATION RIGHTS AND LOCK-UP AGREEMENT (this “Agreement”), dated as of [●] 2024, is made and entered
into by and among [NewPubco], a company organized under the laws of the State of Israel (the “Company”), and
the undersigned parties listed on the signature page hereto (each such party, together with any person or entity who hereafter becomes
a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively
the “Holders”).
RECITALS
WHEREAS,
the Company is party to that certain Business Combination Agreement, dated as of January 2, 2024 (the “BCA”),
by and between Israel Acquisitions Corp, a Cayman Islands exempted company (“SPAC”) and Pomvom Ltd., a company
organized under the laws of the State of Israel (“Pomvom”) whose shares are listed for trading on the TASE,
pursuant to which, among other things, (a) [Merger Sub Corp.], a Cayman Islands exempted company and a wholly owned subsidiary of
the Company (“Merger Sub”), will merge with and into SPAC (with SPAC being the surviving entity and a wholly-owned
subsidiary of the Company) in exchange for SPAC’s shareholders receiving ordinary shares of no par value of the Company (the “Ordinary
Shares”) and (b) the shareholders of Pomvom (the “Pomvom Holders”) will exchange their ordinary
shares of Pomvom in exchange for Ordinary Shares pursuant to, and in accordance with, the Section 350 Approval (as defined in the
BCA), with Pomvom becoming a wholly-owned subsidiary of the Company following the consummation of such exchanges;
WHEREAS,
SPAC, Israel Acquisitions Sponsor LLC, a Delaware limited liability company (the “Sponsor”) and the Underwriter
Purchasers (defined below) are parties to that certain Registration Rights Agreement, dated as of January 12, 2023 (the “Prior
Agreement”), which Prior Agreement will terminate with respect to the Sponsor and the other parties thereto upon execution
of this Agreement.
WHEREAS,
the Sponsor is a holder of Class A ordinary shares of SPAC (“SPAC Class A Shares”) and Class B
ordinary shares of SPAC (“SPAC Founder Shares”) and will acquire Ordinary Shares (including the Ordinary Shares
issued or issuable upon the exercise of any other equity security issued to a Holder pursuant to the terms of the BCA, including the private
placement warrants of SPAC) in connection with the Closing (as defined in the BCA, the “Closing”) pursuant to
the terms of the BCA.
WHEREAS,
each of BTIG, LLC (“BTIG”), Exos Securities LLC (“Exos”) and JonesTrading Institutional
Services LLC a (“JonesTrading” and, together with BTIG and Exos, the “Underwriter Purchasers”)
is a holder of SPAC Class A Shares (each a “Underwriter Holder”) and are acquiring Ordinary Shares (including
the Ordinary Shares issued or issuable upon the exercise of any other equity security issued to a Holder pursuant to the terms of the
BCA, including the private placement warrants of SPAC) in connection with the Closing pursuant to the terms of the BCA; and
WHEREAS,
in connection with the transactions contemplated by the BCA, the Company and the Holders desire to enter into this Agreement, pursuant
to which the Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth
in this Agreement.
NOW,
THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby
agree as follows:
ARTICLE I
DEFINITIONS
1.1 Definitions.
The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth
below:
“Adverse
Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment
of the Chief Executive Officer or Chief Financial Officer of the Company, after consultation with counsel to the Company, (a) would
be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not
to contain any Misstatement, (b) would not be required to be made at such time if the Registration Statement were not being filed,
and (c) the Company has a bona fide business purpose for not making such information public.
“Affiliate”
means, with respect to a specified Person, each other Person that directly, or indirectly through one or more intermediaries, controls
or is controlled by, or is under common control with, the Person specified; provided that no Holder shall be deemed an Affiliate of any
other Holder solely by reason of an investment in, or holding of Ordinary Shares (or securities convertible or exchangeable for share
of Ordinary Shares) of, the Company. As used in this definition, “control” (including with correlative meanings, “controlled
by” and “under common control with”) means possession, directly or indirectly, of power to direct or cause the direction
of management or policies (whether through ownership of voting securities or by contract or other agreement); provided, however,
that in no event shall the term “Affiliate” include any portfolio company of any Holder or their respective Affiliates (other
than the Company).
“Aggregate
Blocking Period” shall have the meaning given in Section 2.4.
“Agreement”
shall have the meaning given in the Preamble.
“BCA”
shall have the meaning given in the Recitals hereto.
“Block
Trade” means an offering and/or sale of Registrable Securities by any Holder on a block trade or underwritten basis (whether
firm commitment or otherwise) without substantial marketing efforts prior to pricing, including, without limitation, a same day trade,
overnight trade or similar transaction.
“Board”
shall mean the Board of Directors of the Company.
“Change
in Control” means the transfer (whether by tender offer, merger, share purchase, consolidation or other similar transaction),
in one transaction or a series of related transactions, to a person or group of affiliated persons of the Company’s voting securities
if, after such transfer, such person or group of affiliated persons would hold more than 50% of outstanding voting securities of the Company
(or surviving entity) or would otherwise have the power to control the board of directors of the Company or to direct the operations of
the Company.
“Claims”
shall have the meaning given in subsection 4.1.1.
“Closing
Date” shall have the meaning set forth in the BCA.
“Commission”
shall mean the Securities and Exchange Commission.
“Commission
Guidance” means (a) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (b) the Securities Act.
“Company”
shall have the meaning given in the Preamble.
“Company
Shelf Take Down Notice” shall have the meaning given in subsection 2.1.3.
“Demand Registration”
shall have the meaning given in subsection 2.2.1.
“Demanding
Holder” shall mean, as applicable, (a) the applicable Holders making a written demand for the Registration of Registrable
Securities pursuant to subsection 2.2.1 or (b) the applicable Holders making a written demand for a Shelf Underwritten Offering
of Registrable Securities pursuant to subsection 2.1.3.
“Effectiveness
Deadline” shall have the meaning given in subsection 2.1.1.
“Exchange
Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.
“Form F-1
Shelf” shall have the meaning given in subsection 2.1.1.
“Form F-3
Shelf” shall have the meaning given in subsection 2.1.2.
“Holders”
shall have the meaning given in the Preamble.
“Lock-up
Holders” shall mean (i) the Sponsor, (ii) the Pomvom Holders listed on Schedule A hereto, and (iii) the
officers and directors of Pomvom.
“Lock-up
Period” shall have the meaning given in Section 5.1.1.
“Maximum
Number of Securities” shall have the meaning given in subsection 2.2.4.
“Minimum
Amount” shall have the meaning given in subsection 2.1.3.
“Misstatement”
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated therein, or necessary
to make the statements therein (in the case of any Prospectus and any preliminary Prospectus, in the light of the circumstances under
which they were made) not misleading.
“Ordinary
Shares” shall have the meaning given in the Recitals.
“Permitted
Transferees” shall mean a person or entity to whom the Sponsor, the officers and directors of Pomvom, and the Pomvom Holders
are permitted to Transfer such Registrable Securities prior to the expiration of the Lock-up Period pursuant to Section 5.2
of this Agreement and any other applicable agreement between the Holders and the Company, and to any transferee thereafter.
“Person”
means an individual, partnership, corporation, limited liability company, joint stock company, unincorporated organization or association,
trust, joint venture or other similar entity, whether or not a legal entity, or governmental entity.
“Piggyback
Registration” shall have the meaning given in subsection 2.3.1.
“Pomvom Holders”
shall have the meaning given in the Recitals.
“Prior Agreement”
shall have the meaning given in the Recitals hereto.
“Prospectus”
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.
“Registrable
Security” shall mean (a) any Ordinary Shares issued to a Holder pursuant to the terms of the BCA (including the Ordinary
Shares issued or issuable upon the exercise of any other equity security issued to a Holder pursuant to the terms of the BCA), and (b) any
other equity security of the Company issued or issuable with respect to any such Ordinary Share referred to in the foregoing clause (a) by
way of a share dividend or share split or in connection with a combination of shares, recapitalization, merger, consolidation or other
reorganization or otherwise; provided, however, that, as to any particular Registrable Security, such securities shall cease
to be Registrable Securities when: (i) a Registration Statement with respect to the sale of such securities shall have become effective
under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration
Statement; (ii) such securities shall have been otherwise transferred, new certificates for such securities not bearing (or book
entry positions not subject to) a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution
of such securities shall not require registration under the Securities Act; (iii) such securities shall have ceased to be outstanding;
(iv) such securities may be sold without registration pursuant to Rule 144 promulgated under the Securities Act (or any successor
rule promulgated thereafter by the Commission) (but with no volume or other restrictions or limitations); or (v) such securities
have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.
“Registration”
shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming
effective.
“Registration
Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:
(a) all
registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.)
and any securities exchange on which the Ordinary Shares are then listed;
(b) fees
and expenses of compliance with securities or blue-sky laws (including reasonable fees and disbursements of counsel for the Underwriters
in connection with blue sky qualifications of Registrable Securities);
(c) printing,
messenger, telephone, delivery and road show or other marketing expenses;
(d) reasonable
fees and disbursements of counsel for the Company;
(e) reasonable
fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such Registration;
and
(f) reasonable
fees and expenses of one (1) legal counsel selected by either (i) the majority-in-interest of the Demanding Holders (and any
local or foreign counsel) initiating a Demand Registration or Shelf Underwritten Offering (including, without limitation, a Block Trade),
or (ii) of a majority-in-interest of participating Holders under Section 2.3 if the Registration was initiated by the
Company for its own account or that of a Company shareholder other than pursuant to rights under this Agreement, in each case to be registered
for offer and sale in the applicable Registration.
“Registration
Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this
Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements
to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.
“Removed
Shares” shall have the meaning given in Section 2.6.
“Requesting
Holder” shall have the meaning given in subsection 2.2.1.
“Securities
Act” shall mean the Securities Act of 1933, as amended from time to time.
“Shelf Take
Down Notice” shall have the meaning given in subsection 2.1.3.
“Shelf Underwritten
Offering” shall have the meaning given in subsection 2.1.3.
“Sponsor”
shall have the meaning given in the Recitals.
“Transfer”
means to, directly or indirectly, sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of, either voluntarily or
involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment,
pledge, encumbrance, hypothecation or similar disposition of, any interest owned by a person or any interest (including a beneficial interest)
in, or the ownership, control or possession of, any interest owned by a person.
“Underwriter”
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
dealer’s market-making activities.
“Underwritten
Registration” or “Underwritten Offering” shall mean a Registration in which securities of the
Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.
ARTICLE II
REGISTRATIONS
2.1 Shelf
Registration.
2.1.1 The
Company shall, as soon as practicable, but in any event within sixty (60) days after the Closing Date, file a Registration Statement under
the Securities Act to permit the public resale of all the Registrable Securities held by the Holders from time to time as permitted by
Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission then in effect) on the terms and
conditions specified in this subsection 2.1.1 and shall use its reasonable best efforts to cause such Registration Statement to
be declared effective as soon as practicable after the filing thereof, but in no event later than ninety (90) days following the filing
deadline (the “Effectiveness Deadline”); provided, that the Effectiveness Deadline shall be extended
to one hundred and twenty (120) days after the filing deadline if the Registration Statement is reviewed by, and receives comments from,
the Commission. The Registration Statement filed with the Commission pursuant to this subsection 2.1.1 shall be on a shelf registration
statement on Form F-1 (a “Form F-1 Shelf”) or such other form of registration statement as is then
available to effect a registration for resale of such Registrable Securities, covering such Registrable Securities, and shall contain
a Prospectus in such form as to permit any Holder to sell such Registrable Securities pursuant to Rule 415 under the Securities Act
(or any successor or similar provision adopted by the Commission then in effect) at any time beginning on the effective date for such
Registration Statement. A Registration Statement filed pursuant to this subsection 2.1.1 shall provide for the resale pursuant
to any method or combination of methods legally available to, and requested by, the Holders. The Company shall use its best efforts to
cause a Registration Statement filed pursuant to this subsection 2.1.1 to remain effective, and to be supplemented and amended
to the extent necessary to ensure that such Registration Statement is available (including to use its best efforts to add Registrable
Securities held by Permitted Transferees) or, if not available, that another Registration Statement is available, for the resale of all
the Registrable Securities held by the Holders until all such Registrable Securities have ceased to be Registrable Securities. As soon
as practicable following the effective date of a Registration Statement filed pursuant to this subsection 2.1.1, but in any event
within one (1) business day of such date, the Company shall notify the Holders of the effectiveness of such Registration Statement.
When effective, a Registration Statement filed pursuant to this subsection 2.1.1 (including the documents incorporated therein
by reference) will comply as to form in all material respects with all applicable requirements of the Securities Act and the Exchange
Act and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein not misleading (in the case of any Prospectus contained in such Registration Statement, in the light of
the circumstances under which such statement is made).
2.1.2 The
Company shall use its best efforts to convert the Form F-1 Shelf filed pursuant to subsection 2.1.1 to a shelf registration
statement on Form F-3 (a “Form F-3 Shelf”) as promptly as practicable after the Company is eligible
to use a Form F-3 Shelf and have the Form F-3 Shelf declared effective as promptly as practicable and to cause such Form F-3
Shelf to remain effective, and to be supplemented and amended to the extent necessary to ensure that such Registration Statement is available
or, if not available, that another Registration Statement is available, for the resale of all the Registrable Securities held by the Holders
until all such Registrable Securities have ceased to be Registrable Securities.
2.1.3 At
any time and from time to time following the effectiveness of the shelf registration statement required by subsection 2.1.1 or
subsection 2.1.2, any Holder may request to sell all or a portion of their Registrable Securities in an Underwritten Offering that
is registered pursuant to such shelf registration statement, including a Block Trade (a “Shelf Underwritten Offering”)
provided that such Holder(s) (a) reasonably expects to sell Registrable Securities yielding aggregate gross proceeds in excess
of $20,000,000 from such Shelf Underwritten Offering or (b) reasonably expects to sell all of the Registrable Securities held by
such Holder in such Shelf Underwritten Offering (the amount of Registrable Securities pursuant to the foregoing clause (a) or (b),
as applicable, the “Minimum Amount”). All requests for a Shelf Underwritten Offering shall be made by giving
written notice to the Company (the “Shelf Take Down Notice”). Each Shelf Take Down Notice shall specify the
approximate number of Registrable Securities proposed to be sold in the Shelf Underwritten Offering and the expected price range (net
of underwriting discounts and commissions) of such Shelf Underwritten Offering. Within three (3) days after receipt of any Shelf
Take Down Notice, the Company shall give written notice of such requested Shelf Underwritten Offering to all other Holders of Registrable
Securities (the “Company Shelf Take Down Notice”) and, subject to the provisions of subsection 2.2.4,
shall include in such Shelf Underwritten Offering all Registrable Securities with respect to which the Company has received written requests
for inclusion therein, within five (5) days after sending the Company Shelf Take Down Notice, or, in the case of a Block Trade, as
provided in Section 2.5. The Company shall enter into an underwriting agreement in a form as is customary in Underwritten
Offerings of securities by the Company with the managing Underwriter or Underwriters selected by the Holders after consultation with the
Company and shall take all such other reasonable actions as are requested by the managing Underwriter or Underwriters in order to expedite
or facilitate the disposition of such Registrable Securities. In connection with any Shelf Underwritten Offering contemplated by this
subsection 2.1.3, subject to Section 3.3 and Article IV, the underwriting agreement into which each
Holder and the Company shall enter shall contain such representations, covenants, indemnities and other rights and obligations as are
customary in underwritten offerings of securities by the Company. Any Shelf Underwritten Offering effected pursuant to this subsection
2.1.3 shall be counted as a Registration for purposes of the limit on the number of Registrations that can be effected under Section 2.2
hereof.
2.2 Demand
Registration.
2.2.1 Request
for Registration. Subject to the provisions of subsection 2.2.5 and Sections 2.4 and 3.4 hereof, at any time
and from time to time on or after the Closing Date, the Holders of at least a majority in interest of the then-outstanding number of Registrable
Securities held by the Holders (the “Demanding Holders”) may make a written demand for Registration of all or
part of their Registrable Securities on (i) Form F-1, or such other form of registration statement as is then available to effect
a registration for resale of such Registrable Securities, covering such Registrable Securities or (ii) if available, Form F-3,
which in the case of either clause (i) or (ii), may be a shelf registration statement filed pursuant to Rule 415 under the Securities
Act, which written demand shall describe the amount and type of securities to be included in such Registration and the intended method(s) of
distribution thereof (such written demand a “Demand Registration”); provided, however, that the
Sponsor shall have one Demand Registration, exercisable in its sole discretion, to register all or part of its Registrable Securities.
In addition, the Company shall, promptly following the Company’s receipt of a Demand Registration, notify, in writing all other
Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a
portion of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes
all or a portion of such Holder’s Registrable Securities in such Registration, a “Requesting Holder”)
shall so notify the Company, in writing, within five (5) days after the receipt by the Holder of the notice from the Company. For
the avoidance of doubt, to the extent a Requesting Holder also separately possesses Demand Registration rights pursuant to this Section 2.2,
but is not the Holder who exercises such Demand Registration rights, the exercise by such Requesting Holder of its rights pursuant to
the foregoing sentence shall not count as the exercise by it of one of its Demand Registration rights. Upon receipt by the Company of
any such written notification from a Requesting Holder(s) to the Company, subject to subsection 2.2.4 below, such Requesting
Holder(s) shall be entitled to have their Registrable Securities included in a Registration pursuant to a Demand Registration and
the Company shall effect, as soon thereafter as practicable, but not more than forty five (45) days immediately after the Company’s
receipt of the Demand Registration, the Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders
pursuant to such Demand Registration. The Company shall not be obligated to effect more than (x) one (1) Registration pursuant
to a Demand Registration or a Shelf Underwritten Offering initiated by the Sponsor and (y) an aggregate of three (3) Registrations
pursuant to a Demand Registration or a Shelf Underwritten Offering initiated by any other Holders, in each case under subsection 2.1.3
or this subsection 2.2.1 with respect to any or all Registrable Securities; provided, however, that a Registration
shall not be counted for such purposes unless a Registration Statement that may be available at such time has become effective and all
of the Registrable Securities requested by the Demanding Holders and the Requesting Holders to be registered on behalf of the Demanding
Holders and the Requesting Holders in such Registration have been sold, in accordance with Section 3.1 of this Agreement.
2.2.2 Effective
Registration. Notwithstanding the provisions of subsection 2.2.1 above or any other part of this Agreement, a Registration
pursuant to a Demand Registration shall not count as a Registration unless and until (a) the Registration Statement filed with the
Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and (b) the
Company has complied with all of its obligations under this Agreement with respect thereto; provided, further, that if,
after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to a Demand
Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any other governmental
agency, the Registration Statement with respect to such Registration shall be deemed not to have been declared effective, unless and until,
(i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of the Demanding
Holders initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly notify the
Company in writing, but in no event later than five (5) days after the removal, rescission or other termination of such stop order
or injunction, of such election; provided, further, that the Company shall not be obligated or required to file another
Registration Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand
Registration by the same Demanding Holder becomes effective or is subsequently terminated.
2.2.3 Underwritten
Offering. Subject to the provisions of subsection 2.2.4 and Sections 2.4 and 3.4 hereof, if a majority-in-interest
of the Demanding Holders so advise the Company as part of their Demand Registration that the offering of the Registrable Securities pursuant
to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder
(if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such
Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided
herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection
2.2.3, subject to Section 3.3 and Article IV, shall enter into an underwriting agreement in customary
form with the Company and the Underwriter(s) selected for such Underwritten Offering by the majority-in-interest of the Demanding
Holders initiating the Demand Registration.
2.2.4 Reduction
of Underwritten Offering. If a Demand Registration is to be an Underwritten Offering and the managing Underwriter or Underwriters,
in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if any) in writing that, in its opinion, the dollar
amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together
with all other Ordinary Shares or other equity securities that the Company desires to sell for its own account and the Ordinary Shares,
if any, as to which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by
any other stockholders of the Company who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that
can be sold in such Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method,
or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum
Number of Securities”), then the Company shall include in such Underwritten Offering, as follows: (a) first, the Registrable
Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities
that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate
number of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration
(such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number
of Securities; (b) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (a),
the Ordinary Shares or other equity securities that the Company desires to sell for its own account, which can be sold without exceeding
the Maximum Number of Securities; and (c) third, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clauses (a) and (b), the Ordinary Shares or other equity securities of other persons or entities that the Company is obligated
to register in a Registration pursuant to separate written contractual arrangements with such persons and that can be sold without exceeding
the Maximum Number of Securities and (d) fourth, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clauses (a), (b) and (c), Ordinary Shares or other equity securities of other persons or entities that the Company is obligated
to register in a Registration pursuant to Section 2.3 and that can be sold without exceeding the Maximum Number of Securities.
2.2.5 Demand
Registration Withdrawal. A Demanding Holder or a Requesting Holder shall have the right to withdraw all or a portion of its Registrable
Securities included in a Demand Registration pursuant to subsection 2.2.1 or a Shelf Underwritten Offering pursuant to subsection
2.1.3 for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of its
intention to so withdraw at any time prior to (a) in the case of a Demand Registration not involving an Underwritten Offering or
a Shelf Underwritten Offering, the effectiveness of the applicable Registration Statement or (b) in the case of any Demand Registration
involving an Underwritten Offering or any Shelf Underwritten Offering, prior to the pricing of such Underwritten Offering or Shelf Underwritten
Offering; provided, however, that upon withdrawal by a majority-in-interest of the Demanding Holders initiating a Demand
Registration (or in the case of a Shelf Underwritten Offering, withdrawal of an amount of Registrable Securities included by the Holders
in such Shelf Underwritten Offering, in their capacity as Demanding Holders, being less than the Minimum Amount), the Company shall cease
all efforts to secure effectiveness of the applicable Registration Statement or complete the Underwritten Offering, as applicable. Notwithstanding
anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with
a Registration pursuant to a Demand Registration or a Shelf Underwritten Offering prior to and including its withdrawal under this subsection
2.2.5.
2.3 Piggyback
Registration.
2.3.1 Piggyback
Rights. If the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities,
or securities or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for
the account of stockholders of the Company (or by the Company and by the shareholders of the Company including, without limitation, pursuant
to Section 2.2 hereof), other than a Registration Statement (a) filed in connection with any employee share option or
other benefit plan, (b) for an exchange offer or offering of securities solely to the Company’s existing shareholders, (c) for
an offering of debt that is convertible into equity securities of the Company, (d) for a dividend reinvestment plan, or (e) filed
pursuant to subsection 2.1.1, then the Company shall give written notice of such proposed filing to all of the Holders of Registrable
Securities as soon as practicable but not less than twenty (20) days (or, in the case of a Block Trade, three (3) business days)
before the anticipated filing date of such Registration Statement, which notice shall (A) describe the amount and type of securities
to be included in such offering, the intended method(s) of distribution (including whether such registration will be pursuant to
a shelf registration statement), and the proposed price and name of the proposed managing Underwriter or Underwriters, if any, in such
offering, (B) such Holders’ rights under this Section 2.3 and (C) offer to all of the Holders of Registrable
Securities the opportunity to register the sale of such number of Registrable Securities as such Holders may request in writing within
ten (10) days after receipt of such written notice (or in the case of a Block Trade, within two (2) business days) (such Registration
a “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities identified
in a Holder’s response noticed described in the foregoing sentence to be included in such Piggyback Registration and shall use its
best efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering, if any, to permit the Registrable
Securities requested by the Holders pursuant to this subsection 2.3.1 to be included in a Piggyback Registration on the same terms
and conditions as any similar securities of the Company or Company shareholder(s) for whose account the Registration Statement is
to be filed included in such Registration and to permit the sale or other disposition of such Registrable Securities in accordance with
the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an
Underwritten Offering under this subsection 2.3.1, subject to Section 3.3 and Article IV, shall
enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company
or Company shareholder(s) for whose account the Registration Statement is to be filed. For purposes of this Section 2.3,
the filing by the Company of an automatic shelf registration statement for offerings pursuant to Rule 415(a) that omits information
with respect to any specific offering pursuant to Rule 430B shall not trigger any notification or participation rights hereunder
until such time as the Company amends or supplements such Registration Statement to include information with respect to a specific offering
of securities (and such amendment or supplement shall trigger the notice and participation rights provided for in this Section 2.3).
2.3.2 Reduction
of Piggyback Registration. If a Piggyback Registration is to be an Underwritten Offering and the managing Underwriter or Underwriters,
in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that,
in its opinion, the dollar amount or number of the Ordinary Shares that the Company desires to sell, taken together with (a) the
Ordinary Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with persons
or entities other than the Holders of Registrable Securities hereunder, (b) the Registrable Securities as to which registration has
been requested pursuant Section 2.3 hereof, and (c) the Ordinary Shares, if any, as to which Registration has been requested
pursuant to separate written contractual piggy-back registration rights of other shareholders of the Company, exceeds the Maximum Number
of Securities, then:
2.3.2.1 if
the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (a) first, the
Ordinary Shares or other equity securities that the Company desires to sell for its own account, which can be sold without exceeding the
Maximum Number of Securities; (b) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing
clause (a), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection
2.3.1 hereof, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (c) third, to the extent that
the Maximum Number of Securities has not been reached under the foregoing clauses (a) and (b), the Ordinary Shares, if any, as to
which Registration has been requested pursuant to written contractual piggy-back registration rights of other shareholders of the Company,
which can be sold without exceeding the Maximum Number of Securities; and
2.3.2.2 if
the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the Company shall
include in any such Registration (a) first, the Ordinary Shares or other equity securities, if any, of such requesting persons or
entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (b) second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (a), the Registrable Securities of
Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.3.1 hereof, Pro Rata, which can
be sold without exceeding the Maximum Number of Securities; (c) third, to the extent that the Maximum Number of Securities has not
been reached under the foregoing clauses (a) and (b), the Ordinary Shares or other equity securities that the Company desires to
sell for its own account, which can be sold without exceeding the Maximum Number of Securities; and (d) fourth, to the extent that
the Maximum Number of Securities has not been reached under the foregoing clauses (a), (b) and (c), the Ordinary Shares or other
equity securities for the account of other persons or entities that the Company is obligated to register pursuant to separate written
contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities.
2.3.3 Piggyback
Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw all or any portion of its Registrable
Securities in a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or
Underwriters (if any) of his, her or its intention to withdraw such Registrable Securities from such Piggyback Registration prior to (a) in
the case of a Piggyback Registration not involving an Underwritten Offering or Shelf Underwritten Offering, the effectiveness of the applicable
Registration Statement or (b), in the case of any Piggyback Registration involving an Underwritten Offering or any Shelf Underwritten
Offering, prior to the pricing of such Underwritten Offering or Shelf Underwritten Offering. The Company (whether on its own good faith
determination or as the result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw
a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness
of such Registration Statement. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration
Expenses incurred in connection with the Piggyback Registration prior to and including its withdrawal under this subsection 2.3.3.
2.3.4 Unlimited
Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.3 hereof shall
not be counted as a Registration pursuant to a Demand Registration effected under Section 2.2 hereof or a Shelf Underwritten
Offering effected under subsection 2.1.3.
2.4 Restrictions
on Registration Rights. If (a) during the period starting with the date sixty (60) days prior to the Company’s good faith
estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company initiated
Registration and provided that the Company has delivered written notice to the Holders prior to receipt of a Demand Registration pursuant
to subsection 2.2.1 and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration
Statement to become effective; (b) the Holders have requested an Underwritten Registration and the Company and the Holders are unable
to obtain the commitment of underwriters to firmly underwrite the offer; or (c) in the good faith judgment of the Board such Registration
would be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer the filing of such Registration
Statement at such time, then in each case the Company shall furnish to such Holders a certificate signed by the Chairman of the Board
stating that in the good faith judgment of the Board it would be seriously detrimental to the Company for such Registration Statement
to be filed in the near future and that it is therefore essential to defer the filing of such Registration Statement. In such event, the
Company shall have the right to defer such filing for a period of not more than thirty (30) days; provided, however, that
the Company shall not defer its obligation in this manner more than once in any twelve (12)-month period (the “Aggregate Blocking
Period”).
2.5 Block
Trades. Notwithstanding any other provision of this Article II, but subject to Sections 2.4 and 3.4,
if the Holders desire to effect a Block Trade, then notwithstanding any other time periods in this Article II, the
Holders shall provide written notice to the Company at least five (5) business days prior to the date such Block Trade will commence.
As expeditiously as possible, the Company shall use its reasonable best efforts to facilitate such Block Trade. The Holders shall use
reasonable best efforts to work with the Company and the Underwriters (including by disclosing the maximum number of Registrable Securities
proposed to be the subject of such Block Trade) in order to facilitate preparation of the Registration Statement, Prospectus and other
offering documentation related to the Block Trade and any related due diligence and comfort procedures. In the event of a Block Trade,
and after consultation with the Company, the Demanding Holders and the Requesting Holders (if any) shall determine the Maximum Number
of Securities, the underwriter or underwriters and share price of such offering. Notwithstanding any other provision of this Agreement,
in the event of a Block Trade in connection with the sale of Registrable Securities by a pledgee upon foreclosure of the Registrable Securities
that were pledged as collateral for a loan, the Company shall not include any other Holders’ Registrable Securities on the Registration
Statement or Prospectus with respect to such Block Trade.
2.6 Rule 415;
Removal. If at any time the Commission takes the position that the offering of some or all of the Registrable Securities in a Registration
Statement on Form F-3 filed pursuant to this Section 2 is not eligible to be made on a delayed or continuous basis under
the provisions of Rule 415 under the Securities Act (provided, however, the Company shall be obligated to use diligent efforts to
advocate with the Commission for the registration of all of the Registrable Securities in accordance with the Commission Guidance, including
without limitation, Compliance and Disclosure Interpretation 612.09) or requires a Holder to be named as an “underwriter,”
the Company shall (i) promptly notify each holder of Registrable Securities thereof and (ii) use reasonable best efforts to
persuade the SEC that the offering contemplated by such Registration Statement is a valid secondary offering and not an offering “by
or on behalf of the issuer” as defined in Rule 415 and that none of the Holders is an “underwriter.” The Holders
shall have the right to select one legal counsel designated by the holders of a majority of the Registrable Securities subject to such
Registration Statement to review and oversee any registration or matters pursuant to this Section 2.6, including participation
in any meetings or discussions with the Commission regarding the Commission’s position and to comment on any written submission
made to the Commission with respect thereto. No such written submission with respect to this matter shall be made to the Commission to
which the applicable Holders’ counsel reasonably objects. In the event that, despite the Company’s reasonable best efforts
and compliance with the terms of this Section 2.6, the Commission refuses to alter its position, the Company shall (i) remove
from such Registration Statement such portion of the Registrable Securities (the “Removed Shares”) and/or (ii) agree
to such restrictions and limitations on the registration and resale of the Registrable Securities as the Commission may require to assure
the Company’s compliance with the requirements of Rule 415; provided, however, that the Company shall not agree
to name any Holder as an “underwriter” in such Registration Statement without the prior written consent of such Holder. In
the event of a share removal pursuant to this Section 2.6, the Company shall give the applicable Holders at least five (5) days
prior written notice along with the calculations as to such Holder’s allotment. Any removal of shares of the Holders pursuant to
this Section 2.6 shall first be applied to holders other than the Holders with securities registered for resale under the
applicable Registration Statement and thereafter allocated between the Holders on a pro rata basis based on the aggregate amount of Registrable
Securities held by the Holders. In the event of a share removal of the Holders pursuant to this Section 2.6, the Company shall
promptly register the resale of any Removed Shares pursuant to subsection 2.1.2 hereof and in no event shall the filing of such
Registration Statement on Form F-1 or subsequent Registration Statement on Form F-3 filed pursuant to the terms of subsection
2.1.2 be counted as a Demand Registration hereunder. Until such time as the Company has registered all of the Removed Shares for resale
pursuant to Rule 415 on an effective Registration Statement, the Company shall not be able to defer the filing of a Registration
Statement pursuant to Section 2.4 hereof.
In
the case of a Form F-1 Shelf filed to register the resale of Removed Shares, upon such date as the Company becomes eligible to register
all of the Removed Shares for resale on a Form F-3 Shelf pursuant to the Commission Guidance and, if applicable, without a requirement
that any of the Holders be named as an “underwriter” therein, the Company shall use its best efforts to file a Form F-3
Shelf as promptly as practicable to replace the applicable Form F-1 Shelf and have the Form F-3 Shelf declared effective as
promptly as practicable and to cause such Form F-3 Shelf to remain effective, and to be supplemented and amended to the extent necessary
to ensure that such Registration Statement is available or, if not available, that another Registration Statement is available, for the
resale of all the Registrable Securities thereunder held by the applicable Holders until all such Registrable Securities have ceased to
be Registrable Securities.
ARTICLE III
COMPANY PROCEDURES
3.1
General Procedures. If the Company is required to effect the Registration of Registrable Securities, the Company shall use its
best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution
thereof, and pursuant thereto the Company shall, as expeditiously as possible:
3.1.1 prepare
and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and use its reasonable
best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by
such Registration Statement have been sold;
3.1.2 prepare
and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the
Prospectus, as may be reasonably requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules,
regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations
thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold
in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;
3.1.3 prior
to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters,
if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such
Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all
exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each
preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such Registration
or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities owned by such
Holders;
3.1.4 prior
to any public offering of Registrable Securities, but in any case no later than the effective date of the applicable Registration Statement,
use its best efforts to (a) register or qualify the Registrable Securities covered by the Registration Statement under such securities
or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration
Statement (in light of their intended plan of distribution) may request and to keep such registration or qualification in effect for so
long as such Registration Statement remains in effect and (b) take such action necessary to cause such Registrable Securities covered
by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of
the business and operations of the Company or otherwise and do any and all other acts and things that may be necessary or advisable, in
each case, to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such
Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally
to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject
to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;
3.1.5 cause
all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities issued
by the Company are then listed no later than the effective date of such Registration Statement;
3.1.6 provide
a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of
such Registration Statement;
3.1.7 promptly
furnish to each seller of Registrable Securities covered by such Registration Statement such number of conformed copies of such Registration
Statement and of each such amendment and supplement thereto (in each case including all exhibits), such number of copies of the Prospectus
contained in such Registration Statement (including each preliminary Prospectus and any summary Prospectus) and any other Prospectus filed
under Rule 424 under the Securities Act, in conformity with the requirements of the Securities Act, and such other documents as such
seller may reasonably request;
3.1.8 advise
each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of any request by the
Commission that the Company amend or supplement such Registration Statement or Prospectus or the issuance of any stop order by the Commission
suspending the effectiveness of such Registration Statement or Prospectus the initiation or threatening of any proceeding for such purpose
and promptly use its best efforts to amend or supplement such Registration Statement or Prospectus or prevent the issuance of any stop
order or to obtain its withdrawal if such stop order should be issued, as applicable;
3.1.9 advise
each Holder of Registrable Securities covered by such Registration Statement, promptly after the Company receives notice thereof, of the
time when such registration statement has been declared effective or a supplement to any Prospectus forming a part of such registration
statement has been filed;
3.1.10 at
least five (5) business days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such
Registration Statement or Prospectus, furnish a copy thereof to each seller of such Registrable Securities or its counsel, and not to
file any such Registration Statement or Prospectus, or amendment or supplement thereto, to which any such Holder or Registrable Securities
shall have reasonably objected on the grounds that such Registration Statement or Prospectus or supplement or amendment thereto, does
not comply in all material respects with the requirements of the Securities Act or the rules and regulations thereunder;
3.1.11 notify
the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act,
of the happening of any event or the existence of any condition as a result of which the Prospectus included in such Registration Statement,
as then in effect, includes a Misstatement, or in the opinion of counsel for the Company it is necessary to supplement or amend such Prospectus
to comply with law, and then to correct such Misstatement or include such information as is necessary to comply with law, in each case
as set forth in Section 3.4 hereof, at the request of any such Holder promptly prepare and furnish to such Holder a reasonable
number of copies of a supplement to or an amendment of such Prospectus as may be necessary so that, as thereafter delivered to the purchasers
of such securities, such Prospectus shall not include a Misstatement or such Prospectus, as supplemented or amended, shall comply with
law;
3.1.12 permit
a representative of the Holders, the Underwriters, if any, and any attorney or accountant retained by such Holders or Underwriter to participate
in the preparation of any Registration Statement, each such Prospectus included therein or filed with the Commission, and each amendment
or supplement thereto, and will give each of them such access to its books and records and such opportunities to discuss the business,
finances and accounts of the Company and its subsidiaries with its officers, directors and the independent public accountants who have
certified its financial statements as shall be necessary, in the opinion of such Holders’ and such Underwriters’ respective
counsel, to conduct a reasonable investigation within the meaning of the Securities Act, and will cause the Company’s officers,
directors and employees to supply all information reasonably requested by any such representative, Underwriter, attorney or accountant
in connection with the Registration; provided, however, that if requested by the Company, such representatives or Underwriters
enter into a confidentiality agreement, in form and substance reasonably satisfactory to the Company, prior to the release or disclosure
of any such information;
3.1.13 obtain
a “cold comfort” letter (including a bring-down letter dated as of the date the Registrable Securities are delivered for sale
pursuant to such Registration) from the Company’s independent registered public accountants in the event of an Underwritten Offering,
in customary form and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter
may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders and any Underwriter;
3.1.14 on
the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion and negative assurance letter,
dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent
or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which
such opinion is being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily
included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders
and any Underwriter;
3.1.15 in
the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the managing Underwriter of such offering;
3.1.16 otherwise
use its reasonable best efforts to comply with all applicable rules and regulations of the Commission, and to make available to its
security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning
with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies
the provisions of Section 11(a) of the Securities Act and the rules and regulations thereunder, including Rule 158
thereunder (or any successor rule promulgated thereafter by the Commission);
3.1.17 use
its reasonable efforts to make available senior executives of the Company to participate in customary “road show” presentations
that may be reasonably requested by the Underwriter in any Underwritten Offering; and
3.1.18 otherwise,
in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, including causing
the officers and directors of the Company to enter into customary “lock-up agreements,” in connection with such Registration.
3.2 Registration
Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the
Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions
and discounts, brokerage fees, and, other than as set forth in the definition of “Registration Expenses,” all reasonable fees
and expenses of any legal counsel representing the Holders.
3.3 Participation
in Underwritten Offerings.
3.3.1 No
person may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration initiated by the Company
hereunder unless such person (a) agrees to sell such person’s securities on the basis provided in any underwriting arrangements
approved by the Company and (b) completes and executes all customary questionnaires, indemnities, lock-up agreements, underwriting
agreements and other customary documents as may be reasonably required under the terms of such underwriting arrangements.
3.3.2 The
Company will use its commercially reasonable efforts to ensure that no Underwriter shall require any Holder to make any representations
or warranties to or agreements with the Company or the Underwriters other than representations, warranties or agreements regarding such
Holder and such Holder’s intended method of distribution and any other representation required by law, and if, despite the Company’s
commercially reasonable efforts, an Underwriter requires any Holder to make additional representation or warranties to or agreements with
such Underwriter, such Holder may elect not to participate in such Underwritten Offering (but shall not have any claims against the Company
as a result of such election). Any liability of such Holder to any Underwriter or other person under such underwriting agreement shall
be limited to an amount equal to the proceeds (net of expenses and underwriting discounts and commissions) that it derives from such registration.
3.4 Suspension
of Sales; Adverse Disclosure. Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains
a Misstatement, or in the opinion of counsel for the Company it is necessary to supplement or amend such Prospectus to comply with law,
each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or
amended Prospectus correcting the Misstatement or including the information counsel for the Company believes to be necessary to comply
with law (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable
after the time of such notice such that the Registration Statement or Prospectus, as so amended or supplemented, as applicable, will not
include a Misstatement and complies with law), or until it is advised in writing by the Company that the use of the Prospectus may be
resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time
would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration Statement of financial statements
that are unavailable to the Company for reasons beyond the Company’s control, the Company may, upon giving prompt written notice
of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest
period of time, but in no event more than thirty (30) days, determined in good faith by the Board to be necessary for such purpose; provided,
that each day of any such suspension pursuant to this Section 3.4 shall correspondingly decrease the Aggregate Blocking Period
available to the Company during any twelve (12)-month period pursuant to Section 2.4 hereof. In the event the Company exercises
its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above,
their use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities. The Company
shall immediately notify the Holders of the expiration of any period during which it exercised its rights under this Section 3.4.
3.5 Covenants
of the Company. As long as any Holder shall own Registrable Securities, the Company hereby covenants and agrees:
3.5.1 the
Company will not file any Registration Statement or Prospectus included therein with the Commission which refers to any Holder of Registrable
Securities by name or otherwise without the prior written approval of such Holder, which may not be unreasonably withheld;
3.5.2 at
all times while it shall be a reporting company under the Exchange Act, to file timely (or obtain extensions in respect thereof and file
within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or
15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings. The Company further
covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to
enable such Holder to sell Ordinary Shares held by such Holder without registration under the Securities Act within the limitation of
the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the
Commission), including providing any legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written
certification of a duly authorized officer as to whether it has complied with such requirements; and
3.5.3 promptly
following the effectiveness of the shelf registration statement required by subsection 2.1.1 (and in any event within three (3) business
days from such effectiveness), the Company shall cause the transfer agent to remove any restrictive legends (including any electronic
transfer restrictions) from any Ordinary Shares held by such Holder and provide or cause any customary opinions of counsel to be delivered
to the transfer agent in connection with such removal.
ARTICLE IV
INDEMNIFICATION AND CONTRIBUTION
4.1 Indemnification.
4.1.1 The
Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors, partners,
shareholders or members, employees, agents, investment advisors and each person who controls such Holder (within the meaning of the Securities
Act and Exchange Act) from and against all losses, claims, damages, liabilities and expenses (including attorneys’ fees), joint
or several (or actions or proceedings, whether commenced or threatened, in respect thereof) (collectively, “Claims”),
to which any such Holder or other persons may become subject, insofar as such Claims arise out of or are based on any untrue or alleged
untrue statement of any material fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof
or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein not misleading, and the Company will reimburse such Holder or other person for any legal or any other expenses reasonably incurred
by them in connection with investigating or defending any such Claim; except insofar as the Claim or expense arises out of or is based
upon an untrue statement or alleged untrue statement or omission or alleged omission made in such filing in reliance upon and in conformity
with information furnished in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters,
their officers and directors and each person who controls such Underwriters (within the meaning of the Securities Act and Exchange Act)
to the same extent as provided in the foregoing with respect to the indemnification of the Holder.
4.1.2 In
connection with any Registration Statement in which a Holder of Registrable Securities is participating, the Company may require that,
as a condition to including any Registrable Securities in any Registration Statement, the Company shall have received an undertaking reasonably
satisfactory to it from such Holder, to indemnify the Company, its directors and officers and agents and each person who controls the
Company (within the meaning of the Securities Act and Exchange Act) from and against any Claims, to which any the Company or such other
persons may become subject, insofar as such Claims arise out of or are based on any untrue statement of any material fact contained in
the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material
fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue
statement or omission is contained in any information furnished in writing by such Holder expressly for use therein; provided,
however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities,
and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by
such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall
indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the Securities
Act and Exchange Act) to the same extent as provided in the foregoing with respect to indemnification of the Company and the Company shall
use its commercially reasonable efforts to ensure that no Underwriter shall require any Holder of Registrable Securities to provide any
indemnification other than that provided hereinabove in this subsection 4.1.2, and, if, despite the Company’s commercially
reasonable efforts, an Underwriter requires any Holder of Registrable Securities to provide additional indemnification, such Holder may
elect not to participate in such Underwritten Offering (but shall not have any claim against the Company as a result of such election).
4.1.3 Any
person entitled to indemnification herein shall (a) give prompt written notice to the indemnifying party of any Claim with respect
to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification
hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (b) unless in such indemnified party’s
reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such Claim, permit
such indemnifying party to assume the defense of such Claim with counsel reasonably satisfactory to the indemnified party. If such defense
is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its
consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume
the defense of a claim shall not be obligated to pay the fees and expenses of more than one (1) counsel for all parties indemnified
by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest
may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall,
without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled
in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement)
and which settlement includes a statement or admission of fault or culpability on the part of such indemnified party or does not include
as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in
respect to such claim or litigation.
4.1.4 The
indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on
behalf of the indemnified party or any officer, director, partners, shareholders or members, employees, agents, investment advisors or
controlling person of such indemnified party and shall survive the Transfer of Registrable Securities.
4.1.5 If
the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any Claims, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute
to the amount paid or payable by the indemnified party as a result of such Claims (a) in such proportion as is appropriate to reflect
the relative benefits received by the indemnifying party or parties on the one hand and the indemnified party or parties on the other
hand from the offering of the Registrable Securities or (b) if the allocation provided by clause (a) above is not permitted
by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (a) above
but also to reflect the relative fault of the indemnifying party or parties on the other hand in connection with the statements or omissions
that resulted in such Claims, as well as any other relevant equitable considerations; provided, however, that the liability
of any Holder or any director, officer, employee, agent, investment advisor or controlling person thereof under this subsection 4.1.5
shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount
paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the
limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 above, any legal or other fees, charges or expenses reasonably
incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just and equitable
if contribution pursuant to this subsection 4.1.5 were determined by pro rata allocation or by any other method of allocation,
which does not take account of the equitable considerations referred to in this subsection 4.1.5. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to
this subsection 4.1.5 from any person who was not guilty of such fraudulent misrepresentation.
4.1.6 The
indemnification required by this Section 4.1 shall be made by periodic payments of the amount thereof during the course of
the investigation or defense, as and when bills are received or expense, loss, damage or liability is incurred.
ARTICLE V
LOCK-UP
5.1 Transfer
Restrictions.
5.1.1 Except
as permitted by Section 5.2, the Lock-up Holders shall not Transfer any Ordinary Shares beneficially owned or owned of record
by such Holder until the date that is one year from the Closing Date. After such date, the Ordinary Shares shall be released from lock-up
over a 12-month period, such that every month following the one-year lock up, 1/12th of the Ordinary Shares shall be released
from lock-up. However, the release of the Ordinary Shares from the lock-up will begin prior to the date that is one year from the Closing
Date in the event that the sale price of the Ordinary Shares equals or exceeds $14.00 per share (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) for any 40 trading days within any 60-trading day period commencing after the Closing
Date (the “Lock-up Period”). Even if such event occurs (and the Ordinary Shares are released prior to one-year
from the Closing Date), the Ordinary Shares shall be released from lock-up over a 12-month period, such that every month, 1/12th
of the Ordinary Shares are released from lock-up.
For
the avoidance of doubt, the Lock-up Period shall not apply to (i) any Ordinary Shares underlying any of the private placement warrants
of the Company to be issued to the Sponsor in exchange for the private placement warrants of the SPAC beneficially owned by the Sponsor,
(ii) any Ordinary Shares that represent SPAC Class A Shares previously underlying the public warrants of SPAC, (iii) any
Ordinary Shares acquired through a PIPE transaction, (iv) any Ordinary Shares that were previously SPAC Class A Shares (which,
for the avoidance of doubt, does not include Ordinary Shares that were previously SPAC Founder Shares or SPAC Class A Shares issued
upon exchange or conversion thereof, which shares shall remain subject to the Lock-up Period),1
(v) any Ordinary Shares underlying the warrants of SPAC or the Company, or (vi) any Ordinary Shares acquired in the open market.
5.2 Exceptions.
The provisions of Section 5.1 shall not apply to:
5.2.1 transactions
relating to Ordinary Shares acquired by the undersigned in open market transactions;
5.2.2 Transfers
of Ordinary Shares or any security convertible into or exercisable or exchangeable for Ordinary Shares as a bona fide gift or gifts, or
to a charitable organization;
5.2.3 Transfers
of Ordinary Shares to a trust, or other entity formed for estate planning purposes for the primary benefit of the spouse, domestic partner,
parent, sibling, child or grandchild of the undersigned or any other person with whom the undersigned has a relationship by blood, marriage
or adoption not more remote than first cousin;
5.2.4 if
the undersigned is an individual, Transfers by will or intestate succession upon the death of the undersigned;
1
Note to RS: Without this clarification and given the deletion of the separate Sponsor lockup section which has been collapsed
into one section, if the Sponsor elected to convert its SPAC Founder Shares into SPAC Class A Shares prior to closing (as is permitted
under the SPAC governing documents), then, as written, it would not appear that the Sponsor would be subject to any lockup as this exception
would completely obviate that.
5.2.5 the
Transfer of Ordinary Shares by operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement;
5.2.6 if
the undersigned is a corporation, partnership (whether general, limited or otherwise), limited liability company, trust or other business
entity, (i) Transfers to another corporation, partnership, limited liability company, trust, syndicate, association or other business
entity that controls, is controlled by or is under common control or management with the undersigned, and (ii) distributions of Ordinary
Shares to its partners, limited liability company members, equity holders or shareholders of the undersigned;
5.2.7 Transfers
(i) to the Company or the Company’s officers, directors or their Affiliates and (ii) to the officers, directors or Affiliates
of the undersigned;
5.2.8 bona
fide pledges of Ordinary Shares as security or collateral in connection with any borrowing or the incurrence of any indebtedness by any
Holder, provided that the aggregate number of Ordinary Shares that can be pledged by any Holder cannot exceed 25% of the total Ordinary
Shares beneficially owned by such Holder; provided, further, that any Holder who is subject to any pre-clearance and trading policies
of the Company must also comply with any additional restrictions on the pledging of Ordinary Shares imposed on such Holder by the Company’s
policies;
5.2.9 pursuant
to a bona fide third-party tender offer, merger, share sale, recapitalization, consolidation or other transaction involving a Change in
Control of the Company, provided that in the event that such tender offer, merger, recapitalization, consolidation or other such transaction
is not completed, the Ordinary Shares subject to this Agreement shall remain subject to this Agreement;
5.2.10 the
establishment of a trading plan pursuant to Rule 10b5-1 promulgated under the Exchange Act, provided that such plan does not provide
for the transfer of Ordinary Shares or any securities convertible into or exercisable or exchangeable for Ordinary Shares during the Lock-up
Period; and
provided,
that in the case of any Transfer or distribution pursuant to subsections 5.2.2 through 5.2.8, each donee, distributee or
other transferee shall agree in writing, in form and substance reasonably satisfactory to the Company, to be bound by the provisions of
this Agreement.
ARTICLE VI
MISCELLANEOUS
6.1 Notices.
Any notice or communication under this Agreement must be in writing and given by (a) deposit in the United States mail, addressed
to the party to be notified, postage prepaid and registered or certified with return receipt requested, (b) delivery in person or
by courier service providing evidence of delivery, or (c) transmission by hand delivery, electronic mail, telecopy, telegram or facsimile.
Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given,
served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in
the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as it
is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the
addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to: 35 Hamasger St.,
Tel Aviv, Israel, Attention: Yehuda Minkovicz, CEO, yehuda.minkovicz@pomvom.com, and, if to any Holder, at such Holder’s address
or facsimile number as set forth in the Company’s books and records. Any party may change its address for notice at any time and
from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) days after
delivery of such notice as provided in this Section 6.1.
6.2 Assignment;
No Third Party Beneficiaries.
6.2.1 This
Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or
in part.
6.2.2 Prior
to the expiration of the Lock-up Period, no Holder may assign or delegate such Holder’s rights, duties or obligations under this
Agreement, in whole or in part, except as permitted in Section 5.2 of this Agreement.
6.2.3 This
Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and
the permitted assigns of the applicable Holders, which shall include Permitted Transferees.
6.2.4 This
Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this
Agreement and Section 6.2 hereof.
6.2.5 No
assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company
unless and until the Company shall have received (a) written notice of such assignment as provided in Section 6.1 hereof
and (b) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions
of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any Transfer or assignment made
other than as provided in this Section 6.2 shall be null and void.
6.3 Counterparts.
This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original,
and all of which together shall constitute the same instrument, but only one of which need be produced.
6.4 Governing
Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY
AGREE THAT (I) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK
RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION
AND (II) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK COUNTY IN
THE STATE OF NEW YORK.
EACH
PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES, AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN
CONNECTION WITH OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
6.5 Amendments
and Modifications. Upon the written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities
at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or
any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the
foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of Ordinary Shares,
in a manner that is adverse and different from the other Holders (in such capacity) shall require the consent of the Holder so affected.
No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the
Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or
the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude
the exercise of any other rights or remedies hereunder or thereunder by such party.
6.6 Other
Registration Rights. The Company represents and warrants that no person, other than a Holder of Registrable Securities, has any right
to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration
filed by the Company for the sale of securities for its own account or for the account of any other person. Further, the Company represents
and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions among
the parties thereto and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement
shall prevail.
6.7 Termination
of Existing Registration Rights. The registration rights granted under this Agreement shall supersede any registration, qualification
or similar rights of the Holders with respect to any shares or securities of the Company, Pomvom or SPAC granted under any other agreement,
including, but not limited to, the Prior Agreement, and any of such preexisting registration, qualification or similar rights and such
agreements shall be terminated and of no further force and effect.
6.8 Term.
This Agreement shall terminate upon the date as of which all of the Registrable Securities have been sold pursuant to a Registration Statement
(but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder
(or any successor rule promulgated thereafter by the Commission)). The provisions of Section 3.5 and Article IV
shall survive any termination.
[Signature Pages Follow]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
|
COMPANY: |
|
|
|
[NEWPUBCO] |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
SPONSOR HOLDER: |
|
|
|
Israel Acquisitions Sponsor LLC |
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
POMVOM HOLDERS: |
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
[Signature Page to Registration Rights
Agreement]
|
POMVOM OFFICERS: |
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
|
POMVOM DIRECTORS: |
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
UNDERWRITER HOLDERS: |
|
|
|
|
BTIG LLC |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
[Signature Page to Registration Rights
Agreement]
|
EXOS CAPITAL LLC |
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
|
|
|
|
JONESTRADING INSTITUTIONAL SERVICES LLC |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
[Signature Page to Registration Rights
Agreement]
SCHEDULE A
Pomvom Holders
[To come]
Exhibit 99.1
Pomvom Ltd. and Israel Acquisitions Corp. Announce
Definitive Business Combination Agreement, Bringing the Leading Experiential Content Company to the Nasdaq
Tel-Aviv, Israel, January 2, 2024 –
Israel Acquisitions Corp. (NASDAQ: ISRL, ISRLU, ISRLW), (“ISRL”), a publicly-traded special purpose acquisition company, and
Pomvom Ltd. (TASE: PMVM), (“Pomvom” or the “Company”), a technology company that develops experiential content
to amusement parks and attractions globally, replacing operative physical solutions, today announced a definitive business combination
agreement at a total equity value for Pomvom of $125 million USD (the "Business Combination Agreement"). The combined company
will trade on the Nasdaq and leverage Pomvom’s leading technology augmented with the expertise of the ISRL team.
Pomvom serves many of the largest theme park and attraction operators
globally, including, parent companies Six Flags, Warner Bros., and Merlin Entertainment. Strategic long-term agreements signed in 2023
with Warner Bros. and Six Flags are expected to increase the number of partner sites for Pomvom to 47 sites by the end of 2024 —
an impressive 23% increase from its current 38 sites, and to accelerate growth in 2024 and onwards. Pomvom’s launch of digital content
across its partner sites is expected to leverage its new online platform and accelerate long-term growth.
Pomvom revenues in 2022 were approximately NIS 192.7 million ($57.4
million). For the nine months ending September 2023 its revenues totaled NIS 165.1 million ($45.3 million), with revenues from its digital
platform of NIS 57 million ($15.6 million), or 34% of total revenues, representing 139% growth compared to revenues during the same period
2022 of NIS 23.8 million ($7.1 million), or 16% of total revenues. Upon completion of the transaction, including the capital injection
of at least $20 million from the business combination, the Company aims to achieve a growth plan based on existing contracts and potential
new wins in 2024 targeting at least a 30% increase in top-line revenues, with a 2024 expectation of reaching a positive adjusted EBITDA.
Izhar Shay, Chairman
of ISRL's Board of Directors: "The business combination agreement signifies a momentous step forward, aligning with the
vision set when we took our SPAC public last year. We believe Pomvom's unique combination of technology, product innovation, and creative
content design positions the company to capitalize on multiple growth opportunities in the Immersive Location-based entertainment experiences
industry, both in the US and worldwide. Collaborating together, we expect Pomvom to become a strategic partner of the largest amusement
parks, attractions, and entertainment groups globally in coming years."
Yehuda Minkovicz,
Pomvom's Founder and CEO: "This business combination is a significant milestone for Pomvom, reflecting the confidence
of key figures in the hi-tech and financial industries in Israel and the United States. We look forward to work collaboratively to complete
the transaction, with a shared objective of accelerating Pomvom's technology development and global presence in the coming years. I would
like to extend my gratitude to Pomvom’s and ISRL's teams for their efforts, dedication and perseverance, in advancing this merger
despite the challenging times in Israel."
Transaction Details:
| · | The Board of Directors of both ISRL and Pomvom
have unanimously approved the Business Combination Agreement and signed transaction support agreements in favor of the transaction. |
| · | Minimum cash condition of $20 million, of which
will be a combination of the net amount in ISRL’s trust account, together with new money that will be raised. |
| · | Pomvom shareholders holding a majority of the
Company's issued share capital will sign support agreements displaying support of the transaction within 30 days of the Business Combination
Agreement. |
| · | The combined company's Board of Directors will
have up to 7 directors in the first stage, of which 2 directors will be nominated by ISRL and up to 5 directors will be nominated by the
Company. Existing Pomvom management is expected to operate the combined company. |
| · | The parties anticipate completing the business
combination by the end of Q3 2024, contingent upon satisfying all closing conditions, including shareholder approvals, regulatory consents,
and compliance with legal and tax requirements. |
| · | Pomvom’s officers, directors, and >10%
shareholders, as well as ISRL’s sponsor will enter into a 12 month lock-up agreement, with a further staggered release of up to
12 months, from the closing of the business combination. |
| · | At the closing of the transaction, Pomvom will
be delisted from the Tel Aviv Stock Exchange and listed solely on the Nasdaq in the United States. |
Advisors:
Tiberius Capital Markets, a division of Arcadia
Securities is acting as Financial Advisor to Israel Acquisitions Corp, with Reed Smith LLP, Naschitz Brandes Amir, and Stuarts Humpries
acting as Legal Advisors.
Roth Capital Partners is acting as Financial Advisor
to Pomvom, with Greenberg Traurig, LLP, Goldfarb Gross Seligman & Co., and Barnea Jaffa Lande acting as Legal Advisors.
About Pomvom Ltd.:
Pomvom, which is traded on the Tel-Aviv Stock
Exchange, (TASE: PMVM), is a technology company, which develops and provides experiential documentation solutions to the global
amusement parks and attractions market, which replace the existing operative photographic solutions. The Company has developed a digital
platform, which combined innovative technology for photographing and creating content, automatically in a cloud environment, the distribution
and the sale thereof to the ultimate user for the purpose of their personal use and for sharing on social networks. The Company provides
its customers with comprehensive media documentation services, which is done, inter alia, by means of the digital platform, in addition
to which it provides photographic equipment and manpower, the creation of content and media processing, printing or the distribution of
pictures and the sale thereof to visitors to amusement parks and attractions.
The Company has exclusive agreements with dozens
of amusement parks in Europe, in the USA and in Japan, and potential access to tens of millions of visitors each year.
Pomvom’s Chairman is Alon Shtruzman, a media
and entertainment executive who served in senior management positions in Israeli, U.S. and international companies.
The Company's head office is located in Tel Aviv
and it also has offices in Europe, in the USA and in Japan.
See the Company's
website: Pomvom - Any media. Any device. Anyone for additional details.
About Israel Acquisitions Corp.:
Israel Acquisitions Corp is a Cayman Islands exempted
company incorporated as a blank-check company. Formed for the purpose of entering into a merger, share exchange, asset acquisition, stock
purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company intends
to focus on high-growth technology companies that are domiciled in Israel, and that either carry out all or a substantial portion of their
activities in Israel or have some other significant Israeli connection. The management team is led by Chairman, Izhar Shay, Chief Executive
Officer, Ziv Elul, and Chief Financial Officer, Sharon Barzik Cohen.
Forward-Looking Statements:
This press release contains “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange
Act of 1934, as amended. All statements, other than statements of present or historical fact included herein, regarding the proposed business
combination ISRL and Pomvom, ISRL and Pomvom’s ability to consummate the transaction, the expected closing date for the transaction,
the benefits of the transaction and the public company’s future financial performance following the transaction, as well as ISRL’s
and Pomvom’s strategy, future operations, financial position, estimated revenues, and losses, projected costs, prospects, plans
and objectives of management are forward looking statements. When used herein, including any oral statements made in connection herewith,
the words “anticipates,” “approximately,” “believes,” “continues,” “could,”
“estimates,” “expects,” “forecast,” “future, ” “intends,” “may,”
“outlook,” “plans,” “potential,” “predicts,” “propose,” “should,”
“seeks,” “will,” or the negative of such terms and other similar expressions are intended to identify forward-looking
statements, although not all forward-looking statements contain such identifying words. Such forward-looking statements are subject to
risks, uncertainties, and other factors, which could cause actual results to differ materially from those expressed or implied by such
forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable
by both ISRL and its management, and Pomvom and its management, as the case may be, are inherently uncertain. Except as otherwise required
by applicable law, ISRL disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements
in this section, to reflect events or circumstances after the date hereof. ISRL cautions you that these forward-looking statements are
subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of ISRL. There may
be additional risks that neither ISRL nor Pomvom presently know of or that ISRL or Pomvom currently believe are immaterial that could
also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded
as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated
results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which
speak only as of the date they are made. Author and any of their affiliates, directors, officers and employees expressly disclaim any
obligation or undertaking to disseminate any updates or revisions to any forward-looking statement to reflect events or circumstances
after the date on which such statement is being made, or to reflect the occurrence of unanticipated events.
Additional
Information and Where to Find It:
Additional information about the proposed business
combination, including a copy of the business combination agreement, is disclosed in the Current Report on Form 8-K that ISRL filed with
the SEC on January 2, 2024 and is available at www.sec.gov. In connection with the proposed transaction, the Company intends to file a
registration statement, which will include a preliminary proxy statement/prospectus with the SEC. The proxy statement/prospectus will
be sent to the stockholders of the Company. The Company and Pomvom also will file other documents regarding the proposed transaction with
the SEC. Before making any voting decision, investors and security holders of the Company are urged to read the proxy statement/prospectus
and all other relevant documents filed or that will be filed with the SEC in connection with the proposed transaction as they become available
because they will contain important information about the proposed transaction.
No Offer or
Solicitation:
This communication is for informational purposes
only and shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the
Business Combination. This communication shall also not constitute an offer to sell or the solicitation of an offer to buy any securities,
or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities
shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or an exemption therefrom.
Investor Contact:
Meirav Gomeh-Bauer
+972-54-476-4979
Meirav@bauerg.com
v3.23.4
Cover
|
Jan. 02, 2024 |
Document Information [Line Items] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Jan. 02, 2024
|
Entity File Number |
001-41593
|
Entity Registrant Name |
ISRAEL ACQUISITIONS
CORP
|
Entity Central Index Key |
0001915328
|
Entity Tax Identification Number |
87-3587394
|
Entity Incorporation, State or Country Code |
E9
|
Entity Address, Address Line One |
12600 Hill Country Blvd
|
Entity Address, Address Line Two |
Building R
|
Entity Address, Address Line Three |
Suite 275
|
Entity Address, City or Town |
Bee Cave
|
Entity Address, State or Province |
TX
|
Entity Address, Postal Zip Code |
78738
|
City Area Code |
800
|
Local Phone Number |
508-1531
|
Written Communications |
true
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Units, each consisting of one Class A ordinary share and one redeemable warrant |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Units, each consisting of one Class A ordinary share and one redeemable warrant
|
Trading Symbol |
ISRLU
|
Security Exchange Name |
NASDAQ
|
Common Class A [Member] |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Class A ordinary shares, par value $0.0001 per share
|
Trading Symbol |
ISRL
|
Security Exchange Name |
NASDAQ
|
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share |
|
Document Information [Line Items] |
|
Title of 12(b) Security |
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
|
Trading Symbol |
ISRLW
|
Security Exchange Name |
NASDAQ
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 3 such as an Office Park
+ References
+ Details
Name: |
dei_EntityAddressAddressLine3 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=ISRLU_UnitsEachConsistingOfOneClassOrdinaryShareAndOneRedeemableWarrantMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=ISRLU_RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareEachAtExercisePriceOf11.50PerShareMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
Israel Acquisitions (NASDAQ:ISRLU)
Historical Stock Chart
From Dec 2024 to Jan 2025
Israel Acquisitions (NASDAQ:ISRLU)
Historical Stock Chart
From Jan 2024 to Jan 2025